rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCAAAGGACAGCTCAGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSKGQLRTSTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	0	3	9	18	30	39	33	48														CASSKGQLRTSTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCACCCTGACGGGTAGCAATCAGCCCCAGTATTTTGGTGAT		Out	VDJ	1	11	7.30552364001036E-5		46	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	5	7	17	12	13	18	30	46	42	59						01,02								X+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTTGGGACAGTAGGGACCACTGAAGCTTTCTTTGGACAA	CASSLVGTVGTTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	4	2	7	18	34	43	36	50														CASSLVGTVGTTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTGGGGCGATTGAAGAGACCCAGTACTTCGGGCCA	CASSSGAIEETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	7	0	3	2	5	18	31	38	33	43														CASSSGAIEETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGNTGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-02	01	1	0	8	2	1	0	18	34	-1	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTGGCGGTCGGGGAGACCCAGTACTTCGGGCCA	CASSLVAVGETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	5	5	4	5	18	32	40	36	45						01,02								CASSLVAVGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGCAGGGGGGCGTGGGGCACAGATACGCAGTATTTTGGCCCA	CASSRRGAWGTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	1	2	7	18	30	39	32	46														CASSRRGAWGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGAGCCGCGGAGGTTAACACTGAAGCTTTCTTTGGACAA	CASRAAEVNTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	2	6	2	18	29	40	35	42														CASRAAEVNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGGGTGGCAGTTTAATCAGCCCCAGCATTTTGGTGAT	CASSQGWQFNQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-05	01	5	5	3	4	2	9	18	30	36	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWQFNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCGGACAGGGTTTGGCGACCCAGTACTTCGGGCCA	CASSFGQGLATQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	3	7	1	6	18	32	41	33	47														CASSFGQGLATQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCCGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSLAGQQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	2	4	0	18	32	-1	36	42														CASSLAGQQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTATGCAGGGGGCGAAACTGAAGCTTTCTTTGGACAA	CASSYAGGETEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	5	3	3	18	31	42	34	45														CASSYAGGETEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTGCCGGAGAGCAGGTGGAATGAGCAGTTCTTCGGGCCA	CASSLVPESRWNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-01	01	3	4	4	7	12	3	18	32	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVPESRWNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCCTAGCGGGCCTAACAGATACGCAGTATTTTGGCCCA	CASSFLAGLTDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	4	3	1	4	18	32	41	33	45						01,02								CASSFLAGLTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGAAGCTTGACGGACAGGGGAACTAACTACGAGCAGTACTTCGGGCCG	CARSLTDRGTNYEQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	3	3	6	18	32	44	35	50														CARSLTDRGTNYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGCGAGGGGCCACGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	1.9260016869118224E-4		49	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-05	01	1	5	2	4	4	6	18	34	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGATCCGCGGACAGGTGGAAACACCATATATTTTGGAGAG	CASSLDPRTGGNTIYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	4	3	6	0	18	34	-1	40	47														CASSLDPRTGGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGATTGACAGGTAGGTTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	2.3244847945487512E-4		49	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	4	5	5	6	18	32	43	37	49														X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGACAGGGAGCTACCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGQGATSSGNTIYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	3	0	0	9	18	-1	41	34	50														CASSLGQGATSSGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCGTGGGGGGTACAGGATGAAGCTTTCTTTGGACAA	CASSPWGVQDEAFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	7	4	7	18	30	40	34	47														CASSPWGVQDEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCGGAGGACTACCCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFGGLPPSGANVLTF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	54	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	1	9	0	4	5	18	32	42	36	47						01,02								CASSFGGLPPSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD02-01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGACCGGGGTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPGSSTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	0	3	3	19	35	43	38	46														CASSLGPGSSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGAAACAGGGGGCATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGKQGASYNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	1	4	1	19	35	48	39	49														CASSLGKQGASYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGCTAGCGGGATCTGAAGCTTTCTTTGGACAA	CASSLALAGSEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	4	3	6	2	1	19	35	46	37	47														CASSLALAGSEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCAGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGTNTGELFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	0	1	1	19	31	37	32	38														CASSPGTNTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGAACTAGCGGTAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLELAVTYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	5	2	3	3	19	33	44	36	47						01,02								CASSLELAVTYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAACAGGGGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQQGADTGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	0	3	2	2	19	31	42	33	44														CASSQQGADTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCATTCGACAGGGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSFDRGFSGANVLTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	54	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	1	0	5	2	19	32	46	37	48														CASSSFDRGFSGANVLTF+TCRBV07-05+TCRBJ02-06	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCTAGGCGGGGGTCCGCCGGACGACAATGAGCAGTTCTTCGGGCCA	CASSLGGGPPDDNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	2	5	8	11	19	27	42	35	53														CASSLGGGPPDDNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGGTCAGGGGGTGGGAGCCCCAGCATTTTGGTGAT	CASSLAVRGWEPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	8	4	4	19	35	46	39	50														CASSLAVRGWEPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCGAACATGCGAGTTACGAGCAGTACTTCGGGCCG	CASSSEHASYEQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-07	01	3	3	6	4	4	7	19	32	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSEHASYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCCCCGGAGATCAGGGGAAGTGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	1.6603462818205365E-4		58	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	2	12	7	19	31	49	43	56														X+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCACAATGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSTMGANVLTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	3	6	4	2	3	19	32	37	34	40														CASSSTMGANVLTF+TCRBV07-05+TCRBJ02-06	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCGACCCGGACTAGCGGGGCGCCTCCGGGATGGCAGTTCTTCGGGCCA		Out	VDJ	1	33	2.1916570920031082E-4		53	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	12	6	13	19	31	49	37	62														X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTCGACAGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSFDSLSGNTIYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	5	0	1	3	19	33	39	34	42														CASSFDSLSGNTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTTGGCGGGGCTGGAACACTGAAGCTTTCTTTGGACAA	CASSFWRGWNTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	7	3	1	3	3	19	33	42	36	45														CASSFWRGWNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGAAGGTCAGCCAGGAGAAAAACTGTTTTTTGGCAGT	CASSLEGQPGEKLFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	8	11	1	19	33	48	44	49														CASSLEGQPGEKLFF+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTAGCGGGGTTAATGAGCAGTTCTTCGGGCCA	CASSLGSGVNEQFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	7	1	2	19	35	44	36	46														CASSLGSGVNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCAGGGACTAGCTTGGAGACCCAGTACTTCGGGCCA	CASSAGTSLETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	7	5	2	3	23	36	47	38	50			01,02			01,02							Vb 1	CASSAGTSLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGGCCGGGACAGGGGGCTTGGATACGCAGTATTTTGGCCCA	CASSSAGTGGLDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	0	6	6	3	23	35	53	41	56			01,02										Vb 1	CASSSAGTGGLDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGACCGGGACGCCACAGATACGCAGTATTTTGGCCCA	CASSDRDATDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	5	0	7	2	5	2	23	34	44	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSDRDATDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAAAGAAGACCGGGACCCAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKEDRDPANTGELFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	54	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	4	0	7	0	10	4	23	35	50	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSKEDRDPANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACACATTCGGGACACCAGTCCTACGAGCAGTACTTCGGGCCG	CASSTHSGHQSYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	1	8	4	23	35	49	43	53			01,02										Vb 1	CASSTHSGHQSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCTTACCCGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPLPGSYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	5	0	8	0	23	35	-1	43	46			01,02			01,02							Vb 1	CASSPLPGSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCAGGGGTTCTGAATTCGGGGGTGGCTACACCTTCGGTTCG	CASSVGRGSEFGGGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	4	2	7	1	15	23	39	46	40	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGRGSEFGGGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTACCCAGAGATACGCAGTATTTTGGCCCA	CASSVVPRDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	5	5	4	0	23	39	-1	43	46			01,02										Vb 1	CASSVVPRDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCACCTTTATCCTTAGAAATCAGCCCCAGCATTTTGGTGAT	CATFILRNQPQHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	9	5	8	4	10	1	23	30	43	40	44			01,02			01,02							Vb 1	CATFILRNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTCGGGTCGGGATTGAACACTGAAGCTTTCTTTGGACAA	CASSLGSGLNTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	0	7	1	23	35	47	42	48			01,02										Vb 1	CASSLGSGLNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGGACAGCGGAATTCACCCCTCCACTTTGGGAAC	CASSVDGQRNSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	5	7	2	3	23	39	47	41	50			01,02										Vb 1	CASSVDGQRNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGCCCCAGGGGGACACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVAPGGHSGANVLTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	1	0	5	3	23	37	49	42	52			01,02										Vb 1	CASSVAPGGHSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCAGGGTCTAATCAGCCCCAGCATTTTGGTGAT	CASSSGSNQPQHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	4	1	3	23	35	41	36	44			01,02										Vb 1	CASSSGSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCAGGATGGGGGTGAAGCTTTCTTTGGACAA	CASSSQDGGEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	6	1	7	9	0	23	35	-1	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSSQDGGEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGAGGGCTCCGGTAATGAAAAACTGTTTTTTGGCAGT	CASREGSGNEKLFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	0	4	0	6	23	-1	40	34	46			01,02										Vb 1	CASREGSGNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCACAGGGGGCAAGAGGCTACACCTTCGGTTCG	CASSQGARGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	8	2	4	23	32	43	34	47			01,02										Vb 1	CASSQGARGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACTCGCCCCGGACTTGCCGGGGAGCTGTTTTTTGGAGAA	CASTRPGLAGELFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	10	6	8	2	23	33	46	41	48			01,02			01,02							Vb 1	CASTRPGLAGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACCCTCTTAGCGGGGGGGCCGGGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	9.962077690923219E-5		52	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	0	5	7	6	23	36	54	43	60			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGGAAGGACAGACCAAGAGACCCAGTACTTCGGGCCA	CASRGRTDQETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	5	0	5	0	23	34	-1	39	45			01,02										Vb 1	CASRGRTDQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCGATTCCGGAACAGGGCTACACCTTCGGTTCG		Out	VDJ	1	15	9.962077690923219E-5		38	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	5	8	11	0	23	34	-1	45	49			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGGGGGTCGTCGGTTACTGAAGCTTTCTTTGGACAA	CASSPRGSSVTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	5	3	9	23	35	44	38	53			01,02										Vb 1	CASSPRGSSVTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGATTTGGGTAGCGGGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSDLGSGGVTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	2	9	3	23	34	52	43	55			01,02										Vb 1	CASSDLGSGGVTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGTCAGGGGAGGAGGCTATGGCTACACCTTCGGTTCG	CASVRGGGYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	7	4	2	4	2	6	23	32	40	34	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASVRGGGYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCACCGAGGGGGATAGAACTAATGAAAAACTGTTTTTTGGCAGT	CATEGDRTNEKLFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	5	1	1	3	4	23	30	39	33	43			01,02										Vb 1	CATEGDRTNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAAGTGGGAGGGGCAGGTCAGCCCCAGCATTTTGGTGAT	CASKVGGAGQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	0	6	4	5	23	33	44	37	49			01,02										Vb 1	CASKVGGAGQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAACCTCCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASKPPGDTGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	3	6	0	23	33	-1	39	45			01,02										Vb 1	CASKPPGDTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGAGAATCGGGATGGGGCCAACGTCCTGACTTTCGGGGCC	CASENRDGANVLTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	8	3	3	6	0	23	32	-1	38	43			01,02										Vb 1	CASENRDGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD02-01*02	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACTCGGAAAATTCTGAAGCTTTCTTTGGACAA	CASSVDSENSEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	1	8	6	4	5	23	39	46	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDSENSEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACTAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSVGLGGEKLFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	0	8	4	0	23	39	-1	43	50			01,02										Vb 1	CASSVGLGGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTCGAGACGGGACAGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDGTGGSTDTQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	0	9	1	23	35	55	44	56			01,02										Vb 1	CASSPRDGTGGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGGACGGAATTACTATGGCTACACCTTCGGTTCG	CASSVEGRNYYGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	0	7	3	1	6	23	39	45	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGRNYYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGCGGGACAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPRDRVNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	0	4	0	23	35	-1	39	48			01,02										Vb 1	CASSPRDRVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCGGGCAGGGAGAAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	1.3946908767292507E-4		44	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	4	3	6	4	5	23	39	48	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGGGACGCTTGAAGCTTTCTTTGGACAA	CASSPGTLEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	0	7	7	3	3	23	35	43	38	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPGTLEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGACGGACAGGGTAAACTATGGCTACACCTTCGGTTCG	CASRTDRVNYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	2	3	2	23	34	45	37	47			01,02										Vb 1	CASRTDRVNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACTACAGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSALQGQGEKLFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	7	7	0	23	36	-1	43	52			01,02										Vb 1	CASSALQGQGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAGTGGGTGATTCACCCCTCCACTTTGGGAAC	CASSVGVGDSPLHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-06	01	0	0	9	8	4	2	23	39	46	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGVGDSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGACGCCCGAGCACAGATACGCAGTATTTTGGCCCA	CASSVGGRPSTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	0	7	0	1	5	23	39	45	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGGRPSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCCTCGTGGACAGCGTGAAGCTTTCTTTGGACAA	CASSPRGQREAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	7	7	2	23	34	47	41	49			01,02										Vb 1	CASSPRGQREAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAATTGGGCACAGATACGCAGTATTTTGGCCCA	CASSELGTDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	3	0	10	1	4	0	23	36	-1	40	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSELGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCATCGGGAAAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	29	1.9260016869118224E-4		46	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	8	3	0	3	4	23	32	40	35	44			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTAGGATGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSVVGWGQETQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	0	6	2	1	6	0	23	39	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVVGWGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGACAGGGGTTAACACTGAAGCTTTCTTTGGACAA	CASSVGTGVNTEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	2	0	2	23	-1	48	39	50			01,02										Vb 1	CASSVGTGVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGCCAGGGACAGGGGGCAGCCGAATTTTACAATGAGCAGTTCTTCGGGCCA	CASSGQGQGAAEFYNEQFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	57	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	0	4	4	10	23	36	52	40	62			01,02										Vb 1	CASSGQGQGAAEFYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCAACAGTAACACTGAAGCTTTCTTTGGACAA	CASSANSNTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	2	3	1	23	36	43	39	44			01,02										Vb 1	CASSANSNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAACAGGGTGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEQGDSYNEQFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	0	3	3	23	34	43	37	46			01,02										Vb 1	CASSEQGDSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGAGGACAGGCTCACTGAAGCTTTCTTTGGACAA	CASSVEDRLTEAFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	4	3	2	23	37	47	40	49			01,02										Vb 1	CASSVEDRLTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACTTATAGCTCTGGAAACACCATATATTTTGGAGAG	CASTYSSGNTIYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	5	8	0	4	0	23	33	-1	37	40			01,02			01,02							Vb 1	CASTYSSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGGGATAGGGGGCGGTTTGGATGAGCAGTTCTTCGGGCCA	CASSGGIGGGLDEQFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	8	7	7	23	36	50	43	57			01,02										Vb 1	CASSGGIGGGLDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGACACAATGAGCAGTTCTTCGGGCCA	CASSVEGHNEQFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	1	7	5	2	0	23	39	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGHNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGTACCCGGGACTAGCGGTCCACGAGCAGTACGTCGGGCCG		Out	VDJ	1	42	2.7893817534585015E-4		52	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	5	17	8	15	23	39	58	47	73			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGTAGTGAAGGGGAACGGCAAGCGGACATTCAGTACTTCGGCGCC	CASSEGERQADIQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-04	01	8	5	2	8	6	12	23	31	42	37	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEGERQADIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTAGCCGAGGGTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	57	3.785589522550823E-4		44	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	2	5	2	23	37	47	42	49			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATCCGGGGGAACTTAATGAAAAACTGTTTTTTGGCAGT	CASSVDPGELNEKLFF	In	VDJ	2	95	6.309315870918038E-4	7.35407957888218E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	2	4	3	4	23	39	48	42	52			01,02										Vb 1	CASSVDPGELNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATATATGAACACTGAAGCTTTCTTTGGACAA	CASSVYMNTEAFF	In	VDJ	4	170	0.0011290354716379648	0.001315993187799969	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	9	0	0	2	23	-1	40	38	42			01,02			01,02							Vb 1	CASSVYMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGAGGAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSPEEGTNTEAFF	In	VDJ	5	191	0.0012685045593108899	0.0014785570521752593	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	1	5	3	23	35	46	40	49			01,02										Vb 1	CASSPEEGTNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCTTAGCCGAGGGACTAGACCTCACAGATACGCAGTATTTTGGCCCA	CASTLAEGLDLTDTQYF	In	VDJ	6	251	0.0016669876669478186	0.0019430252361046603	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	2	10	4	23	33	51	43	55			01,02			01,02							Vb 1	CASTLAEGLDLTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCAACCGCCTGGGGCCCCGTACCTAACTTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	8.633800665466789E-5		59	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	7	0	4	9	14	19	31	45	40	59														X+TCRBV11-01+TCRBJ01-04	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGGGGCCGCCCACAGATACGCAGTATTTTGGCCCA	CASSLGPPTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	2	0	4	19	-1	38	33	42														CASSLGPPTDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGYAGCTTAAATGAGCAGGGGGATGGCTACACCTTCGGTTCG	CASSLNEQGDGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	1	6	6	0	19	34	-1	40	47														CASSLNEQGDGYTF+TCRBV11-01+TCRBJ01-02	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGATAAGGGGGTACTACAATGAGCAGTTCTTCGGGCCA	CASSLIRGYYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	1	3	4	2	19	33	43	37	45														CASSLIRGYYNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCACCCTCTCCGGCCCAGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASTLSGPGNTGELFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	4	2	12	1	19	29	45	41	46														CASTLSGPGNTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCTGTCCCGGGTCAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSRVSTGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	4	4	6	4	19	31	41	37	45						01,02								CASSLSRVSTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGAAACACCATATATTTTGGAGAG	CASSQGNTIYF	In	VJ	1	11	7.30552364001036E-5	8.515250038705682E-5	33	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	3	0	0	4	0	1	29	-1	43	-1	44													Vb 16	CASSQGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGTCGGACAGCTATGGCTACACCTTCGGTTCG	CASSQGSDSYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	4	4	0	29	45	-1	49	55													Vb 16	CASSQGSDSYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCCTACAGAAGCTCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.0626216203651434E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	4	4	6	29	42	50	46	56													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACAGGGACCACCTACGAGCAGTACTTCGGGCCG	CASSQGTGTTYEQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	3	2	0	4	29	-1	53	45	57													Vb 16	CASSQGTGTTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCTCCGCCCTAGGGGGGACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSALGGTANTGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	8	5	1	0	8	5	29	38	52	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSALGGTANTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGGCCCCCGAGAGAGACCCAGTACTTCGGGCCA	CASSQRPPRETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	2	5	4	4	0	8	29	-1	47	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQRPPRETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGCAGGGGGATTCTATGGCTACACCTTCGGTTCG	CASSQAGGFYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	4	2	3	29	43	52	45	55													Vb 16	CASSQAGGFYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCCTAGCGGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQVLAGGPYEQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	2	2	29	45	58	47	60													Vb 16	CASSQVLAGGPYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGGAGGGCGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	2.1916570920031082E-4		46	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	0	6	3	3	29	46	56	49	59													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTTAGCGGGGGGGCAGCAGTACGTCGGGCCG	CASSQDLAGGQQYV	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	0	17	2	10	29	46	59	48	69													Vb 16	CASSQDLAGGQQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCATGAGGTGGATCGCGCTGAAGCTTTCTTTGGACAA	CASSQDHEVDRAEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	1	6	4	9	29	46	54	50	63													Vb 16	CASSQDHEVDRAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTGTGGAAAGGGAGCAGTTCTTCGGGCCA	CASSQGVEREQFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	1	1	8	10	4	4	29	45	52	49	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGVEREQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCTCGGGGGGGTTAGATGAGCAGTTCTTCGGGCCA	CASSQVSGGLDEQFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	8	3	4	29	45	56	48	60													Vb 16	CASSQVSGGLDEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGACAGGGCGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	40	2.656554050912858E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	2	3	3	0	3	29	-1	50	43	53													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSQEGRNTEAFF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	2	1	1	0	29	46	-1	47	52													Vb 16	CASSQEGRNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACCTGGACAGGGGGGTCTGAAGCTTTCTTTGGACAA	CASSQTWTGGSEAFF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	6	4	2	29	44	58	48	60													Vb 16	CASSQTWTGGSEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTCTTGGGGGAGGACACTGAAGCTTTCTTTGGACAA	CASSQLLGEDTEAFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	3	7	0	29	44	-1	51	57													Vb 16	CASSQLLGEDTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCTCGGGCATGATACAATACGAGCAGTACTTCGGGCCG	CASSGMIQYEQYF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	8	8	0	4	2	9	29	38	44	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSGMIQYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGTATGGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSQEGMGPNEQFF	In	VDJ	2	70	4.6489695890975023E-4	5.418795479176343E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	6	6	1	29	46	57	52	58													Vb 16	CASSQEGMGPNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGACCTTCTATGGCTACACCTTCGGTTCG	CASSQETFYGYTF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	2	7	4	0	3	29	-1	49	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQETFYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATTACATACAGTACTTCGGGCCA		Out	VDJ	3	114	7.571179045101647E-4		34	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	6	11	3	2	29	46	52	49	54													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGACAGGGGGTCAGGGATGAAGCTTTCTTTGGACAA		Out	VDJ	3	122	8.102489855284218E-4		40	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	7	0	7	29	-1	49	40	56													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTGAGACCCGGGGTTTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	5	181	0.0012020907080380683		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	0	8	5	28	40	53	48	58													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGACTCGAAGAGACCCAGTACTTCGGGCCA	CASSPGLEETQYF	In	VDJ	5	183	0.0012153734782926328	0.0014166279609846726	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	3	1	2	29	42	49	43	51						01,02							Vb 16	CASSPGLEETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGACTGCAAGAGACCCAGTACTTCGGGCCA	CASSQGLQETQYF	In	VDJ	6	218	0.0014478219577475078	0.0016875677349434898	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	10	2	0	1	29	-1	49	43	50						01,02							Vb 16	CASSQGLQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVEGPSYNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	5	3	0	5	2	24	36	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGPSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGCCCGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSLARQGTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	1	7	0	24	36	-1	43	49														CASSLARQGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGCGCCCAGGGGGCCTGGCTACACCTTCGGTTCG	CASSLAPRGPGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	7	8	1	24	36	52	44	53														CASSLAPRGPGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCACGGACCGGGGAGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSHGPGRGQETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	2	10	2	24	35	52	45	54														CASSHGPGRGQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGAGTTTGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSLGSNQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	6	0	8	1	9	0	24	35	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLGSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCAGGGGAAATGAGCAGTTCTTCGGGCCA	CASSSRGNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	7	2	1	24	36	44	38	45														CASSSRGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGATCCAGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDPGYSNQPQHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	4	0	5	3	24	35	44	40	47														CASSDPGYSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAAGTAGAGGCACAGATACGCAGTATTTTGGCCCA	CASSVSRGTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	1	5	2	24	36	44	41	46						01,02								CASSVSRGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGGGGGGGCCTATGGTGAGCAGTTCTTCGGGCCA	CASSVGGGAYGEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	9	4	7	24	36	49	40	56														CASSVGGGAYGEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCGATAGCGGGGGGTCAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSVVDSGGSATGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	5	1	4	8	5	24	36	54	44	59														CASSVVDSGGSATGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTAGAGGCTTTCTACCACTCTGGAAACACCATATATTTTGGAGAG	CASSVEAFYHSGNTIYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	11	1	0	4	10	24	35	43	39	53														CASSVEAFYHSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGACAGGAAACTATGGCTACACCTTCGGTTCG	CASSVTGNYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	2	2	1	24	36	44	38	45														CASSVTGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGGACAGGGGACAGCTACACCTTCGGTTCG	CASSRTGDSYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	9	0	3	24	-1	46	37	49														CASSRTGDSYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSASSTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	10	0	0	0	4	24	-1	38	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGACTAGCGACCAAGAGACCCAGTACTTCGGGCCA	CASSVGTSDQETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	6	0	3	0	24	36	-1	39	49						01,02								CASSVGTSDQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCGGGGCTCTGACTGAAGCTTTCTTTGGACAA	CASSVGALTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	7	0	5	3	4	24	36	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGALTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCACGGTATTTCTGTGCCAGCAGCAAAGCACAGGGGGTAGGGGGAGTAGGGTTGGCATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.1290354716379648E-4		62	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	6	0	21	13	-1	38	30	59														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAACAGCCACGGGACAGGGGAACATGGTACCAAGTTCTTCGGGCCA	CANSHGTGEHGTKFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	14	3	12	24	36	49	39	61														CANSHGTGEHGTKFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCCCCGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSVGPGTVNTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	9	0	24	36	-1	45	52														CASSVGPGTVNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTTGGCGGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSVGWRGDYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	3	8	1	24	36	52	44	53														CASSVGWRGDYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGACCTCCGGGACACGGGATCTGAAGCTTTCTTTGGACAA	CASSDLRDTGSEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	6	7	6	24	36	49	43	55														CASSDLRDTGSEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGAGGACAGGGCGCTAATGAAAAACTGTTTTTTGGCAGT	CASSGGQGANEKLFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	3	3	2	24	36	47	39	49														CASSGGQGANEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGTAACCAATGAGCAGTTCTTCGGGCCA	CASSVEVTNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	1	6	3	4	24	36	43	39	47														CASSVEVTNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGAGAGGTGGCGGGAGACCCAGTACTTCGGGCCA	CASSKERWRETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	5	5	7	0	24	40	-1	47	51						01,02								CASSKERWRETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCCCGGCAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPPGRVNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	8	0	24	36	-1	44	49														CASSPPGRVNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCTGCGGACTGGGACGGAGGGCTACACCTTCGGTTCG	CASSLRTGTEGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	0	7	8	10	4	24	35	50	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRTGTEGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACAGGGGAATGGGTCAGCCCCAGCATTTTGGTGAT	CASSNRGMGQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	6	0	6	24	-1	44	38	50														CASSNRGMGQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGACCTTGGAGATGGCTACACCTTCGGTTCG	CASSPDLGDGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	1	7	6	2	7	24	36	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDLGDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGGGTCCCTTGCACACTGAAGCTTTCTTTGGACAA	CASSLGPLHTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	0	9	3	2	8	24	36	41	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPLHTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGGAAGTACGGGACAGGGTACAGAGACCCAGTACTTCGGGCCA	CASRGSTGQGTETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	4	9	3	24	35	53	44	56														CASRGSTGQGTETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGGGGCGATTGAGCAGTTCTTCGGGCCA	CASSPGAIEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	6	0	9	2	3	24	36	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAIEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACAGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSADRGYQETQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	1	0	2	1	24	36	48	38	49														CASSADRGYQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAGATGACGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CASRDDGYTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	6	2	7	3	4	4	24	35	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDDGYTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACTTCTCTAGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	1.5275185792748935E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	4	6	1	8	0	24	31	-1	39	45						01,02								X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATCCAGGGCTCTCCAGGGCGACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	1.5275185792748935E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	4	3	1	5	14	24	31	41	36	55														X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSSGGTDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	1	1	0	24	36	-1	37	43														CASSSGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTCTTCCGGGGTCTAACACTGAAGCTTTCTTTGGACAA	CASSFLPGSNTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	2	7	3	24	36	48	43	51														CASSFLPGSNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGGACAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSGTGQETQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	2	1	0	24	35	-1	36	45														CASSGTGQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGAGGGGACAGGGGTAATTCACCCCTCCACTTTGGGAAC	CASSRGDRGNSPLHF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	2	6	3	0	24	37	-1	40	50														CASSRGDRGNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGGCACTGGGTCGGACACCATATATTTTGGAGAG	CASSVGGTGSDTIYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	7	5	8	4	11	24	36	44	40	55						01,02								CASSVGGTGSDTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTTCCTTGAGGGCCTCCATGGCCACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	33	2.1916570920031082E-4		52	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	0	17	7	26	24	36	48	43	74														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTAGTTTAGTAACCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	2.3244847945487512E-4		52	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	22	0	24	35	-1	57	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGAGAACCGGGGAGCTGTTTTTTGGAGAA	CASSVRTGELFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	2	5	2	1	24	36	41	38	42														CASSVRTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGACTGGAATTCACCCCTCCACTTTGGGAAC	CASSLDWNSPLHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	2	10	7	4	2	24	35	43	39	45						01,02								CASSLDWNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGGGTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVVGSGANVLTF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-06	01	5	5	3	4	5	3	24	36	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVGSGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAAGACTGGATAGTGAAGCTTTCTTTGGACAA	CASSPRLDSEAFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	2	10	7	4	6	24	36	44	40	50						01,02								CASSPRLDSEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGGATCCTTCTTTTGAAGCTTTCTTTGGACAA	CASSLDPSFEAFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	1	8	7	3	9	24	35	41	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPSFEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCCCCCAACGGCCTTCGGGACGGCCAAGAGACCCAGTACTTCGGGCCA	CASSAPNGLRDGQETQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	54	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	6	0	7	1	17	2	24	35	57	52	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPNGLRDGQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATCCACTGTGGGAGAGACCCAGTACTTCGGGCCA	CASRSTVGETQYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	6	0	9	4	9	0	24	35	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSTVGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGGGACAGGGGGTGTTTGAGACCCAGTACTTCGGGCCA	CASSLGQGVFETQYF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	5	2	5	24	36	49	38	54														CASSLGQGVFETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACGACGATCCCAAAAGACAGACCCAGTACTTCGGGCCA		Out	VDJ	3	111	7.371937491283182E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	2	2	7	6	1	13	24	39	43	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACCGAAGGAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSTEGAGGTDTQYF	In	VDJ	3	114	7.571179045101647E-4	8.824895494658616E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	2	1	7	0	24	37	-1	44	52														CASSTEGAGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACCCGGGGTGGATCCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	7.30552364001036E-5		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	3	1	3	7	19	30	38	33	45													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGACACGGGTGATGAAAAACTGTTTTTTGGCAGT	CASSWDTGDEKLFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	6	6	0	6	19	-1	38	32	44													Vb 5.1	CASSWDTGDEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATGGCAGTTCCTACGAGCAGTACTTCGGGCCG	CASSLDGSSYEQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	1	4	1	19	35	42	39	43													Vb 5.1	CASSLDGSSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTGTTGCTAGTCTGGGTACAGATACGCAGTATTTTGGCCCA	CASSVASLGTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	8	3	5	7	19	30	39	35	46						01,02							Vb 5.1	CASSVASLGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCTATCGGGACAGGGTTCAAACACAGATACGCAGTATTTTGGCCCA	CASLSGQGSNTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	3	2	5	6	19	28	42	33	48													Vb 5.1	CASLSGQGSNTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCTCTCTGGGGCCAACGTCCTAACTTTCGGGGCC	CASSPLSGANVLTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	7	0	19	9	10	19	31	45	40	55													Vb 5.1	CASSPLSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGAGGGGGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSPEGGGNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	7	8	0	19	31	-1	39	46													Vb 5.1	CASSPEGGGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGATCGGGGGACAGTCTCAACTATGGCTACACCTTCGGTTCG	CASSPGSGDSLNYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	2	10	4	19	31	48	41	52													Vb 5.1	CASSPGSGDSLNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCCTACCGGGACGGCCACCAATTCACCCCTCCACTTTGGGAAC	CASSSPTGTATNSPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	3	0	7	7	8	7	19	32	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSPTGTATNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGGGGCGCGGACACTGAAGCTTTCTTTGGACAA	CASSSGGADTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	3	0	5	19	-1	39	32	44													Vb 5.1	CASSSGGADTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAGACAGGTTTCGAATGAGCAGTTCTTCGGGCCA	CASSLRQVSNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	4	7	2	5	19	33	41	35	46													Vb 5.1	CASSLRQVSNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCGGGGACAGGGTTTTCACAATGAGCAGTTCTTCGGGCCA	CASSLGRGQGFHNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	5	4	5	19	35	48	39	53													Vb 5.1	CASSLGRGQGFHNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGGCAGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSLVAGVYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	3	3	1	19	35	44	38	45													Vb 5.1	CASSLVAGVYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTAGGGAGCGACACAATGAGCAGTTCTTCGGGCCA	CASSLVRERHNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	2	5	3	4	19	35	43	38	47													Vb 5.1	CASSLVRERHNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATCCTAGCGGGGGAGGAGATACGCAGTATTTTGGCCCA	CASSQDPSGGGDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	5	7	3	19	31	48	38	51													Vb 5.1	CASSQDPSGGGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCATTACTAGCGGGTCAGACAGATACGCAGTATTTTGGCCCA	CASSPLLAGQTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	4	3	5	4	19	31	45	36	49						01,02							Vb 5.1	CASSPLLAGQTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCTATTCGGGACCCTCCTACGAGCAGTACTTCGGGCCG	CASSPYSGPSYEQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	0	8	1	19	31	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPYSGPSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCGACTATAATGAGCAGTTCTTCGGGCCA	CASSLDYNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	9	7	3	1	19	31	39	34	40						01,02							Vb 5.1	CASSLDYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGGACGGATGGAACTATGGCTACACCTTCGGTTCG	CASSEDGWNYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	4	1	7	2	2	6	19	31	37	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSEDGWNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAATTACTAGCGGGGGAGATACGCAGTATTTTGGCCCA	CASSSITSGGDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	5	5	0	19	32	-1	37	48													Vb 5.1	CASSSITSGGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACAGGGCGACCTCCCACAGATACGCAGTATTTTGGCCCA	CASSLTGRPPTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	3	2	0	8	19	-1	40	34	48													Vb 5.1	CASSLTGRPPTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGAGGGGAAGTCTCACCCCTCCACTTTGGGAAC	CASSLGGGEVSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	10	0	10	2	6	19	35	43	37	49													Vb 5.1	CASSLGGGEVSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCCGACACGGAAACTGAAGCTTTCTTTGGACAA	CASSPPDTETEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	6	5	6	5	19	31	41	37	46													Vb 5.1	CASSPPDTETEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTGGACAGGGGAGTCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	9.297939178195004E-5		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	7	3	4	19	31	43	34	47													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCTGGGGATGGGCTATGGCTACACCTTCGGTTCG	CASSLLGMGYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	1	0	8	4	3	4	19	34	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLLGMGYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTCGGGGATCCCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		49	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	0	2	6	19	35	42	37	48													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTACGACAGGGGGGGCCAACACTGAAGCTTTCTTTGGACAA	CASTTGGANTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	1	2	3	4	19	27	39	30	43													Vb 5.1	CASTTGGANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGGTTGCAGGGAGCCCAACAGATACGCAGTATTTTGGCCCA	CASSGVAGSPTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	4	4	3	3	7	6	19	31	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSGVAGSPTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATAGGGGTTGGGGAAAAACTGTTTTTTGGCAGT	CASSLIGVGEKLFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	5	2	8	2	5	19	34	41	36	46													Vb 5.1	CASSLIGVGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTAGCGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVAVNTGELFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	5	5	1	0	1	19	-1	41	35	42						01,02							Vb 5.1	CASSLVAVNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCAACCCGCGAACTATGGCTACACCTTCGGTTCG	CASSFQPANYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	6	2	7	0	19	33	-1	40	43						01,02							Vb 5.1	CASSFQPANYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAAACCGGCTTCAGTGACAATGAGCAGTTCTTCGGGCCA	CASSKTGFSDNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	4	4	5	5	11	2	19	31	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSKTGFSDNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATAAGACAGGGGGACCAGCCCCAGCATTTTGGTGAT	CASSIRQGDQPQHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	1	7	4	2	19	31	44	35	46													Vb 5.1	CASSIRQGDQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTACAGGGGGCTCCAAAAACATTCAGTACTTCGGCGCC	CASSFTGGSKNIQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	3	0	2	1	1	19	33	43	34	44													Vb 5.1	CASSFTGGSKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACGAACCTCGTGGGGAATTCACCCCTCCACTTTGGGAAC	CASTNLVGNSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	6	6	2	7	10	0	19	29	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASTNLVGNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGACTCTAGCGGGGGAGTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	1.1290354716379648E-4		47	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	5	6	3	19	31	47	37	50													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTATTGTTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSLLLLAGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	8	6	7	0	19	34	-1	41	44						01,02							Vb 5.1	CASSLLLLAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCCCGGGACAGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGPGTGLQETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	4	1	5	3	19	35	48	40	51													Vb 5.1	CASSLGPGTGLQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGAGCAGGGGAGGTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSSSRGGSYNSPLHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	3	4	2	1	4	4	19	32	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSSRGGSYNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGTTGGGCGGGGAGGCCCAGAGACCCAGTACTTCGGGCCA	CASSLEVGRGGPETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	3	4	7	6	19	35	48	42	54						01,02							Vb 5.1	CASSLEVGRGGPETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAACCGGGACACTTTACACTGAAGCTTTCTTTGGACAA	CASSSTGTLYTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	3	5	4	19	32	43	37	47													Vb 5.1	CASSSTGTLYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTGGAGGAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSSLEEPNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	1	4	4	19	32	41	36	45													Vb 5.1	CASSSLEEPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGTAGCGGGGGACGTCTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLVAGDVLAKNIQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	5	2	0	2	7	19	33	44	35	51													Vb 5.1	CASSLVAGDVLAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGAACGGTAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGGTVVNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	0	1	7	19	35	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGTVVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGGAGGAGCAGATACGCAGTATTTTGGCCCA	CASSLGGGADTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	1	4	2	2	19	35	42	37	44													Vb 5.1	CASSLGGGADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTAAAGGACAGGATCTACGAGCAGTACTTCGGGCCG	CASSLVKDRIYEQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	4	3	4	2	19	35	46	39	48													Vb 5.1	CASSLVKDRIYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTGGGACAGGGGCAGGGCGGCTACACCTTCGGTTCG	CASSLLGQGQGGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	8	2	6	19	34	46	36	52													Vb 5.1	CASSLLGQGQGGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGTTAGAACCCGGGGGACTCAATGAGCAGTTCTTCGGGCCA	CASRLEPGGLNEQFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	12	0	19	30	-1	42	48						01,02							Vb 5.1	CASRLEPGGLNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGAGGACTAGCGGGGATTTCAATGAGCAGTTCTTCGGGCCA	CASSSRTSGDFNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	6	3	4	19	32	47	35	51													Vb 5.1	CASSSRTSGDFNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGGGTCCCAACGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLDGSQRMNTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	0	1	10	19	35	40	36	50						01,02							Vb 5.1	CASSLDGSQRMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGATACAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSSIQGTNTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	1	4	2	19	32	43	36	45													Vb 5.1	CASSSIQGTNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTGGGCAGGACGGGGGGAAAATTGATGAAGCTTTCTTTGGACAA	CASSRGQDGGKIDEAFF	In	VDJ	3	120	7.969662152738575E-4	9.289363678588017E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	7	11	8	19	31	49	42	57													Vb 5.1	CASSRGQDGGKIDEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGCGGGACAGCGCAAGGAAACACCATATATTTTGGAGAG	YSSGGTAQGNTIYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	4	1	5	22	33	41	34	46														YSSGGTAQGNTIYF+TCRBV17-01+TCRBJ01-03	TCRBV17-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGCGGGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSPAGFQETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	4	1	4	3	25	36	45	40	48						01,02							Vb 3	CASSPAGFQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGACAGGGGGCCGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	9.297939178195004E-5		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	1	3	3	25	36	49	39	52													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCTTCAGGACAGGGCGGAAACACCATATATTTTGGAGAG	CASSSPSGQGGNTIYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	3	4	8	1	25	38	54	46	55													Vb 3	CASSSPSGQGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTAGGGACACCCACTCAATCTAACTATGGCTACACCTTCGGTTCG	CASTLGTPTQSNYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	6	0	5	10	25	35	46	40	56													Vb 3	CASTLGTPTQSNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCGGGGGGGATCAACACTGAAGCTTTCTTTGGACAA	CASSFPGGINTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	2	2	3	25	39	49	41	52													Vb 3	CASSFPGGINTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACCCTGGGGAACTATGGCTACACCTTCGGTTCG	CASSRTLGNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	1	7	2	1	7	25	37	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRTLGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGGGGGGGGTAACACTGAAGCTTTCTTTGGACAA	CASSSGGGNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	4	1	2	0	4	25	-1	45	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGGGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGCCAGTGAAGAGACCCAGTACTTCGGGCCA	CASSWASEETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	8	0	3	0	5	25	-1	42	38	47													Vb 3	CASSWASEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGTGGATCGAAGGGTTGAAAAACTGTTTTTTGGCAGT	CASRGVDRRVEKLFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	6	1	7	0	13	25	-1	41	36	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRGVDRRVEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCCGGGACAGACTATGGCTACACCTTCGGTTCG	CASSPSGTDYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	3	6	0	25	37	-1	43	50													Vb 3	CASSPSGTDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGGGACACCTTCAATCAGCCCCAGCATTTTGGTGAT	CASSFRDTFNQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	6	3	2	4	25	39	47	41	51													Vb 3	CASSFRDTFNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCGACCCGGAGGGAGTAAGGTACGAGCAGTACTTCGGGCCG	CASTPDPEGVRYEQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	10	0	4	10	7	25	35	51	45	58													Vb 3	CASTPDPEGVRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGCTCCTCAACTATGGCTACACCTTCGGTTCG	CASSRLLNYGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	9	0	2	2	5	25	36	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRLLNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAACACAGGGGGCAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSQTQGAGTYNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	0	2	6	5	25	36	51	42	56													Vb 3	CASSQTQGAGTYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSSTGELFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	10	4	1	1	25	41	44	42	45						01,02							Vb 3	CASSLSSTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGGGACAGGAGCTTTACCTACGAGCAGTACTTCGGGCCG	CASRRDRSFTYEQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	2	7	25	36	46	38	53													Vb 3	CASRRDRSFTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTGGGGAGTTCACTGAAGCTTTCTTTGGACAA	CASSLIGEFTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	2	4	4	2	25	40	49	44	51													Vb 3	CASSLIGEFTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTTGGTGGGAGCGGGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSLIWWERGGYNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	4	10	1	25	40	60	50	61													Vb 3	CASSLIWWERGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCCCTAATTCACCCCTCCACTTTGGGAAC	CASSLLPNSPLHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	4	10	6	0	3	25	-1	42	40	45						01,02							Vb 3	CASSLLPNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTACAGGGTGAGCAGTACTTCGGGCCG	CASSLLQGEQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	3	7	1	1	25	41	48	42	49													Vb 3	CASSLLQGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCACCTCAACAACTAATGAAAAACTGTTTTTTGGCAGT	CATTSTTNEKLFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	10	3	7	0	2	5	25	32	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATTSTTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCTGCCGGAGGGGAGACCCAGTACTTCGGGCCA	CASRSAGGETQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	5	7	0	25	36	-1	43	49													Vb 3	CASRSAGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAACAGGGGCTCGGGACACTGAAGCTTTCTTTGGACAA	CASSPTGARDTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	3	3	6	25	37	47	40	53													Vb 3	CASSPTGARDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGTTGGGCCAGGTGACAGGGCGGGCTACACCTTCGGTTCG	CAVGPGDRAGYTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	2	3	8	12	2	25	31	50	43	52													Vb 3	CAVGPGDRAGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGGGACTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDFSTDTQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	5	2	25	36	47	41	49						01,02							Vb 3	CASSPRDFSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGACGGGAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGREGYNEQFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	0	3	3	0	25	40	-1	43	51													Vb 3	CASSLGREGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGGTATCGGGGTCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	2.1916570920031082E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	7	7	2	25	39	51	46	53													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCACAGGGGGGTGGATGGCTACACCTTCGGTTCG	CASSPHRGVDGYTF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	1	6	4	4	25	37	49	41	53													Vb 3	CASSPHRGVDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGCAGCCGGGTCAGAACACTGAAGCTTTCTTTGGACAA	CASSGQPGQNTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	1	0	10	25	-1	41	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGQPGQNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGCCAAAGGGGGGCACGAGACCCAGTACTTCGGGCCA	CASSSAKGGHETQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	4	5	1	5	7	4	25	38	51	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSAKGGHETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATATCTGGCTACAATGAGCAGTTCTTCGGGCCA	CASISGYNEQFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	7	0	10	3	5	0	25	35	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASISGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTAGGGGGCGCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASLGGAGNQPQHF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	5	0	2	2	4	25	34	43	36	47													Vb 3	CASLGGAGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTCGACAGGGGCGGAGACTGAAGCTTTCTTTGGACAA	CASSTGAETEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	2	5	3	5	25	33	44	36	49													Vb 3	CASSTGAETEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGACTCGGGACAGGACGTAATTCACCCCTCCACTTTGGGAAC	CASRLGTGRNSPLHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	4	6	6	3	25	34	48	40	51													Vb 3	CASRLGTGRNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTACAGGGGCCCTACGAGCAGTACGTCGGGCCG	CASSLLQGPYEQYV	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	2	17	1	16	25	41	49	42	65													Vb 3	CASSLLQGPYEQYV+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGCGACAGCCCCAGATACGCAGTATTTTGGCCCA	CASSWATAPDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	4	4	3	25	38	47	42	50													Vb 3	CASSWATAPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCAGGGACAGGGCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	44	2.922209456004144E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	3	3	1	25	39	51	42	52													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGAACGGAGGCATCGGGCACTGAAGCTTTCTTTGGACAA	CASSRTEASGTEAFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	4	6	7	25	36	47	42	54													Vb 3	CASSRTEASGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGGSGANVLTF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	4	8	1	0	0	0	25	-1	-1	38	45													Vb 3	CASSSGGSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGCAGGGCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	54	3.586347968732359E-4		37	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	8	3	2	25	38	46	41	48													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTACAGGGTCCGGCTACACCTTCGGTTCG	CASSFTGSGYTF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	8	4	3	25	36	46	40	49													Vb 3	CASSFTGSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTCCCATGACCGAAGCTTTCTTTGGACAA	CASSPPMTEAFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	2	7	8	9	1	25	36	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPMTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCCCACTAGCGGTGAGCACAGATACGCAGTATTTTGGCCCA	CASSTPLAVSTDTQYF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	5	0	5	2	25	37	50	42	52						01,02							Vb 3	CASSTPLAVSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATCTCGACAGGGCGGTAGATACGCAGTATTTTGGCCCA	CASNLDRAVDTQYF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	3	5	5	4	25	35	47	40	51													Vb 3	CASNLDRAVDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATAACCCCAATTCACCCCTCCACTTTGGGAAC	CASNNPNSPLHF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	7	3	7	7	3	3	25	35	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASNNPNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTCATGTACAGAACCTTTACAATGAGTGGCAGTTCTTCGGGCCA	CASSLSHVQNLYNEWQFF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	5	12	7	17	25	41	52	48	69													Vb 3	CASSLSHVQNLYNEWQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAACGGTAGCGGACAGGGTCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	77	5.113866548007252E-4		52	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	3	9	3	25	40	57	49	60													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTATCGGGGCAGGGGACTATGGCTACACCTTCGGTTCG	CASSFIGAGDYGYTF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	3	11	0	25	36	-1	47	53													Vb 3	CASSFIGAGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCCTATAGGTCTAACTATGGCTACACCTTCGGTTCG	CASSLAYRSNYGYTF	In	VDJ	2	97	6.442143573463681E-4	7.508902306858647E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	5	4	0	6	1	25	40	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLAYRSNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCGGGACACTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	119	7.903248301465754E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	5	5	3	25	37	48	42	51													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTACAGGGGGCGCGAACCGAGCAGTACTTCGGGCCG	CASSEVQGARTEQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	0	6	1	6	23	39	49	40	55														CASSEVQGARTEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGAGAGCCAGCCCCAGCATTTTGGTGAT	CASSEGESQPQHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	2	7	0	3	23	-1	44	39	47														CASSEGESQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGCCCAGGGGAAGTATGGCTACACCTTCGGTTCG	CASSEAQGKYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	5	1	3	24	41	48	42	51														CASSEAQGKYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGATAGCGGGTCGGACTTCGCACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.1290354716379648E-4		56	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	4	2	3	12	23	39	49	42	61						01,02								X+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEEAGNTGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	7	4	1	2	0	23	39	-1	41	46						01,02								CASSEEAGNTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACAGGATGGGACATTCAGTACTTCGGCGCC	CASSEGTGWDIQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	4	8	0	5	23	-1	46	39	51														CASSEGTGWDIQYF+TCRBV06-01+TCRBJ02-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTCAAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSEAQGGTDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	1	3	0	23	40	-1	43	48														CASSEAQGGTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGATTCGGGGGCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	21	1.3946908767292507E-4		52	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-04	01	1	6	0	0	7	0	23	39	-1	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGGGGGACGGGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSEAGGRGNNSPLHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	2	5	7	1	23	40	53	47	54														CASSEAGGRGNNSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAACCAACCTACGAGCAGTACGTCGGGCCG	CASSEEPTYEQYV	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	17	14	4	23	39	56	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEPTYEQYV+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGAGACAGGGTCAAATCAGCCCCAGCATTTTGGTGAT	CASSEETGSNQPQHF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	4	1	3	24	40	48	41	51														CASSEETGSNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGAGGAACCTTAACTATGGCTACACCTTCGGTTCG	CASSEARNLNYGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	1	1	0	5	23	-1	44	40	49														CASSEARNLNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACAAAGACACCCAAGGGTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	41	2.72296790218568E-4		56	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-06	01	1	2	6	3	0	14	23	-1	43	39	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCACCAGGGGCAAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGANQPQHF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	4	2	2	23	40	48	42	50														CASSEAPGANQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGQNQPQHF	In	VDJ	5	203	0.0013482011808382756	0.0015714506889611395	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	0	8	0	4	4	2	23	40	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAPGQNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCCTCCCACTTCTTAATGAGCAGTTCTTCGGGCCA	CASSEALPLLNEQFF	In	VDJ	10	382	0.0025370091186217797	0.0029571141043505185	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	7	6	4	23	40	49	46	53						01,02								CASSEALPLLNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCTCGGGACGGAGAGACCCAGTACTTCGGGCCA	CASSPRDGETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-05	01	5	0	7	4	4	2	22	34	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDGETQYF+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTATTGGGGCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLLGPGTGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	7	0	4	2	4	22	37	44	39	48														CASSLLGPGTGELFF+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCAGACGGGGTTGAGACCCAGTACTTCGGGCCA	CASSPDGVETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	3	5	5	2	22	34	44	39	46														CASSPDGVETQYF+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTATACCAGATAATAAACCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	14	9.297939178195004E-5		50	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	5	2	3	9	22	37	43	40	52														X+TCRBV07-04+TCRBJ01-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCGTCGGACAGGCGAGGAATGAAAAACTGTTTTTTGGCAGT	CASSVGQARNEKLFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	4	5	3	5	22	34	44	37	49														CASSVGQARNEKLFF+TCRBV07-04+TCRBJ01-04	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CAWTGTVNTEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	2	0	26	36	-1	38	45			unresolved										Vb 20	CAWTGTVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACGAGGACAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CAWSVTRTGGGYGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	0	4	5	2	26	40	56	45	58			unresolved										Vb 20	CAWSVTRTGGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCTTTTGGGGGCCAGACCCACTACACCTTCGGTTCG	CAWSFGGQTHYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	6	0	10	6	8	26	35	47	41	55													Vb 20	CAWSFGGQTHYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCCCGGAGGGATCGAGCAGTACGTCGGGCCG	CAWSGPGGIEQYV	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	17	5	13	26	39	50	44	63													Vb 20	CAWSGPGGIEQYV+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGACGGCCTTTGGGGGGAGACCCAGTACTTCGGGCCA	CAWNDGLWGETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	4	6	1	5	12	0	26	36	-1	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNDGLWGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCACCGGGACAGACCACAAAAACATTCAGTACTTCGGCGCC	CAWSTGTDHKNIQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	5	3	4	4	26	37	48	41	52			unresolved										Vb 20	CAWSTGTDHKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGTGAACACTGAAGCTTTCTTTGGACAA	CAWAVNTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	0	0	0	26	-1	-1	35	39			unresolved			01,02							Vb 20	CAWAVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTGGAGGGTCCTGGCACAGATACGCAGTATTTTGGCCCA	CALEGPGTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	10	0	1	2	5	26	32	40	34	45													Vb 20	CALEGPGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACAGAGGAATGAGCAGTTCTTCGGGCCA	CAWSGQRNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	5	7	0	3	26	-1	44	39	47													Vb 20	CAWSGQRNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCAGGAGCCGAACACTGAAGCTTTCTTTGGACAA	CAWSVQEPNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	4	4	1	1	4	26	40	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQEPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGCAAGCCACGTTTGGTGCTTCTCAGTGACTCTGGCTTCTWCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	9.962077690923219E-5		35	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	19	4	2	6	20	0	46	41	-1	61	67													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGCACAGATACGCAGTATTTTGGCCCA	CAWRGTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-03	01	3	0	10	1	0	0	26	-1	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCACAGTGGAGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.0626216203651434E-4		38	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	3	5	3	2	5	26	36	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCGGTCCCTACAATGAGCAGTTCTTCGGGCCA	CAWSFGPYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	5	2	2	2	26	38	43	40	45						01,02							Vb 20	CAWSFGPYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGTGCAGGGGGCAAACGGAAACACCATATATTTTGGAGAG	CAWNVQGANGNTIYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	0	4	1	4	26	40	49	41	53													Vb 20	CAWNVQGANGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTCGGACAGGGCCGGTGGGGCTACACCTTCGGTTCG	CAWVGQGRWGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	8	3	7	26	35	46	38	53													Vb 20	CAWVGQGRWGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGCCGGGGTGGACGCAGTATTTTGGCCCA	CAWSLPGWTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	3	9	4	3	26	38	47	42	50													Vb 20	CAWSLPGWTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCCGAAGCAGGGATGGGAACTGAAGCTTTCTTTGGACAA	CAWSAEAGMGTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	5	8	6	26	37	50	45	56													Vb 20	CAWSAEAGMGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGCCCCGTGGTAGTTCTTCGGGCCA		Out	VDJ	1	18	1.1954493229107863E-4		35	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	0	5	4	14	1	9	26	40	44	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTGGCGAGGGACTGAAGCTTTCTTTGGACAA	CAWWRGTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	5	4	0	26	35	-1	39	44													Vb 20	CAWWRGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGTTGCAGGGCAAAGCTTTCTTTGGACAA	CAWSQLQGKAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	9	6	2	26	38	49	44	51			unresolved										Vb 20	CAWSQLQGKAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACAGATCGGATACGCAGTATTTTGGCCCA	CAWSYRSDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	6	1	4	26	38	43	39	47													Vb 20	CAWSYRSDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGAGGTCGGGATTCACCCCTCCACTTTGGGAAC	CAWSRGRDSPLHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	8	4	8	6	0	26	38	-1	44	48			unresolved			01,02							Vb 20	CAWSRGRDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGCGGGGACGAGGAAATTGGACAA	CAWSVGGDEEI	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	18	2	9	26	40	48	42	57			unresolved										Vb 20	CAWSVGGDEEI+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATTCAGAGACCCAGTAATGAAAAACTGTTTTTTGGCAGT	CAWSIQRPSNEKLFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	2	2	7	4	7	4	26	38	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSIQRPSNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCAGAAAAACATTCAGTACTTCGGCGCC	CAWRQKNIQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	5	4	1	0	26	37	-1	38	41													Vb 20	CAWRQKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGTCCAGGGGTGGACTGAAGCTTTCTTTGGACAA	CAWRVQGWTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	5	4	3	26	37	47	41	50			unresolved										Vb 20	CAWRVQGWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGCGGGGTGGGTCGCAGTACTTCGGGCCG	CAWSSRGGSQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	3	9	2	6	26	38	46	40	52			unresolved										Vb 20	CAWSSRGGSQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCCGAGGGGGCGGGAGCTTTCTTTGGACAA	CAWSEGAGAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	10	4	3	26	35	46	39	49													Vb 20	CAWSEGAGAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ACGTTTGGTGCTTCTCAGTGACTCTGGTTCTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV30	TCRBV30-01					TCRBJ02	TCRBJ02-04	01	0	2	8	0	4	3	36	50	56	54	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGGGCTTAGGCACTGAAGCTTTCTTTGGACAA	CAWAGGLGTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	4	0	6	26	-1	43	35	49			unresolved										Vb 20	CAWAGGLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTGACCCGCTGGAGGGCACCTTCGGTTCG	CAWTDPLEGTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	0	13	10	0	26	36	-1	46	52													Vb 20	CAWTDPLEGTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGTGGACAGAGGGGCCAGATACGCAGTATTTTGGCCCA	CAWSRWTEGPDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	5	4	4	6	26	38	48	42	54													Vb 20	CAWSRWTEGPDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGACTCAAATGAGCAGTTCTTCGGGCCA	CAWSVDSNEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	10	7	0	2	26	-1	45	40	47						01,02							Vb 20	CAWSVDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCCCCCGGGACAGGGTTATTCCGTACACTGAAGCTTTCTTTGGACAA	CAWSAPRDRVIPYTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	3	6	9	26	39	54	45	63													Vb 20	CAWSAPRDRVIPYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCTGTGCCTGGAGGGATTGCAGAAACGCTAAGCTAGCGGGGGCTTCAGAAAGTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	26	1.7267601330933578E-4		68	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	17	19	26	2	13	42	32	68			01,02										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACCGGGACAGGGGCTCTAGAGCTTTCTTTGGACAA	CAWDRDRGSRAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	10	4	6	26	35	49	39	55			unresolved										Vb 20	CAWDRDRGSRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAACGTGATCGGGACAGGGAACCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	1.7931739843661795E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	9	4	26	34	52	43	56			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCAGGGACCGGACTTAACTATGGCTACACCTTCGGTTCG	CAWSAGTGLNYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	1	4	6	26	37	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAGTGLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGAATCACAATGAGTAGTTCTTCGGGCCA	CAWAGNHNE*FF	Stop	VDJ	1	27	1.7931739843661795E-4		36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	14	0	13	26	-1	41	35	54			unresolved										Vb 20	CAWAGNHNE*FF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGCGTCCAACTCTGGAAACACCATATATTTTGGAGAG	CALASNSGNTIYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	7	9	0	0	1	6	26	33	37	34	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALASNSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATACAGTGGGGACAGGAGAGCAGTACTTCGGGCCG	CAWNTVGTGEQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	7	8	1	26	36	52	44	53													Vb 20	CAWNTVGTGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGGCCGGGACAGGGGACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.8595878356390008E-4		44	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	5	5	2	26	36	51	41	53			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCAGGATTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CACRISNTGELFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	4	0	0	4	26	-1	38	34	42			unresolved										Vb 20	CACRISNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGGCTGGAGGGGAGGGACAGATACGCAGTATTTTGGCCCA	CAWSAGWRGGTDTQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	0	3	10	0	26	39	-1	49	56													Vb 20	CAWSAGWRGGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGGACAGGGGATTATCGCACTGAAGCTTTCTTTGGACAA	CAWSVGTGDYRTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	2	4	1	7	26	40	51	41	58													Vb 20	CAWSVGTGDYRTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTCCCGGGAGGATGCCACCCGAGCTTTCTTTGGACAA		Out	VDJ	1	28	1.8595878356390008E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	1	10	4	10	26	36	47	40	57													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACTAGTATACAATGAGCAGTTCTTCGGGCCA	CAWSGLVYNEQFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	8	4	0	2	26	-1	45	39	47						01,02							Vb 20	CAWSGLVYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTCCTGAGGGGGCGAGGTATGGCTACACCTTCGGTTCG	CAWIPEGARYGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	0	5	6	4	26	36	49	42	53			unresolved										Vb 20	CAWIPEGARYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGACAGGGGACACCTATAATTCACCCCTCCACTTTGGGAAC	CAWTTGDTYNSPLHF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	2	1	3	26	36	45	37	48													Vb 20	CAWTTGDTYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGAGGGGGGCCGCCCCAGCATTTTGGTGAT	CAWSVGGGPPQHF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	5	1	9	3	3	26	40	49	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGGGPPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGCGTGGCAGCGTAAACACTGAAGCTTTCTTTGGACAA	CAWERGSVNTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	6	6	2	1	10	26	35	40	36	50						01,02							Vb 20	CAWERGSVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTCACAGGGTGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	36	2.3908986458215725E-4		37	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	8	3	4	26	35	44	38	48													Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCAGGGAGACCGGGCGATCAGCCCCAGCATTTTGGTGAT	CAWSPGRPGDQPQHF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	3	4	3	5	2	10	26	37	44	39	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGRPGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCCAGCGGGGCTTTGGATACGCAGTATTTTGGCCCA	CAWRPSGALDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	3	6	4	5	26	37	48	41	53													Vb 20	CAWRPSGALDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAATACAGGGACGAAACACCATATATTTTGGAGAG	CAWEIQGRNTIYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	5	5	2	26	35	46	40	48													Vb 20	CAWEIQGRNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCGGGGAACAGATACGCAGTATTTTGGCCCA	CAWNRGTDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	3	3	2	1	26	36	43	38	44													Vb 20	CAWNRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCAACGAGGGCCGCTCGGGCTACACCTTCGGTTCG	CASNEGRSGYTF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	11	0	8	5	7	26	33	43	38	50													Vb 20	CASNEGRSGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGATGGAAACAGAATACTTACGAGCAGTACTTCGGGCCG	CAWRWKQNTYEQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	5	4	6	6	26	37	47	43	53													Vb 20	CAWRWKQNTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAATGGAGAAATTTACTGAAGCTTTCTTTGGACAA	CAWRMEKFTEAFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	5	3	6	26	37	44	40	50			unresolved										Vb 20	CAWRMEKFTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGGACAGCTCCCCGTATGGCTACACCTTCGGTTCG	CAWSSDSSPYGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	5	5	2	7	26	38	46	40	53			unresolved										Vb 20	CAWSSDSSPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGAGACCGAGGGACAGAAGCTTTCTTTGGACAA	CARDRGTEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	6	8	9	0	26	32	-1	41	47													Vb 20	CARDRGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGGACACCCATGAAGCTTTCTTTGGACAA	CAWSRDTHEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	7	1	4	26	38	45	39	49													Vb 20	CAWSRDTHEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAGGGGGGAACCCAAGAGACCCAGTACTTCGGGCCA	CAWSEGGTQETQYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	3	5	1	1	2	4	26	37	45	39	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEGGTQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACAGGGATCGGATGAAAAACTGTTTTTTGGCAGT	CAWRQGSDEKLFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	6	0	5	26	-1	43	37	48													Vb 20	CAWRQGSDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGCGGAAACACCATATATTTTGGAGAG	CAWSVGGNTIYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	8	0	4	0	0	26	-1	-1	40	44													Vb 20	CAWSVGGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCGGAGAGCCTACAATGAGCAGTTCTTCGGGCCA	CACRRAYNEQFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	2	2	2	2	26	34	40	36	42													Vb 20	CACRRAYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CAWSVGGSTDTQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	0	0	1	26	-1	46	40	47			unresolved										Vb 20	CAWSVGGSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCGAGAGGAACACTGAAGCTTTCTTTGGACAA	CACERNTEAFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	2	1	1	2	26	34	38	35	40			unresolved										Vb 20	CACERNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAATGGGATTCTAGGGAATGAAAAACTGTTTTTTGGCAGT	CAWKNGILGNEKLFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	4	0	8	5	5	8	26	36	45	41	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKNGILGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGACACAGTGGGGGCGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	49	3.2542787123682513E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	6	0	8	9	1	26	37	52	46	53			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTAACAGGGTCGTTGGATGAAAAACTGTTTTTTGGCAGT	CALTGSLDEKLFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	3	6	2	7	26	33	41	35	48													Vb 20	CALTGSLDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTCAATACGCGGGTGCACATTCAGTACTTCGGCGCC		Out	VDJ	1	50	3.320692563641073E-4		43	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	7	4	8	9	3	26	38	52	47	55			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02	TCRBD02-01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGCGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWGASGANVLTF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	7	0	1	0	1	26	-1	40	35	41													Vb 20	CAWGASGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCAGCCCTCCAGGGATTCGAACTGAAGCTTTCTTTGGACAA	CAGSPPGIRTEAFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	3	5	10	6	26	32	47	42	53													Vb 20	CAGSPPGIRTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGCCCCGCCTATGAGCAGTTCTTCGGGCCA	CAWSVSPAYEQFF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	7	8	1	7	26	40	44	41	51			unresolved			01,02							Vb 20	CAWSVSPAYEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACCAGGGGTTGGAAACACCATATATTTTGGAGAG	CAWKPGVGNTIYF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	2	3	3	1	26	36	45	39	46													Vb 20	CAWKPGVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCAAGGGGCCGGTTGGAAACACCATATATTTTGGAGAG	CAWSVKGPVGNTIYF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	2	3	2	5	26	40	47	42	52													Vb 20	CAWSVKGPVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSWDSNQPQHF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	2	0	7	1	1	0	26	38	-1	39	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSWDSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGGGAAGAGTGAAAAACTGTTTTTTGGCAGT	CAWSWGKSEKLFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	2	6	1	7	1	5	26	38	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSWGKSEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGGGGCCCTATGGCTACACCTTCGGTTCG	CAWSVRGPYGYTF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	4	1	1	26	40	48	41	49			unresolved										Vb 20	CAWSVRGPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTTCACAAACACTGAAGCTTTCTTTGGACAA	CAWTFTNTEAFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	6	2	5	0	26	36	-1	41	44													Vb 20	CAWTFTNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAATGAACACTGAAGCTTTCTTTGGACAA	CAWEMNTEAFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	5	2	8	0	0	2	26	-1	37	35	39			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWEMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGAGGGGGGGCTCGCAATGAGCAGTTCTTCGGGCCA	CAWSVGGGARNEQFF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	6	4	4	26	40	51	44	55													Vb 20	CAWSVGGGARNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACAGGGACTCTGGAAACACCATATATTTTGGAGAG	CAWNRDSGNTIYF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	0	0	1	26	-1	42	36	43			unresolved										Vb 20	CAWNRDSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGGGTTCGTAAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSEGFVSNQPQHF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	1	0	6	26	-1	44	39	50			unresolved										Vb 20	CAWSEGFVSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAACCTGGGCGGCCACCAAAGAGACCCAGTACTTCGGGCCA	CAWSETWAATKETQYF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	1	8	0	3	6	8	26	39	49	45	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSETWAATKETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCACAGGGGTTCAACACTGAAGCTTTCTTTGGACAA	CAWAQGFNTEAFF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	2	2	3	26	35	44	37	47			unresolved										Vb 20	CAWAQGFNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTCCGGGACAGGGTCGTAACATTCAGTACTTCGGCGCC	CAWSAPGQGRNIQYF	In	VDJ	2	74	4.914624994188788E-4	5.728440935129277E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	3	7	4	4	26	39	52	43	56			unresolved										Vb 20	CAWSAPGQGRNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTGGGGAGGTACGAGCAGTACTTCGGGCCG	CAWSVVGRYEQYF	In	VDJ	2	74	4.914624994188788E-4	5.728440935129277E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	1	4	4	0	26	40	-1	44	50			unresolved										Vb 20	CAWSVVGRYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACAGCGGGGGCCGGTTCGAATGAGCAGTTCTTCGGGCCA	CAWRTAGAGSNEQFF	In	VDJ	2	76	5.047452696734431E-4	5.883263663105743E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	2	7	3	8	26	37	48	40	56													Vb 20	CAWRTAGAGSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGACAGGAAACAATCAGCCCCAACATTTTGGTGAT	CAWTTGNNQPQHF	In	VDJ	2	78	5.180280399280074E-4	6.03808639108221E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	16	1	16	26	36	43	37	59			unresolved										Vb 20	CAWTTGNNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGACCATGCCAGGGCGGAGACCCAGTACTTCGGGCCA	CAWSADHARAETQYF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	5	10	2	26	39	54	49	56													Vb 20	CAWSADHARAETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGGAGTCGGGGAGACCCAGTACTTCGGGCCA	CAWRGVGETQYF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	5	6	0	26	37	-1	43	47						01,02							Vb 20	CAWRGVGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAAATGAGGCCTATGGCTACACCTTCGGTTCG	CAWENEAYGYTF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	4	6	1	26	35	45	41	46													Vb 20	CAWENEAYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAAAGGCGGGACTGTGGAAACTGAAGCTTTCTTTGGACAA	CAWKKGGTVETEAFF	In	VDJ	2	93	6.176488168372396E-4	7.199256850905712E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	5	8	6	26	36	50	44	56						01,02							Vb 20	CAWKKGGTVETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGACAGGGGGCTGTAGATACGCAGTATTTTGGCCCA	CAWSRQGAVDTQYF	In	VDJ	2	93	6.176488168372396E-4	7.199256850905712E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	0	5	1	3	26	38	49	39	52													Vb 20	CAWSRQGAVDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCACGGGGGACGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CAWSPHGGRSTNEKLFF	In	VDJ	2	94	6.242902019645217E-4	7.276668214893946E-4	51	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	2	0	5	5	26	38	49	43	54			unresolved										Vb 20	CAWSPHGGRSTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGGACACCCTTTTTTTCACAGATACGCAGTATTTTGGCCCA	CAWSLDTLFFTDTQYF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	6	2	2	10	26	38	45	40	55			unresolved										Vb 20	CAWSLDTLFFTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGATATGGCTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	3	110	7.305523640010361E-4		52	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	6	5	14	5	26	36	53	50	58			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTGGAGGGGACAGGCGGACACTGAAGCTTTCTTTGGACAA	CAWWRGQADTEAFF	In	VDJ	3	114	7.571179045101647E-4	8.824895494658616E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	3	5	3	26	35	48	40	51			unresolved										Vb 20	CAWWRGQADTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGCAAAGGAGTAGGAGAGACCCAGTACTTCGGGCCA	CVCKGVGETQYF	In	VDJ	3	120	7.969662152738575E-4	9.289363678588017E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	2	4	4	4	26	34	42	38	46			unresolved										Vb 20	CVCKGVGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGACAGCAATGAGCAGTTCTTCGGGCCA	CAWSPDSNEQFF	In	VDJ	3	127	8.434559111648325E-4	9.83124322650565E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	6	3	0	26	37	-1	40	46			unresolved										Vb 20	CAWSPDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAAAGGGGGGATCAGCCCCAGCATTTTGGTGAT	CAWRERGDQPQHF	In	VDJ	3	136	9.032283773103718E-4	0.0010527945502399752	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	3	5	1	5	4	1	26	37	47	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRERGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATCTGGAAACACCATATATTTTGGAGAG	CAWKSGNTIYF	In	VJ	4	141	9.364353029467826E-4	0.001091500232234092	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	0	0	1	0	2	26	-1	36	-1	38													Vb 20	CAWKSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAACAGCGACATTCACCCCTCCACTTTGGGAAC	CAWSEQRHSPLHF	In	VDJ	4	167	0.0011091113162561184	0.001292769778603499	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	1	3	5	8	1	4	26	39	44	40	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEQRHSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTSAGDGYTF	In	VDJ	5	185	0.001228656248547197	0.0014321102337823194	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48			unresolved										Vb 20	CAWTSAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCTGACAGGGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	10	376	0.002497160807858087		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	0	3	1	26	35	46	38	47			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCATGGGGCAAGGTGAAGCTTTCTTTGGACAA	CAWSMGQGEAFF	In	VDJ	22	851	0.005651818743317106	0.006587707075398668	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	7	3	4	26	37	45	40	49			unresolved										Vb 20	CAWSMGQGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTAAGDGYTF	In	VDJ	41	1610	0.010692630054924254	0.012463229602105589	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48			unresolved										Vb 20	CAWTAAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	118	4666	0.030988703003898492	0.03612014243690974	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-04	01	0	2	8	0	4	3	26	40	46	44	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCACTAAGCTTGCGGGAATACAGGGATGCCCCCCGGACGAGCAGTACGTCGGGCCG	CATKLAGIQGCPPDEQYV	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	54	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-07	01	12	3	3	17	18	23	18	23	47	41	70				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATKLAGIQGCPPDEQYV+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCGGCCCTGTATCTCTGTGCAAGTCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	79	5.246694250552895E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	20	-1	44	37	47														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAGAGGGGCCACGGGAAACACCATATATTTTGGAGAG	CASSQRGATGNTIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-03	01	2	5	2	4	2	5	23	38	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGATGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGTCCTCCGGTACGGGAAAAACTGTTTTTTGGCAGT	CASSQEGPPVREKLFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	0	5	4	8	0	13	23	-1	43	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGPPVREKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAATAGAGGGTTGGGCCAGCCCCAGCATTTTGGTGAT	CASSQNRGLGQPQHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	0	7	4	6	23	38	47	42	53														CASSQNRGLGQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATGGAGCGCGGCGCACAGATACGCAGTATTTTGGCCCA	CTSSQDGARRTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	6	1	3	4	23	40	47	43	51						01,02								CTSSQDGARRTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTACTCCCTCAATTGGGGGGAGGAACTGTTTTTTGGCAGT	CASSQEYSLNWGEELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	9	1	12	14	3	23	40	60	54	63						01,02								CASSQEYSLNWGEELFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGTGGGACAGGACCTAAACTATGGCTACACCTTCGGTTCG	CASSQEVGQDLNYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	2	3	5	23	40	51	43	56														CASSQEVGQDLNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGAGTGAAGGGGAGAGGGTACTTCGGGCCG		Out	VDJ	1	15	9.962077690923219E-5		37	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	4	5	2	12	7	5	23	36	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAATCGTTGTAGAGACCCAGTACTTCGGGCCA	CASSQIVVETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	6	4	2	4	23	38	42	40	46						01,02								CASSQIVVETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTTCAATAGCTATGGCTACACCTTCGGTTCG	CASSQDFNSYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	5	8	4	6	0	23	40	-1	46	49						01,02								CASSQDFNSYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCTGGCCCCCTAGCAGATACGCAGTATTTTGGCCCA	CASSQDPGPLADTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	8	4	10	0	23	40	-1	50	54						01,02								CASSQDPGPLADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCGATTCACGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHRFTSYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	3	2	8	1	2	6	23	37	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRFTSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGGGGGCGTCCAGCCCCAGCATTTTGGTGAT	CASSQGGGVQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	9	0	7	0	4	23	-1	46	39	50														CASSQGGGVQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQEGNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	0	0	9	1	0	0	23	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCTAGAGCAGGACAGGTTTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	1.328277025456429E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	3	7	3	23	35	49	42	52														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGGGACGCGGCGGGGGCTATGGCTACACCTTCGGTTCG	CASSLGRGGGYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	2	4	9	0	23	36	-1	45	52														CASSLGRGGGYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCAATCTCGAAATTTATCAGCCCCAGCATTTTGGTGAT	CASSRNLEIYQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	4	2	8	5	8	5	23	36	46	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRNLEIYQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGCCGGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSQEAGGNEKLFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	1	5	3	0	23	40	-1	43	50														CASSQEAGGNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAGGACCACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDRTTTNEKLFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	0	1	7	0	2	2	23	40	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRTTTNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQTGTNEKLFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	4	1	0	0	23	-1	-1	38	43														CASSQTGTNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCGGGACAGGAGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQAGQEDSGANVLTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	0	4	0	1	4	23	39	48	40	52														CASSQAGQEDSGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGGACTTCAGGTTTGATTCACCCCTCCACTTTGGGAAC	CASSRDFRFDSPLHF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	0	10	8	0	9	23	-1	42	36	51						01,02								CASSRDFRFDSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSQEFTGELFF	In	VJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	0	0	4	0	3	23	-1	40	-1	43														CASSQEFTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTCTAGCAAATGAGCAGTTCTTCGGGCCA	CASSQGLANEQFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	7	7	2	1	23	39	46	41	47						01,02								CASSQGLANEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTGGCACAGGAGGGCACTGAAGCTTTCTTTGGACAA	CASSQVAQEGTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	0	4	7	0	23	39	-1	46	52														CASSQVAQEGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCACAGGGGGGCGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	2.3244847945487512E-4		50	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	1	0	1	6	23	36	45	37	51														X+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCCTACCGCCGGGAGTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	35	2.3244847945487512E-4		46	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	8	2	5	10	2	23	36	52	46	54														X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCCCCGGGGTAGACCCTAAGTATGGCTACACCTTCGGTTCG	CASSLPGVDPKYGYTF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	5	4	11	23	36	45	40	56														CASSLPGVDPKYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGTCCTCATGGGGCCCAAGGGACATTCAGTACTTCGGCGCC	CASSQSSWGPRDIQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	7	0	8	8	7	23	37	50	45	57														CASSQSSWGPRDIQYF+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAGAACGGACTAGGATCCACGAGCAGTACGTCGGGCCG		Out	VDJ	1	40	2.656554050912858E-4		44	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	8	17	4	17	23	37	48	41	65						01,02								X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTTTGGGAATCCTCGGGGGTAGCTATGGCTACACCTTCGGTTCG	CASSQGLGILGGSYGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	2	4	13	3	23	39	58	52	61														CASSQGLGILGGSYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATTTGAGGGGGAGAGCTCCTACGAGCAGTACGTCGGGCCG	CASSQFEGESSYEQYV	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	1	17	4	21	23	38	48	42	69														CASSQFEGESSYEQYV+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACCACAGGAAACACCATATATTTTGGAGAG	CASSQTTGNTIYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	6	4	3	0	23	38	-1	41	44														CASSQTTGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGAATATGGCGAGACCCAGTACTTCGGGCCA	CASSQEYGETQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-05	01	3	1	8	5	0	7	23	-1	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEYGETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTATCTCAAGTCCGCGGAAGAAACACCATATATTTTGGAGAG	CASSLSQVRGRNTIYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	7	5	5	12	2	23	36	52	48	54						01,02								CASSLSQVRGRNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATGAGGGGGGGGCAATGGCGACAGATACGCAGTATTTTGGCCCA	CASSHEGGAMATDTQYF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	3	3	9	23	37	47	40	56														CASSHEGGAMATDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTATGACCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSMTSYNSPLHF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-06	01	6	2	7	0	3	0	23	34	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMTSYNSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTCAGCCGGGCAGATACAATGAGCAGTTCTTCGGGCCA	CASSQGQPGRYNEQFF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	1	8	0	4	7	3	23	39	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGQPGRYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGACCCCCGGGGGTAGCGGGGGGGCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	4	159	0.0010559802352378613		56	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	9	10	5	23	40	61	50	66														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGGGACAGGGGAGGGAAAACTGTTTTTTGGCAGT	CASGTGEGKLFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	2	10	0	4	23	-1	42	32	46													Vb 14	CASGTGEGKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCACCTCCTGGCCCAGCTATGGCTACACCTTCGGTTCG	CASTSWPSYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	5	4	10	0	23	33	-1	43	46													Vb 14	CASTSWPSYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAAACCAGCGGTCACAGATACGCAGTATTTTGGCCCA	CASKPAVTDTQYF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	6	5	2	4	1	23	33	42	37	43						01,02							Vb 14	CASKPAVTDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAAAGCGGGACAGGGTACGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	2.922209456004144E-4		47	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	7	4	4	23	38	51	42	55													Vb 14	X+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGCCGAAGCGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASAEAGGNTGELFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	6	1	1	5	0	23	32	-1	37	46													Vb 14	CASAEAGGNTGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCCGGGGACACCGACCTAACAGATACGCAGTATTTTGGCCCA	CSASGDTDLTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	6	3	6	8	25	32	44	38	52													Vb 4	CSASGDTDLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTAGCGGGGGTCCGCACAGATACGCAGTATTTTGGCCCA	CSVLAGVRTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	1	1	3	25	34	44	35	47													Vb 4	CSVLAGVRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGCAGACACAGATACGCAGTATTTTGGCCCA	CSVGADTDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	4	5	2	3	1	25	35	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGADTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTACAACCCGTCACAGGGAGTGGAAGTGGCTACACCTTCGGTTCG	CSVLQPVTGSGSGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	13	8	25	33	52	46	60													Vb 4	CSVLQPVTGSGSGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTGAGAGGGTCAGGGAACACTAAAGCTTTCTTTGGACAA	CSVLRGSGNTKAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	4	3	9	10	7	25	34	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLRGSGNTKAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATTCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	9.297939178195004E-5		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	19	3	3	6	16	5	43	38	60	54	65													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTTGAGGGACAGGGGCTATGGCTACACCTTCGGTTCG	CSALRDRGYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	4	6	0	25	32	-1	38	48													Vb 4	CSALRDRGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCACCAGGGTAGGGACCACTTATGGCTACACCTTCGGTTCG	CSVTRVGTTYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	5	10	4	25	33	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVTRVGTTYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTACCCATGACCCCTTTAGGGGGTGAAAAACTGTTTTTTGGCAGT	CSVLPMTPLGGEKLFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	7	17	0	25	34	-1	51	57													Vb 4	CSVLPMTPLGGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCTTGCGGGGGGTAAAAGAGACCCAGTACTTCGGGCCA	CSVEALRGVKETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	1	3	4	3	25	38	50	42	53													Vb 4	CSVEALRGVKETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGACGCAGGGGGATGGCTATGGCTACACCTTCGGTTCG	CSGTQGDGYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	4	5	4	25	32	44	37	48													Vb 4	CSGTQGDGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACAGGGGGGAGAGACCCAGTACTTCGGGCCA	CSVEQGGETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	4	0	1	25	-1	44	37	45													Vb 4	CSVEQGGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGGGAACCACTAGCCTATGGCTACACCTTCGGTTCG	CSVDGEPLAYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	3	7	4	9	0	25	36	-1	45	51						01,02							Vb 4	CSVDGEPLAYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGMGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGGCCCTAGCGGGGGGAATGAGCAGTTCTTCGGGCCA	CSVVGPSGGNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	7	6	0	25	35	-1	41	52													Vb 4	CSVVGPSGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGCAGACCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.1954493229107863E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	0	3	0	6	25	-1	40	35	46													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCCGAGGGGACAGCAGCTAACTATGGCTACACCTTCGGTTCG	CSVAEGTAANYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	0	7	3	25	33	47	40	50													Vb 4	CSVAEGTAANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGCAAAGCGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CSVAKRGPYNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	2	5	1	25	33	46	38	47													Vb 4	CSVAKRGPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAGGGCAGGGTCTAGCTATGGCTACACCTTCGGTTCG	CSVARAGSSYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	4	6	5	25	35	46	41	51													Vb 4	CSVARAGSSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGTTCTACAATGAGCAGTTCTTCGGGCCA	CSVAGFYNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	4	0	9	3	2	2	25	35	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAGFYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGTCTCTGGGGCTTCGAACACTGAAGCTTTCTTTGGACAA	CSAVSGASNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	7	0	1	8	3	25	32	45	40	48													Vb 4	CSAVSGASNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCCCGGGACGGTTCAAGGCCCCAGCATTTTGGTGAT	CSVSRDGSRPQHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	6	0	7	9	5	8	25	33	43	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSRDGSRPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACAGGGGATTGACTATGGCTACACCTTCGGTTCG	CSVGQGIDYGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	3	0	4	25	-1	43	35	47													Vb 4	CSVGQGIDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTATCGTCAGGCAGCACTGAAGCTTTCTTTGGACAA	CSVVSSGSTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	4	6	3	25	35	45	41	48													Vb 4	CSVVSSGSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATACGGGACAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CSIRDSNTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	2	4	1	25	31	42	35	43													Vb 4	CSIRDSNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCTTAGGGGGGATTCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.461104728002072E-4		41	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	6	5	1	2	4	5	25	33	43	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATGGGGGTGTTCACTGAAGCTTTCTTTGGACAA	CSVMGVFTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	6	1	4	2	4	25	34	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVMGVFTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCAGCGGTGCGGGGCTCACAGATACGCAGTATTTTGGCCCA	CSVVSGAGLTDTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	2	8	2	25	35	49	43	51													Vb 4	CSVVSGAGLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTCGGGAACAGGGGAACTACAATGAGCAGTTCTTCGGGCCA	CSVVREQGNYNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	3	7	2	25	35	49	42	51													Vb 4	CSVVREQGNYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCAGGCGGGGATGCCGGGACAGACCAAGAGACCCAGTACTTCGGGCCA	CSVSGGDAGTDQETQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	0	15	0	25	34	-1	49	56													Vb 4	CSVSGGDAGTDQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTATAACCGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CSGITGTVNTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	8	0	25	32	-1	40	47													Vb 4	CSGITGTVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCAAGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CSVLKGGTGELFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	4	5	0	25	34	-1	39	45													Vb 4	CSVLKGGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCGAGGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSVVEGPSTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	5	2	0	3	3	25	35	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVEGPSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTGCTAATTCCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CSVLLIPGQGTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	1	11	0	25	34	-1	45	53													Vb 4	CSVLLIPGQGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAAACAGGGGGTCACTGAAGCTTTCTTTGGACAA	CSVKQGVTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	4	3	1	25	33	44	36	45													Vb 4	CSVKQGVTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTACGACTTAACGGATGGCTACACCTTCGGTTCG	CSVDYDLTDGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	2	10	6	4	6	25	36	44	40	50						01,02							Vb 4	CSVDYDLTDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCTGAGAACACCTACGAGCAGTACTTCGGGCCG	CSVSENTYEQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	5	3	6	2	7	0	25	34	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSENTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTCAGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSVGVRGGTDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	1	1	4	1	25	35	46	39	47													Vb 4	CSVGVRGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGACAGGAGATTACAATGAGCAGTTCTTCGGGCCA	CSAGTGDYNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	4	2	4	25	32	42	34	46													Vb 4	CSAGTGDYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGCAAGGGGGTCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	1.7931739843661795E-4		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	5	1	5	4	3	25	32	42	36	45													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CSVDGGMNTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	0	1	1	25	36	43	37	44													Vb 4	CSVDGGMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.8595878356390008E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	21	3	3	6	18	5	43	36	60	54	65													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAAGCCCGGGACGTTAACACCGGGGAGCTGTTTTTTGGAGAA	CSAQARDVNTGELFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	7	0	7	2	9	3	25	32	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAQARDVNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATAGGACAGGGGATATCTATGGCTACACCTTTGGTTCG	CSVDRTGDIYGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	20	2	20	25	36	47	38	67													Vb 4	CSVDRTGDIYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGACAGCCAAGGATACGCAGTATTTTGGCCCA	CSVATAKDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	6	1	5	25	35	41	36	46													Vb 4	CSVATAKDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGCAGTTATGGGGAGACAAACGGCTACACCTTCGGTTCG	CSGGSYGETNGYTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	7	0	8	0	18	25	-1	37	32	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGGSYGETNGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAATGGGGGGGCGTCGGAATGAGCAGTTCTTCGGGCCA	CSVEMGGRRNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	7	2	6	25	37	46	39	52													Vb 4	CSVEMGGRRNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGCCAGGGCTAGGGAGGGCACGGATACGCAGTATTTTGGCCCA	CSVVARAREGTDTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	6	12	4	25	35	54	47	58													Vb 4	CSVVARAREGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCAACAGAGATGAGCAGTTCTTCGGGCCA	CSVETNRDEQFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	8	4	2	25	37	45	41	47													Vb 4	CSVETNRDEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACTCCGCAAGGTCTGACGAGCAGTACTTCGGGCCG	CSVDSARSDEQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	3	5	4	5	7	4	25	36	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDSARSDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATTAGCGGGGGGCTCACAGATACGCAGTATTTTGGCCCA	CSISGGLTDTQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	5	1	2	2	2	25	31	43	33	45													Vb 4	CSISGGLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTTGGGGACGAGGCGGGCTACACCTTCGGTTCG	CSVFGDEAGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	5	0	7	8	4	6	25	34	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVFGDEAGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAGCGGGATAATGAAAAACTGTTTTTTGGCAGT	CSAQRDNEKLFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	6	3	4	3	0	25	32	-1	35	42													Vb 4	CSAQRDNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCTAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVGSSGGNTGELFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	1	3	0	25	35	-1	38	48													Vb 4	CSVGSSGGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTTATCGGACGGACACTGAAGCTTTCTTTGGACAA	CSVVYRTDTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	1	7	3	6	2	25	35	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVYRTDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTGGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CSVWGATGELFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	6	6	0	4	3	0	25	33	-1	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVWGATGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGAGAGGGTGAAGCTTTCTTTGGACAA	CSVEEGEGEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	7	4	0	25	39	-1	43	48													Vb 4	CSVEEGEGEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTCTTGCGGCGGACAACACTGAAGCTTTCTTTGGACAA	CSLAADNTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	9	1	7	2	9	0	25	30	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSLAADNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCTAATCCGGGACAGGGCAAAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	2.3244847945487512E-4		46	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	5	8	5	25	32	49	40	54													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGAACTCTCCAGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	36	2.3908986458215725E-4		34	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	4	8	5	0	25	37	-1	42	46													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTTGAGGTGCGGACAGGGTTAAAGTTCTTCGGGCCA	CSVEFEVRTGLKFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	14	11	4	25	36	55	47	59													Vb 4	CSVEFEVRTGLKFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGACAGGGACTATGGCTACACCTTCGGTTCG	CSVGDRDYGYTF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	3	0	0	25	-1	-1	35	44													Vb 4	CSVGDRDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGCGCAGGGGTGGCCACCGGGGAGCTGTTTTTTGGAGAA	CSVGAGVATGELFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	4	5	4	25	33	44	38	48													Vb 4	CSVGAGVATGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGACAGGTCAAAATGAGCAGTTCTTCGGGCCA	CSVGTGQNEQFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	7	1	4	25	33	42	34	46													Vb 4	CSVGTGQNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTTGGCACAGATACGCAGTATTTTGGCCCA	CSVEDLGTDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	1	1	2	25	39	42	40	44						01,02							Vb 4	CSVEDLGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATAGGACAGGGTTCCCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	2.457312497094394E-4		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	3	6	2	5	25	37	47	39	52													Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGTCCGAAGGGGGGCTGGAGACCCAGTACTTCGGGCCA	CSVQSEGGLETQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	5	5	1	5	8	4	25	34	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVQSEGGLETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCACAGGGGGCAGAATCTATGGCTACACCTTCGGTTCG	CSVEATGGRIYGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	0	4	2	5	25	38	49	40	54													Vb 4	CSVEATGGRIYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGTGGGCCGACTAACTATGGCTACACCTTCGGTTCG	CSVSGPTNYGYTF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	0	3	3	25	34	41	37	44													Vb 4	CSVSGPTNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGTTGGACGCTGGAAACACCATATATTTTGGAGAG	CSVRLDAGNTIYF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	5	1	7	2	5	1	25	34	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRLDAGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGAACGGCGAAGTGGGAGACCCAGTACTTCGGGCCA	CSVEGGTAKWETQYF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	1	0	8	5	1	12	25	38	43	39	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGGTAKWETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTGCGGAACAGGGTCCACCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	44	2.922209456004144E-4		58	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	3	0	8	5	23	37	51	45	56													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGCAGGTCAAGAGACCCAGTACTTCGGGCCA	CSVRAGQETQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	2	0	5	25	-1	38	33	43													Vb 4	CSVRAGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGCGGGTCTGGAAACACCATATATTTTGGAGAG	CSVEGGSGNTIYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	7	4	1	2	0	25	36	-1	38	43						01,02							Vb 4	CSVEGGSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTTGGCTCGGGCGATTATCTAGATACGCAGTATTTTGGCCCA	CSVEFGSGDYLDTQYF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	2	8	0	5	8	8	25	37	49	45	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEFGSGDYLDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATAAGAGTGTGAGGGACCTGTCCTATGGCTACACCTTCGGTTCG	CSVDKSVRDLSYGYTF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	4	11	5	25	36	52	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDKSVRDLSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCWATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCTGAGTAGCGGGGGATCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVPE*RGISYNEQFF	Stop	VDJ	1	51	3.3871064149138946E-4		48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	0	7	2	25	33	49	40	51													Vb 4	CSVPE*RGISYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTACAGGGGAATGGGGCGGTGAGCAGTTCTTCGGGCCA	CSATGEWGGEQFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	2	9	2	10	25	32	41	34	51													Vb 4	CSATGEWGGEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGGTCCTTACCAAAAACATTCAGTACTTCGGCGCC	CSVRVLTKNIQYF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	8	4	2	1	6	25	33	38	34	44						01,02							Vb 4	CSVRVLTKNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD02-01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCTACGGCATAGAGGGAGGAAACACCATATATTTTGGAGAG	CSVVYGIEGGNTIYF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	11	0	4	11	1	25	35	51	46	52													Vb 4	CSVVYGIEGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGTCCAGGGGATCCTAAAGAAAAACTGTTTTTTGGCAGT	CSVSPGDPKEKLFF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	8	4	8	25	34	44	38	52													Vb 4	CSVSPGDPKEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGGACGTGGGCTACTATGGCTACACCTTCGGTTCG	CSAEDVGYYGYTF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	1	7	3	4	7	25	32	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAEDVGYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGACAGCCACCTCCAGCCCCAGCATTTTGGTGAT	CSVRDSHLQPQHF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	7	2	7	25	33	42	35	49													Vb 4	CSVRDSHLQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGAATTTGCTCACAGATACGCAGTATTTTGGCCCA	CSVKNLLTDTQYF	In	VDJ	3	125	8.301731409102683E-4	9.676420498529185E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	5	2	8	2	2	7	25	34	38	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVKNLLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGACGAGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSVDETGDTEAFF	In	VDJ	8	310	0.0020588293894574653	0.0023997522836352375	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	6	0	25	33	-1	39	47													Vb 4	CSVDETGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAACTCTGGCGGTCGGGACCGGGGAGCTGTTTTTTGGAGAA	CSVTLAVGTGELFF	In	VDJ	10	397	0.002636629895531012	0.003073231150332869	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	5	5	7	5	25	33	44	40	49						01,02							Vb 4	CSVTLAVGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAGACACATTCAGATACGCAGTATTTTGGCCCA	CSVKTHSDTQYF	In	VDJ	11	430	0.0028557956047313227	0.0033286886514940395	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	4	3	4	25	33	40	36	44													Vb 4	CSVKTHSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGATATTCCACGGGACAGCACATGAACACTGAAGCTTTCTTTGGACAA	CSARYSTGQHMNTEAFF	In	VDJ	22	873	0.0057979292161173136	0.006758012076172782	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	13	4	25	32	52	45	56													Vb 4	CSARYSTGQHMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	197	7756	0.051510583047200326	0.06004025390927388	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	25	-1	43	37	48													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCCCTAGGTATAGGGATGGAGACCCAGTACTTCGGGCCA	CASSPLGIGMETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	6	0	8	5	13	2	23	34	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSPLGIGMETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGTGCCCGTGGCTGCCGAGGTAGAGCAGTACGTCGGGCCG		Out	VDJ	1	11	7.30552364001036E-5		44	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	1	17	15	12	23	34	53	49	65													Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGGGGTTCAATCAGCCCCAGCATTTTGGTGAT	CASSGGFNQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	4	6	1	3	0	2	23	-1	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSGGFNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAAAGGACAGGGGGGGAACTCTGGAAACACCATATATTTTGGAGAG	CAKGQGGNSGNTIYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	1	1	0	2	4	23	30	42	32	46													Vb 22	CAKGQGGNSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTTGGGACTGTGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSVGTVSYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	3	2	5	23	36	44	38	49						01,02							Vb 22	CASSVGTVSYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGGGACAGGGTTTGGCTACACCTTCGGTTCG	CASRGTGFGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	7	1	2	23	34	44	35	46													Vb 22	CASRGTGFGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTCCCAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSQGYTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	2	3	3	1	23	32	41	35	42													Vb 22	CASSQGYTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCAGGAAACAGGAGGGGAAGCTTTCTTTGGACAA	CASSQETGGEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	8	10	0	23	34	-1	44	50													Vb 22	CASSQETGGEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGAACTAGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRTRDTGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	8	3	3	2	23	35	43	38	45						01,02							Vb 22	CASSRTRDTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTGGACAGGGCTGGGCAGCCCCAGCATTTTGGTGAT	CASSVDRAGQPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	7	1	5	23	36	45	37	50													Vb 22	CASSVDRAGQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACGAGGACGGGGGCGGAAGGCTACACCTTCGGTTCG	CASTRTGAEGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	7	6	0	8	7	4	23	33	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTRTGAEGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGCCGACAGGAATGAAGCTTTCTTTGGACAA	CASSADRNEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	7	4	2	23	34	44	38	46													Vb 22	CASSADRNEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGACGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRDDSNQPQHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	6	1	7	0	0	2	23	-1	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRDDSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGCACAGGGGGACTATGGCTACACCTTCGGTTCG	CASRAQGDYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	1	3	3	0	23	34	-1	37	45													Vb 22	CASRAQGDYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGAGGGGGCCCATTTCTATGGCTACACCTTCGGTTCG	CASSEEGAHFYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	0	4	0	6	23	-1	46	39	52													Vb 22	CASSEEGAHFYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGCATTGGACAGGGACTAAACTATGGCTACACCTTCGGTTCG	CASSGIGQGLNYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	2	5	4	23	36	49	41	53													Vb 22	CASSGIGQGLNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGGGTGGTCGGGGGGATGGGACACTGAAGCTTTCTTTGGACAA	CASSEGWSGGWDTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	3	8	5	23	37	52	45	57													Vb 22	CASSEGWSGGWDTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCCGGCAGCCAACGGGGCAGTATTTTGGCCCA	CASSVRQPTGQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	11	12	0	23	36	-1	48	52						01,02							Vb 22	CASSVRQPTGQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCTCGGCGGGGGCTCGCTCCTTACCTACGAGCAGTACTTCGGGCCG	CASLGGGSLLTYEQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	7	2	2	4	11	23	32	43	36	54													Vb 22	CASLGGGSLLTYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGATTGGACAGGATGGGTCAGCCCCAGCATTTTGGTGAT	CASRLDRMGQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	4	6	3	5	23	34	44	37	49													Vb 22	CASRLDRMGQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCGGAACACTGAAGCTTTCTTTGGACAA	CASSEARNTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	6	1	0	0	23	-1	-1	40	43						01,02							Vb 22	CASSEARNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGATCGCTCGCAGATACGCAGTATTTTGGCCCA	CASRSLADTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	6	10	0	4	3	3	23	34	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRSLADTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATGGAACAGGGGCGGCGGAGACCCAGTACTTCGGGCCA	CASSDGTGAAETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	2	5	4	5	23	37	48	41	53													Vb 22	CASSDGTGAAETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCGGGACAGGGGGCTTTAGCGCCTATAATTCACCCCTCCACTTTGGGAAC	CASSSGTGGFSAYNSPLHF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	57	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	0	2	3	7	23	35	50	38	57													Vb 22	CASSSGTGGFSAYNSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCCAGGGGACGTCTAGCGGGGAGGGAAATGAGCAGTTCTTCGGGCCA	CASSPQGTSSGEGNEQFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	54	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	7	13	5	23	35	57	48	62													Vb 22	CASSPQGTSSGEGNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGGGCGCTGGGGGGCCGATGGCTACACCTTCGGTTCG	CASSDGRWGADGYTF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	3	6	0	6	9	2	23	37	52	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGRWGADGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTGGGGGAGGTTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASGGGSSNQPQHF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	9	9	1	1	3	4	23	31	40	34	44													Vb 22	CASGGGSSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGCCGGGACAGGTCCGGATACGCAGTATTTTGGCCCA	CASAGTGPDTQYF	In	VDJ	2	70	4.6489695890975023E-4	5.418795479176343E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	4	6	3	4	23	32	43	35	47													Vb 22	CASAGTGPDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCAGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAVYSNQPQHF	In	VDJ	3	116	7.70400674764729E-4	8.979718222635083E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	0	4	23	-1	39	36	43													Vb 22	CASSAVYSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGGAGGACGGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	7.30552364001036E-5		44	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	1	1	1	5	28	42	48	43	53			01,02											X+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGAGGGACCTTCAGGCTACACCTTCGGTTCG	CASSDEGPSGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-02	01	2	0	7	8	2	5	28	43	50	45	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDEGPSGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTTCGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGGSSYNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	0	2	2	28	40	49	42	51			01,02											CASSFGGSSYNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGCATCAGGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSASGGSNQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	0	1	3	0	28	41	-1	44	52			01,02											CASSASGGSNQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCAGGGAGTCGAACCAGCCCCAGCATTTTGGTGAT	CASSRESNQPQHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	6	4	3	7	0	8	28	-1	44	39	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRESNQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCAAAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSDSKGGTDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	1	2	0	28	45	-1	47	53			01,02											CASSDSKGGTDTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAATCTTTCGGGGGGGCCTGGTTCTTCGGGCCA	CASSESFGGAWFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	15	6	4	28	42	56	48	60			01,02											CASSESFGGAWFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCGGACAGGGGGTAGAGACCCAGTACTTCGGGCCA	CAGQGVETQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	33	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	1	1	4	0	1	28	-1	44	34	45			01,02											CAGQGVETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCTAAACCCCCAATAAGGCGAAACACCATATATTTTGGAGAG		Out	VDJ	2	72	4.781797291643145E-4		43	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-03	01	10	5	4	5	15	1	28	35	53	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ01-03	TCRBV06-04		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTACCAGCAGCCCGGGGGTTGAAGCTTTCTTTGGACAA	CTSSPGVEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	7	2	1	26	37	45	39	46														CTSSPGVEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATCAGTGGGCCCTGGATGGGGACCGGGGAGCTGTTTTTTGGAGAA	CAISGPWMGTGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	5	6	2	5	11	0	26	38	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGPWMGTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCTCCCTTGGTTCTGGAAACACCATATATTTTGGAGAG	CASLGSGNTIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	11	0	10	1	6	1	26	32	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATAGGGGATCTCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYRGSLGANVLTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	5	2	3	1	6	26	40	46	41	52														CASSYRGSLGANVLTF+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCAGGTGACAGGCCATGGGAAAAACTGTTTTTTGGCAGT	CASSEAGDRPWEKLFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	8	9	6	26	38	53	47	59														CASSEAGDRPWEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATCCCGGGGAGCTGTTTTTTGGAGAA	CASSYPGELFF	In	VJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	3	0	0	6	0	2	26	-1	40	-1	42														CASSYPGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCGAGGGGGCAATAACAGATACGCAGTATTTTGGCCCA	CASTEGAITDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	0	3	3	4	26	36	46	39	50														CASTEGAITDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGGCGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRADSNQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	7	5	0	1	1	26	37	42	38	43						01,02								CASRADSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCGGGGACAGGGGGTAGGGCTTTCTTTGGACAA		Out	VDJ	1	18	1.1954493229107863E-4		37	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	11	2	4	26	37	50	39	54														X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTCCTGACTAGCGGGGGTAAAGGTAGTGAGCAGTTCTTCGGGCCA	CASSFLTSGGKGSEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	9	4	9	26	39	55	43	64														CASSFLTSGGKGSEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGATGGACCAGCAATCAGCCCCAGCATTTTGGTGAT	CASRWTSNQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	6	1	7	1	2	1	26	37	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRWTSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGTACGCTGGCTCTGGAAACACCATATATTTTGGAGAG	CASRYAGSGNTIYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	2	0	10	0	3	0	26	41	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYAGSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCCGGGACAGGGGAATCACCCCTCCACTTTGGGAAC	CASSEAGTGESPLHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	10	6	2	26	38	54	44	56														CASSEAGTGESPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCCGGGACAGGGAGTCGGGATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.461104728002072E-4		53	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	4	1	10	26	43	53	44	63														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTACAGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	1.5275185792748935E-4		38	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	2	1	0	26	39	-1	40	46														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGGGCAGGGAAGGCTCACAGATACGCAGTATTTTGGCCCA	CASSEGQGRLTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	6	6	26	38	49	44	55														CASSEGQGRLTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCTCTAGCGGGGCCCCGAGATACGCAGTATTTTGGCCCA	CASSEALAGPRDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	5	6	5	26	38	53	44	58														CASSEALAGPRDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGACGACAGGCTGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	1.7931739843661795E-4		41	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	4	3	3	4	26	37	46	40	50														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGTTCTGGACTCACCACGACTAATGAAAAACTGTTTTTTGGCAGT	CASSGLTTTNEKLFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	9	1	10	2	4	7	26	34	43	38	50						01,02								CASSGLTTTNEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCTATGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTLWTSGSTDTQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	4	0	6	0	26	36	-1	42	53						01,02								CASTLWTSGSTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCGGGAGCAGGGCGCTGAAGCTTTCTTTGGACAA	CASSREQGAEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	6	0	7	26	-1	44	38	51														CASSREQGAEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCATACTGGACGGCGGCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	2.1252432407302868E-4		43	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	7	4	5	14	0	26	35	-1	49	54						01,02								X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGATGAGGGGGCGGCTGGCTACACCTTCGGTTCG	CASSYDEGAAGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	0	7	4	3	26	41	52	45	55														CASSYDEGAAGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCTTGACAGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSYLDSAGELFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	5	6	3	2	26	41	49	44	51														CASSYLDSAGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTCAGTTACATCAGAATATACCGGGGAGCTGTTTTTTGGAGAA	CASSVTSEYTGELFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	3	6	5	6	9	26	35	44	41	53														CASSVTSEYTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCAGGACGGACAGGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASQDGQGDSNQPQHF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	1	0	6	1	26	35	51	41	52														CASQDGQGDSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGAAATTGACAGCCAAGAGACCCAGTACTTCGGGCCA	CASSEEIDSQETQYF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	1	9	0	26	38	-1	47	52														CASSEEIDSQETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGTGGGGGCGCGGGAGGTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	65	4.3169003327333947E-4		52	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	7	1	3	8	1	26	41	57	49	58														X+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTCCCCTTTTCGGACAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPFRTGSTDTQYF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	3	0	10	0	26	35	-1	45	53														CASSPFRTGSTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCAAGGGGACAGGAGCCTACGAGCAGTCCTTCGGGCCG	CASSSKGTGAYEQSF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	15	5	15	19	32	45	37	60														CASSSKGTGAYEQSF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTACAACGGCAGGGCGTCCGAAGGGCGCTGTTTTTTGGAGAA	CASSLQRQGVRRALFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	13	9	12	19	31	45	40	57														CASSLQRQGVRRALFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAATAGGGCTTTTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	8.633800665466789E-5		43	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-04	01	2	5	3	8	2	7	19	34	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGACCGACAGGGCTGGGAGATACGCAGTATTTTGGCCCA	CASRPTGLGDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	5	3	5	19	30	40	33	45														CASRPTGLGDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCAGGCAACTAGCGGGGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.2618631741836078E-4		50	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	2	6	2	19	31	48	37	50														X+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGACGCCCATGACAGATACGCAGTATTTTGGCCCA	CASSLTPMTDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-03	01	3	2	7	3	0	7	19	-1	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPMTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGTTGGGACGGTCGGAAACACCATATATTTTGGAGAG	CASSVGTVGNTIYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-03	01	5	0	7	4	3	4	19	31	39	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTVGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCGTCAAACAGGGGGTAATGAGCAGTTCTTCGGGCCA	CASSRQTGGNEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	7	6	1	19	31	45	37	46														CASSRQTGGNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGGCGAAGGAGACGGTGAAAAACTGTTTTTTGGCAGT	CASSLGEGDGEKLFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-04	01	3	8	0	7	0	11	19	-1	37	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGEGDGEKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCTTACGCCCCCCTAGCTCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	1.7931739843661795E-4		41	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	4	7	5	10	3	19	25	40	35	43						01,02								X+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGAGGGACAACCCACAGATACGCAGTATTTTGGCCCA	CASSLEGQPTDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-03	01	3	0	6	2	3	3	19	33	42	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGQPTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCAAGACAGGGGAGGGGTTCACCCCTCCACTTTGGGAAC	CASSSRQGRGSPLHF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	9	3	5	19	32	43	35	48														CASSSRQGRGSPLHF+TCRBV07-07+TCRBJ01-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCGCTCGGGGGGCGGTGGACACTGAAGCTTTCTTTGGACAA	CASARGAVDTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	1	3	3	6	29	38	48	41	54			01,02											CASARGAVDTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAGGGCGACGGTCTCAACACTGAAGCTTTCTTTGGACAA	CASSQGDGLNTEAFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	2	0	9	29	-1	47	43	56			01,02											CASSQGDGLNTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCCGGGACTTTTAACAATGAGCAGTTCTTCGGGCCA	CASSPGTFNNEQFF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	42	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	5	2	4	29	42	50	44	54			01,02			01,02								CASSPGTFNNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGACCGAGGGGCGATGGTAATGAAAAACTGTTTTTTGGCAGT	CATRPRGDGNEKLFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	6	5	2	4	4	6	18	29	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRPRGDGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGCTGACTCTAACGGGGAGCTGTTTTTTGGAGAA	CATSRDADSNGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	10	7	4	4	18	35	43	39	47						01,02								CATSRDADSNGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTATACAGAGTATGGCTACACCTTCGGTTCG	CATSRDYTEYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	5	4	2	18	35	43	39	45														CATSRDYTEYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTAGACAGGGGGCCTAATGAGCAGTTCTTCGGGCCA	CASSLDRGPNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	7	3	2	18	30	43	33	45														CASSLDRGPNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACGGCCGGGACAGGGGCTTTGTCAGCTTTCTTTGGACAA	CATSTAGTGALSAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	10	5	7	18	31	46	36	53														CATSTAGTGALSAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACAGGGGACACTAAAGCTTTCTTTGGACAA	CATSRGTGDTKAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	2	9	0	6	18	-1	43	34	49														CATSRGTGDTKAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCTGGGCGGCGGTACGCAGTATTTTGGCCCA	CATSRDLGGGTQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	0	8	0	8	3	5	18	35	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLGGGTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGAACTGGGACTAGCGGGGGACCTCACAGATACGCAGTATTTTGGCCCA	CATSREELGLAGDLTDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	60	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	2	6	4	18	35	55	41	59														CATSREELGLAGDLTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGACAGCGCCTTTTCTGGAAACACCATATATTTTGGAGAG	CATSRDSAFSGNTIYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	5	1	0	7	18	-1	38	32	45														CATSRDSAFSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGAGACATAGAGACCCAGTACTTCGGGCCA	CATSRDRDIETQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	6	4	4	1	18	35	43	39	44														CATSRDRDIETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTAGCGCCAACTATGGCTACACCTTCGGTTCG	CATSRGSANYGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	5	6	2	1	2	18	34	40	35	42						01,02								CATSRGSANYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCCTCCGGGACAGGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	3.055037158549787E-4		50	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	1	6	0	18	34	-1	40	49														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTTTGGGACAGGTCTATGGCTACACCTTCGGTTCG	CATSSLGQVYGYTF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	4	3	1	18	32	43	35	44														CATSSLGQVYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCTCCGGGGGCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	3.918417225096466E-4		44	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	2	6	0	2	5	1	18	33	44	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACCAGGGGGAACTCCTACAATGAGCAGTTCTTCGGGCCA	CATSRTRGNSYNEQFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	0	3	2	18	32	42	35	44														CATSRTRGNSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTGGAGGGGAGGTGAGACCCAGTACTTCGGGCCA	CATSRDWRGGETQYF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	1	5	6	1	18	35	47	41	48														CATSRDWRGGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCCCCCCATCAGGGGACTGGCGTAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	68	4.516141886551859E-4		58	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	4	2	8	10	10	18	35	51	45	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAATCGGACAGCCTCGGAAACACCATATATTTTGGAGAG	CATSRESDSLGNTIYF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	5	4	3	4	18	35	44	38	48														CATSRESDSLGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGCCAGGGAGGAGCCGATACGCAGTATTTTGGCCCA	CATSSGQGGADTQYF	In	VDJ	2	87	5.778005060735467E-4	6.734788666976312E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	6	6	4	18	32	44	38	48														CATSSGQGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCCGCGAGGTGTAGACTCTGGAAACACCATATATTTTGGAGAG	CATSSPRGVDSGNTIYF	In	VDJ	3	101	6.707798978554967E-4	7.818547762811581E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	1	0	5	6	18	32	41	37	47														CATSSPRGVDSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACGGGACAGGGGACTGAAAAACTGTTTTTTGGCAGT	CATSTGQGTEKLFF	In	VDJ	3	107	7.106282086191896E-4	8.283015946740982E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	7	1	2	18	31	42	32	44														CATSTGQGTEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCAGGGTCGGATCAGCCCCAGCATTTTGGTGAT	CATSRDPGSDQPQHF	In	VDJ	3	130	8.633800665466789E-4	0.0010063477318470351	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	5	2	4	18	35	42	37	46														CATSRDPGSDQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCCCGGGACAGAGGAACACCCGGGGAGCTGTTTTTTGGAGAA	CATSARDRGTPGELFF	In	VDJ	7	291	0.0019326430720391044	0.002252670692057594	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	6	4	8	18	30	41	34	49														CATSARDRGTPGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAACAGGGGGCGCTGGGCTATACCTTCGGTTCG	CASSQEQGALGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	14	0	10	23	-1	49	40	59													Vb 7.1	CASSQEQGALGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGGGCGGGGGGCAGATCGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	7.30552364001036E-5		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	1	6	4	7	23	40	52	44	59													Vb 7.1	X+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCCAGCGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDPAGGSYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	1	0	3	0	23	40	-1	43	52													Vb 7.1	CASSQDPAGGSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCAGGGAAGAGGAAATGAAAAACTGTTTTTTGGCAGT	YASSQDQGRGNEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	5	1	7	22	39	45	40	52													Vb 7.1	YASSQDQGRGNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGGACTAGCGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSQGTSGTYNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	2	1	2	23	37	49	38	51						01,02							Vb 7.1	CASSQGTSGTYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATACAGGGTAGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	9.962077690923219E-5		43	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	3	7	1	4	23	40	47	41	51													Vb 7.1	X+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTCGCGCACAATGAGCAGTTCTTCGGGCCA	CASSQVAHNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	7	6	5	2	1	23	39	44	41	45						01,02							Vb 7.1	CASSQVAHNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGATACAGGGGGAGACCCAGTACTTCGGGCCA	CASSQIQGETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	2	5	3	0	23	37	-1	40	47													Vb 7.1	CASSQIQGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACCCAGCAGGGGGGGGAGAGCCCCAGCATTTTGGTGAT	CASSQDPAGGGEPQHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	0	4	1	8	5	5	23	40	52	45	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDPAGGGEPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCGTTGGGGGTTTTAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	16	1.0626216203651434E-4		47	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-04	01	1	6	1	4	4	4	23	39	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-04	TCRBV04-01*01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGCCCCCTCCTATGAGCAGTACTTCGGGCCG	XASSQAPSYEQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	9	7	7	1	22	38	48	45	49						01,02							Vb 7.1	XASSQAPSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGTGAGCGGGGGGGCGGGGACCCAGTACTTCGGGCCA	CASSVSGGAGTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	0	7	3	4	23	35	48	38	52													Vb 7.1	CASSVSGGAGTQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAACTCGGGACGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	0	0	7	0	4	2	23	40	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQELGTATNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCTTCGGAGGGTCCAATGAGCAGTTCTTCGGGCCA	CASSPFGGSNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	6	5	2	23	36	47	41	49													Vb 7.1	CASSPFGGSNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGCAGCTAGTAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	1.2618631741836078E-4		44	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	1	5	3	5	9	0	22	38	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATATGGGACAGGGGCAAGGCTACACCTTCGGTTCG	CASSQDMGQGQGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	8	3	3	23	40	53	43	56													Vb 7.1	CASSQDMGQGQGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCCGTGAGGGAGGGACCCAGTACTTCGGGCCA	CASSPREGGTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	1	7	7	0	23	36	-1	43	49													Vb 7.1	CASSPREGGTQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAGGGCGGAAAGCTGAACACTGAAGCTTTCTTTGGACAA	XASSQEGGKLNTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	0	8	0	0	0	7	23	-1	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQEGGKLNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGACCCGGGAGCGGGGTCTTTCAATGAGCAGTTCTTCGGGCCA	XASSQDPGAGSFNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	3	6	6	5	22	39	52	45	57													Vb 7.1	XASSQDPGAGSFNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTTCCGGGACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSSGTGNQPQHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	3	4	4	0	23	34	-1	38	47													Vb 7.1	CASSSGTGNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCGACGGAAGAGTACTATGGCTACACCTTCGGTTCG	CASSQATEEYYGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	1	1	8	3	4	5	23	39	46	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQATEEYYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTTTTGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVLRDTGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	0	3	4	0	23	39	-1	43	48													Vb 7.1	CASSQVLRDTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAAGGCCTGGAGCAGCTATGAGCAGTTCTTCGGGCCA	CASKAWSSYEQFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	2	8	6	5	23	33	43	39	48													Vb 7.1	CASKAWSSYEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGCTCCCACTAGCGCCGAGCAGTACGTCGGGCCA	YASSQAPTSAEQYV	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02			1	3	6	20	5	12	22	38	50	43	62						01,02		TCRBJ02-01,TCRBJ02-05					Vb 7.1	YASSQAPTSAEQYV+TCRBV04-01+TCRBJ02-X	TCRBV04-01*01	TCRBD02-01	TCRBJ02	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAACAGGGGTACGGCTCTCTTAGAAAAACTGTTTTTTGGCAGT	CASSQNRGTALLEKLFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	2	8	1	13	23	38	46	39	59													Vb 7.1	CASSQNRGTALLEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGTCAGCAGCCAAGATAATTGGGAGGAGACCCAGTACTTCGGGCCA	CVSSQDNWEETQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	2	5	5	0	23	40	-1	45	50													Vb 7.1	CVSSQDNWEETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATATCGGGGGACTTGAAGCTTTCTTTGGACAA	CASSQDIGGLEAFF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	0	10	7	6	0	23	40	-1	46	52						01,02							Vb 7.1	CASSQDIGGLEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCAAATAACAAGGTTCAATGGCTACACCTTCGGTTCG	CASSQDQITRFNGYTF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	3	6	6	7	7	23	40	50	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDQITRFNGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCACCAGCAGCCAAGTCAGAAGACTTCCCACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	59	3.918417225096466E-4		46	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	2	10	7	6	5	23	39	49	45	54						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGGAAGAGCCTTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQEGRAFATNEKLFF	In	VDJ	2	77	5.113866548007252E-4	5.960675027093977E-4	54	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	0	0	8	0	0	10	23	-1	44	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQEGRAFATNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAAACAGGGGGTAGTTATGGCTACACCTTCGGTTCG	CASSQETGGSYGYTF	In	VDJ	2	91	6.043660465826753E-4	7.044434122929246E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	5	1	4	23	40	49	41	53													Vb 7.1	CASSQETGGSYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGGTGGGGACAGGGGGATTATTCACCCCTCCACTTTGGGAAC	XASSQGWGQGDYSPLHF	In	VDJ	3	101	6.707798978554967E-4	7.818547762811581E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	1	8	4	3	23	39	54	43	57													Vb 7.1	XASSQGWGQGDYSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAAATGAGGGAGGGAACACTGAAGCTTTCTTTGGACAA	XASSQNEGGNTEAFF	In	VDJ	5	185	0.001228656248547197	0.0014321102337823194	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	1	5	0	23	38	-1	43	49													Vb 7.1	XASSQNEGGNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCATATAAGGGCTGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	7.30552364001036E-5		41	TCRBV06	TCRBV06-09	01				TCRBJ01	TCRBJ01-05	01	7	5	3	4	4	5	26	36	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	X+TCRBV06-09+TCRBJ01-05	TCRBV06-09*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCACCGGTGTGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	9.962077690923219E-5		35	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-02	01	10	6	1	4	7	0	26	33	-1	40	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ01-02	TCRBV10-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSEAGDTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	3	1	0	26	41	-1	42	48			01,02										Vb 12	CASSEAGDTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCACCTTGCCTTGCGAGTGAGTGAAGACCCAGTACTTCGGGCCA	CASTLPCE*VKTQYF	Stop	VDJ	1	18	1.1954493229107863E-4		45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	7	6	6	9	9	26	36	48	45	57			01,02			01,02							Vb 12	CASTLPCE*VKTQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCGAAGACAGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.2618631741836078E-4		47	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	2	3	4	0	26	43	-1	47	55			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCGCTCTTTCGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	1.5275185792748935E-4		35	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	2	5	8	0	26	35	-1	43	46			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAGCTGGGGGGGACGGGGAGACCCAGTACTTCGGGCCA	CASSEAGGDGETQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	5	4	5	26	40	51	44	56			01,02										Vb 12	CASSEAGGDGETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCACCGCTGCCCAAGGGAAGGGCGTGCAGTACTTCGGGCCG	CATAAQGKGVQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	10	0	8	9	11	7	26	33	48	44	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CATAAQGKGVQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTTATCTAGCGGGGGTGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	1.7931739843661795E-4		49	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	3	3	2	26	42	55	45	57			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGCGGCGACGGCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSAATAGNTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	4	1	8	0	26	39	-1	47	52			01,02			01,02							Vb 12	CASSAATAGNTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCGGGACAGCTATCAGCCCCAGCATTTTGGTGAT	CASSRDSYQPQHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	5	2	2	26	37	46	39	48			01,02										Vb 12	CASSRDSYQPQHF+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCACCCCTGAAGGGACAGGGGAGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	36	2.3908986458215725E-4		50	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	0	2	0	8	3	26	33	51	41	54			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-03	TCRBV10-01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGATTAGGGACATGGGTGTTCTTCGGGCCA		Out	VDJ	1	48	3.18786486109543E-4		41	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	6	15	6	5	26	43	55	49	60			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAGCCGGCGGGGGTGACGATGAGCAGTTCTTCGGGCCA	CASSEAGGGDDEQFF	In	VDJ	3	118	7.836834450192932E-4	9.13454095061155E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	8	5	5	26	40	52	45	57			01,02										Vb 12	CASSEAGGGDDEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGGTCGGGCGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	6	222	0.0014743874982566364	0.001718532280538783	42	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-01	01	0	6	2	8	0	7	26	-1	47	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGSGDEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGGGCAGCCGGACTTGGAAACACCATATATTTTGGAGAG	YASRAAGLGNTIYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	1	10	3	7	0	27	38	-1	45	50						01,02								YASRAAGLGNTIYF+TCRBV26-01+TCRBJ01-03	TCRBV26-01*01	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGCCCGAGTTGAATGAGCAGTTCTTCGGGCCA	CASSEPELNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	7	7	1	8	23	35	39	36	47		TCRBV06-04,TCRBV06-08				unresolved								CASSEPELNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAACCCGGGATTAGCGGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASNPGLAGPGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	5	3	6	9	1	26	36	53	45	54		TCRBV06-07,TCRBV06-09												CASNPGLAGPGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCGGGACATCCTCACTGAAGCTTTCTTTGGACAA	CASSRDILTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	4	1	4	18	30	37	31	41		TCRBV07-02,TCRBV07-08												CASSRDILTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRRRGACTCRGCCSTGTATCTCTRCGCCAGCAGCCAAGTGATGACCGTTGAAGCTTTCTTTGGACAA	XASSQVMTVEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV04	unresolved					TCRBJ01	TCRBJ01-01	01	1	2	7	7	4	3	22	38	45	42	48		TCRBV04-01,TCRBV04-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQVMTVEAFF+TCRBV04-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTGATTCCACAGGGGACTATGGCTACACCTTCGGTTCG	CASSDSTGDYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	3	6	0	26	38	-1	44	51		TCRBV06-07,TCRBV06-09												CASSDSTGDYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAAGGTCCGGAGGGGAATTACAGCCCCAGCATTTTGGTGAT	CASSERSGGELQPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	0	7	6	6	24	39	51	45	57		TCRBV06-01,TCRBV06-04												CASSERSGGELQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTATTGGGTTGAAGAGACCCAGTACTTCGGGCCA	CASSYWVEETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	3	0	9	3	2	3	23	37	42	39	45		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWVEETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGCTAGCGGGGGGGCGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	9.297939178195004E-5		46	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	3	0	3	26	-1	51	39	54		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCCTGACAGGGGAGACTGAGCAGTTCTTCGGGCCA	CASSLTGETEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	9	2	4	22	34	44	36	48		TCRBV07-01,TCRBV07-08												CASSLTGETEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATTTCACCAGGATCACGACGAGCAGTACGTCGGGCCG	CASSEFHQDHDEQYV	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	17	7	18	28	42	53	49	71		TCRBV06-01,TCRBV06-04,TCRBV06-08												CASSEFHQDHDEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACCACTACAGGGTAGGCACTGAAGCTTTCTTTGGACAA	CASSDHYRVGTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	4	5	4	23	37	48	42	52		TCRBV10-01,TCRBV10-02												CASSDHYRVGTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCTGTRTACTTSTGTGCCAGCAGCGAGCTATCCTCGAACGTGGGGTCTGCAGGTCGTAGGACTGAAGCTTTCTTTGGACAA	CASSELSSNVGSAGRRTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	63	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	6	4	4	5	26	7	12	23	53	49	60		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELSSNVGSAGRRTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGTCGGCGGGGACGCTAATGAAAAACTGTTTTTTGGCAGT	CASSVGGDANEKLFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	7	3	3	3	3	28	41	50	44	53		TCRBV06-04,TCRBV06-08												CASSVGGDANEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATATGAGGGGAGTAATTCACCCCTCCACTTTGGGAAC	CASSEYEGSNSPLHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	2	5	2	6	4	2	23	38	47	42	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEYEGSNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCACCCTATTCGGCACTGAAGCTTTCTTTGGACAA	CATLFGTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	4	9	4	2	5	26	33	38	35	43		TCRBV06-07,TCRBV06-09				01,02								CATLFGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGACAGGGGGTTCTTAGTTCACCCCTCCACTTTGGGAAC	CASRQGVLSSPLHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	9	0	7	19	-1	38	30	45		TCRBV07-05,TCRBV07-07												CASRQGVLSSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCGACGCCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSYSTPGNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	1	5	0	28	45	-1	50	54		TCRBV06-04,TCRBV06-07				01,02								CASSYSTPGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAATCTAACCCCCCAGGTGACGAAAAACTGTTTTTTGGCAGT	CASSESNPPGDEKLFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	8	10	4	23	38	52	48	56		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSESNPPGDEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAGGCGGCGGCCGGCCGCTACGAGCAGTACTTCGGGCCG	CASSEAAAGRYEQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	3	3	10	23	35	42	38	52		TCRBV06-07,TCRBV06-08				01,02								CASSEAAAGRYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCTCCGAGACAGGGGGCAAGAGGGCCTGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.328277025456429E-4		50	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	7	7	9	23	34	51	41	60		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGCGGGACAGGGATGATTGGCTACACCTTCGGTTCG	CASSGTGMIGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	7	1	5	23	34	44	35	49		TCRBV06-08,TCRBV06-09												CASSGTGMIGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCTCTGATGGGTCTTCCACAGATACGCAGTATTTTGGCCCA	CASSSDGSSTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	6	0	9	2	7	5	23	34	44	41	49		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDGSSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAGCCCTGGACTAGCAGAACCTACGAGCAGTACGTCGGGCCG	CASSEPWTSRTYEQYV	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	17	7	19	23	35	50	42	69		TCRBV06-07,TCRBV06-08				01,02								CASSEPWTSRTYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTTGGTGAACACTGAAGCTTTCTTTGGACAA	CASSYLVNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	1	0	10	0	1	0	23	39	-1	40	42		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLVNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCTCAGGGGAGAGTTCACCCCTCCACTTTGGGAAC	CASSSSGESSPLHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	0	5	2	9	0	4	26	-1	48	43	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSGESSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCGACAGGGGGACATCCTCCGGAGCGAAAAACTGTTTTTTGGCAGT	CASSRQGDILRSEKLFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	8	1	14	18	30	40	31	54		TCRBV07-06,TCRBV07-07												CASSRQGDILRSEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGAGTGGGACGGTGAATTCACCCCTCCACTTTGGGAAC	CASSDSSGTVNSPLHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	0	0	7	7	4	4	23	40	49	44	53		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSSGTVNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCTTTAACGACAGGATAGGGACCCAGTACTTCGGGCCA	CAIFNDRIGTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	2	4	7	8	5	23	30	44	38	49		TCRBV06-04,TCRBV06-08												CAIFNDRIGTQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCCTCCCARACATCTGTGTACTTSTGTGCCTTCCGACAGGACGGCACCGGGGAGCTGTTTTTTGGAGAA	CAFRQDGTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	2	4	4	4	4	23	29	39	33	43		TCRBV06-02,TCRBV06-03,TCRBV06-08												CAFRQDGTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGTTACGGAGACCTACGAGCAGTACTTCGGGCCG	CASSLVTETYEQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	2	4	1	19	35	43	39	44		TCRBV07-05,TCRBV07-06												CASSLVTETYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAGCCGAGGGGCCAGTAAACAGCCCCAGCATTTTGGTGAT	CASSSRGASKQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-05	01	5	5	2	7	5	8	26	38	48	43	56		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGASKQPQHF+TCRBV06-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGGACAGGGGGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTGGHTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	1	3	0	2	26	-1	49	38	51		TCRBV06-07,TCRBV06-08												CASSGTGGHTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGRGGACTCMGCYGTGTATCTCTGTGCCAGCAGCTTAGGTGACGGGTATGGCTACACCTTCGGTTCG	CASSLGDGYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	5	4	0	22	38	-1	42	46		TCRBV07-04,TCRBV07-08				01,02								CASSLGDGYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCCTCCCARACATCTGTGTACTTSTGTGCCAGCAGTTCGGGGAGCCGCGGCAATGAGCAGTTCTTCGGGCCA	CASSSGSRGNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	3	6	0	8	25	-1	43	38	51		TCRBV06-02,TCRBV06-03,TCRBV06-08				01,02								CASSSGSRGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGTACCCCCACTAGATCTCCCTACAATGAGCAGTTCTTCGGGCCA	CASTPTRSPYNEQFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	3	8	2	7	5	26	34	46	41	51		TCRBV06-07,TCRBV06-09				01,02								CASTPTRSPYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTCCGAGGGCCGCAGAGCGGGGAGCTGTTTTTTGGAGAA	CASSLRGPQSGELFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	7	4	8	18	30	39	34	47		TCRBV11-01,TCRBV11-03												CASSLRGPQSGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCCTTAGCGGGGGGATAGGAGATACGCAGTATTTTGGCCCA	CASSFLSGGIGDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	5	3	5	18	32	45	35	50		TCRBV11-01,TCRBV11-03												CASSFLSGGIGDTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAAGTGGGACAGGGGCACTTGGAGGCTACACCTTCGGTTCG	CASSLSGTGALGGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	8	3	8	19	34	47	37	55		TCRBV07-05,TCRBV07-07												CASSLSGTGALGGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCAGTTCGGTCAGTCCTTCTACAATGAGCAGTTCTTCGGGCCA	CASSQFGQSFYNEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	5	4	5	3	0	14	23	-1	38	35	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFGQSFYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCTCAGGGAGGGCACTGAAGCTTTCTTTGGACAA	CASSLREGTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	4	4	0	23	35	-1	39	46		TCRBV06-07,TCRBV06-08												CASSLREGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCTAGCGGGGCGATCCATGAGCAGTTCTTCGGGCCA	CASSDSSGAIHEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	0	6	23	-1	48	40	54		TCRBV06-04,TCRBV06-08												CASSDSSGAIHEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACACCGTAGGGGCTTCTGAGGGCACTGAAGCTTTCTTTGGACAA	CASSYTVGASEGTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	51	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	2	5	2	4	5	10	23	38	48	43	58		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTVGASEGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCATAGACAGGCCTACTATGGCTACACCTTCGGTTCG	CASHRQAYYGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	4	3	4	3	23	32	42	36	45		TCRBV06-07,TCRBV06-08												CASHRQAYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCGCTGGCCCTACCAAGAGACCCAGTACTTCGGGCCA	CASRWPYQETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	9	0	0	4	3	23	32	39	36	42		TCRBV06-07,TCRBV06-08												CASRWPYQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAAGTCAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	1.593932430547715E-4		40	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	5	4	3	1	19	34	40	37	41		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCAAGAAGGGTTTACTGGAAACACCATATATTTTGGAGAG	CASSQEGFTGNTIYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-03	01	5	5	3	2	5	4	18	30	39	35	43		TCRBV07-02,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGFTGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGACTGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRLTGNTEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	3	0	23	34	-1	37	43		TCRBV06-04,TCRBV06-08												CASRLTGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAACAGTGACCCTACAGGGGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CANSDPTGGGGETQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	1	4	4	6	26	40	52	44	58		TCRBV10-01,TCRBV10-02												CANSDPTGGGGETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCCGGGAAGGGCCTGTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	26	1.7267601330933578E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	8	3	17	2	21	23	33	40	35	61		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTGACATCGAGGGGGCCCAGTTCTTCGGGCCA	CASSDIEGAQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	13	7	1	23	35	49	42	50		TCRBV06-08,TCRBV06-09												CASSDIEGAQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCTTTCCCGGGACAGGGTATCGAAGCTTTCTTTGGACAA	CASSPFPGQGIEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	8	8	4	26	38	55	46	59		TCRBV06-07,TCRBV06-08												CASSPFPGQGIEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACACTAGCGGGGGGTTGAATGAGCAGTTCTTCGGGCCA	CASSYTSGGLNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	7	0	3	26	-1	53	41	56		TCRBV06-07,TCRBV06-08												CASSYTSGGLNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASGACTCSGCYGTGTATCTCTGTGCCAGCAGCTCCCTTGGTGGGCACAATGAGCAGTTCTTCGGGCCA	CASSSLGGHNEQFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	5	8	0	19	32	-1	40	44		TCRBV07-05,TCRBV07-08												CASSSLGGHNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCACTAGCGGCCAATTTAGTAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.8595878356390008E-4		46	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	5	3	0	11	22	-1	39	32	50		TCRBV07-01,TCRBV07-02				01,02								X+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCCCAACGGAATCTATGGCTACACCTTCGGTTCG	CASTPNGIYGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	7	1	8	4	8	2	23	33	44	41	46		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPNGIYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCTGCCGGGGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSYSAGGVYNEQFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	3	3	1	23	40	51	43	52		TCRBV06-07,TCRBV06-08												CASSYSAGGVYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTTACGCAGATACGCAGTATTTTGGCCCA	CASSYADTQYF	In	VJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	33	TCRBV06	unresolved		unresolved			TCRBJ02	TCRBJ02-03	01	2	0	0	4	0	1	26	-1	41	-1	42		TCRBV06-07,TCRBV06-09		TCRBD02										CASSYADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTTAGCGGGGGGGACGAATGAGCAGTTCTTCGGGCCA	CASSYLAGGTNEQFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	0	7	0	3	26	-1	53	42	56		TCRBV06-07,TCRBV06-08												CASSYLAGGTNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCGGATGGACTAGCGGGGGTGCAGATACGCAGTATTTTGGCCCA	CASSGWTSGGADTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	4	4	2	18	30	47	34	49		TCRBV07-02,TCRBV07-06												CASSGWTSGGADTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCCCTAGCGGGGGATACCGGGGAGCTGTTTTTTGGAGAA	CASSDSLAGDTGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	5	1	2	28	45	56	46	58		TCRBV06-04,TCRBV06-08												CASSDSLAGDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGAAGGGCACGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSEGHATGELFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	5	5	3	4	2	5	26	38	44	40	49		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGHATGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCGCGGGGGATTACAGGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	32	2.1252432407302868E-4		44	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	2	7	0	9	18	-1	37	30	46		TCRBV07-06,TCRBV07-07												X+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTTGGTGKYMRGRRRMMMAGCACGGTATTTCTGTGCCAGCACCGGGACAGGTGAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	32	2.1252432407302868E-4		50	TCRBV21	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	0	4	0	5	5	31	38	51	43	56		TCRBV21-01,TCRBV21-or09_02												X+TCRBV21-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGAACGGGATGGGAGAAGGTGTTTTTTGGAGAA		Out	VDJ	1	33	2.1916570920031082E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	3	15	2	10	23	38	45	40	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAATCTCTTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASNLLGTGELFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	7	6	2	5	7	0	28	38	-1	45	49		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNLLGTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCTTCCCTTACTGTTGCGGGGGGGCCCGGAATGAGCAGTTCTTCGGGCCA	CASFPYCCGGARNEQFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	0	7	13	5	23	32	54	45	59		TCRBV06-07,TCRBV06-08												CASFPYCCGGARNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCTCACCTCAGAAAGGACAGGGGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	2.2580709432759295E-4		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	1	2	8	12	2	23	29	50	41	52		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTCGCGACAGGGCCTATGTTTCTTCGGGCCA	CASSSRQGLCFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	16	3	7	26	39	49	42	56		TCRBV06-04,TCRBV06-07												CASSSRQGLCFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGCTGGGACACACAATGAGCAGTTCTTCGGGCCA	CASSAGTHNEQFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	5	3	1	23	35	44	38	45		TCRBV06-07,TCRBV06-08												CASSAGTHNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGAACAGCATGAACACTGAAGCTTTCTTTGGACAA	CASSYSNSMNTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	0	2	2	26	43	49	45	51		TCRBV06-07,TCRBV06-08												CASSYSNSMNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGCTGGGTCAGCTTTCTTTGGACAA	CASSYSAGSAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	0	0	9	10	4	2	26	43	50	47	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSAGSAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAACTATCCCCTCGAAAGAGATACGCAGTATTTTGGCCCA	CASNYPLERDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	9	5	0	12	26	-1	40	36	52		TCRBV06-07,TCRBV06-08				01,02								CASNYPLERDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCTTCCAGGGGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASTFQGRGNTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	0	1	8	1	23	33	48	41	49		TCRBV06-07,TCRBV06-08												CASTFQGRGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAACAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	38	2.5237263483672155E-4		37	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	5	4	0	1	26	-1	44	40	45		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCTGGAGAAAGTCCTGAAGCTTTCTTTGGACAA	CASSYSGESPEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	6	1	6	26	43	48	44	54		TCRBV06-07,TCRBV06-08												CASSYSGESPEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCGCACCGCACACCTTTAACTATGGCTACACCTTCGGTTCG	CASAPHTFNYGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	6	1	7	4	19	28	38	35	42		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASAPHTFNYGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTTGGGACAGCCGATCAGCCCCAGCATTTTGGTGAT	CASSFGTADQPQHF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	5	1	3	19	33	41	34	44		TCRBV07-05,TCRBV07-07												CASSFGTADQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	2.7893817534585015E-4		37	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	2	1	8	2	0	0	26	-1	-1	41	44		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGATAGAAGCAGATACGCAGTATTTTGGCCCA	CASSESIEADTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	8	4	2	3	26	43	48	45	51		TCRBV10-01,TCRBV10-02				01,02								CASSESIEADTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTCTTTATCGGGGATACGCAGTATTTTGGCCCA	CASSVFIGDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	39	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	6	7	0	26	39	-1	46	50		TCRBV10-01,TCRBV10-02				01,02								CASSVFIGDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAATGGGGTTGCGGAAAAACTGTTTTTTGGCAGT	CASNGVAEKLFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	36	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	7	6	2	8	2	5	26	36	42	38	47		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGVAEKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCTGCAGGGAACAATCAGCCCCAGTATTTTGGTGAT		Out	VDJ	1	45	2.988623307276966E-4		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	17	4	16	28	39	48	43	64		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTGCCAGCAGCCCCGTCACCCTTTGGCTAGCGGGGGGGCCGGGGTGAGAAAAGGAGACCCAGTACTTCGGGCCA	CASSPVTLWLAGGPG*EKETQYF	Stop	VDJ	1	45	2.988623307276966E-4		69	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	5	16	15	0	11	39	27	54		TCRBV06-01,TCRBV06-02,TCRBV06-03,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSPVTLWLAGGPG*EKETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCAACAGGTCGCGGGCGGGGAACTGTTTTTTGGAGAA	CASSQQVAGGELFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	3	14	13	2	23	35	54	48	56		TCRBV06-07,TCRBV06-08												CASSQQVAGGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTGTGGGGAGAGAGCACTGAAGCTTTCTTTGGACAA	CASSLWGESTEAFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	2	4	2	4	19	34	41	36	45		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSLWGESTEAFF+TCRBV05-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGATTTAAAGACTAGCGGAGCTCCTACGAGCAGTACGTCGGGCCG	CASRFKD*RSSYEQYV	Stop	VDJ	1	49	3.2542787123682513E-4		48	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	5	17	7	19	18	29	45	36	64		TCRBV11-01,TCRBV11-03				01,02								CASRFKD*RSSYEQYV+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTCAAAGGACAGGTGGCGAAAAACTGTTTTTTGGCAGT	CASSQRTGGEKLFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	4	8	4	4	26	38	49	42	53		TCRBV06-07,TCRBV06-09												CASSQRTGGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGCCCGGGACAGGGCCTTCACCCCTCCACTTTGGGAAC	CASRPGTGPSPLHF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	9	4	2	23	34	47	38	49		TCRBV06-07,TCRBV06-08												CASRPGTGPSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCACGCGGACAGGGGGGTCCAGATACGCAGTATTTTGGCCCA	CASSYSRGQGGPDTQYF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	1	4	4	3	23	40	54	44	57		TCRBV06-07,TCRBV06-08												CASSYSRGQGGPDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAGGTAGCGGGGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	3	0	26	43	-1	46	54		TCRBV10-01,TCRBV10-02												CASSESGSGDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCACAGGGGACCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPTGDLSGANVLTF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	2	0	4	4	23	34	45	38	49		TCRBV06-04,TCRBV06-08												CASSPTGDLSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGTAGCCCAGGGGGCGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	66	4.3833141840062163E-4		40	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	4	0	5	5	2	23	31	44	36	46		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCCGGGGTACGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSEAGVRTYNEQFF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	2	0	6	23	-1	45	40	51		TCRBV06-01,TCRBV06-07												CASSEAGVRTYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCGCGTGTGACCTTGGATTTAGGGTAGTACCCAGTACTTCGGGCCA		Out	VDJ	2	87	5.778005060735467E-4		47	TCRBV10	unresolved					TCRBJ02	TCRBJ02-05	01	8	5	3	8	18	4	23	32	54	50	58		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCAGCCGGGACTAGCGGGGGTAACAATGAGCAGTTCTTCGGGCCA	CASSYSAGTSGGNNEQFF	In	VDJ	3	104	6.907040532373431E-4	8.050781854776281E-4	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	2	5	4	2	23	40	58	44	60		TCRBV06-07,TCRBV06-08												CASSYSAGTSGGNNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCGCCGGGACAGGGTCTGAAGCTTTCTTTGGACAA	CASSFAGTGSEAFF	In	VDJ	3	108	7.172695937464718E-4	8.360427310729215E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	6	4	1	18	32	45	36	46		TCRBV11-01,TCRBV11-03												CASSFAGTGSEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTATCGTCGACAGGGAACATCTATGGCTACACCTTCGGTTCG	CASSLSSTGNIYGYTF	In	VDJ	3	110	7.305523640010361E-4	8.515250038705681E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	7	5	23	36	50	43	55		TCRBV06-07,TCRBV06-08												CASSLSSTGNIYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTATTGCAGGGCCCTTCTAATACGCAGTATTTTGGCCCA	CASSLLQGPSNTQYF	In	VDJ	4	152	0.0010094905393468862	0.0011766527326211487	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	7	3	8	18	33	41	36	49		TCRBV11-01,TCRBV11-03												CASSLLQGPSNTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCGAAGTAACAGGACAGAGAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	53	2084	0.013840646605255993		56	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	5	1	11	4	25	36	53	47	57		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTACATAGGCTACTATGGCTACACCTTCGGTTCG	CASSYIGYYGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	4	3	6	3	0	6	22	-1	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYIGYYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGACCACAGGGGGCAGAGACCCAGTACTTCGGGCCA	CASRPQGAETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	4	3	0	22	33	-1	36	45														CASRPQGAETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAGACAGGGATCTAATTCACCCCTCCACTTTGGGAAC	CASSRQGSNSPLHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	6	1	3	22	34	42	35	45														CASSRQGSNSPLHF+TCRBV07-01+TCRBJ01-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAATAGGCAGGGGGCTGGGAGAGACCCAGTACTTCGGGCCA	CASSLIGRGLGETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	4	7	4	22	35	50	42	54														CASSLIGRGLGETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGATCGTAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLAIVGGQETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	1	6	0	22	39	-1	45	51														CASSLAIVGGQETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GTATCTCTGTGCCAGCAGCTCCCGTGGGGTCCTCGGGAACCTTGAACGAGGGGGCGTGGAGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	1.3946908767292507E-4		74	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	1	27	7	7	21	55	48	62														X+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGCCCAGGAATCCCGAAACACCATATATTTTGGAGAG	CASSAQESRNTIYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	4	5	3	6	22	34	41	37	47														CASSAQESRNTIYF+TCRBV07-01+TCRBJ01-03	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCAGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSQGLNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	0	0	1	20	-1	38	32	39			01,02											CASSQGLNTEAFF+TCRBV07-08+TCRBJ01-01	TCRBV07-08	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCTCCGGAGGGGAGCGGGGGGGCCGGGCCATGAGCAGTTCTTCGGGCCA	CASSLRRGAGGPGHEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	54	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	8	11	7	20	32	53	43	60			01,02											CASSLRRGAGGPGHEQFF+TCRBV07-08+TCRBJ02-01	TCRBV07-08	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCTACTAGCGGGGGGCTACAATGAGCAGTTCTTTGGGCCA	CASSLLAGGYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	01	TCRBJ02			5	3	1	22	2	19	20	32	46	34	65			01,02					TCRBJ02-01,TCRBJ02-05						CASSLLAGGYNEQFF+TCRBV07-08+TCRBJ02-X	TCRBV07-08	TCRBD02-01*01	TCRBJ02	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTCTCAGGTTACAGATACGCAGTATTTTGGCCCA	CASSSQVTDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	3	2	2	20	33	39	35	41			01,02											CASSSQVTDTQYF+TCRBV07-08+TCRBJ02-03	TCRBV07-08	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGGGGTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWGSNTGELFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	5	6	2	0	1	2	23	35	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSWGSNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTTGCGACAGAAAACACTGAAGCTTTCTTTGGACAA	CASSFATENTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	2	5	2	23	35	45	40	47													Vb 12	CASSFATENTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGATCTTACAGAAATACTGAGTATACGCAGTATTTTGGCCCA	CASGSYRNTEYTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	3	5	7	7	11	23	32	43	39	54													Vb 12	CASGSYRNTEYTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACTTAGGACGGACCCTATGGCTACACCTTCGGTTCG	CAST*DGPYGYTF	Stop	VDJ	1	14	9.297939178195004E-5		39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	7	1	7	4	4	5	23	33	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAST*DGPYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCCGGGGACAGGAGGTAATCAGCCCCAGCATTTTGGTGAT	CASSPGTGGNQPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	4	4	4	23	34	46	38	50													Vb 12	CASSPGTGGNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACGGCAGGAGGGTCACTGAAGCTTTCTTTGGACAA	CASSDGRRVTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	4	5	1	23	37	48	42	49													Vb 12	CASSDGRRVTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCATCGGGGGGTATAATTCACCCCTTCACTTTGGGAAC		Out	VDJ	1	15	9.962077690923219E-5		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	1	19	2	15	23	40	49	42	64													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGCGGGAGACGAATGAAAAACTGTTTTTTGGCAGT	CASSESRETNEKLFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	7	2	5	0	3	23	-1	47	40	50													Vb 12	CASSESRETNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGCCGGCCAGGGGGCATCCTATAATTCACCCCTCCACTTTGGGAAC	CASRAGQGASYNSPLHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	0	1	7	1	23	34	49	41	50													Vb 12	CASRAGQGASYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCGGGACAGGGGAGAACTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	1.0626216203651434E-4		50	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	4	2	6	23	37	49	39	55													Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGTCGGGGGGGCTTAATGAGCAGTTCTTCGGGCCA	CASRSGGLNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	7	2	3	23	34	44	36	47													Vb 12	CASRSGGLNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCACGGACTAGCGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEHGLAGGNTGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	54	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	1	1	1	3	0	23	38	-1	41	55													Vb 12	CASSEHGLAGGNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGGGGGGTGCGTCGGGACCAAGAGACCCAGTACTTCGGGCCA	CASGGVRRDQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	9	0	0	0	9	23	-1	39	32	48													Vb 12	CASGGVRRDQETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCAGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSEPGANYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	2	4	4	0	1	2	23	38	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEPGANYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGAGGGGGCGGTCAGCCCCAGCATTTTGGTGAT	CASSESGGGGQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	5	0	6	3	2	23	40	50	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGGGQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGTACGGGGAATTAGACTATGGCTACACCTTCGGTTCG	CASSESYGELDYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	3	3	6	23	40	48	43	54													Vb 12	CASSESYGELDYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCCTGGCACGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.1954493229107863E-4		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	9	0	0	3	4	23	32	38	35	42													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCAGGGGTTATAACTATGGCTACACCTTCGGTTCG	CASSESRGYNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	1	0	3	23	-1	46	40	49													Vb 12	CASSESRGYNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCAGACAGGTGTTGGATGGCTACACCTTCGGTTCG	CASSRQVLDGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	6	2	6	23	34	42	36	48													Vb 12	CASSRQVLDGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAAGTGAGGTTGGAGCTGACTATGGCTACACCTTCGGTTCG	CASSESSEVGADYGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	2	3	10	3	23	40	54	50	57													Vb 12	CASSESSEVGADYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAACGGCTTCTGAAGCTTTCTTTGGACAA	CASSETASEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	3	9	0	6	3	2	23	37	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSETASEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAACAGGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	1.5275185792748935E-4		40	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	3	4	1	1	23	37	44	38	45													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGGCGTGCTTTACGAGCAGTACGTCGGGCCG	CASSEGVLYEQYV	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	3	4	5	17	16	4	23	37	56	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGVLYEQYV+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCTTAGACAGGGGAGCCTACGAGCAGTACTTCGGGCCG	CATLDRGAYEQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	2	2	5	2	23	30	43	35	45													Vb 12	CATLDRGAYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCCCCCGCGGGAGTTACGCAGTATTTTGGCCCA	CASSAPAGVTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	8	5	1	23	36	48	41	49													Vb 12	CASSAPAGVTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGATGGGGGAGTACCCTTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	1.7267601330933578E-4		50	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	2	6	1	3	2	11	23	38	45	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGACGGACAGGGGACTATGGCTACACCTTCGGTTCG	CASSRRTGDYGYTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	3	5	0	23	34	-1	39	48													Vb 12	CASSRRTGDYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAACAGGGCCCTACCTACAATGAGCAGTTCTTCGGGCCA	CASKQGPTYNEQFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	2	1	5	23	33	40	34	45													Vb 12	CASKQGPTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGAATCCAGACCGAGGACACTGAAGCTTTCTTTGGACAA	CASRIQTEDTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	1	3	12	0	23	32	-1	44	48													Vb 12	CASRIQTEDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTGGGGACAGGGGGCCTATGAGCAGTTCTTCGGGCCA	CASSEWGQGAYEQFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	0	8	1	2	23	39	52	40	54													Vb 12	CASSEWGQGAYEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGAGTGGACGGAAACACCATATATTTTGGAGAG	CASSRVDGNTIYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	5	1	7	4	5	0	23	35	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSRVDGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGGCCTAATTACGGGGGCAGATACGCAGTATTTTGGCCCA	CASSDGLITGADTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	2	4	11	0	23	37	-1	48	54													Vb 12	CASSDGLITGADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCTTAGGACGGAACACTGAAGCTTTCTTTGGACAA	CASTLGRNTEAFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	7	1	7	1	5	1	23	33	42	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASTLGRNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGAGGGGTCGGTTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSESRGRLGTGELFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	51	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	0	5	2	4	1	9	23	40	46	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESRGRLGTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGCTAGGACTTTCTGGAGCTTTCTTTGGACAA	CASSESLGLSGAFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	1	10	10	4	6	23	40	49	44	55						01,02							Vb 12	CASSESLGLSGAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGCCAGGGACAGCTAAGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	44	2.922209456004144E-4		44	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	8	4	7	23	34	45	38	52													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCATCGGGGGGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	47	3.1214510098226086E-4		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	1	4	2	0	23	40	-1	42	49													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGGCAATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSERAISNQPQHF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	2	5	3	0	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSERAISNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCCTGAAGGGGGATGTAACTAATGAAAAACTGTTTTTTGGCAGT	CATLKGDVTNEKLFF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	5	1	1	6	4	23	30	42	36	46													Vb 12	CATLKGDVTNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAGGGACCGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSRDRTYNEQFF	In	VDJ	4	152	0.0010094905393468862	0.0011766527326211487	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	5	0	7	2	1	4	23	35	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSRDRTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGGGTGGAGGTCAGCCCCAGCATTTTGGTGAT	CASSESGGGGQPQHF	In	VDJ	7	262	0.0017400429033479223	0.002028177736491717	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	6	1	6	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGGGQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACCCGGGACAGGGGGTCTATGGCTACACCTTCGGTTCG	CASNPGQGVYGYTF	In	VDJ	45	1756	0.011662272283507448	0.013593435516333798	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	4	4	1	23	33	48	37	49													Vb 12	CASNPGQGVYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAGTCAAGAGGGGGGTCGGATGGCTACACCTTCGGTTCG	CAISESRGGSDGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	0	5	1	6	3	5	24	41	50	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESRGGSDGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGATAAGAACTGAAGCTTTCTTTGGACAA	CAISEIRTEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	2	8	5	4	0	23	38	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEIRTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGACCTCGACCGGGACAGGGTGGAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CAISGPRPGQGGGTYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	60	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	2	10	8	21	34	53	44	61													Vb 12	CAISGPRPGQGGGTYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCCGCAGACCCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	13	8.633800665466789E-5		44	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-06	01	2	2	7	7	6	2	23	38	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ01-06	TCRBV10-03*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGAAGGAGGGGGTCGGGACTACACCTTCGGTTCG	CAISEEGGGRDYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	2	5	1	10	5	6	23	38	49	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEEGGGRDYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGACCCACTCTAGCGGGGGGGCCGAAAAATGAGCAGTTCTTCGGGCCA	CARPTLAGGPKNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	4	0	7	8	6	24	31	51	39	57													Vb 12	CARPTLAGGPKNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGTGACTCCGGGACAGACCTCCACGAGCAGTACTTCGGGCCG	CASDSGTDLHEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	5	5	8	6	24	31	46	39	52													Vb 12	CASDSGTDLHEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCGCGGGGGGCCTGGAATTCACCCCTCCACTTTGGGAAC	CAISESRGAWNSPLHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	7	1	7	0	5	23	-1	48	40	53													Vb 12	CAISESRGAWNSPLHF+TCRBV10-03+TCRBJ01-06	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCGCCAGGACAGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CAARTGASTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	1	2	0	4	2	24	30	43	34	45													Vb 12	CAARTGASTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGACTAGACAGGGAAGAGACCCAGTACTTCGGGCCA	CAIRLDREETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	3	4	0	24	35	-1	39	46													Vb 12	CAIRLDREETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGACAGGACTAGCGAAACCCCTGTCGACGCAGTATTTTGGCCCA	CAISESTGLAKPLSTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	6	9	4	12	23	40	53	44	65						01,02							Vb 12	CAISESTGLAKPLSTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTGTGCCATCAGTGCCGAAGCCCTACAGGGGGCGTCCGGTGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	18	1.1954493229107863E-4		67	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	0	0	10	10	3	16	35	26	45													Vb 12	X+TCRBV10-03+TCRBJ01-06	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCGGCGGACAGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CAGGQTSNQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	1	5	0	3	2	24	30	39	33	41													Vb 12	CAGGQTSNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGCCCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	1.6603462818205365E-4		37	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	6	0	3	23	-1	41	38	44													Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGACTAGGGCCGATACGTAGTATTTTGGCCCA	CAISETRADT*YF	Stop	VDJ	1	29	1.9260016869118224E-4		39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	8	13	0	11	23	-1	43	38	54						01,02							Vb 12	CAISETRADT*YF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCCGGGCACTGAAGCTTTCTTTGGACAA	CAISESPGTEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	2	0	23	40	-1	42	46						01,02							Vb 12	CAISESPGTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGAAGCGTCTCACGCACAGATACGCAGTATTTTGGCCCA	CAISGSVSRTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	6	1	2	6	24	37	43	39	49						01,02							Vb 12	CAISGSVSRTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCGACTAGTGGATGCAGATACGCAGTATTTTGGCCCA	CASRLVDADTQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	2	8	4	3	6	24	31	40	34	46						01,02							Vb 12	CASRLVDADTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTTGGGACTAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISELGLANTGELFF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	8	0	1	0	23	39	-1	40	48						01,02							Vb 12	CAISELGLANTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGGCAGGGCAGCGGGGAGCTGTTTTTTGGAGAA	CAISESRQGSGELFF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	7	4	3	23	40	49	44	52													Vb 12	CAISESRQGSGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGCAGGGACCTTCAACACCATATATTTTGGAGAG	CAISESAGTFNTIYF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-03	01	0	0	7	7	4	4	23	40	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESAGTFNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGATCATTCAGGGCTTTCTTTGGACAA	CASSMGSFRAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	11	0	9	27	-1	45	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGSFRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGACTAGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGAYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	2	2	0	27	39	-1	41	55			01,02										Vb 17	CASSPGLAGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGTCCGGGACAGTCAAGTTCTCTGGAAACACCATATATTTTGGAGAG	CASSIGSGTVKFSGNTIYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	7	7	24	38	52	45	59			01,02										Vb 17	CASSIGSGTVKFSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGATAACGTGGAAACACCATATATTTTGGAGAG	CAR*RGNTIYF	Stop	VDJ	1	13	8.633800665466789E-5		33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	9	3	7	3	3	1	27	35	40	38	41			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAR*RGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGGGGCAGAACGAGGGTCACCCCTCCACTTTGGGAAC	CASTPGAERGSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	7	7	0	10	5	10	27	37	47	42	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPGAERGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAATTCGGGTTCGGATCAGCCCCAGCATTTTGGTGAT	CASSNSGSDQPQHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	8	4	5	5	5	27	38	47	43	52			01,02			01,02							Vb 17	CASSNSGSDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGACAGGGGCTCCAACGATGAGCAGTTCTTCGGGCCA	CASSRDRGSNDEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	0	8	27	-1	50	40	58			01,02										Vb 17	CASSRDRGSNDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGACTGACCAACACAGATACGCAGTATTTTGGCCCA	CASGLTNTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	10	2	0	6	27	-1	41	36	47			01,02			01,02							Vb 17	CASGLTNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAAGAACACTGAAGCTTTCTTTGGACAA	CASTKNTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	6	1	1	1	27	37	40	38	41			01,02										Vb 17	CASTKNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAACCCCGAGGGGGGGGACCTGAAGCTTTCTTTGGACAA	CASSKPRGGGPEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	6	8	3	27	40	55	48	58			01,02										Vb 17	CASSKPRGGGPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGTCGGTGGCGGGTGCGTTTCTGACCGGGGAGCTGTTTTTTGGAGAA	CASSKSVAGAFLTGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	4	5	8	10	27	40	53	48	63			01,02			01,02							Vb 17	CASSKSVAGAFLTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGCAGCGCTACCGGGGAGCTGTTTTTTGGAGAA	CASSIDRSATGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	6	5	4	2	27	44	52	48	54			01,02			01,02							Vb 17	CASSIDRSATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGGGAAACCGGAGCTTTCTTTGGACAA	CASSIDRETGAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	10	1	6	27	44	50	45	56			01,02										Vb 17	CASSIDRETGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGAGGGGGCTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIWRGLTNTGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	0	0	4	3	27	41	52	45	55			01,02										Vb 17	CASSIWRGLTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTACCAGTAGTCCTCCCACAGGGCGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	9.962077690923219E-5		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	2	4	11	0	27	39	-1	50	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTGGGCAGGCGAACTATGGCTACACCTTCGGTTCG	CASSPGQANYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	2	7	2	27	38	49	45	51			01,02										Vb 17	CASSPGQANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGACAGCGTTAATCAGCCCCAGCATTTTGGTGAT	CASSIVDSVNQPQHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	5	4	1	4	27	43	50	44	54			01,02										Vb 17	CASSIVDSVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGAGACGGCTTATGGCTACACCTTCGGTTCG	CASSVETAYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	2	7	5	0	4	27	-1	47	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVETAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGACTAGCCAGGGGGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	9.962077690923219E-5		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	3	4	10	27	39	51	43	61			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCCGGGACAGGGGAGTTTTGGTCTAGATACGCAGTATTTTGGCCCA	CASSIAPGQGSFGLDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	2	5	4	11	24	40	54	44	65			01,02										Vb 17	CASSIAPGQGSFGLDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGACAGGGCGTGCTGAAGCTTTCTTTGGACAA	CASSTRTGRAEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	6	3	4	27	40	51	43	55			01,02										Vb 17	CASSTRTGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGACAGGGTGGACTGAAGCTTTCTTTGGACAA	CASSLGTGWTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	5	3	3	27	39	51	42	54			01,02										Vb 17	CASSLGTGWTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGGAGGGGCTGGGTCTATGGCTACACCTTCGGTTCG	CASWRGWVYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	10	0	4	1	7	27	36	43	37	50			01,02										Vb 17	CASWRGWVYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACAGGGGGGACAGCCCCAGCATTTTGGTGAT	CASSMGQGGQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	1	7	0	2	27	-1	52	41	54			01,02										Vb 17	CASSMGQGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACAGGCCCCCCGGCCCAGCATTTTGGTGAT	CASSITGPPAQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	4	11	0	8	27	-1	47	42	55			01,02										Vb 17	CASSITGPPAQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGGCGACCCCCGCTATGGCTACACCTTCGGTTCG	CASSIAGDPRYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	4	0	9	27	-1	47	43	56			01,02										Vb 17	CASSIAGDPRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGAAAACACTGAAGCTTTCTTTGGACAA	CASSIGENTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	2	2	0	2	27	-1	46	43	48			01,02										Vb 17	CASSIGENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGACAGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSIDRVTGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	3	4	1	1	27	41	49	42	50			01,02										Vb 17	CASSIDRVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGAGAGGGATCAGCCCCAGCATTTTGGTGAT	CASSSERDQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	5	5	0	27	39	-1	44	49			01,02										Vb 17	CASSSERDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCTGTGCCAGTAACCGTTGGGGGGGAGGACAGAGGTCTTACTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNRWGGGQRSYYSGANVLTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	66	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	7	9	0	0	6	18	2	12	25	18	43			01,02										Vb 17	CASNRWGGGQRSYYSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGAAGTTTCGACAGGGACTATGGCTACACCTTCGGTTCG	CASRSFDRDYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	3	7	0	27	38	-1	45	52			01,02										Vb 17	CASRSFDRDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCTCCCCCGACAGGGAACCACTGAAGCTTTCTTTGGACAA	CASSTLPRQGTTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	4	9	3	27	40	56	49	59			01,02										Vb 17	CASSTLPRQGTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGAACTCTGGAAACACCATATATTTTGGAGAG	CASSTNSGNTIYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	4	2	8	0	1	1	27	40	43	41	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTNSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGGTGGCTATGGCTACACCTTCGGTTCG	CASSMRGGYGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	5	2	4	1	3	27	41	47	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMRGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATCCGGGACAGGGGTCCAATGAGCAGTTCTTCGGGCCA	CASHPGQGSNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	6	5	2	27	36	51	41	53			01,02										Vb 17	CASHPGQGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGACAGGTCCCTGAATCAGCCCCAGCATTTTGGTGAT	CASDRSLNQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	4	4	0	6	27	-1	42	36	48			01,02										Vb 17	CASDRSLNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGAAAAACTGTTTTTTGGCAGT	CASSRQEKLFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	8	0	0	27	-1	-1	40	45			01,02										Vb 17	CASSRQEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGGGACGGTGAACATTGAAGCTTTCTTTGGACAA	CASSMGGTVNIEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	7	0	11	27	-1	48	41	59			01,02										Vb 17	CASSMGGTVNIEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGGACAGCCATGAAAAACTGTTTTTTGGCAGT	CASSPRDSHEKLFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	6	4	2	27	39	50	43	52			01,02										Vb 17	CASSPRDSHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGACAGCCCCTACACAGATACGCAGTATTTTGGCCCA	CASSRDSPYTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	1	6	27	39	47	40	53			01,02										Vb 17	CASSRDSPYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTCGGGGGCCGGGGGCTTTCTTTGGACAA	CASSVRGPGAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	6	0	11	4	5	27	39	49	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVRGPGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGACAGATTGGAGAGACCCAGTACTTCGGGCCA	CASSTGQIGETQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	4	1	5	27	40	48	41	53			01,02										Vb 17	CASSTGQIGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGCCGGGCGGGGAGGGGACTGAAGCTTTCTTTGGACAA	CASSITPGGEGTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	5	10	1	27	42	59	52	60			01,02										Vb 17	CASSITPGGEGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACTAGAAGGAACAATGAGCAGTTCTTCGGGCCA	CASSITRRNNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	5	1	5	27	41	47	42	52			01,02			01,02							Vb 17	CASSITRRNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGCTTAAAATCTCCGAGCAGTACGTCGGGCCG		Out	VDJ	1	22	1.461104728002072E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	17	1	22	27	41	47	42	69			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGCGGACAGGGGGTTAGAGGCTACACCTTCGGTTCG	CASTRGQGVRGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	1	8	5	5	27	37	52	42	57			01,02										Vb 17	CASTRGQGVRGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGCGACAGGGGAATCTAATGAAAAACTGTTTTTTGGCAGT	CASSRATGESNEKLFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	2	3	4	3	27	40	52	44	55			01,02										Vb 17	CASSRATGESNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACCCCTAGCGGGGGCCACCGGAAGACCCAGTACTTCGGGCCA	CASSITPSGGHRKTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	6	5	8	27	41	56	46	64			01,02										Vb 17	CASSITPSGGHRKTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTTGCTGCCAAGAGACCCAGTACTTCGGGCCA	CASSMGCCQETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	0	9	1	0	6	27	-1	44	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGCCQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCACAACAGGGGCTGAAACTTTCTTTGGACAA	CATTTGAETFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	3	2	12	5	6	27	34	46	39	52			01,02										Vb 17	CATTTGAETFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTCCGGGACCACATCGGGGGGCTACACCTTCGGTTCG	CASSTSGTTSGGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	0	7	8	5	10	27	40	50	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTSGTTSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCACTTTGGACAATCAGCCCCAGCATTTTGGTGAT	CASSPTLDNQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	1	8	3	8	0	27	39	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPTLDNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGACAGGGCAAGCACAGATACGCAGTATTTTGGCCCA	CASMDRASTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	3	0	1	2	27	37	46	38	48			01,02										Vb 17	CASMDRASTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCAACCGGGGGGACTCATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSIDQPGGLIAKNIQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	8	1	0	5	6	24	41	53	46	59			01,02										Vb 17	CASSIDQPGGLIAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTATGGGTCCAGGGAACACTGAAGCTTTCTTTGGACAA	CASTMGPGNTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	5	0	27	41	-1	46	50			01,02										Vb 17	CASTMGPGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTCCGGGACAGCTACGCCGGGCTACACCTTCGGTTCG	CASSTSGTATPGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	8	5	8	27	40	52	45	60			01,02										Vb 17	CASSTSGTATPGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGGGGCGGACTATGGCTACACCTTCGGTTCG	CASSIQGADYGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	3	0	2	27	-1	50	42	52			01,02										Vb 17	CASSIQGADYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTTGAAACAGGGAACTATGGCTACACCTTCGGTTCG	CASSILETGNYGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	2	7	0	27	41	-1	48	54			01,02										Vb 17	CASSILETGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTGGAAGAACTATGAGCAGTTCTTCGGGCCA	CASWKNYEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	9	1	8	8	2	6	27	35	40	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASWKNYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTCTAGCAGGTTCGAATTCACCCCTCCACTTTGGGAAC	CASTPLAGSNSPLHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	4	7	7	5	7	27	37	47	42	54			01,02			01,02							Vb 17	CASTPLAGSNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGACAGGGGAGAAGCTTTCTTTGGACAA	CASRDRGEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	8	1	1	27	38	47	39	48			01,02										Vb 17	CASRDRGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGATCGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIGSVATNEKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	5	0	3	3	27	43	49	46	52			01,02			01,02							Vb 17	CASSIGSVATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCCAAAACACTGAAGCTTTCTTTGGACAA	CASSISQNTEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	6	2	3	1	27	42	47	45	48			01,02										Vb 17	CASSISQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCACAGAGATACGCAGTATTTTGGCCCA	CASSIHRDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	5	5	2	0	27	41	-1	43	47			01,02										Vb 17	CASSIHRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGGAGCGGGATCGTACAATGAGCAGTTCTTCGGGCCA	CASGGAGSYNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	3	4	5	3	27	36	48	41	51			01,02										Vb 17	CASGGAGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCACAAGAAGTTCGGTACTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	1.7267601330933578E-4		43	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	13	3	6	1	2	14	27	31	36	33	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCCGGGGCAGCCTGAAGCTTTCTTTGGACAA	CASSPPGQPEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	7	0	6	6	3	27	38	49	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPGQPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGGACAGGGCAACACTGAAGCTTTCTTTGGACAA	CASSIAGQGNTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	3	2	2	1	27	43	53	45	54			01,02										Vb 17	CASSIAGQGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGCCTACACCTTCGGTTCG	CASSIGGAYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	7	0	10	0	2	27	-1	48	43	50			01,02										Vb 17	CASSIGGAYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTTCCTAATTATGGCTACACCTTCGGTTCG	CASSIVPNYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	4	9	5	5	2	27	41	49	46	51			01,02			01,02							Vb 17	CASSIVPNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCCAGCCTAGGGATTCAGTACTTCGGCGCC	CASSMSSLGIQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	3	5	3	10	9	0	27	41	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSSLGIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTGGACAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSPWTGGYYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	3	4	1	27	39	54	43	55			01,02										Vb 17	CASSPWTGGYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAACAGGGGAATATAGATGAAAAACTGTTTTTTGGCAGT	CASQQGNIDEKLFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	3	2	6	2	7	27	36	45	38	52			01,02										Vb 17	CASQQGNIDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATCCCCTTGGTAGGCTAAATCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	1.8595878356390008E-4		53	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	5	4	6	12	7	27	41	56	53	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGAACAGGCCGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	1.8595878356390008E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	4	3	3	5	27	36	44	39	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGACCCGAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASNDPRSYNEQFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	11	1	1	7	0	27	37	-1	44	48			01,02										Vb 17	CASNDPRSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGTAGGGTCGGATACGCAGTATTTTGGCCCA	CASSIRVGSDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	6	0	8	27	-1	46	41	54			01,02										Vb 17	CASSIRVGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGATCCCAAGAAGTAAATGGCTACACCTTCGGTTCG	CASSPRSQEVNGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	2	8	6	4	13	27	39	45	43	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRSQEVNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACAGGGTGGACACTGAAGCTTTCTTTGGACAA	CASSIDRVDTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	3	0	3	27	-1	49	44	52			01,02										Vb 17	CASSIDRVDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGTCCACCGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	1.9924155381846438E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	9	3	0	7	27	-1	46	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTCGACAGGAGCCTACGAGCAGTACTTCGGGCCG	CASSIDSTGAYEQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	4	2	3	2	27	44	53	47	55			01,02										Vb 17	CASSIDSTGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCGGGGCCGCCAGGAGCCCCAGCATTTTGGTGAT	CASSSRGRQEPQHF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	3	8	2	8	27	39	47	41	55			01,02										Vb 17	CASSSRGRQEPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCTAAGAGGACTTTAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	2.0588293894574652E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	1	10	1	8	5	27	37	50	45	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCACACGTCGGACAGGGTCAGCACTGAAGCTTTCTTTGGACAA	CASSHTSDRVSTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	4	9	4	27	38	55	47	59			01,02										Vb 17	CASSHTSDRVSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTAACGGGGAGCTGTTTTTTGGAGAA	CASSIVNGELFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	9	7	1	1	27	43	46	44	47			01,02			01,02							Vb 17	CASSIVNGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGGGCCGAGCTATGGCTACACCTTCGGTTCG	CASSWGPSYGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	6	0	4	1	4	27	39	46	40	50			01,02										Vb 17	CASSWGPSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCCGCCGGGACACAGAACACTGAAGCTTTCTTTGGACAA	CASAAGTQNTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	6	1	7	2	27	35	48	42	50			01,02										Vb 17	CASAAGTQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTCCAGGGTTGGGAAATGAGCAGTTCTTCGGGCCA	CASSIVPGLGNEQFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	7	3	6	27	43	51	46	57			01,02										Vb 17	CASSIVPGLGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGTCGGGGGGGATTCTACGGCTACACCTTCGGTTCG	CASSMSRGGFYGYTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	8	4	7	27	41	53	45	60			01,02										Vb 17	CASSMSRGGFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAGGGACCGAGCTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	2.2580709432759295E-4		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	0	7	1	3	6	27	37	45	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGGTCTCTAATCAGCCCCAGCATTTTGGTGAT	CASRRVSNQPQHF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	0	4	0	5	27	-1	43	38	48			01,02										Vb 17	CASRRVSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGAGGCGAGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSGGGEGQETQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	1	2	2	7	27	39	47	41	54			01,02										Vb 17	CASSGGGEGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCCTCGTTGCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSTLVAGDYEQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	2	3	10	1	27	38	55	48	56			01,02										Vb 17	CASSTLVAGDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCACAGGAGGATTAATGAAAAAACTGTTTTTTGGCAGT	CASRPTGGLMKKLFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	3	4	9	4	11	27	38	47	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPTGGLMKKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGACAGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSRGQGLYEQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	3	2	2	27	40	51	42	53			01,02										Vb 17	CASSRGQGLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGGGGGGGCCCTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	2.3244847945487512E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	1	2	6	27	40	49	42	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCCGCCCCGACGGGCTTTCTTTGGACAA	CASSFPPRRAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	2	7	11	10	2	27	39	52	49	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFPPRRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGCCGCGAGCTCGCGAGAGCAGTACGTCGGGCCG		Out	VDJ	1	35	2.3244847945487512E-4		34	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	11	4	5	17	19	4	27	33	55	52	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGTTTCGACAGAGACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	36	2.3908986458215725E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	5	17	7	19	27	35	47	42	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACTGGGGGAGGAGGGGAGCTGTTTTTTGGAGAA	CASTTGGGGELFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	9	1	8	7	1	27	37	50	44	51			01,02										Vb 17	CASTTGGGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATACGGGACAGGGACCCATTGAAGCTTTCTTTGGACAA	CASSNTGQGPIEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	7	4	6	27	40	53	44	59			01,02										Vb 17	CASSNTGQGPIEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCACAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSMHRVNEQFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	6	2	1	27	41	49	43	50			01,02										Vb 17	CASSMHRVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCACCGGACTAGCGGGGGATCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	36	2.3908986458215725E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	1	2	7	5	2	27	41	59	46	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGGGGTAGCTATGGCTACACCTTCGGTTCG	CASSPGGSYGYTF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	4	1	3	27	39	47	40	50			01,02										Vb 17	CASSPGGSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGAACAAGAACAGGGGCTTATCAGCCCCAGCATTTTGGTGAT	CARTRTGAYQPQHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	3	2	5	9	3	27	33	49	42	52			01,02										Vb 17	CARTRTGAYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAATGACGGTTCTATGGCTACACCTTCGGTTCG	CASK*RFYGYTF	Stop	VDJ	1	37	2.457312497094394E-4		36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	2	7	4	3	4	27	37	43	40	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASK*RFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGACAGGGGATAAGGGGCACTGAAGCTTTCTTTGGACAA	CASSRQGIRGTEAFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	4	2	8	27	38	48	40	56			01,02										Vb 17	CASSRQGIRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGATCCGGGGTGAAAAACTGTTTTTTGGCAGT	CASSRIRGEKLFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	7	6	0	27	39	-1	45	50			01,02										Vb 17	CASSRIRGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCATGACAGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSTMTGATGELFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	4	6	1	27	38	52	44	53			01,02										Vb 17	CASSTMTGATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGAGGAGACCCAGTACTTCGGGCCA	CASSIREETQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	2	5	1	0	27	42	-1	43	48			01,02										Vb 17	CASSIREETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCTCAGGGGCACGGAACACTGAAGCTTTCTTTGGACAA	CASSISSGARNTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	1	4	4	27	42	52	46	56			01,02										Vb 17	CASSISSGARNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTCAGGGGCTAGGCTACACCTTCGGTTCG	CASSIGQGLGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	8	4	3	27	41	51	45	54			01,02										Vb 17	CASSIGQGLGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACGAGGGTACTGAAGCTTTCTTTGGACAA	CASSHEGTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	5	3	1	27	39	47	42	48			01,02										Vb 17	CASSHEGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCATCCCGCTGGGGCAACCTACAATGAGCAGTTCTTCGGGCCA	CASSHPAGATYNEQFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	2	9	2	27	39	53	48	55			01,02										Vb 17	CASSHPAGATYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTACGAAAGGGGGGTGGTCCGGGGAGCTGTTTTTTGGAGAA	CATTKGGWSGELFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	10	5	1	6	7	5	27	34	47	41	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATTKGGWSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCCTCTAGGGGTTCACCCCTCCACTTTGGGAAC	CASSSSRGSPLHF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	2	9	7	0	27	38	-1	45	50			01,02										Vb 17	CASSSSRGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTATAACAGGGACACTGAAGCTTTCTTTGGACAA	CASRYNRDTEAFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	3	5	0	27	38	-1	43	49			01,02										Vb 17	CASRYNRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACGGCCTGGGACGAGCAGTACTTCGGGCCG	CASSIGTAWDEQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	7	5	1	8	27	41	47	42	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTAWDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATGGGGGGCTGAACAATCAGCCCCAGCATTTTGGTGAT	CASSIYGGLNNQPQHF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	6	0	3	5	4	27	41	52	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYGGLNNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGAGCGGTAAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSARAVRGEKLFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	5	2	7	12	0	27	39	-1	51	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSARAVRGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGACTAGCCAGGGGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSRTSQGGGYNEQFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	3	4	11	27	39	51	43	62			01,02			01,02							Vb 17	CASSSRTSQGGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGGCCCGGAGATCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASWPGDHSNQPQHF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	10	2	0	6	4	27	36	46	42	50			01,02										Vb 17	CASWPGDHSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGGGACAGGGGTCCGCAATGGCTACACCTTCGGTTCG	CASSIGGTGVRNGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	6	4	6	27	41	55	45	61			01,02										Vb 17	CASSIGGTGVRNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCGGGGGGACGGGGTGGTTCAATGAGCAGTTCTTCGGGCCA	CASSTGGTGWFNEQFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	6	3	11	27	38	48	41	59			01,02										Vb 17	CASSTGGTGWFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTATCGGAGATCCTAAGCAGTATTTTGGCCCA	CASSTIGDPKQYF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	2	11	5	7	27	40	49	45	56			01,02										Vb 17	CASSTIGDPKQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGAGCCTGCAGAGCAGTTCTTCGGGCCA	CASSIEPAEQFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	7	10	2	5	27	41	46	43	51			01,02			01,02							Vb 17	CASSIEPAEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTAGAATGGATGAGCAGTTCTTCGGGCCA	CASSIGRMDEQFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	8	3	5	27	41	47	44	52			01,02			01,02							Vb 17	CASSIGRMDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACGACGAACACTGAAGCTTTCTTTGGACAA	CASSPTTNTEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	2	7	1	2	3	27	39	44	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPTTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGGGGATCTTGAACACTGAAGCTTTCTTTGGACAA	CASSGILNTEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	3	0	1	4	27	36	42	37	46			01,02										Vb 17	CASSGILNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCAGGCCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	2.7893817534585015E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	4	3	1	2	27	40	45	41	47			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGGGGCTCGATCAGCCCCAGCATTTTGGTGAT	CASSQGLDQPQHF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	5	0	4	27	-1	45	39	49			01,02										Vb 17	CASSQGLDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTATTGACCGTGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	2.7893817534585015E-4		40	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	2	7	5	6	4	27	39	48	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCTCGACAGGGGACTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSTGDYTGELFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	3	5	3	27	39	52	44	55			01,02										Vb 17	CASSLSTGDYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCATAGTAAGAACCGCACGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	43	2.8557956047313226E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	12	5	8	3	1	14	27	32	36	33	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGGGACGGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CATRDGGPYNEQFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	10	6	0	2	8	1	27	34	48	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRDGGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGATGGGACCTACGAGCAGTACTTCGGGCCG	CASSIRDGTYEQYF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	2	0	6	27	-1	46	41	52			01,02										Vb 17	CASSIRDGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCCAAAGCAGATACTGAAGCTTTCTTTGGACAA	CASSMSKADTEAFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	4	5	5	8	2	27	41	52	49	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSKADTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPQMNTEAFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	0	2	1	27	39	45	41	46			01,02										Vb 17	CASSPQMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATCACAGGGGACGTATCAGCCCCAGCATTTTGGTGAT	CASSPSQGTYQPQHF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	5	5	4	27	39	51	44	55			01,02										Vb 17	CASSPSQGTYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGCTATCGGGACAGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	45	2.988623307276966E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	5	8	0	27	38	-1	46	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGACAGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSIGTGGNTEAFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	2	1	1	27	41	53	42	54			01,02										Vb 17	CASSIGTGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACTGACAGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLTGTNTGELFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	0	5	1	27	39	51	44	52			01,02										Vb 17	CASSPLTGTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGCAGGATGGGGAGATCAGCCCCAGCATTTTGGTGAT	CASSKAGWGDQPQHF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	2	5	10	0	27	40	-1	50	55			01,02										Vb 17	CASSKAGWGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTGGGGATACAATCAGCCCCAGCATTTTGGTGAT	CASSTWGYNQPQHF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	8	3	4	2	27	40	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTWGYNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSMGQGTDTQYF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	4	1	0	0	27	-1	-1	41	49			01,02										Vb 17	CASSMGQGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTGGACTCCTTAATTCACCCCTCCACTTTGGGAAC	CASSSGLLNSPLHF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	1	10	6	3	3	27	39	47	42	50			01,02			01,02							Vb 17	CASSSGLLNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTACGGGACTAGCGGGGGACGGGACAGATACGCAGTATTTTGGCCCA	CASSPTGLAGDGTDTQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	3	6	5	27	38	58	44	63			01,02										Vb 17	CASSPTGLAGDGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGESSYNEQFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	0	8	0	0	3	27	-1	47	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGESSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGAGGGGACCTACCTACAATGAGCAGTTCTTCGGGCCA	CASARGPTYNEQFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	8	0	7	2	5	3	27	36	46	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASARGPTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGGGGATAGATACGCAGTATTTTGGCCCA	CASSIGQGIDTQYF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	2	5	1	2	27	41	51	42	53			01,02										Vb 17	CASSIGQGIDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGTCAGGGACCTCCTATGGCTACACCTTCGGTTCG	CASSESGTSYGYTF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	7	4	6	3	27	39	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSESGTSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGCGGCCCCCGCAGACAGGCCCACAATGAGCAGTTCTTCGGGCCA	CASSGPRRQAHNEQFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	4	5	14	3	27	35	55	49	58			01,02										Vb 17	CASSGPRRQAHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGCTAGCGGGGGCCTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTASGGLSSYNEQFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	0	3	6	27	40	53	43	59			01,02										Vb 17	CASSTASGGLSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGACTGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSIGLEYNEQFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	4	1	4	27	41	47	42	51			01,02			01,02							Vb 17	CASSIGLEYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTCCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSIGPAGELFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	5	6	5	0	27	41	-1	46	49			01,02			01,02							Vb 17	CASSIGPAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCGGCAGGGTCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	3.3871064149138946E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	5	5	3	27	41	51	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACAGGGTTTAGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	3.3871064149138946E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	2	6	27	39	48	41	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCACAGGGGACCCGCGGTTAATGAAAAACTGTTTTTTGGCAGT	CASHRGPAVNEKLFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	3	2	4	1	9	27	36	44	37	53			01,02										Vb 17	CASHRGPAVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTGAAGGGAACTGAAGCTTTCTTTGGACAA	CASLKGTEAFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	0	8	5	5	0	27	36	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLKGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTAGGGGGCAGTTGAGACTCAGTACTTCGGGCCA		Out	VDJ	1	52	3.4535202661867156E-4		35	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	7	0	11	0	10	27	-1	43	38	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCCCCTAGGGGCTTGGGGGCAGTACGTCGGGCCG	CASTPLGAWGQYV	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	6	0	17	15	6	27	37	58	52	64			01,02										Vb 17	CASTPLGAWGQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAACCGTGGCAGCCGAAGCGGTTCACCCCTCCACTTTGGGAAC	CASTNRGSRSGSPLHF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	6	5	9	17	0	27	37	-1	54	59			01,02			01,02							Vb 17	CASTNRGSRSGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAGACTAGCGGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSTRLAGGQETQYF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	1	2	3	1	27	40	56	43	57			01,02										Vb 17	CASSTRLAGGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTTAACTGGGGACTCCCGCATGAACACTGAAGCTTTCTTTGGACAA	CASSTLTGDSRMNTEAFF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	0	9	6	27	40	55	49	61			01,02			01,02							Vb 17	CASSTLTGDSRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCATGGGCCCCCAGGGGACCTACGAGCAGTACTTCGGGCCG	CASSPMGPQGTYEQYF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	2	12	1	27	39	57	51	58			01,02										Vb 17	CASSPMGPQGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGTTGGGAAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPRWEGENTEAFF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	11	1	27	39	55	50	56			01,02										Vb 17	CASSPRWEGENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGGGAGTACCAAGAGACCCAGTACTTCGGGCCA	CASSREYQETQYF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	4	3	0	0	3	27	-1	43	38	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSREYQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGACACCAACGATTTTGTATGGCTACACCTTCGGTTCG	CASSPRTPTILYGYTF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	5	4	12	27	39	48	43	60			01,02										Vb 17	CASSPRTPTILYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGCTCGCACAGATACGCAGTATTTTGGCCCA	CASSLARTDTQYF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	1	2	2	27	39	44	41	46			01,02										Vb 17	CASSLARTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTGGACAGGGGGCGCGGATCAGCCCCAGCATTTTGGTGAT	CASSFWTGGADQPQHF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	0	5	4	4	27	39	54	43	58			01,02										Vb 17	CASSFWTGGADQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGACAGGTTCAGGGGAGCTGTTTTTTGGAGAA	CASSIWTGSGELFF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	4	8	2	4	27	41	50	43	54			01,02										Vb 17	CASSIWTGSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGACAGCGGACTTACTTTCTTTGGACAA	CASSIGDSGLTFF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	12	2	8	27	41	50	43	58			01,02										Vb 17	CASSIGDSGLTFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGGGCGTCCGATAGGAAAACTGTTTTTTGGCAGT	CASTGRPIGKLFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	10	0	11	27	-1	42	37	53			01,02										Vb 17	CASTGRPIGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCAACCCCGAACACTGAAGCTTTCTTTGGACAA	CASTSTPNTEAFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	3	7	1	5	3	27	37	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTSTPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCAGATTACAATGAGCAGTTCTTCGGGCCA	CASSPDYNEQFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	5	4	2	2	27	38	43	40	45			01,02										Vb 17	CASSPDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCCTACTAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLLAYNEQFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	8	2	6	0	27	38	-1	44	49			01,02			01,02							Vb 17	CASSLLLAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCAGGCCCTATAATTCACCCCTCCACTTTGGGAAC	CASRPRPYNSPLHF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	4	2	3	1	27	38	45	41	46			01,02										Vb 17	CASRPRPYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCAACACAGCCTATGGATCCTACGAGCAGTACTTCGGGCCG	CASSSNTAYGSYEQYF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	5	1	5	8	27	40	49	45	57			01,02										Vb 17	CASSSNTAYGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAGATACGCAGTATTTTGGCCCA	CASSIGTDTQYF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	10	3	0	0	27	-1	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASTPGTAYGYTF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	4	5	1	27	37	49	42	50			01,02										Vb 17	CASTPGTAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCAGGGGGCTCGGGTTCACCCCTCCACTTTGGGAAC	CASSSGGSGSPLHF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	0	9	2	5	27	38	48	40	53			01,02										Vb 17	CASSSGGSGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAAGGGGACACCTCCCATTCACCCCTCCACTTTGGGAAC	CASSQGDTSHSPLHF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	8	4	6	27	39	49	43	55			01,02										Vb 17	CASSQGDTSHSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGCGGCGTCCGGGGAGCTGTTTTTTGGAGAA	CASSWAASGELFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	8	0	6	1	5	27	39	44	40	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWAASGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGGGCTGCTCCACAGATACGCAGTATTTTGGCCCA	CASSGCSTDTQYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	8	0	2	2	5	27	36	42	38	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGCSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGCGGGGAGGGAGCACTGAAGCTTTCTTTGGACAA	CASSTRRGGSTEAFF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	0	4	7	2	27	40	54	47	56			01,02										Vb 17	CASSTRRGGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACGGGACAAAGGACAGATACGCAGTATTTTGGCCCA	CASRTGQRTDTQYF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	3	3	4	27	38	47	41	51			01,02										Vb 17	CASRTGQRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCTTAGAAGGGACTGAAGCTTTCTTTGGACAA	CASSTLEGTEAFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	5	3	5	9	0	27	38	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTLEGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGTTTCAATCTACCGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSVFQSTGGEKLFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	1	8	14	0	27	39	-1	53	60			01,02										Vb 17	CASSVFQSTGGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATTGGAAGCGGCGATTACAATGAGCAGTTCTTCGGGCCA	CAIGSGDYNEQFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	6	5	4	5	4	27	34	44	39	48			01,02			01,02							Vb 17	CAIGSGDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGGGGGCCTTCCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGGAFRTGELFF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	0	4	0	7	27	-1	46	38	53			01,02										Vb 17	CASSGGAFRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAAAGGGGGCGCAGCCCCAGCATTTTGGTGAT	CASSKKGAQPQHF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	0	7	3	1	27	40	50	43	51			01,02										Vb 17	CASSKKGAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGGGGCGCAGCCCCAGCATTTTGGTGAT	CASSMTGAQPQHF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	7	0	2	27	-1	49	41	51			01,02										Vb 17	CASSMTGAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCAGACAGGGAGGTTCACCCCTCCACTTTGGGAAC	CASSLRQGGSPLHF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	9	4	3	27	39	50	43	53			01,02										Vb 17	CASSLRQGGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGACAGGGAGATGAAAAACTGTTTTTTGGCAGT	CASSPRQGDEKLFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	6	4	2	27	39	50	43	52			01,02										Vb 17	CASSPRQGDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGTTAACACTGAAGCTTTCTTTGGACAA	CASSIQVNTEAFF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	2	0	2	27	-1	46	42	48			01,02										Vb 17	CASSIQVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGCCAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSANSGANVLTF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	5	4	6	0	5	1	27	39	46	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSANSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATACAAAGTTTAATGAACACTGAAGCTTTCTTTGGACAA	CASSIQSLMNTEAFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	4	6	0	0	8	27	-1	44	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIQSLMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGAAAAACTGTTTTTTGGCAGT	CASSMTEKLFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	6	8	0	0	27	-1	-1	41	45			01,02										Vb 17	CASSMTEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCCGAACCAATGAGCAGTTCTTCGGGCCA	CASSISRTNEQFF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	2	8	6	4	2	27	42	48	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISRTNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCCCAAGGGCATAGCACTGAAGCTTTCTTTGGACAA	CASAQGHSTEAFF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	5	3	4	5	5	27	36	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAQGHSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGGCGGACGGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSKGGRPSYEQYF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	1	7	0	5	4	27	40	49	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKGGRPSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGCAGCTACCACCTATGGCTACACCTTCGGTTCG	CASSIGAATTYGYTF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	4	0	9	27	-1	47	43	56			01,02										Vb 17	CASSIGAATTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCCCTCTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIGGPLNTGELFF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	2	0	6	27	-1	48	43	54			01,02										Vb 17	CASSIGGPLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGACGGGGGCGCCTAATCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	68	4.516141886551859E-4		47	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	6	0	4	6	9	27	37	49	43	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGGGGCAATTCATTCACCCCTCCACTTTGGGAAC	CASSKGAIHSPLHF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	5	0	8	0	5	27	-1	47	40	52			01,02										Vb 17	CASSKGAIHSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTAATGCGGGACCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPNAGPSNQPQHF	In	VDJ	2	69	4.5825557378246807E-4	5.34138411518811E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	7	3	1	7	3	27	38	51	45	54			01,02										Vb 17	CASSPNAGPSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCGGGACAGGAGATGAAAAACTGTTTTTTGGCAGT	CASRTGTGDEKLFF	In	VDJ	2	69	4.5825557378246807E-4	5.34138411518811E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	6	4	2	27	38	50	42	52			01,02										Vb 17	CASRTGTGDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGGGACCGTCAATGAGCAGTTCTTCGGGCCA	CASSTPGTVNEQFF	In	VDJ	2	69	4.5825557378246807E-4	5.34138411518811E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	0	7	6	5	3	27	40	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPGTVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSISVNTEAFF	In	VDJ	2	69	4.5825557378246807E-4	5.34138411518811E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	5	0	1	0	27	42	-1	43	46			01,02			01,02							Vb 17	CASSISVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAACTTACAATGAGCAGTTCTTCGGGCCA	CASSIGTYNEQFF	In	VDJ	2	69	4.5825557378246807E-4	5.34138411518811E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	1	8	4	1	3	27	41	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGGGCTCACAGGGGACTATGGCTACACCTTCGGTTCG	CASSIDGLTGDYGYTF	In	VDJ	2	70	4.6489695890975023E-4	5.418795479176343E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	3	7	0	27	44	-1	51	58			01,02										Vb 17	CASSIDGLTGDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACCACAGCAGTTTAATTCACCCCTCCACTTTGGGAAC	CASKPQQFNSPLHF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	5	6	4	5	27	37	45	41	50			01,02										Vb 17	CASKPQQFNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTTGGGTCTCACTATGGCTACACCTTCGGTTCG	CASSIDLGSHYGYTF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	0	9	3	4	4	27	44	51	48	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLGSHYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGAACAGGACATGAACACTGAAGCTTTCTTTGGACAA	CASSMEQDMNTEAFF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	0	6	0	27	41	-1	47	52			01,02										Vb 17	CASSMEQDMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTCAATCTGGGTCTCGGAGGCAGCCCCAGCATTTTGGTGAT	CASSVQSGSRRQPQHF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	1	7	16	0	27	39	-1	55	60			01,02										Vb 17	CASSVQSGSRRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASTATGGSGNTIYF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	1	0	4	0	27	37	-1	41	50			01,02										Vb 17	CASTATGGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAAATCCTAGCGGGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASEILAGRTGELFF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	5	6	3	27	36	51	42	54			01,02										Vb 17	CASEILAGRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCTGGCCGAATTCCGCAGCCCCAGCATTTTGGTGAT	CASGRIPQPQHF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	9	0	7	3	9	27	33	39	36	48			01,02										Vb 17	CASGRIPQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACCGGGGGCGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASRDRGRAYNEQFF	In	VDJ	2	76	5.047452696734431E-4	5.883263663105743E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	6	0	2	5	3	27	38	49	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRDRGRAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGAGGTTCGAACAGATACGCAGTATTTTGGCCCA	CASREVRTDTQYF	In	VDJ	2	76	5.047452696734431E-4	5.883263663105743E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	1	3	0	5	27	-1	43	38	48			01,02										Vb 17	CASREVRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGGGCCGGAGGGACGGGCGATCCGCAGTATTTTGGCCCA	CASRRAGGTGDPQYF	In	VDJ	2	78	5.180280399280074E-4	6.03808639108221E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	0	10	7	10	27	38	51	45	61			01,02										Vb 17	CASRRAGGTGDPQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGAGGCCGGGACTCTCCACACCGGGGAGCTGTTTTTTGGAGAA	CASEAGTLHTGELFF	In	VDJ	2	79	5.246694250552895E-4	6.115497755070444E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	0	10	3	7	4	27	35	48	42	52			01,02			01,02							Vb 17	CASEAGTLHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGAAGAGGGTCAGATACGCAGTATTTTGGCCCA	CASSRRGSDTQYF	In	VDJ	2	79	5.246694250552895E-4	6.115497755070444E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	4	4	1	27	39	48	43	49			01,02										Vb 17	CASSRRGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTAGCGGGACTAAAGCCGCCTGGGGATGAGCAGTTCTTCGGGCCA	CASSILAGLKPPGDEQFF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	8	0	16	27	-1	51	42	67			01,02										Vb 17	CASSILAGLKPPGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACAGGACAGCTTGAAGAAAAACTGTTTTTTGGCAGT	CASRTGQLEEKLFF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	8	4	6	27	38	48	42	54			01,02										Vb 17	CASRTGQLEEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACGACTCCACAGATACGCAGTATTTTGGCCCA	CASSDDSTDTQYF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	2	3	1	27	39	46	42	47			01,02			01,02							Vb 17	CASSDDSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGTTCGTTAGGCATTCAGTACTTCGGCGCC	CASSMSSLGIQYF	In	VDJ	2	82	5.44593580437136E-4	6.347731847035145E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	3	5	4	9	9	0	27	41	-1	50	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSSLGIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGGACGGAACTAACTATGGCTACACCTTCGGTTCG	CASSIWDGTNYGYTF	In	VDJ	2	84	5.578763506917003E-4	6.502554575011612E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	0	7	0	1	4	27	42	48	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWDGTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGCGGGGCCAGAGGCATCTCCTACGAGCAGTACTTCGGGCCG	CASSMSGARGISYEQYF	In	VDJ	2	84	5.578763506917003E-4	6.502554575011612E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	3	0	1	10	27	41	49	42	59			01,02										Vb 17	CASSMSGARGISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGAGCGGGGGCGTGAGAGCTTTCTTTGGACAA		Out	VDJ	2	85	5.645177358189824E-4		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	6	2	10	3	6	27	37	48	40	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGACATTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	85	5.645177358189824E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	2	2	2	27	39	47	41	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCACGGGGTAGGCGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	85	5.645177358189824E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	3	0	2	7	27	36	43	38	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGCAGATCCGGTCCAAACACTGAAGCTTTCTTTGGACAA	CAGRSGPNTEAFF	In	VDJ	2	88	5.844418912008288E-4	6.812200030964546E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	11	4	5	2	2	10	27	33	38	35	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAGRSGPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIRAATNEKLFF	In	VDJ	2	89	5.91083276328111E-4	6.889611394952779E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	5	3	0	0	3	27	-1	46	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRAATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGTATGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIVGMGSGANVLTF	In	VDJ	2	89	5.91083276328111E-4	6.889611394952779E-4	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	1	0	9	0	1	6	27	43	47	44	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGMGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGTCCACAGATACGCAGTATTTTGGCCCA	CASSMRSTDTQYF	In	VDJ	2	89	5.91083276328111E-4	6.889611394952779E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	2	0	2	27	-1	45	41	47			01,02										Vb 17	CASSMRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGTACAGGGGGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	91	6.043660465826753E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	5	3	2	27	40	51	43	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACAGACAGTCCCCGTGGGAGACCCAGTACTTCGGGCCA	CASSNRQSPWETQYF	In	VDJ	2	92	6.110074317099574E-4	7.12184548691748E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	5	5	3	9	27	40	48	43	57			01,02										Vb 17	CASSNRQSPWETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCCGGAGTGGCGGGAGATCAGCCCCAGCATTTTGGTGAT	CASRAGVAGDQPQHF	In	VDJ	2	94	6.242902019645217E-4	7.276668214893946E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	7	2	5	10	0	27	38	-1	48	55			01,02										Vb 17	CASRAGVAGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGGYSNQPQHF	In	VDJ	2	97	6.442143573463681E-4	7.508902306858647E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	1	0	0	2	27	-1	45	38	47			01,02										Vb 17	CASSGGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACAAGGACAGGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSHKDRPNEKLFF	In	VDJ	3	102	6.774212829827789E-4	7.895959126799814E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	4	3	5	1	27	39	51	44	52			01,02										Vb 17	CASSHKDRPNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACGGGCAATCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSDGQSQSRANVLTF	In	VDJ	3	103	6.84062668110061E-4	7.973370490788048E-4	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	5	8	0	5	3	12	27	39	46	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDGQSQSRANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCCCTGGGACAGTCGCGGTACAATGAGCAGTTCTTCGGGCCA	CASRPLGQSRYNEQFF	In	VDJ	3	106	7.039868234919075E-4	8.205604582752748E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	4	6	6	27	38	51	44	57			01,02										Vb 17	CASRPLGQSRYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCAACCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPQPYSNQPQHF	In	VDJ	3	107	7.106282086191896E-4	8.283015946740982E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	3	7	0	5	4	27	39	46	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPQPYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGCGTGGCAATACTCTGGAAACACCATATATTTTGGAGAG	CASKAWQYSGNTIYF	In	VDJ	3	108	7.172695937464718E-4	8.360427310729215E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	7	5	4	0	0	10	27	-1	40	37	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKAWQYSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACGAAGAGGACAGGGGGCAACTATGGCTACACCTTCGGTTCG	CATKRTGGNYGYTF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	0	2	6	0	27	34	-1	40	51			01,02										Vb 17	CATKRTGGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGCTCGACCAGCCGGGGAGCTGTTTTTTGGAGAA	CASTARPAGELFF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	2	7	6	6	3	27	37	46	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTARPAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACTGGACACTCGAACACTGAAGCTTTCTTTGGACAA	CASSIDTGHSNTEAFF	In	VDJ	3	114	7.571179045101647E-4	8.824895494658616E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	1	4	3	27	44	53	48	56			01,02										Vb 17	CASSIDTGHSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATCGAGGGGGTTCTAACTATGGCTACACCTTCGGTTCG	CASSDRGGSNYGYTF	In	VDJ	3	115	7.637592896374468E-4	8.902306858646849E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	1	0	5	2	27	39	50	44	52			01,02										Vb 17	CASSDRGGSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGGTCTCCCCTAAGAACAGATACGCAGTATTTTGGCCCA	CATRSPLRTDTQYF	In	VDJ	3	116	7.70400674764729E-4	8.979718222635083E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	4	4	3	1	12	27	34	39	35	51			01,02										Vb 17	CATRSPLRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATAAACAGGGATTGAACACTGAAGCTTTCTTTGGACAA	CASNKQGLNTEAFF	In	VDJ	3	120	7.969662152738575E-4	9.289363678588017E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	0	4	2	27	37	47	41	49			01,02										Vb 17	CASNKQGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACTAGCGGGGATCGTGGGGATGAGCAGTTCTTCGGGCCA	CASSPGTSGDRGDEQFF	In	VDJ	3	121	8.036076004011396E-4	9.36677504257625E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	3	9	27	39	55	42	64			01,02										Vb 17	CASSPGTSGDRGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCCCGGGGGGCCTCGTGGCACTGAAGCTTTCTTTGGACAA	CASSSPGGPRGTEAFF	In	VDJ	3	122	8.102489855284218E-4	9.444186406564484E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	4	5	8	27	39	51	44	59			01,02										Vb 17	CASSSPGGPRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAAGTTAGGGCAGATACGCAGTATTTTGGCCCA	CASREVRADTQYF	In	VDJ	3	127	8.434559111648325E-4	9.83124322650565E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	5	3	4	7	0	27	38	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASREVRADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCGACGGTTTCTAATGAAAAACTGTTTTTTGGCAGT	CASSIPTVSNEKLFF	In	VDJ	3	135	8.965869921830897E-4	0.0010450534138411519	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	2	7	3	2	5	27	42	47	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPTVSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTAGGGACTTAGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	146	9.696422285831933E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	2	2	6	27	39	47	41	53			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGAGGTGGGGGCGGATGAGCAGTTCTTCGGGCCA	CASSIGEVGADEQFF	In	VDJ	4	160	0.0010626216203651433	0.0012385818238117355	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	6	0	8	7	2	27	43	56	50	58			01,02										Vb 17	CASSIGEVGADEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGAAGAGATTACAATGAGCAGTTCTTCGGGCCA	CASRRRDYNEQFF	In	VDJ	5	211	0.0014013322618565327	0.0016333797801517263	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	4	5	2	27	38	46	43	48			01,02										Vb 17	CASRRRDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTAGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSIGREYNEQFF	In	VDJ	6	222	0.0014743874982566364	0.001718532280538783	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	2	4	5	0	27	41	-1	46	51			01,02										Vb 17	CASSIGREYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACTCTGATGGGTCTGACACTGAAGCTTTCTTTGGACAA	CASRDSDGSDTEAFF	In	VDJ	8	302	0.002005698308439208	0.002337823192444651	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	3	0	12	27	-1	43	38	55			01,02			01,02							Vb 17	CASRDSDGSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGACCAACAGGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	10	376	0.002497160807858087		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	4	7	1	27	38	51	45	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCAGGGAGGGGGGAACGGACAGTACGTCGGGCCG		Out	VDJ	11	453	0.003008547462658812		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	17	5	16	27	38	50	43	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACTCAGGGAACTGAAGCTTTCTTTGGACAA	CASRTQGTEAFF	In	VDJ	15	606	0.004024679387132981	0.0046911286576869484	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	5	4	1	27	38	47	42	48			01,02										Vb 17	CASRTQGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGAGACAGGGGATTATCTGCCCTACGAGCAGTACTTCGGGCCG	CASSEETGDYLPYEQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	2	3	9	23	37	48	40	57													Vb 11	CASSEETGDYLPYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAATGGGGTAGCGGAGTACCAAGAGACCCAGTACTTCGGGCCA	CASNGVAEYQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	5	5	0	6	3	23	33	45	39	48						01,02							Vb 11	CASNGVAEYQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAACCCCACGGGGTCGGAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		44	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	3	6	7	7	23	34	46	41	53						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGGACAGGCCTAACTATGGCTACACCTTCGGTTCG	CASSGDRPNYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	0	0	1	23	-1	44	36	45													Vb 11	CASSGDRPNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGGGGAGGGTCAGCCCCAGCATTTTGGTGAT	CASSESGEGQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	0	6	3	0	23	39	-1	42	49													Vb 11	CASSESGEGQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTCACTTGTTGGCACTGAAGCTTTCTTTGGACAA	CASSSLVGTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	4	2	6	23	35	40	37	46						01,02							Vb 11	CASSSLVGTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSGGWNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	4	6	1	1	0	2	23	-1	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSGGWNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAGGGCAGGAGGAGGAGAGACCCAGTACTTCGGGCCA	CASSERAGGGETQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	1	4	6	3	23	38	49	44	52													Vb 11	CASSERAGGGETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATACCCGGGACAGGCGTCGAACACTGAAGCTTTCTTTGGACAA	CASSEYPGQASNTEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	4	1	3	4	23	40	51	43	55													Vb 11	CASSEYPGQASNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCAATGTCTTCGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSNVFGGNTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	1	9	0	23	34	-1	43	49													Vb 11	CASSNVFGGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGATCGACAGACTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	2.5237263483672155E-4		50	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	4	12	23	36	45	40	57													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGGGCAGGGGGGTTCACCCCTCCACTTTGGGAAC	CASSESGQGGSPLHF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	1	9	5	1	23	39	51	44	52													Vb 11	CASSESGQGGSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGCAGTCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGQSNTGELFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	5	2	2	3	23	36	41	38	44													Vb 11	CASSGQSNTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTGGGAGGGCACCCAGATACGCAGTATTTTGGCCCA	CASSVGGHPDTQYF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	4	1	4	23	36	44	37	48													Vb 11	CASSVGGHPDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACACGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSDTGTGELFF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	4	4	2	0	23	37	-1	39	43						01,02							Vb 11	CASSDTGTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTGGGGGGGCCTCTAATCAGCCCCAGCATTTTGGTGAT	CASSFGGASNQPQHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV12	TCRBV12-01	01				TCRBJ01	TCRBJ01-05	01	1	6	0	4	1	4	22	38	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGASNQPQHF+TCRBV12-01+TCRBJ01-05	TCRBV12-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTTACCGGACAGGGGCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	8	318	0.0021119604704757226		56	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	2	0	4	3	22	37	50	41	53														X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCCCCCTACTCATTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSPLLISSTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	10	0	7	7	18	31	41	38	48						01,02								CASSSPLLISSTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAAGACAGACCCTATGGCTACACCTTCGGTTCG	CASSQDRPYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	4	3	3	18	30	38	33	41														CASSQDRPYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTATTTTCAGCCGGGGACTCTGGAAACACCATATATTTTGGAGAG	CASSLFSAGDSGNTIYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	51	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	8	3	0	8	1	18	33	46	41	47														CASSLFSAGDSGNTIYF+TCRBV07-02+TCRBJ01-03	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTCGACGGACTGAGTATGGCTACACCTTCGGTTCG	CASSRRTEYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	5	5	3	18	29	39	34	42						01,02								CASSRRTEYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCACCGAGGGGGAGACTGAAGCTTTCTTTGGACAA	CASSTEGETEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	5	4	2	18	30	40	34	42														CASSTEGETEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCGGCCAGGGGATATGAAGCTTTCTTTGGACAA	CASSPARGYEAFF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	5	3	18	30	41	35	44														CASSPARGYEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTACCAGCAGCAGGGGACGCGCCGGGCATGAGCAGTTCTTCGGGCCA	CTSSRGRAGHEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	0	7	8	2	9	18	30	37	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSRGRAGHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACTTCGACGGGGGGGCAGATGGCTACACCTTCGGTTCG	CASNFDGGADGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	6	3	3	18	32	43	35	46														CASNFDGGADGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACGGACGGGGAACACTGAAGCTTTCTTTGGACAA	CASSKRTGNTEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	1	7	1	4	3	18	30	38	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKRTGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCTACGCCGGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSPSTPAGQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	4	6	12	0	18	30	-1	42	47						01,02								CASSPSTPAGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAACTTTAGAGGGCTTAGTAGGGGGAAACATTCAGTACTTCGGCGCC	CASSRTLEGLVGGNIQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	5	1	6	20	0	18	30	-1	50	56														CASSRTLEGLVGGNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGGGGGGCGCGGGAGACCCAGTACTTCGGGCCA	CASSGRGARETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	5	1	5	3	6	18	30	39	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRGARETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATAAATAGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSS*IGGLNTEAFF	Stop	VDJ	1	11	7.30552364001036E-5		48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	5	1	0	7	2	18	31	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSS*IGGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGATTCTAGGGGGAGGTCGGCAGTTCTTCGGGCCA	CASSSILGGGRQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	5	1	12	7	6	18	31	44	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSILGGGRQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGTCTGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLMSASTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	10	0	0	6	1	18	33	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMSASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCAGACACTCTCTGGAAACACCATATATTTTGGAGAG	CASSLDQTLSGNTIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	6	0	3	2	18	35	42	38	44														CASSLDQTLSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGAGATGGATGGCTACACCTTCGGTTCG	CASSLGTEMDGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	6	0	6	18	-1	40	34	46														CASSLGTEMDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTSGDTGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	1	3	3	0	0	18	-1	-1	34	46														CASSLGTSGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGGCGACAGATACGCAGTATTTTGGCCCA	CASSLGGATDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	3	2	1	18	34	41	36	42														CASSLGGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTGGGGACCTTGAAGGTGGAAACACCATATATTTTGGAGAG	CASSLSGDLEGGNTIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	2	0	7	3	4	8	18	33	42	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGDLEGGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCGGGGTCCGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLSGSGGANVLTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	3	8	3	3	2	5	18	32	39	34	44														CASSLSGSGGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGTCCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	7.30552364001036E-5		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	0	10	0	2	4	18	32	36	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGCACTTGGAGCGGGTCGGAGACCCAGTACTTCGGGCCA	CASSRTWSGSETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	4	5	9	3	18	30	45	39	48						01,02								CASSRTWSGSETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACCAGATGAACACTGAAGCTTTCTTTGGACAA	CASSLNQMNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	0	3	1	18	33	39	36	40														CASSLNQMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGAGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	7.969662152738576E-5		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	5	2	0	2	18	-1	39	34	41														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGAGAGTCATACAATGAGCAGTTCTTCGGGCCA	CASSLGESYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	2	4	0	5	18	-1	37	34	42														CASSLGESYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACAGCTCGAACACTGAAGCTTTCTTTGGACAA	CASSLYSSNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	1	1	3	18	33	38	34	41														CASSLYSSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGGCGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSLGGRNNEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	9	0	4	0	5	18	-1	39	32	44														CASSLGGRNNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGCCGGACACTTTAATGAAAAACTGTTTTTTGGCAGT	CASRAGHFNEKLFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	6	4	4	3	18	29	38	33	41														CASRAGHFNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGACTACCTCAATTCACCCCTCCACTTTGGGAAC	CASSPDYLNSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	2	9	7	3	4	18	30	38	33	42						01,02								CASSPDYLNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGCGGGGGAGATAGGCGAGCAGTACTTCGGGCCG	CASSSPAGEIGEQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	2	6	5	7	18	31	43	36	50														CASSSPAGEIGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGGGACAGGGACACAATGAGCAGTTCTTCGGGCCA	CASSSPGQGHNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	5	4	2	18	31	44	35	46														CASSSPGQGHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGCGGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLMAGGSYNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	1	1	3	1	18	33	44	36	45														CASSLMAGGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGGCCTTAAGGCTGAAGCTTTCTTTGGACAA	CASSLMGLKAEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	6	2	7	18	33	39	35	46														CASSLMGLKAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCGCGGCGGGGGGGCGGTGAGCAGTTCTTCGGGCCA	CASSLPRRGGGEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	9	5	3	18	33	47	38	50														CASSLPRRGGGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGACTCAAAACTACGAGCAGTACTTCGGGCCG	CASSLRTQNYEQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	10	3	1	5	18	33	39	34	44						01,02								CASSLRTQNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTTGAACCAGATGGAGACCCAGTACTTCGGGCCA	CASSFLNQMETQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	5	7	3	18	32	42	39	45														CASSFLNQMETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCAGGGCAAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	13	8.633800665466789E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	5	2	3	18	32	39	34	42														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCCGGACTGGCAGCTAACTATGGCTACACCTTCGGTTCG	CASRSGLAANYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	0	4	5	18	29	38	33	43						01,02								CASRSGLAANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGTCACAGACAGATACGCAGTATTTTGGCCCA	CASSLRSQTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	3	5	0	18	33	-1	38	42														CASSLRSQTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAGATTGGCAGGTGAGGAGTGAAGCTTTCTTTGGACAA	CASSLDWQVRSEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	4	4	7	4	7	18	35	43	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDWQVRSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAAGTGCCAGGGTAACGCTTAGTGAAAAACTGTTTTTTGGCAGT	CASSLLSARVTLSEKLFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	7	8	10	18	33	46	41	56														CASSLLSARVTLSEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGAACGGGCGGGGGGTACTGGTGGCCCAGTACTTCGGGCCA	CASSFRNGRGVLVAQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	1	9	9	9	18	32	49	41	58														CASSFRNGRGVLVAQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGACACTTATAACTATGGCTACACCTTCGGTTCG	CASSFRDTYNYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	6	1	2	4	18	32	40	34	44														CASSFRDTYNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACCCTTAAGTTCCGGGGAGCTGTTTTTTGGAGAA	CASSLGPLSSGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	0	7	6	0	9	18	-1	37	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPLSSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGGGTCCTGACAGGGCCTAATTCACCCCTCCACTTTGGGAAC	CASRVLTGPNSPLHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	6	6	2	18	29	42	35	44														CASRVLTGPNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCCCGAGACGGGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSPPRRGVNEKLFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	4	10	1	18	29	46	39	47														CASSPPRRGVNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAGTCAATGCAGAAGAGGGGGAGGGGACGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	9.962077690923219E-5		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	5	17	3	18	28	52	45	55														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTAAGGGACTAGCGGGAGATACGCAGTATTTTGGCCCA	CASTKGLAGDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	4	5	4	0	18	28	-1	32	44						01,02								CASTKGLAGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCGCCCCGACCGGGACACCCGGGCCCCTCCACTTTGGGAAC	CASSIAPTGTPGPLHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	13	12	6	18	30	48	42	54														CASSIAPTGTPGPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTGTAGGGACGGTTAACACTGAAGCTTTCTTTGGACAA	CASSQVVGTVNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	0	7	2	9	4	18	30	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVVGTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCTTGGGGGACAGGGGAGTACGAGCAGTACTTCGGGCCG	CASSPPWGTGEYEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	4	9	2	18	30	49	39	51														CASSPPWGTGEYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCGGGGTAATTTTCCCCCACGAGCAGTTCTTCGGGCCA	CASSPSGVIFPHEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	10	1	14	18	30	40	31	54														CASSPSGVIFPHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTTTTAAACAGGGAACGAGATACGAGCAGTACTTCGGGCCG	CASSRFKQGTRYEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	4	8	7	18	30	44	38	51														CASSRFKQGTRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTATGTTGGGGGGCCGCTGGAGTGAGCAGTACTTCGGGCCG	CASSSMLGGRWSEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	6	0	7	8	9	18	31	45	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSMLGGRWSEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGAGCCAGGGCGACTATGGCTACACCTTCGGTTCG	CASSLMSQGDYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	6	2	18	33	44	39	46														CASSLMSQGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACGACAGGGTACATTCAGTACTTCGGCGCC	CASSLGTTGYIQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	3	8	4	1	18	34	45	38	46														CASSLGTTGYIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCGACAGGTAAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	9.962077690923219E-5		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	1	3	5	18	32	41	35	46														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACTAGCGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLTSGGQETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	2	0	1	18	-1	44	32	45														CASSLTSGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGGGTAGGCTATGGCTACACCTTCGGTTCG	CASSLEGVGYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	5	1	4	2	4	18	32	40	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGVGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACAAGCGGGGAATCGCGTTGAAGCTTTCTTTGGACAA	CASRQAGNRVEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	6	3	7	3	8	18	29	39	32	47														CASRQAGNRVEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCAAGGGCCTCTTCGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	7	17	15	10	18	30	50	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACAGGGAGGTATCTATGGCTACACCTTCGGTTCG	CASSPGQGGIYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	3	6	18	30	41	33	47														CASSPGQGGIYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAAGGACAGGACTGCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	17	5	18	18	30	42	35	60														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGGTGCGGGGGGGCTTTATGAGCAGTTCTTCGGGCCA	CASSPRGAGGLYEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	8	9	4	18	30	48	39	52														CASSPRGAGGLYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCTTCCGTCAACAGATACGCAGTATTTTGGCCCA	CASSPLPSTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	6	3	10	0	18	30	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACCTGGACTAGCGGGGGAAAGAGCAGTACTTCGGGCCG	CASSLYLD*RGKEQYF	Stop	VDJ	1	16	1.0626216203651434E-4		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	7	5	3	18	33	51	38	54														CASSLYLD*RGKEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCGGGCCAGTCGCGGGAGACCCAGTACTTCGGGCCA	CASSLPGQSRETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	8	0	5	3	9	18	32	39	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPGQSRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTACCAGCAGCTTGGAGGCAGGGGGGTTGGAGACCCAGTACTTCGGGCCA	CTSSLEAGGLETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	5	5	4	18	32	44	37	48														CTSSLEAGGLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACTTACGGACAGGGTTTACTTCACCCCTCCACTTTGGGAAC	CASNLRTGFTSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	3	9	1	5	18	33	42	34	47														CASNLRTGFTSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCTGGGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASTPGGANTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	1	5	1	18	28	40	33	41														CASTPGGANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAACCCGGGACAGGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	1.1290354716379648E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	1	7	0	18	30	-1	37	46														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGACTAGCGGGGGCCCCCCCGGATAACACAGATACGCAGTATTTTGGCCCA	CASSTGLAGAPPDNTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	2	3	13	18	30	46	33	59														CASSTGLAGAPPDNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSQTGNNQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	3	2	2	18	30	39	32	41														CASSQTGNNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGGGAGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPWGGSSGNTIYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	0	0	5	2	18	30	42	35	44														CASSPWGGSSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCAGGGATATCCAAGAGACCCAGTACTTCGGGCCA	CASSRRDIQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	1	2	4	18	30	37	32	41														CASSRRDIQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGACTCCGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSRDSVSTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	0	1	5	18	30	37	31	42						01,02								CASSRDSVSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGGGACTAGCGGCTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGTSGFQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	1	3	3	18	30	44	33	47						01,02								CASSLGTSGFQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGATCTCACAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSDLTGDNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	5	6	0	18	30	-1	36	43														CASSDLTGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGAGACAGGGGCAGGCTATGGCTACACCTTCGGTTCG	CASSYETGAGYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	4	4	4	18	31	43	35	47														CASSYETGAGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTTGGCCGGGACTAGCGGGGGGTCAACAGATACGCAGTATTTTGGCCCA	CASSLDLAGTSGGSTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	1	3	7	3	18	35	57	42	60														CASSLDLAGTSGGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGTTCGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGQFVAGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	5	6	0	7	18	-1	39	34	46														CASSLGQFVAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCGGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSFSGLNTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	7	0	0	3	0	18	32	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAACGGAATAACTATGGCTACACCTTCGGTTCG	CASSLKRNNYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	1	8	1	5	1	18	32	40	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKRNNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGACAGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLRTGATNEKLFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	2	0	2	0	18	32	-1	34	43														CASSLRTGATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGACAGGGCAAACTGAAGCTTTCTTTGGACAA	CASSLETGQTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	5	3	3	18	32	42	35	45														CASSLETGQTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCCGGGGGGGCCAGTAACACTGAAGCTTTCTTTGGACAA	CASTPGGASNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	2	4	5	18	28	40	32	45														CASTPGGASNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCCCAGGGTAGGGAAGATGGCTACACCTTCGGTTCG	CASTSQGREDGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	6	5	8	18	28	38	33	46														CASTSQGREDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGTTGGGGGCCAATCCTACGAGCAGTACTTCGGGCCG	CASSLVGGQSYEQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	1	6	3	18	30	42	36	45														CASSLVGGQSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCGGGTTTTCGTGAAAAACTGTTTTTTGGCAGT	CASSLPGFREKLFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	4	7	1	6	18	33	38	34	44						01,02								CASSLPGFREKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGCCCCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFQGPGTGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	5	1	7	18	32	38	33	45														CASSFQGPGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTTCGGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSSSGGNEKLFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	4	5	0	18	29	-1	34	41														CASSSSGGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGTCCAAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPVQGDTGELFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	3	8	0	18	30	-1	38	43														CASSPVQGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGAGGGACATGAAGGGGAAAAACTGTTTTTTGGCAGT	CASSAEGHEGEKLFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	0	6	8	5	7	18	30	41	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAEGHEGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCAGGGTAGACTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	1.2618631741836078E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	5	2	7	18	30	37	32	44														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAATAAGTGGGGACTACGAGCAGTACTTCGGGCCG	CASSLVISGDYEQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	0	8	3	11	0	18	32	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVISGDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTGGCCACCTCCGAACTATGGCTACACCTTCGGTTCG	CASSFWPPPNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	9	0	2	2	8	18	32	37	34	45														CASSFWPPPNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTCTGAGGACCCTCGATAATTCACCCCTCCACTTTGGGAAC	CASSLRTLDNSPLHF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	6	1	7	5	5	5	18	29	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRTLDNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACGCTTGGCAGGCCCCACCTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	1.328277025456429E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	4	3	7	8	18	28	39	35	47														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACGGGGGCGCCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.328277025456429E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	6	0	3	4	5	18	30	40	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACTAGCGGGGGCTTCCTCGTAGAGCTGTTTTTTGGAGAA	CASSPGTSGGFLVELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	11	3	10	18	30	47	33	57														CASSPGTSGGFLVELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGACACCTTTGGAAACACCATATATTTTGGAGAG	CASSPDTFGNTIYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	6	3	3	4	18	30	37	33	41														CASSPDTFGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCTTTCCAGGGGCAGAGACCCAGTACTTCGGGCCA	CASSLSFPGAETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	4	7	1	18	33	46	40	47														CASSLSFPGAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTATCGGACAGACTAGCGGAAGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.328277025456429E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	0	10	3	18	32	51	42	54						01,02								X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATAGGGACAGCTACAATGAGCAGTTCTTCGGGCCA	CASSLDRDSYNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	3	5	0	18	32	-1	37	44														CASSLDRDSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGCCAGGGGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGQGRGNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	0	1	5	1	18	34	46	39	47														CASSLGQGRGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCTGGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSIWRGNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	1	4	1	18	30	40	34	41														CASSIWRGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAAGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPKTVNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	0	5	0	18	30	-1	35	40														CASSPKTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCACATCCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLATSSYNSPLHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	6	0	4	2	18	32	39	36	41														CASSLATSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTTCAGCGGGGGGCGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSFFQRGAFTGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	1	4	5	4	18	32	46	37	50														CASSFFQRGAFTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACTGACAGGCTCATATCGGGCTACACCTTCGGTTCG	CASRTDRLISGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	8	4	9	18	29	39	33	48														CASRTDRLISGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCGGACTATGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPDYGTGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	9	5	3	4	18	29	38	32	42						01,02								CASSPDYGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAATCCGTGGGACGCTAACTATGGCTACACCTTCGGTTCG	CASNPWDANYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	7	0	7	0	6	1	18	28	39	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPWDANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCAGCTCGGGACTAGCGGGGAAGACCCAGTACTTCGGGCCA	CASSSSGLAGKTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	6	5	1	18	30	48	35	49														CASSSSGLAGKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACAGGGGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSLTGGGQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	0	7	0	3	18	-1	42	33	45														CASSLTGGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTACAGGGATTTGGCACTGAAGCTTTCTTTGGACAA	CASSLLQGFGTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	4	2	6	18	33	41	35	47														CASSLLQGFGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFASGANVLTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	10	0	0	1	0	18	32	-1	33	35				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFASGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCCCGCTGCCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDPAALSGANVLTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	1	7	0	0	11	18	-1	36	32	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPAALSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTGGGAAACTTCGGCGAAGCTTTCTTTGGACAA	CASSLALGNFGEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	8	8	6	9	18	32	42	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALGNFGEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGCAAGATACGGGGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	1.5275185792748935E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	8	11	0	18	30	-1	41	47														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSSGRGQETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	8	0	2	1	2	18	31	40	32	42														CASSSGRGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGCTCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSGLDSNQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	7	0	0	1	4	18	31	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGLDSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTACAGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSSTGGPDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	4	2	1	18	31	42	33	43														CASSSTGGPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTCCCCGGGCGGAAGAATGAAAAACTGTTTTTTGGCAGT	CASRLPGRKNEKLFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	6	8	0	5	7	5	18	29	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLPGRKNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGGGACATGGAAACACCATATATTTTGGAGAG	CASSPPGHGNTIYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	3	5	0	18	30	-1	35	41														CASSPPGHGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTTTACCCGGGACGGTACTAACTATGGCTACACCTTCGGTTCG	CASSSFTRDGTNYGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	0	7	0	9	4	18	31	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSFTRDGTNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGGGAAGGGGCACCCCTCCACTTTGGGAAC	CASSPGTGEGAPLHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	11	3	6	18	30	43	33	49														CASSPGTGEGAPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCTGTCGGGCAGGTCCCAGATACGCAGTATTTTGGCCCA	CASSSPVGQVPDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	4	4	4	11	3	18	31	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPVGQVPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGTGGACAGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSSRGQGGNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	6	5	1	18	31	46	36	47														CASSSRGQGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAACAGGGGGTTTTTCACCCCTCCACTTTGGGAAC	CASSLGTGGFSPLHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	1	9	2	3	18	34	44	36	47														CASSLGTGGFSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGATGGGAGCCTACGAGCAGTACGTCGGGCCG	CASSFGMGAYEQYV	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	3	17	0	21	18	-1	37	32	58														CASSFGMGAYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGTGTTTTGAATGAAAAACTGTTTTTTGGCAGT	CASSFGVLNEKLFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	5	5	0	7	18	-1	35	32	42						01,02								CASSFGVLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	25	1.6603462818205365E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	3	5	0	0	18	-1	-1	32	39														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCTCGCCTATACCTCTACACAGATACGCAGTATTTTGGCCCA	CASSPRLYLYTDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	9	2	7	8	18	29	39	36	47						01,02								CASSPRLYLYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGAGCAGAGCATAGTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.6603462818205365E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	8	2	7	4	19	0	18	27	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGGGCCAATAATGAAAAACTGTTTTTTGGCAGT	CASSFQGANNEKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	0	4	1	3	18	32	41	33	44														CASSFQGANNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCCCCCCCTGCGGGGGGATGGGAGACCCAGTACTTCGGGCCA	CASSPPPPAGGWETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	1	5	12	4	18	30	50	42	54														CASSPPPPAGGWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGCTCGGGGGGGCTGTTAACAAAAGATACGCAGTATTTTGGCCCA	CASSSRSGGLLTKDTQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	5	6	11	18	31	45	37	56														CASSSRSGGLLTKDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGACAGGGGTAGTGCTTCTGGAAACACCATATATTTTGGAGAG	CASSLRDRGSASGNTIYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	2	1	1	7	18	33	44	34	51														CASSLRDRGSASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGACGGGACAGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASRDGTGGADTQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	0	4	4	1	18	29	45	33	46														CASRDGTGGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCGGGACAGAAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRKNTGELFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	1	2	3	18	29	38	31	41														CASSRDRKNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATACTACACCAAGGACTCGTCCAAGAGACCCAGTACTTCGGGCCA	CASILHQGLVQETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	1	10	1	11	3	18	28	44	39	47						01,02								CASILHQGLVQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGCGGGGGTAGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	1.8595878356390008E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	8	2	5	18	32	43	34	48														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQYTGELFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	5	3	0	1	18	-1	39	34	40														CASSLGQYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCCGGCTAGTGGGAGAGAGACCCAGTACTTCGGGCCA	CASSLAPASGRETQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	2	4	13	0	18	32	-1	45	50														CASSLAPASGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATGACCCCATCGGACAGGTCACAGATACGCAGTATTTTGGCCCA	CASSNDPIGQVTDTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	2	12	1	18	30	49	42	50														CASSNDPIGQVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACCGAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGPSSYNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	0	7	1	0	5	18	-1	37	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCGGCAGGGGGGGCGCGCACTGAAGCTTTCTTTGGACAA	CASSPAGGARTEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	1	4	4	6	18	30	41	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAGGARTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCTGGGGGGTGGGACTGAAGCTTTCTTTGGACAA	CASSPLGGGTEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	5	5	4	18	30	41	35	45														CASSPLGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGGGGGGCCGCGCATATCCTACGAGCAGTACTTCGGGCCG	CASSSPGGPRISYEQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	1	1	4	9	18	31	42	35	51														CASSSPGGPRISYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGATTGGGACATCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSFDWDILYNEQFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	3	5	4	18	32	43	37	47														CASSFDWDILYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGAAGGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSKKGAGANVLTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	5	3	2	4	2	18	30	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKKGAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGTAGGGAGATTAATAAACACTGAAGCTTTCTTTGGACAA	CASSRVGRLINTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	2	6	7	18	30	41	36	48														CASSRVGRLINTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCAGAAAGTGGTCCAGCGGTGTATGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	33	2.1916570920031082E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	5	17	15	17	18	29	49	44	66						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTACCCAGAAGGGGGCGAGTACTGAAGCTTTCTTTGGACAA	CASSPTQKGASTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	5	10	4	18	30	47	40	51														CASSPTQKGASTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTACCCGCAGTCAGATACGCAGTATTTTGGCCCA	CASSPYPQSDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	5	4	9	1	18	30	42	39	43														CASSPYPQSDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGGAGGCATCGGCAACACTGAAGCTTTCTTTGGACAA	CASSLGGIGNTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	2	0	7	18	-1	38	32	45														CASSLGGIGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGCCAAGGGCTAGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	36	2.3908986458215725E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	5	3	10	7	6	18	31	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGAAGCGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSLRSGGRETQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	1	5	4	3	18	32	45	36	48														CASSLRSGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGGGACTAGCGGGCGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	2.5237263483672155E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	0	3	6	18	30	45	33	51						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGTGGCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSFVAGDTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	5	0	18	32	-1	37	43														CASSFVAGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGGTGGTAGAGGGGACACAGATACGCAGTATTTTGGCCCA	CASRGGRGDTDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	6	5	2	2	9	1	18	29	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGGRGDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTCGGGTTCGGCGAGACCCAGTACTTCGGGCCA	CASSLFGFGETQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	5	3	6	18	32	39	35	45						01,02								CASSLFGFGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAACTCCGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSANSGDYNEQFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	3	8	1	18	30	43	38	44														CASSANSGDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACTAGCGGGGGCCTGTTCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGGLFTDTQYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	2	1	6	18	32	47	33	53														CASSLGTSGGLFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGACCGCCTTCGGCCAAACTGTTTTTTGGCAGT	CASSPGPPSAKLFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	1	7	11	3	11	18	30	37	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPPSAKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACCCGGGACGGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQPGTGSSGANVLTF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	0	7	0	6	6	18	30	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGTGSSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGATCACACAGATACGCAGTATTTTGGCCCA	CASSLDDHTDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	1	7	2	0	5	18	-1	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDDHTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTAAGAGACAGGGGCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	3.055037158549787E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	2	0	1	18	-1	43	35	44														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGAGGACAGCTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFEDSLNTGELFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	5	1	3	3	18	32	41	35	44														CASSFEDSLNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGACAGGGGTTCACCTATGGCTACACCTTCGGTTCG	CASSAGQGFTYGYTF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	4	3	5	18	30	42	33	47														CASSAGQGFTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCCGGAAGACTCTGGAAACACCATATATTTTGGAGAG	CASSLDPEDSGNTIYF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	1	7	0	0	8	18	-1	36	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPEDSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGCGGGGGAAAGGCACTGAAGCTTTCTTTGGACAA	CASSLDGRGKGTEAFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	2	4	3	5	18	35	45	38	50														CASSLDGRGKGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGAGACAGCCGTTGAAGCTTTCTTTGGACAA	CASSLEETAVEAFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	7	3	4	18	35	43	38	47														CASSLEETAVEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAGGGGGGAGTTATATGGCTACACCTTCGGTTCG	CASSQRGELYGYTF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	5	1	5	3	6	18	30	39	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGELYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAAACAGGGTTGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	53	3.5199341174595373E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	5	4	4	18	30	40	34	44														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCCTCCGGAACAAGAGACCCAGTACTTCGGGCCA	CASSDPPEQETQYF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	1	8	2	8	1	18	30	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPPEQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQTNTGELFF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	4	6	0	1	2	18	32	35	33	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGGAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSSGEGYNEQFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	4	3	1	18	31	41	34	42														CASSSGEGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGAGACTAGCGGGGGGGCCTACAGATACGCAGTATTTTGGCCCA	CASSLRLAGGPTDTQYF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	3	4	3	18	30	48	34	51														CASSLRLAGGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAAAGGGGGGACAGCGGAGCAGTACTTCGGGCCG	CASSSKGGTAEQYF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	7	8	2	18	31	46	39	48														CASSSKGGTAEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCACAAGGTGGTTAGGGGATAGCTACACCTTCGGTTCG	CASSLTRWLGDSYTF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	9	14	3	18	30	49	44	52														CASSLTRWLGDSYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGCTGGGACAGGGGACGGGGAGACCCAGTACTTCGGGCCA	CASSWAGTGDGETQYF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	5	5	5	18	31	46	36	51														CASSWAGTGDGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACAGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASSLEGTGGSYEQYF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	1	1	1	18	35	47	36	48														CASSLEGTGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASRTGTGNYGYTF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	2	4	0	18	29	-1	33	42														CASRTGTGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACTCCCGTAGATACGCAGTATTTTGGCCCA	CASSPGTPVDTQYF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	5	3	5	18	30	39	33	44						01,02								CASSPGTPVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTATTCGTTCATTGGACTAAGCACTGAGACCCAGTACTTCGGGCCA	CASSLYSFIGLSTETQYF	In	VDJ	2	77	5.113866548007252E-4	5.960675027093977E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	9	5	13	6	18	32	51	45	57						01,02								CASSLYSFIGLSTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAAAGGGATGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSKGMGANVLTF	In	VDJ	2	79	5.246694250552895E-4	6.115497755070444E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	0	8	4	5	2	18	31	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSKGMGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGGACTAGCGGTCTACAAGAGACCCAGTACTTCGGGCCA	CASSPRTSGLQETQYF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	5	2	4	4	18	30	44	34	48						01,02								CASSPRTSGLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCGGTCTGGGCTACGGGGGCGATGGCTACACCTTCGGTTCG	CASSFSGLGYGGDGYTF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	6	0	6	16	1	18	32	54	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGLGYGGDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAGAGGGGACATTGAAGCTTTCTTTGGACAA		Out	VDJ	2	85	5.645177358189824E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	7	7	1	18	32	45	39	46														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAGGGGCAGGGCGGAGGGGAGCTGTTTTTTGGAGAA	CASSPEGQGGGELFF	In	VDJ	2	93	6.176488168372396E-4	7.199256850905712E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	0	8	2	10	18	30	38	32	48														CASSPEGQGGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGTTTTCGGGACATAACACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	95	6.309315870918038E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	3	8	4	18	33	47	41	51														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGTTGAGTCAGGCGGCTGAAGCTTTCTTTGGACAA	CASSLVLSQAAEAFF	In	VDJ	3	107	7.106282086191896E-4	8.283015946740982E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	4	6	10	3	18	32	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLSQAAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCGGGACAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGQSYNEQFF	In	VDJ	3	111	7.371937491283182E-4	8.592661402693915E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	1	3	0	18	29	-1	32	39														CASSPGQSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCAAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLKGGTDTQYF	In	VDJ	3	116	7.70400674764729E-4	8.979718222635083E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	1	4	0	18	30	-1	34	40														CASSLKGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGAAGCGGCTAGCGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSWKRLAGNNEQFF	In	VDJ	3	117	7.770420598920111E-4	9.057129586623316E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	8	1	18	31	48	39	49														CASSWKRLAGNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTGACGGAGGGGATTTCGCGCAGTATTTTGGCCCA	CASSVDGGDFAQYF	In	VDJ	3	120	7.969662152738575E-4	9.289363678588017E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	10	6	7	18	30	42	36	49														CASSVDGGDFAQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGCAGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSSRRAQETQYF	In	VDJ	3	137	9.09869762437654E-4	0.0010605356866387986	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	1	4	1	18	31	40	35	41														CASSSRRAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGTCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLESSSYNEQFF	In	VDJ	4	146	9.696422285831933E-4	0.0011302059142282088	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	0	0	5	18	-1	36	32	41														CASSLESSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGAGGTGGCTGTGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSSGEVAVLNQPQHF	In	VDJ	4	151	0.001002849154219604	0.0011689115962223255	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	4	2	3	0	13	18	-1	37	31	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGEVAVLNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAGAGAGTTATGGAAGGGCTACACCTTCGGTTCG	CASSWDRELWKGYTF	In	VDJ	5	203	0.0013482011808382756	0.0015714506889611395	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	8	0	13	18	-1	38	31	51														CASSWDRELWKGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	220	0.0014611047280020722		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	3	2	0	18	32	-1	34	43														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGCGGGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSFRAGESYEQYF	In	VDJ	7	282	0.0018728706058935651	0.002183000464468184	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	1	4	2	18	32	43	36	45														CASSFRAGESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTACCGGGGGGCGGGGCCAGAGACCCAGTACTTCGGGCCA	CASSYRGAGPETQYF	In	VDJ	8	314	0.0020853949299665937	0.002430716829230531	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	4	4	7	18	29	40	33	47														CASSYRGAGPETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAACGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGTGSSYNSPLHF	In	VDJ	17	686	0.004555990197315552	0.005310419569592816	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	8	3	0	5	2	18	32	42	37	44						01,02								CASSLGTGSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGACAGGGGGCTTATGGCTACACCTTCGGTTCG	CASSFGQGAYGYTF	In	VDJ	23	905	0.006010453540190342	0.00700572844093513	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	0	5	1	1	18	32	44	33	45														CASSFGQGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAGCGACAGGGGGTGGAAACACCATATATTTTGGAGAG	CASGLATGGGNTIYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	1	3	3	0	26	40	-1	43	52														CASGLATGGGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTAAAGGGGGCCGGGGACAAGCTTTCTTTGGACAA	CASTKGGRGQAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	5	0	9	9	7	26	31	47	40	54														CASTKGGRGQAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCCTCAGGAGGGCCCCTCGGGGGGAGCTGTTTTTTGGAGAA	CALRRAPRGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	10	0	8	5	8	26	31	42	36	50														CALRRAPRGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTAGCCGGACAGCGGGTTCACCCCTCCACTTTGGGAAC	CASSRTAGSPLHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-06	01	8	1	5	9	4	4	26	35	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTAGSPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACAGGGGCCTCCTCCCACAATGAGCAGTTCTTCGGGCCA	CASTGASSHNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	2	5	4	9	26	31	42	35	51														CASTGASSHNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTCTCCTCCAATGAACACTGAAGCTTTCTTTGGACAA	CASSPPMNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	12	4	5	0	0	11	26	-1	34	31	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPMNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCGGACAGGGGGGAACTATGGCTACACCTTCGGTTCG	CASGRTGGNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	2	1	1	26	38	49	39	50														CASGRTGGNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACCAACCCGGGACAGGGGAACTGTCCGTCCTGACTTTCGGGGCC	CASNQPGTGELSVLTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	12	0	2	12	13	7	26	31	54	44	61														CASNQPGTGELSVLTF+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCTGGGACAGCACCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	1.328277025456429E-4		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	3	4	5	26	38	49	42	54														X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGGAATGGCCCGGGGAGCTGTTTTTTGGAGAA	CASGLGEWPGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	1	0	8	6	0	5	26	-1	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGEWPGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGGCAGCCACCTCAGGAAACACCATATATTTTGGAGAG	CASGSAATSGNTIYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	4	4	5	4	3	8	26	39	45	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSAATSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCACCCGGGACAGGGGGATAAAAAAGCTTTCTTTGGACAA	CASTHPGQGDKKAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	1	9	12	6	26	31	54	43	60														CASTHPGQGDKKAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGCCTACATGAACACTGAAGCTTTCTTTGGACAA	CASAYMNTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	12	6	6	0	1	6	26	31	36	32	42						01,02								CASAYMNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGGACAGCCTACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	22	1.461104728002072E-4		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	17	1	19	26	39	46	40	65														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACGAGATGGGGAACAGGGGCCCGTTCCAGATACGCAGTATTTTGGCCCA	CASGLVRDGEQGPVPDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	60	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	2	4	12	7	15	32	51	44	58														CASGLVRDGEQGPVPDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACAAGGAAACACCATATATTTTGGAGAG	CASGLVQGNTIYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	6	4	0	1	26	-1	46	43	47														CASGLVQGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGGCAGGGACCACGAACGAGCAGTACTTCGGGCCG	CASGLGAGTTNEQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	1	0	7	5	5	5	26	42	52	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGAGTTNEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGLVLGANTGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	0	6	1	0	3	0	26	43	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVLGANTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATACCCCAGCAGGGGTAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	26	1.7267601330933578E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	12	4	2	7	13	2	26	31	50	44	52														X+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTAACATCTTCCAAACAGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CASGNIFQTGGNQPQHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	51	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	4	12	1	26	38	58	50	59														CASGNIFQTGGNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGTGCTAGCGGGGGATGAGCAGTTCTTCGGGCCA	CASGLVVLAGDEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	8	4	0	26	43	-1	47	57														CASGLVVLAGDEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCAACAACAGGGGAACTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	1.9260016869118224E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	2	4	6	5	26	36	49	42	54														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCCCGGGGGAACGCTCCTACGAGCAGTACTTCGGGCCG	CASGPPGERSYEQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	0	4	4	26	38	48	42	52														CASGPPGERSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCAGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASTQTGGTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	2	1	4	9	0	26	31	-1	40	49														CASTQTGGTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACCGGGGCCCAGCACAGATACGCAGTATTTTGGCCCA	CASGLVPGPSTDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	0	7	0	0	3	2	26	43	51	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVPGPSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGCGGGGGGTGCTTCACCCCTCCACTTTGGGAAC	CASAGGASPLHF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	12	7	1	9	4	3	26	31	43	35	46														CASAGGASPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGATCTCCCTCGGACTAGCGAGGAATGAGCAGTTCTTCGGGCCA	CASGLISLGLARNEQFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	6	7	9	3	26	41	59	50	62						01,02								CASGLISLGLARNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCGACTCAACCCCCCGCCTGGGACTAGCGGACTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	2.3908986458215725E-4		58	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	12	0	5	4	22	3	23	28	61	50	64						01,02								X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTTGTGCTAGTGGTTTGGGGACTCTTAGGGGAGGCTGGAGGACCTCAGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	2.457312497094394E-4		65	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	1	2	10	16	2	18	34	28	50														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACCCGACTAGCCGAGCAGTACGTCGGGCCG		Out	VDJ	1	40	2.656554050912858E-4		35	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	7	17	4	11	26	37	48	41	59						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCACCCAGGACGGCGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASGFTQDGVYSNQPQHF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	54	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	3	1	7	0	6	8	26	40	50	46	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGFTQDGVYSNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACCCGAGGCAGGGAGGATAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	2.7893817534585015E-4		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	1	5	10	4	26	37	53	47	57														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTGGGGACAGAGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	43	2.8557956047313226E-4		43	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	5	4	1	5	26	39	47	40	52														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTCTCCTTGGGGGAACATGAAAAACTGTTTTTTGGCAGT	CASALSLGEHEKLFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	7	6	1	6	10	3	26	36	51	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASALSLGEHEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGGGAACAGATACGCAGTATTTTGGCCCA	CASGLGQGTDTQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	3	3	0	1	26	-1	49	42	50														CASGLGQGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGCCTGGCAACAATGAGCAGTTCTTCGGGCCA	CASGLVPGNNEQFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	5	4	1	26	43	50	47	51														CASGLVPGNNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCCGGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASGLARDRNTEAFF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	1	3	0	26	42	-1	45	52														CASGLARDRNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAATCGGGGACCCAATTTGGTCAGAGACCCAGTACTTCGGGCCA	CASGLVIGDPIWSETQYF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	54	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	0	0	7	4	5	11	26	43	53	48	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVIGDPIWSETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCCTTGACCAGCGGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASGLSLTSGGVNEQFF	In	VDJ	2	76	5.047452696734431E-4	5.883263663105743E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	6	9	1	26	41	60	50	61														CASGLSLTSGGVNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCTCGGCCGGGACACGGATGAAGCTTTCTTTGGACAA	CASGLGRDTDEAFF	In	VDJ	2	77	5.113866548007252E-4	5.960675027093977E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	7	7	4	26	38	51	45	55														CASGLGRDTDEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGACTCGGACTAGCGGGGCTACCTACAATGAGCAGTTCTTCGGGCCA	CASGLTRTSGATYNEQFF	In	VDJ	2	78	5.180280399280074E-4	6.03808639108221E-4	54	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	2	4	3	26	41	57	45	60														CASGLTRTSGATYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGATCTTGAGGCGACAGGGAAAGCATTGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	79	5.246694250552895E-4		49	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	3	8	10	10	26	34	51	44	61														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTATTTTTGTGCTAGTGGTTTGGCGACACTCCCCGGGACTAGCGGGGTCAGGAGATTCGGCTGTTTTTTGGAGAA		Out	VDJ	2	80	5.313108101825716E-4		62	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	0	3	13	11	12	8	24	48	35	60														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCGGGACCTCCGCACAGATACGCAGTATTTTGGCCCA	CASARDLRTDTQYF	In	VDJ	2	82	5.44593580437136E-4	6.347731847035145E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	7	0	7	1	3	4	26	36	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASARDLRTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGGGACACCACGAGTTCCTATCATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	85	5.645177358189824E-4		49	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	6	8	0	15	26	-1	43	37	58														X+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTATGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASYGGAGELFF	In	VDJ	3	138	9.165111475649361E-4	0.001068276823037622	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	10	0	6	7	1	26	31	44	38	45														CASYGGAGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGACGGCGAGGGCACGGCTTTCTTTGGACAA	CASSLDGEGTAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	11	10	4	20	31	46	41	50														CASSLDGEGTAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGACCGGACAGGGCACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	8.633800665466789E-5		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	0	3	1	20	31	42	34	43														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTATCGACAGGGCAACAGTACCCCTCCACTTTGGGAAC		Out	VDJ	1	16	1.0626216203651434E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	12	5	7	20	31	43	36	50														X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCCCGGCCAGGGACCAAATCAGCCCCAGCATTTTGGTGAT	CASSPPGQGPNQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	4	10	2	20	33	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGQGPNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCGGAGAACGAACACTGAAGCTTTCTTTGGACAA	CASSQSRRTNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	5	1	0	5	20	-1	41	37	46						01,02								CASSQSRRTNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATGTCGGGATTCAAGAGACCCAGTACTTCGGGCCA	CASSQDVGIQETQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	3	2	5	2	20	35	45	40	47														CASSQDVGIQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGGGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGTGMNTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	0	4	1	20	31	44	35	45														CASSLGTGMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTCGATAGGGGGTAAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	1.5275185792748935E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	5	5	5	20	37	48	42	53														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGTCCCCCCGGCGGTGCACCTTCGGTTCG		Out	VDJ	1	25	1.6603462818205365E-4		40	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	13	10	2	20	37	51	47	53						01,02								X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCGCCGGGAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAAGRSSYNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	8	1	0	2	2	20	26	35	28	37														CAAGRSSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCGTGACAGCGGTCTGGGTTAGGCTACACCTTCGGTTCG	CASSP*QRSGLGYTF	Stop	VDJ	1	26	1.7267601330933578E-4		45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	4	2	5	8	3	12	20	33	41	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSP*QRSGLGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTAGCCGGGCGGGCGAAGGGACCCAGTACTTCGGGCCA	CASSPSRAGEGTQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	7	7	2	14	20	31	38	33	52						01,02								CASSPSRAGEGTQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCCTAGACGGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	2.1252432407302868E-4		40	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	3	4	7	0	20	30	-1	37	42														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACTTCAATTAAGGTTTCCAGGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	33	2.1916570920031082E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	4	3	3	16	0	20	30	-1	46	51														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACCCCCGGACAGCCCCAAAATACACAGATACGCAGTATTTTGGCCCA	CASSHPRTAPKYTDTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	2	5	10	20	34	45	39	55														CASSHPRTAPKYTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTTTCGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSLSGGTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	5	3	0	20	33	-1	36	44														CASSLSGGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTGGCAGGGAAGAAGTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	34	2.2580709432759295E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	17	3	19	20	37	45	40	64														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGGTGTTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	2.3244847945487512E-4		41	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	1	0	10	1	0	4	20	-1	38	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAGGGCTTGCAGGGGGCGAAAGGAAGGATTCTTCGGGCCA		Out	VDJ	1	38	2.5237263483672155E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	16	8	11	20	37	53	45	64														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGTGGTAGCGAATGAGCAGTTCTTCGGGCCA	CASSQVVANEQFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	6	7	8	0	20	31	-1	39	44						01,02								CASSQVVANEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCGTGCAGAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPCRNSNQPQHF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	4	3	20	33	40	37	43														CASSPCRNSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGACAATTATTTGGGGCAGGTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	46	3.055037158549787E-4		52	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	7	0	1	11	4	20	33	49	44	53														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCCCGGTGCCTGGGCGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	55	3.6527618200051805E-4		46	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	4	8	0	4	11	2	20	33	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCCTCCGCAGCAGTCGGGGCGACGAGCAGTACTTCGGGCCG	CASSLLRSSRGDEQYF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	48	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	4	7	0	5	15	1	20	33	53	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLRSSRGDEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCACCGGAGCAGGTATGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	151	0.001002849154219604		47	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	4	4	4	3	9	4	20	33	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAAGGGACAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	6	235	0.0015607255049113044		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	6	4	3	1	20	37	46	40	47														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATCTAGAAACGGCCGGGACACCGAGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	6	239	0.0015872910454204328		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	6	4	13	6	20	34	53	47	59														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGCTTTGGACAGGGACGGACGATGGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	7.30552364001036E-5		62	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	1	8	13	19	31	47	39	60														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATTTCTCGGAGGGGGATACGCAGTATTTTGGCCCA	CASNFSEGDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	6	0	1	23	-1	46	40	47														CASNFSEGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASTQGNQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	4	2	2	0	23	33	-1	35	39														CASTQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCGGGCCATATAATTCACCCCTCCACTTTGGGAAC	CASSSGPYNSPLHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	8	0	4	4	2	23	34	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGAGGGGAAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	7.30552364001036E-5		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	5	2	3	4	3	23	35	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGGGGGTACGGGAGATACGCAGTATTTTGGCCCA	CASSDSGGTGDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	1	5	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGGTGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACTAGCGGGGGGGCAGGCGGGGAGCTGTTTTTTGGAGAA	CASSVTSGGAGGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	2	0	7	2	4	23	35	51	37	55														CASSVTSGGAGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTCCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSVSSSTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	10	0	5	2	23	35	42	40	44						01,02								CASSVSSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTAGCGGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSYSLAGGPDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	4	2	2	23	40	52	42	54														CASSYSLAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGCCAGCACTGAAGCTTTCTTTGGACAA	CASSLASTEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	5	7	4	0	3	23	-1	40	36	43						01,02								CASSLASTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGTTCCTAAGACAGGGCTTAAGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	7.30552364001036E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	5	5	5	23	36	48	41	53														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGAACAGGGGTAATGAGCAGTTCTTCGGGCCA	CASENRGNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	3	2	7	4	1	23	32	43	36	44														CASENRGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGACGGCGGACAGGGGACGTTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	11	7.30552364001036E-5		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	17	5	17	23	34	48	39	65														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCCTGACAGGGAATTCTATGGCTACACCTTCGGTTCG	CAISPDREFYGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	4	4	23	34	45	38	49														CAISPDREFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAGGACAGGGTCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	12	7.969662152738576E-5		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	17	4	15	23	34	46	38	61														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTATACAGGGGCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPIQGRSYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	0	5	2	23	35	47	40	49														CASSPIQGRSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGACAGCTATGAAGCTTTCTTTGGACAA	CASSDDSYEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	7	3	3	23	35	43	38	46														CASSDDSYEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGGGACAGGGATGAAAAACTGTTTTTTGGCAGT	CASSDSRDRDEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	3	6	2	0	23	40	-1	42	51														CASSDSRDRDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGACAGCTATATGGCTACACCTTCGGTTCG	CASSYSRQLYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	5	2	3	23	40	47	42	50														CASSYSRQLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGCTAGCGGGGGACGAGATCCAGTTCTTCGGGCCA	CASSYSWLAGDEIQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	13	4	8	23	40	54	44	62														CASSYSWLAGDEIQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAATACAGGGGTCTGAAGCTTTCTTTGGACAA	CAIRIQGSEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	6	3	1	23	34	44	37	45														CAIRIQGSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTGGGACAGGAGAACACTGAAGCTTTCTTTGGACAA	CAISVGQENTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	1	2	1	23	35	45	37	46														CAISVGQENTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCGTTGGACAGGGGCTCTTCTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	12	7.969662152738576E-5		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	1	2	6	4	6	23	29	42	33	48														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGACCGCCCGCTTCAGCTAATTATGGCTACACCTTCGGTTCG	CASSAGPPASANYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	7	3	5	0	18	23	-1	41	35	59														CASSAGPPASANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAAGCTGGCGCTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYQAGAANTGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	9	0	0	6	4	23	38	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYQAGAANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTATCCTCCGGGGCAGCTGAAGCTTTCTTTGGACAA	CASVSSGAAEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	7	0	6	9	2	23	32	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVSSGAAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCGGGACACAGCACAGATACGCAGTATTTTGGCCCA	CAISSGHSTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	6	0	1	1	23	36	43	37	44														CAISSGHSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGACGAAGCGGGGAGGATAATTCACCCCTCCACTTTGGGAAC	CAGRSGEDNSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	11	6	3	5	6	3	23	29	42	35	45														CAGRSGEDNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGTTACTCGGAAGGGAATGAGTAGTTCTTCGGGCCA	CASSYSEGNE*FF	Stop	VDJ	1	13	8.633800665466789E-5		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	0	8	14	4	6	23	40	48	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSEGNE*FF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTGGGAGAGGGAGCCGAAAAGTACGTCGGGCCG		Out	VDJ	1	14	9.297939178195004E-5		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	2	17	4	18	23	34	43	38	61														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGCGGGCCTTCCGATGAGCAGTTCTTCGGGCCA	CASSTGGPSDEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	3	4	8	0	11	23	-1	40	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGGPSDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACTAGCGGGGGAGTACGAGCAGTACGTCGGGCCG	CASSRLAGEYEQYV	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	17	1	15	23	35	48	36	63														CASSRLAGEYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGCAGGGCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSYSGRAAGELFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	6	3	3	23	40	48	43	51														CASSYSGRAAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGAGCGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSRERGGTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	1	1	5	0	23	40	-1	45	54														CASSYSRERGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGCGGGGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSYGGGGNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	7	2	2	23	37	48	39	50														CASSYGGGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGACAGGGTGAGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	3	6	1	4	23	32	42	33	46														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATTTAGGCCTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNLGLSGANVLTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	7	5	4	1	4	4	23	33	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNLGLSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGACAGGGGGCCGTGCAGCCCCAGCATTTTGGTGAT	CASTGQGAVQPQHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	0	7	2	4	23	33	46	35	50														CASTGQGAVQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCGGGACAGTTCAGGGTATGGCTACACCTTCGGTTCG	CASTRDSSGYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	5	3	7	23	33	43	36	50														CASTRDSSGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAAAGGACGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSEKDGSTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	1	7	0	6	3	23	34	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEKDGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCGGGGCTGGAAACACCATATATTTTGGAGAG	CASSTGAGNTIYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	3	2	2	0	23	35	-1	37	42														CASSTGAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCAACCTGACAGGGCCGACGGCTACACCTTCGGTTCG	CASSPQPDRADGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	8	9	5	23	35	51	44	56														CASSPQPDRADGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACCTCCGGTCGGGAGACCCAGTACTTCGGGCCA	CASSPGTSGRETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	3	10	23	35	43	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTSGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAACCCTCCAAGGGCCAACGTCCTGACTTTCGGGGCC	CASSDNPPRANVLTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	0	9	23	-1	39	35	48														CASSDNPPRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAAACAGGGGGCATATATCAGCCCCAGCATTTTGGTGAT	CASQTGGIYQPQHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	0	5	3	4	23	32	44	35	48														CASQTGGIYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCATGGAGACATACCCCAATGAGCAGTTCTTCGGGCCA	CAIMETYPNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	10	2	6	6	7	5	23	30	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIMETYPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGCGGGGGGAACAAGAGACCCAGTACTTCGGGCCA	CAIGRGEQETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	7	1	2	4	2	23	30	42	34	44														CAIGRGEQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTACCCGAGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	9.962077690923219E-5		37	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	11	5	2	1	6	0	23	29	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGAGGACACTACCTACAATGAGCAGTTCTTCGGGCCA	CASSREDTTYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	2	1	6	23	34	42	35	48														CASSREDTTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCACAGGGTAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.0626216203651434E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	2	4	3	23	35	45	39	48														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSPGTQETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	1	3	0	23	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCCTGGGTACTATGGCTACACCTTCGGTTCG	CASSPPGYYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	9	3	6	1	23	35	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACCCGCGGGGGTCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	2	0	5	3	23	38	50	43	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGCTTAGCGGGGGTGCCACAGATACGCAGTATTTTGGCCCA	CAIRLSGGATDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	2	2	3	3	23	34	46	37	49														CAIRLSGGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAACGGGGGACAGTCGCTGGCTACACCTTCGGTTCG	CASSQRGTVAGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	7	7	4	23	34	48	41	52														CASSQRGTVAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAACTAGCGGGGGCTCGGTAGATACGCAGTATTTTGGCCCA	CASSPTSGGSVDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	5	4	6	23	34	49	38	55														CASSPTSGGSVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAGGACAGGGCTCCAATCAGCCCCAGCATTTTGGTGAT	CASSPGQGSNQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	3	4	3	23	34	46	38	49														CASSPGQGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGGGTGGACGCCTATAATTCACCCCTCCACTTTGGGAAC	CASRRVDAYNSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	11	0	2	0	6	23	-1	39	34	45														CASRRVDAYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCTGCCGGGACTAGCGGTCCCGGGGAGCTGTTTTTTGGAGAA	CASRPAGTSGPGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	5	6	7	2	23	34	52	41	54						01,02								CASRPAGTSGPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTCGGACAGGGGGTCACTGAAGCTTTTTTTGGACAA	CASRVGQGVTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	17	4	14	23	34	48	38	62														CASRVGQGVTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGCGGACAGGGACGAATAAAGCTTTCTTTGGACAA	CASSPRTGTNKAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	9	4	7	23	35	47	39	54														CASSPRTGTNKAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGGGCAGGGGATGAAAAACTGTTTTTTGGCAGT	CASSPGAGDEKLFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	4	2	6	7	0	23	35	-1	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAGDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTAAGGGGGACAGGGGGCGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	1.1290354716379648E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	0	4	6	6	23	35	53	41	59														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCAGGGGGCAAGTAGATGGCTACACCTTCGGTTCG	CASSGRGQVDGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	6	2	6	23	35	45	37	51														CASSGRGQVDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCATGCGGGACAGCACCTACGAGCAGTACGTCGGGCCG	CATMRDSTYEQYV	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	5	17	6	17	23	30	43	36	60														CATMRDSTYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCCGGGGGGGAGACAGATACGCAGTATTTTGGCCCA	CATSGGETDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	8	0	3	4	2	23	30	42	34	44														CATSGGETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACACTTAAATTGGGGAGGTAATTCACCCCTCCACTTTGGGAAC	CASRHLNWGGNSPLHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	9	1	6	12	0	23	34	-1	46	52														CASRHLNWGGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAGAGGACGGTGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSKRTVGATNEKLFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	6	1	0	12	0	23	34	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKRTVGATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSYEGQGNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	1	2	0	23	38	-1	40	49														CASSYEGQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATGGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSYDGGDTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	3	3	0	23	38	-1	41	48														CASSYDGGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCAGGGGACGGCTACACCTTCGGTTCG	CASSYGAGDGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	8	4	2	23	38	48	42	50														CASSYGAGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAGGACAGGGGACCTGAAGCTTTCTTTGGACAA	CAIKDRGPEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	2	6	4	2	23	30	43	34	45														CAIKDRGPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCAACCAGGCAGGGATGAACACTGAAGCTTTCTTTGGACAA	CAISNQAGMNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	0	8	1	23	34	47	42	48														CAISNQAGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCAACCGGGGAGACAGGGTCATTTCATCAGCCCCAGCATTTTGGTGAT	CAATGETGSFHQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	2	3	5	11	7	23	29	47	40	54														CAATGETGSFHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTCCGGGACAGGGAGGGAGACCCAGTACTTCGGGCCA	CASSESGTGRETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	6	3	23	35	50	41	53														CASSESGTGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCAGACTCTTAACTATGGCTACACCTTCGGTTCG	CASSSQTLNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	10	1	4	2	23	36	44	40	46						01,02								CASSSQTLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTTCGGAGGGGACAGGGAGCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	1.2618631741836078E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	0	3	0	7	3	23	28	44	35	47														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCATTCCCGGGACAGCCCTTGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSIPGTALVGANVLTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	60	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	5	3	7	7	21	38	52	45	59														CASSYSIPGTALVGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACGACAGGGAGAGACCCAGTACTTCGGGCCA	CASSRRQGETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	4	5	0	23	34	-1	39	46														CASSRRQGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTCAGGGACACTGAAGCTTTCTTTGGACAA	CASSVRDTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	3	3	0	23	34	-1	37	42														CASSVRDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCGATGGGGGAGACCCAGTACTTCGGGCCA	CASSDSMGETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	6	2	5	8	0	23	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSMGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGAAGAACACTGAAGCTTTCTTTGGACAA	CASSYQKNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	1	0	2	23	-1	41	38	43														CASSYQKNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCATCAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSYSSGAYEQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	2	2	0	23	40	-1	42	48														CASSYSSGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGTCTATCCAGGATACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	1.328277025456429E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	3	7	3	23	37	48	44	51														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTCCCAAGGCCTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSSQGLGNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	9	1	9	0	23	40	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSQGLGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGGGACAGGCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASGTGDSNQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	4	0	1	3	23	31	40	32	43														CASGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTACAGATTGGGTGTTTAGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CAISTDWVFRVTGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	3	5	4	0	16	23	-1	39	35	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISTDWVFRVTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGTTTTCGAGGAGGGCCCCTCCACTTTGGGAAC	CASSFRGGPLHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	10	0	13	5	0	23	36	-1	41	47														CASSFRGGPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGTCGTTGGGGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASKVVGVSSYNEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	6	2	0	8	4	23	33	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKVVGVSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGACTTAGGGAATGGCTACACCTTCGGTTCG	CASSPDLGNGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	10	6	2	6	23	35	42	37	48						01,02								CASSPDLGNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGGACAGGGAACTCAGCCCCAGCATTTTGGTGAT	CASSRGQGTQPQHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	6	3	3	23	35	46	38	49														CASSRGQGTQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCATAGGACAGGGAGCTACACCTTCGGTTCG	CASSDHRTGSYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	9	7	1	23	35	50	42	51														CASSDHRTGSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGTTTGGGACTCCCCGGCACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	1.3946908767292507E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	3	7	7	23	35	48	42	55						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACAGGACTAGCGTGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	1.3946908767292507E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	6	5	3	3	23	37	49	40	52						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGGCAGGCTGACTATGGCTACACCTTCGGTTCG	CASSYSGQADYGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	4	4	3	4	3	23	40	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGQADYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGGTACTGAAGCTTTCTTTGGACAA	CASSYLGTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	0	9	5	1	1	23	39	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCGGACTAGCGGGGGGGGATGAGCAGTTCTTCGGGCCA	CAAGLAGGDEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	1	0	8	3	1	23	29	47	32	48														CAAGLAGGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCCACTAGAGGACTTGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.461104728002072E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	6	11	3	23	34	50	45	53						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCGGCTTTCCTATGGCTACACCTTCGGTTCG	CASSDRLSYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	9	0	4	4	4	23	35	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDRLSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCAGGACCGAAACTATGGCTACACCTTCGGTTCG	CASSAQDRNYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	1	7	2	5	3	23	35	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAQDRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGACAGGACCCTCGGCGAGCAGTACTTCGGGCCG	CASSVDRTLGEQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	6	3	8	23	35	44	38	52														CASSVDRTLGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGCTCGCTGGGGCGATTTGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	1.461104728002072E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	7	0	8	9	6	23	40	54	49	60														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCACAGGGGGCGGTTGAAGCTTTCTTTGGACAA	CASSYSPQGAVEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	0	7	3	3	23	40	52	43	55														CASSYSPQGAVEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCATTTGGGCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	22	1.461104728002072E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	17	8	13	23	36	48	44	61														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACAAGACAGCCTCACTGAAGCTTTCTTTGGACAA	CASKQDSLTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	5	4	5	3	23	33	43	38	46														CASKQDSLTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCGCAACAGCAACAAACACTGAAGCTTTCTTTGGACAA	CASTPATATNTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	5	2	8	5	23	33	45	41	50														CASTPATATNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAATTTACGGTGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLIYGGNQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	9	4	13	0	23	34	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIYGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGCAACTATGGCTACACCTTCGGTTCG	CASSPGNYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	9	0	2	3	0	23	35	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGTAGGGCAGGGGGCGAGGCTACACCTTCGGTTCG		Out	VDJ	1	23	1.5275185792748935E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	8	9	2	23	35	52	44	54														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGGGGGTCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	1.5275185792748935E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	6	1	2	23	40	47	41	49														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCACACCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	23	1.5275185792748935E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	3	6	0	3	3	23	38	44	41	47														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGACAGGGGTTAACCATCGAAAACTGTTTTTTGGCAGT	CASSLTGVNHRKLFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	2	10	1	10	23	36	45	37	55														CASSLTGVNHRKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACGCTCACCGGAGCCTCGGGTACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	24	1.593932430547715E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	3	9	17	20	11	23	30	54	50	65						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGCTACTACAGGGTAACGAGCAGTACTTCGGGCCG	CASTLLQGNEQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	5	7	2	23	33	46	40	48														CASTLLQGNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGACAGGGAGGGAATCAGCCCCAGCATTTTGGTGAT	CASRRQGGNQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	2	3	4	2	4	23	34	43	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRQGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACTCTTCAGGGAGAACGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSHSSGRTDTGELFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	4	3	3	8	7	23	34	47	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHSSGRTDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGCTCTAGCGATTTAAACATTCAGTACTTCGGCGCC	CASSPGSSDLNIQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	4	6	6	8	4	23	34	48	42	52						01,02								CASSPGSSDLNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGTCGACAGGGAGTCTACGAGCAGTACGTCGGGCCG	CASSSRQGVYEQYV	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	17	4	17	23	35	46	39	63														CASSSRQGVYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCAGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYARGNTGELFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	2	2	1	23	38	46	40	47														CASSYARGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCGGGGATGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSGMYTGELFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	3	3	2	4	23	37	44	39	48														CASSYSGMYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCGGACTAGCGGGGGGCTCCCAGGATACGCAGTATTTTGGCCCA	CASSRGLAGGSQDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	1	6	4	7	23	34	52	38	59														CASSRGLAGGSQDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGGTGTCGCCCTCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPGVALSYNSPLHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	0	1	9	23	35	40	36	49														CASSPGVALSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGAGGAGAGTACGCAGTATTTTGGCCCA	CASSDSEESTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	8	3	2	23	40	47	43	49														CASSDSEESTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTCTGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	1.6603462818205365E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	6	2	2	4	0	23	38	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATATCCGGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CAISGTGTYEQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	3	2	5	1	23	30	44	35	45														CAISGTGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCATCAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CATSSGGGYGYTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	0	4	6	2	23	30	44	36	46														CATSSGGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGAGGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSVEGVNTEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	0	3	2	23	35	43	38	45														CASSVEGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCAGGGGGCAATAATTCACCCCTCCACTTTGGGAAC	CASSYSAGGNNSPLHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	0	5	2	1	23	40	50	42	51														CASSYSAGGNNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTTCTCTACGAGCAGTACGTCGGGCCG	CASSYSFLYEQYV	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	4	5	17	13	4	23	40	56	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSFLYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGGCCACCGGCAAACCCCTCCACTTTGGGAAC	CASSSRATGKPLHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	4	8	0	12	3	9	23	36	43	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRATGKPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCAGAATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFQNSGANVLTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	5	1	2	3	23	36	41	38	44														CASSFQNSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CASKVSNQPQHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	5	4	1	0	2	23	-1	36	33	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKVSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGTCGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSRRQQETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	5	2	5	0	23	34	-1	39	44														CASSRRQQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCGAGGACACGGCCACTGAAGCTTTCTTTGGACAA	CASSDSEDTATEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	4	3	4	23	40	48	43	52														CASSDSEDTATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGATGGGACAGGGGAATAATCAGCCCCAGCATTTTGGTGAT	CASSEMGQGNNQPQHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	4	5	3	23	35	50	40	53														CASSEMGQGNNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCGAAGGGGGTATGAGATGAAGCTTTCTTTGGACAA	CASSAPKGV*DEAFF	Stop	VDJ	1	27	1.7931739843661795E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	7	7	7	23	35	48	42	55														CASSAPKGV*DEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCCCCGGCCAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	1.7931739843661795E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	9	0	6	0	7	23	-1	43	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACTAGCGGGGATCCAAGCACAGATACGCAGTATTTTGGCCCA	CAISGTSGDPSTDTQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	0	1	5	23	34	48	35	53														CAISGTSGDPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTGGTCCGGAGGGAGAGACCCAGTACTTCGGGCCA	CAISGGPEGETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	4	8	0	23	35	-1	43	49														CAISGGPEGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGGGCGCGTCTTCGTCACTATGGCTACACCTTCGGTTCG	CASRGARLRHYGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	2	3	0	12	23	-1	39	34	51														CASRGARLRHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGACAGGGCCGCAGATACGCAGTATTTTGGCCCA	CASSPDRAADTQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	4	3	3	23	35	45	38	48														CASSPDRAADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTGACTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSADSSGANVLTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	2	10	0	3	1	23	35	42	38	43						01,02								CASSADSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAAAGGTGGGACAGGGGGGCCCTGGACGAGCAGTACGTCGGGCCG	CASSKRWDRGALDEQYV	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	17	8	19	23	34	53	42	72														CASSKRWDRGALDEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATGATTCTAGATACGCAGTATTTTGGCCCA	CASSMILDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	2	8	5	3	4	23	34	39	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMILDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGGACAGCCAACTATGGCTACACCTTCGGTTCG	CASRPGTANYGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	2	4	2	23	34	45	38	47														CASRPGTANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACTTTCGACAGGGAACCCCTATGACTAATGAAAAACTGTTTTTTGGCAGT	CASSHFRQGTPMTNEKLFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	3	2	3	10	23	39	49	42	59														CASSHFRQGTPMTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACAGGATGAACACTGAAGCTTTCTTTGGACAA	CASSRDRMNTEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	0	1	1	23	35	44	36	45														CASSRDRMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTCTTACGGGACAGCTGGAAACACCATATATTTTGGAGAG	CASSVSYGTAGNTIYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	2	9	0	23	35	-1	44	51														CASSVSYGTAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGTACGACAGCCGAGACCCAGTACTTCGGGCCA	CASSYSSTTAETQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	5	5	6	2	23	40	51	46	53														CASSYSSTTAETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCAAACCCGTGGGGGGCAGGGTGAAGCTTTCTTTGGACAA	CASSFQTRGGQGEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	6	0	7	12	4	23	36	54	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQTRGGQGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGAGAGGGGCTTCTACCTACGAGCAGTACTTCGGGCCG	CASMRGASTYEQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	5	2	2	4	6	23	33	42	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMRGASTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAAAAAACCGGGACTAAGGCGGTGCAGTACTTCGGGCCG	CASQKTGTKAVQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	9	9	9	7	23	32	48	41	55						01,02								CASQKTGTKAVQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCATGAAAGATCTGGGACAGCCCCAGCATTTTGGTGAT	CAIMKDLGQPQHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	0	8	7	13	0	23	30	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIMKDLGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGTTGGGCAGGGGAAAACATTCAGTACTTCGGCGCC	CANSWAGENIQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	2	5	3	0	23	36	-1	39	45														CANSWAGENIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACGAACGCGGGGGGAGCCACAGATACGCAGTATTTTGGCCCA	CATNAGGATDTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	7	1	2	5	3	23	30	43	35	46														CATNAGGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACTGCCCCAACGGGCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	1.9924155381846438E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	8	0	0	11	1	23	38	53	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAAGGGTCCAGGTTGGAAACACCATATATTTTGGAGAG	CASKRVQVGNTIYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	7	4	4	3	8	1	23	33	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKRVQVGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCGGGTAGCGGGGGGCCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASTSGSGGPNTGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	5	1	2	7	3	23	33	50	40	53														CASTSGSGGPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGCGGGGGATCAGTCAGATACGCAGTATTTTGGCCCA	CASSYGAGDQSDTQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	4	2	6	23	38	48	40	54														CASSYGAGDQSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTGACAGGGTCGGAAACACCATATATTTTGGAGAG	CASIDRVGNTIYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	3	4	2	2	23	33	42	35	44														CASIDRVGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTTACAGGGATTCTAGTACTGAAGCTTTCTTTGGACAA	CASYRDSSTEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	3	3	5	2	8	23	31	39	33	47														CASYRDSSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAGGAAGGTTCACTACGAGCAGTACTTCGGGCCG	CASSYSRKVHYEQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	3	0	8	23	-1	44	40	52														CASSYSRKVHYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGATTTGGTCCAGCCGATTTACCTGATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASDLVQPIYLISNQPQHF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	4	5	0	9	14	23	32	44	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASDLVQPIYLISNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCAGCCTAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	2.1916570920031082E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	5	3	1	8	0	23	33	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGGGCGGGGGCTATGGCTACACCTTCGGTTCG	CASSEGGGYGYTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	7	2	4	5	0	23	34	-1	39	46														CASSEGGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGGACAGGGTGGTCAGAGACCCAGTACTTCGGGCCA	CASRRTGWSETQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	4	2	5	23	34	44	36	49														CASRRTGWSETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGGCCAAGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASRGAKGAQETQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	0	1	8	0	23	34	-1	42	49														CASRGAKGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGAGGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGEGAGANVLTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	9	0	2	1	2	23	35	43	36	45														CASSGEGAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCAGAACTCCGGGACAGGGCTATATGGCTACACCTTCGGTTCG	CASNQNSGTGLYGYTF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	5	11	3	23	33	53	44	56														CASNQNSGTGLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCAGGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSDSRGTTDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	2	0	2	23	-1	47	40	49														CASSDSRGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATACCAGCGGGGGGATATCGCGGGGCACAGATACGCAGTATTTTGGCCCA	CASSDTSGGISRGTDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	1	1	6	10	23	35	50	41	60														CASSDTSGGISRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTCACTAGCGGGGGGGTATGAGCAGTTCTTCGGGCCA	CASSYSSLAGGYEQFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	8	3	1	23	40	56	43	57														CASSYSSLAGGYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGACCGGAACACTGAAGCTTTCTTTGGACAA	CASMDRNTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	1	7	1	1	2	23	33	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMDRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGACACTCCTACGAGCAGTACTTCGGGCCG	CASTGHSYEQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	0	1	0	23	33	-1	34	40														CASTGHSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTCAGGGGTTGGACAGATACGCAGTATTTTGGCCCA	CASRLRGWTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	3	3	4	23	34	43	37	47														CASRLRGWTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGTGAAAGGGAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	35	2.3244847945487512E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	9	1	0	9	0	23	35	-1	44	50														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAACCCGGGACAGGGTGGGTTGGCAGTACTTCGGGCCG	CASSVTRDRVGWQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	9	7	7	23	35	51	42	58														CASSVTRDRVGWQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCGACAGGGTTGGACTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	2.3244847945487512E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	2	3	6	2	7	23	29	38	31	45														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAGGTCATAGTCACAGATACGCAGTATTTTGGCCCA	CASRQVIVTDTQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	4	2	0	7	23	-1	39	34	46														CASRQVIVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACTCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRDSNTGELFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	10	2	0	2	23	-1	39	34	41						01,02								CASRDSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGTGACAGGGCGCATGAAAAACTGTTTTTTGGCAGT	CAIRDRAHEKLFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	2	3	6	5	3	23	30	42	35	45														CAIRDRAHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCGGGACAGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAAGTGDSNQPQHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	2	0	3	1	23	29	42	32	43														CAAGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTAGGGGAGGGGGCCGATAATGCAGATACGCAGTATTTTGGCCCA	CASTLGEGADNADTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	5	0	4	9	8	23	33	49	42	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLGEGADNADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGACTCATCTAATACGCAGTATTTTGGCCCA	CASSWDSSNTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	7	0	6	23	-1	42	36	48						01,02								CASSWDSSNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGTCCTAATGAAAAACTGTTTTTTGGCAGT	CASSLQGPNEKLFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	3	1	2	23	36	43	37	45														CASSLQGPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCGGGTTGGAATCACCCCTCCACTTTGGGAAC	CASSGLESPLHF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	8	8	4	10	2	6	23	32	38	34	44						01,02								CASSGLESPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTACGAGGGGCGACTAACTATGGCTACACCTTCGGTTCG	CASSLRGATNYGYTF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	5	2	0	6	3	23	34	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGATNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGGTCGGAACAGATACGCAGTATTTTGGCCCA	CASSKVGTDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	1	8	3	6	0	23	35	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKVGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTTCTAGCGGGGGGGCTGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSFLAGGLGTDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	1	4	4	23	40	56	44	60														CASSYSFLAGGLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAACGGACTTTTCACCCCTCCACTTTGGGAAC	CASGTDFSPLHF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	8	1	10	9	5	1	23	32	42	37	43						01,02								CASGTDFSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGAAGGGGTCGGGCACTGAAGCTTTCTTTGGACAA	CASGKGSGTEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	2	4	4	5	23	32	41	36	46														CASGKGSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTCCCGGGGGTTTACGAGCAGTACGTCGGGCCG	CASSEVPGVYEQYV	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	17	7	15	23	35	48	42	63														CASSEVPGVYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGAATCTGACTCGCGGGGCTACACCTTCGGTTCG	CASSVESDSRGYTF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	2	10	8	9	5	23	35	48	44	53						01,02								CASSVESDSRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGAAGGCTAGCGGGGGGTGGCTGAGCAGTTCTTCGGGCCA	CASS*EG*RGVAEQFF	Stop	VDJ	1	43	2.8557956047313226E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	9	6	4	23	37	54	43	58														CASS*EG*RGVAEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGATGGGGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRDGGRSYNEQFF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	0	4	2	23	34	44	38	46														CASRDGGRSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCGGTTGACACAGATACGCAGTATTTTGGCCCA	CASSYGAVDTDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	2	0	6	23	-1	43	38	49														CASSYGAVDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGAGGACAGTCCTATGGCTACACCTTCGGTTCG	CASSPGGQSYGYTF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	1	4	2	6	23	34	43	36	49														CASSPGGQSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGCCGGGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSDSAGGGTDTQYF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	0	1	4	1	23	40	50	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSAGGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCGGGGACGGGGGAAGGCGTACGCAGTATTTTGGCCCA	CASTPGDGGRRTQYF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	2	8	10	6	23	33	49	43	55														CASTPGDGGRRTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGACTTCCAAATGAAAAACTGTTTTTTGGCAGT	CASTGLPNEKLFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	0	10	5	1	4	23	33	40	34	44						01,02								CASTGLPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGACAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSGTGGQETQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	1	1	0	23	34	-1	35	46														CASSGTGGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACGACTCAGGGGGCAGGGGATACGCAGTATTTTGGCCCA	CASSSTTQGAGDTQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	6	8	4	23	36	52	44	56														CASSSTTQGAGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTACAGGGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSDYREGNQPQHF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	3	3	2	4	3	23	35	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDYREGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAGCGGGGACCGAACACTGAAGCTTTCTTTGGACAA	CASQRGPNTEAFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	6	3	1	1	3	23	32	40	33	43														CASQRGPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATCGGGACTAGCGGGGGAAACATTCAGTACTTCGGCGCC	CASSYIGTSGGNIQYF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	0	2	6	3	0	23	38	-1	41	55														CASSYIGTSGGNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGCAGGGGGCTCTGTGGAAAAACTGTTTTTTGGCAGT	CASSSAGGSVEKLFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	8	3	6	23	36	47	39	53														CASSSAGGSVEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCGCCCTAGCGGGGGGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRPSGGPSGANVLTF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	4	1	0	7	2	23	35	53	42	55														CASSLRPSGGPSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACGGGGCGGTTGAGCAGTTCTTCGGGCCA	CASSYNGAVEQFF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	7	0	9	3	3	23	38	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNGAVEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACGAGTGCCAAAAACATTCAGTACTTCGGCGCC	CASSYTSAKNIQYF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	11	2	1	3	1	23	37	43	40	44														CASSYTSAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGAGGGAGGGAACGAAAAACTGTTTTTTGGCAGT	CASSYSEGGNEKLFF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	9	0	8	3	3	23	40	50	43	53														CASSYSEGGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGCCCGGAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSDSPGETGELFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	10	2	5	4	2	23	40	48	44	50														CASSDSPGETGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCACGCGGACTAGCTTCCACAGATACGCAGTATTTTGGCCCA	CASSSRGLASTDTQYF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	7	2	5	3	23	36	49	41	52						01,02								CASSSRGLASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACATTCATCTGGGGGTCTAACTATGGCTACACCTTCGGTTCG	CASTFIWGSNYGYTF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	6	1	0	9	1	23	33	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTFIWGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACGACAGGGGTAGAGGGAACATTCAGTACTTCGGCGCC	CASSHDRGRGNIQYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	2	7	3	7	23	35	46	38	53														CASSHDRGRGNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGTCCAGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSVVQGGYNEQFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	3	8	0	23	35	-1	43	49														CASSVVQGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGGGACAGGGGGAAACTATGGCTACACCTTCGGTTCG	CASGTGGNYGYTF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	1	2	1	1	23	31	43	32	44														CASGTGGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGCCAGGGGGAAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	61	4.051244927642109E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	7	6	4	23	40	53	46	57														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGGCCTGAACGAATTGAAAAACTGTTTTTTGGCAGT	CASRPERIEKLFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	9	5	4	7	1	11	23	31	35	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPERIEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTTTGGGGGCCAGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSVFGGQGGETQYF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	6	0	4	6	8	23	35	47	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVFGGQGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCGGGGACTACCCAGTTAAGCGGGGAGCTGTTTTTTGGAGAA	CASSSGTTQLSGELFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	9	7	4	10	23	34	45	38	55						01,02								CASSSGTTQLSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTAGGACAGGGCGAGAGACCCAGTACTTCGGGCCA	CASSLRTGRETQYF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	4	4	2	23	35	47	39	49														CASSLRTGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTGDSGANVLTF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	4	0	0	3	23	-1	40	35	43														CASSTGDSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTATATGAGCTTCGCACAGATACGCAGTATTTTGGCCCA	CASSEVYELRTDTQYF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	1	0	12	23	-1	39	35	51														CASSEVYELRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGAGTCGGGGGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSPESGASGELFF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	6	0	6	8	2	23	35	49	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPESGASGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGACTATCAGATACGCAGTATTTTGGCCCA	CASRRLSDTQYF	In	VDJ	2	70	4.6489695890975023E-4	5.418795479176343E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	9	4	2	1	23	34	41	36	42						01,02								CASRRLSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTGAACAGGGACCGACGAACTATGGCTACACCTTCGGTTCG	CASRPEQGPTNYGYTF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	2	6	7	23	34	46	40	53														CASRPEQGPTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACTCGTGCAAACTGAAGCTTTCTTTGGACAA	CASSLLVQTEAFF	In	VDJ	2	71	4.7153834403703234E-4	5.496206843164577E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	3	10	5	1	7	23	36	40	37	47						01,02								CASSLLVQTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGACGGGACGGAGTCAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	74	4.914624994188788E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	9	0	7	5	3	6	23	31	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGGGATGACACTGAAGCTTTCTTTGGACAA	CASSLRDDTEAFF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	0	8	3	3	2	23	36	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGGACTAGCGGGGGGGCCTGGGGCAGATACGCAGTATTTTGGCCCA	CASSHGLAGGPGADTQYF	In	VDJ	2	82	5.44593580437136E-4	6.347731847035145E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	4	4	7	23	34	53	38	60														CASSHGLAGGPGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACTGCTCACAATGAGCAGTTCTTCGGGCCA	CAISGTAHNEQFF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	5	1	4	23	34	41	35	45						01,02								CAISGTAHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCGACTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASNRLAGSTDTQYF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	2	3	0	3	0	23	33	-1	36	47														CASNRLAGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCATTTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSEHLSSYNSPLHF	In	VDJ	2	96	6.37572972219086E-4	7.431490942870413E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	6	7	0	1	7	23	35	39	36	46						01,02								CASSEHLSSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGGGACTCCACTGAAGCTTTCTTTGGACAA	CASSLGDSTEAFF	In	VDJ	3	111	7.371937491283182E-4	8.592661402693915E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	4	3	1	23	36	45	39	46						01,02								CASSLGDSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGACAGGACTCCCTTCTCTTCGGTTCG	CASSLGQDSLLF	In	VDJ	3	119	7.903248301465754E-4	9.211952314599783E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	16	2	10	23	36	45	38	55														CASSLGQDSLLF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTGGAGGCCTTCCGGTCGGGAGTGACAAGAGACCCAGTACTTCGGGCCA	CAWRPSGRE*QETQYF	Stop	VDJ	3	137	9.09869762437654E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	8	2	2	15	3	23	29	50	44	53														CAWRPSGRE*QETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCATACAGGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASIIQGSSTDTQYF	In	VDJ	4	156	0.0010360560798560149	0.001207617278216442	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	3	0	4	4	23	33	43	37	47														CASIIQGSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGAGGACAGGGCTCCCTACGAGCAGTACGTCGGGCCG	CATEDRAPYEQYV	In	VDJ	8	309	0.0020521880043301833	0.0023920111472364143	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	3	17	4	18	23	30	42	34	60														CATEDRAPYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGAGGCGGGAACGAAAAACTGTTTTTTGGCAGT	CAISGGGNEKLFF	In	VDJ	9	361	0.0023975400309488547	0.0027945502399752283	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	7	3	8	4	2	23	35	45	39	47														CAISGGGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTTCCCAGGAGACCTATGGCTACACCTTCGGTTCG	CASSYSSQETYGYTF	In	VDJ	13	511	0.0033937478000411764	0.0039557206997987305	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	4	4	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSQETYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCGGGACAGGAGATCAGCCCCAGCATTTTGGTGAT	CASSYTGTGDQPQHF	In	VDJ	15	598	0.003971548306114723	0.004629199566496362	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	5	4	2	23	37	49	41	51														CASSYTGTGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTTTGGGGAGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	41	1623	0.010778968061578922		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	3	5	1	23	38	49	43	50														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGGACGGTCCGCTGTGGCCCCAGCATTTTGGTGAT	CATGDGPLWPQHF	In	VDJ	71	2781	0.018469692038971648	0.021528100325127728	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	0	7	9	3	11	23	30	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGDGPLWPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGGACAGATGAGCAGTTCTTCGGGCCA	CASSPGTDEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	8	1	0	24	38	-1	39	46													Vb 18	CASSPGTDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGAACAGGGTAAATCAGCCCCAGCATTTTGGTGAT	CASSPGNRVNQPQHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	4	4	2	24	39	49	43	51													Vb 18	CASSPGNRVNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTGGTCCTTCCCAGTGGTTTCAGTACTTCGGCGCC	CASSLGPSQWFQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	5	11	11	4	24	37	51	48	55													Vb 18	CASSLGPSQWFQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATCCTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPILAGNTGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	4	1	3	0	24	39	-1	42	50						01,02							Vb 18	CASSPILAGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPQGNTGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	1	1	0	24	41	-1	42	47													Vb 18	CASSPPQGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCTAGCGGGGGAGAGGACCCAGTACTTCGGGCCA	CASSPLAGERTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	7	1	4	24	38	49	39	53													Vb 18	CASSPLAGERTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGCCACGTTTGGTGGCGAGGAGTTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	1	5	39	53	59	54	64													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCTAGGGTTGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		43	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	4	3	3	24	41	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTTAGGGGGCTTCACTGAAGCTTTCTTTGGACAA	CASSLLGGFTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	4	4	2	24	37	48	41	50													Vb 18	CASSLLGGFTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACAGGGGTGCCAAAAACATTCAGTACTTCGGCGCC	CASSPDRGAKNIQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	2	2	1	0	1	24	-1	47	39	48													Vb 18	CASSPDRGAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGATATCTCTGGAAACACCATATATTTTGGAGAG	CASSPGDISGNTIYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	2	0	8	0	1	3	24	39	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGDISGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTGCGGGGACAGTTCGCGAGGCTACACCTTCGGTTCG	CASSPCGDSSRGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	8	5	7	24	38	50	43	57													Vb 18	CASSPCGDSSRGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTACAGGGATACCAAGAGACCCAGTACTTCGGGCCA	CASSPLQGYQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	3	0	1	2	24	40	47	41	49													Vb 18	CASSPLQGYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTTTGGACTAGCGGGCCGCGAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.1290354716379648E-4		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	4	6	4	6	24	38	53	42	59						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGCTCGGGGGTTCCAAGAGACCCAGTACTTCGGGCCA	CASSPARGFQETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	2	1	4	2	24	38	48	42	50													Vb 18	CASSPARGFQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGACAGCCCCTGGCTATGGCTACACCTTCGGTTCG	CASSPSTAPGYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	2	7	24	39	46	41	53													Vb 18	CASSPSTAPGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCGGGGGCGGGGGCTTCGGGAGATACGCAGTATTTTGGCCCA	CASSPPGAGASGDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	5	7	7	24	38	52	45	59													Vb 18	CASSPPGAGASGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCTTTCGACAGACCCACTGAAGCTTTCTTTGGACAA	CASSAFDRPTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	4	6	3	24	36	47	42	50													Vb 18	CASSAFDRPTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTTAAGGGACGGTTCTGGAAACACCATATATTTTGGAGAG	CASSPPLRDGSGNTIYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	0	7	1	5	3	24	41	51	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPLRDGSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGTGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRVASTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	1	0	9	0	0	5	24	-1	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRVASTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTGGACCGAACATGGCTACACCTTCGGTTCG	CASSPRWTEHGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	1	1	7	6	3	5	24	40	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRWTEHGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	4	3	3	16	5	40	38	59	54	64													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTTATTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	1.461104728002072E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	4	3	3	16	5	40	38	59	54	64													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGGACAGAATGAGCAGTTCTTCGGGCCA	CASSPQGQNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	5	7	2	0	24	40	-1	42	48													Vb 18	CASSPQGQNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTGAACTAGCGGGGGCCCAGTACTTCGGGCCA	CASSPRELAGAQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	2	9	4	0	24	40	-1	44	55													Vb 18	CASSPRELAGAQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTTTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPFSGGTDTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	3	1	3	0	24	38	-1	41	49													Vb 18	CASSPFSGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCCCAAGTGGTTACTGAAGCTTTCTTTGGACAA	CASSPSQVVTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	10	5	9	2	24	38	49	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSQVVTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAACAGGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSPQQVMNTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	0	3	3	24	38	46	41	49													Vb 18	CASSPQQVMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCAGGGTTTCGTGGCTACACCTTCGGTTCG	CASSPSGFRGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	7	2	5	24	38	45	40	50													Vb 18	CASSPSGFRGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGCGCTAGCGGGGGGGCCCACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSALAGGPTSYNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	0	4	5	24	35	51	39	56													Vb 18	CASSALAGGPTSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGATCCAAGAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	1.9260016869118224E-4		44	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	1	0	8	5	0	9	24	-1	44	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGGCAGGGACGAGCACTGAAGCTTTCTTTGGACAA	CASSPAAGTSTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	7	4	6	3	24	39	50	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPAAGTSTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCTTTCAGCGGGGGGGTCCCGGAGATACGCAGTATTTTGGCCCA	CASSPPFQRGGPGDTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	5	8	6	24	38	56	46	62													Vb 18	CASSPPFQRGGPGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGACAGGGGGCTTCAGCTATGGCTACACCTTCGGTTCG	CASSPGTGGFSYGYTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	4	1	5	24	38	51	39	56													Vb 18	CASSPGTGGFSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGACAGGGCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	2.1252432407302868E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	7	1	3	24	37	46	38	49													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCGGACAGGGTACTTTCTTTGGACAA	CASSPLGQGTFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	3	12	2	2	24	40	50	42	52													Vb 18	CASSPLGQGTFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	2.1916570920031082E-4		37	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	9	2	0	1	24	-1	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLGPTDTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	5	0	7	2	2	1	24	36	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLGPTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTCGAGGGGGGAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPFEGGSSGNTIYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	2	5	1	0	4	4	24	39	49	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPFEGGSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCCGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPSGSYEQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	5	0	3	0	24	38	-1	41	44						01,02							Vb 18	CASSPSGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACCCGGGACAGCTGAAGCTTTCTTTGGACAA	CASSRPGTAEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	6	1	0	24	41	-1	42	49													Vb 18	CASSRPGTAEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTGGGCCCTCGGGCTACGAGCAGTACTTCGGGCCG	CASGPSGYEQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	9	8	0	3	1	7	24	32	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASGPSGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTTGATGGGGGGTACGAGCAGTACGTCGGGCCG	CASFDGGYEQYV	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	9	1	17	5	13	24	34	45	39	58													Vb 18	CASFDGGYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGTCCCATTAGCGGGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSPRVPLAGEYNEQFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	4	10	2	24	39	58	49	60													Vb 18	CASSPRVPLAGEYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGATAACACTGAAGCTTTCTTTGGACAA	CASSPPDNTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	2	8	2	4	1	24	38	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTGGGACAGGGGCCTTCCTAATTCACCCCTCCACTTTGGGAAC	CASSLWDRGLPNSPLHF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	2	6	3	6	24	37	50	40	56													Vb 18	CASSLWDRGLPNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGATCCAGTCGGGTGCACCCCTCCACTTTGGGAAC	CASSSIQSGAPLHF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	8	4	11	10	2	24	36	50	46	52						01,02							Vb 18	CASSSIQSGAPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACAGTTCCTACGAGCAGTACTTCGGGCCG	CASSPDSSYEQYF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	1	0	1	24	-1	44	39	45													Vb 18	CASSPDSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGGGTTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSEGFTGELFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	4	0	3	24	-1	41	36	44													Vb 18	CASSEGFTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCACCGGGACAGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSTGTGNYNEQFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	3	4	2	24	35	48	39	50													Vb 18	CASSTGTGNYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGAAGGCGGGGGTACCTACAATGAGCAGTTCTTCGGGCCA	CASSPEGGGTYNEQFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	2	5	2	24	38	50	43	52													Vb 18	CASSPEGGGTYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGGGGAGAAACACTGAAGCTTTCTTTGGACAA	CASSPQGGRNTEAFF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	2	1	3	24	40	48	41	51													Vb 18	CASSPQGGRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACAGGGGCCAGACCCAGTACTTCGGGCCA	CASSPDRGQTQYF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	2	6	0	2	24	-1	47	39	49													Vb 18	CASSPDRGQTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCCAACAGGGGCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	2.72296790218568E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	3	6	2	24	38	51	44	53													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGGGAGCGATACGCAGTATTTTGGCCCA	CASSPTGSDTQYF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	6	1	3	24	38	45	39	48													Vb 18	CASSPTGSDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACATTTACCCCCGGGAGAAACACCGAATCAGCCCCAGCATTTTGGTGAT	CASSPHLPPGETPNQPQHF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	57	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	2	4	9	8	24	40	55	49	63													Vb 18	CASSPHLPPGETPNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCGGAAGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	2.922209456004144E-4		43	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	1	1	8	4	2	4	24	40	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGCGGGGGGCTCCACAGATACGCAGTATTTTGGCCCA	CASSLAGGSTDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	2	0	3	24	-1	47	37	50													Vb 18	CASSLAGGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGCGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSERFQETQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	6	1	1	3	24	36	41	37	44						01,02							Vb 18	CASSERFQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCGGGACAAGTTATGGCTACACCTTCGGTTCG	CASSPSGTSYGYTF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	5	3	3	24	39	48	42	51													Vb 18	CASSPSGTSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGAGAGGATTGAAGCTTTCTTTGGACAA	CASSPQERIEAFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	4	4	7	1	7	24	38	43	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQERIEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGCCGGGACAGGGACCATTGTGAACACTGAAGCTTTCTTTGGACAA	CASSSAGTGTIVNTEAFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	0	6	7	24	36	51	42	58													Vb 18	CASSSAGTGTIVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACGGACGAGGGTAATTCACCCCTCCACTTTGGGAAC	CASSPTDEGNSPLHF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	11	0	6	7	0	24	38	-1	45	50													Vb 18	CASSPTDEGNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGCGGGGGTCCACAGATACGCAGTATTTTGGCCCA	CASSPERGSTDTQYF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	2	2	2	2	24	38	48	40	50													Vb 18	CASSPERGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAAGGGGACACTGAAGCTTTCTTTGGACAA	CASSEGDTEAFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	3	2	0	24	36	-1	38	43													Vb 18	CASSEGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATCGACAGGCGCTTCGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	48	3.18786486109543E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	8	3	8	24	36	45	39	53													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATACACAGCCCCAACTATGGCTACACCTTCGGTTCG	CASSPIHSPNYGYTF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	2	5	4	24	38	47	43	51													Vb 18	CASSPIHSPNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCTCCGGACAGACCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	48	3.18786486109543E-4		49	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	5	1	5	3	24	38	49	43	52													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCGGGCTAGCGGGACACACAGATACGCAGTATTTTGGCCCA	CASSPPGLAGHTDTQYF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	3	2	4	2	24	41	54	45	56													Vb 18	CASSPPGLAGHTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCGGTTAACACTGAAGCTTTCTTTGGACAA	CASSPAVNTEAFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	2	1	2	24	38	43	39	45						01,02							Vb 18	CASSPAVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGATAGCGGGGGAACGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	3.320692563641073E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	5	3	4	24	39	51	42	55													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGCGGCCGGCCGCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	50	3.320692563641073E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	5	1	9	24	41	46	42	55						01,02							Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACTTCGGATCAGCCCCAGCATTTTGGTGAT	CASSPTSDQPQHF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	2	10	5	0	4	24	-1	42	38	46						01,02							Vb 18	CASSPTSDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAGGGGACTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPQGTNSNQPQHF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	0	9	0	4	1	24	38	49	42	50						01,02							Vb 18	CASSPQGTNSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCATTAAAGGGGCGAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	50	3.320692563641073E-4		49	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	17	7	21	24	38	50	45	71													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGAGGGCTTGGACACTGAAGCTTTCTTTGGACAA	CASSPREGLDTEAFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	3	1	5	24	39	47	40	52													Vb 18	CASSPREGLDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGACAGGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSPRQGLDTEAFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	3	2	4	24	38	48	40	52													Vb 18	CASSPRQGLDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGCCCAGACAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSPPAQTGTNEKLFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	3	2	6	0	24	41	-1	47	54													Vb 18	CASSPPAQTGTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCATCGTCAGGGGGTCCCACCGATAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	52	3.4535202661867156E-4		55	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	10	4	1	0	4	12	24	31	42	35	54													Vb 18	X+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGACAGGGGGCGAAACACTGAAGCTTTCTTTGGACAA	CASSQDRGRNTEAFF	In	VDJ	1	54	3.586347968732359E-4	4.180213655364608E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	2	2	2	24	37	49	39	51													Vb 18	CASSQDRGRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACTACCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPTTGGTDTQYF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	1	6	0	24	38	-1	44	49													Vb 18	CASSPTTGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAGGGTAACAACTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	56	3.7191756712780016E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	9	1	7	24	38	44	39	51													Vb 18	X+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCACGCTGCCCTGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSTLPWKNTEAFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	1	8	1	11	1	24	35	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSTLPWKNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCTGGGAAGGACGGTGAAGCTTTCTTTGGACAA	CASSPPGKDGEAFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	8	7	4	7	24	38	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGKDGEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTTTCTCGGGGGGCTACTGAAGTTTTCTTTGGACAA	CASSFSRGATEVFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	13	6	10	24	36	49	42	59													Vb 18	CASSFSRGATEVFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCGGCGTACACTGAAGCTTTCTTTGGACAA	CASSPAYTEAFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	9	0	3	3	2	24	35	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPAYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCTACAGGATACGAGCAGTACGTCGGGCCG	CASSSTGYEQYV	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	17	3	14	24	36	44	39	58													Vb 18	CASSSTGYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTTCGACTAGCGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSLSTSGGPDTQYF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	4	4	2	24	37	53	41	55													Vb 18	CASSLSTSGGPDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAATCCATCGCCAATGAGCAGTTCTTCGGGCCA	CASSPESIANEQFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	1	8	6	0	9	24	-1	41	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPESIANEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAACACATAGGGGGACTCCGTTAGAATCAGCCCCAGCATTTTGGTGAT	CASSQHIGGLR*NQPQHF	Stop	VDJ	2	63	4.184072630187752E-4		54	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	6	5	1	4	9	10	24	35	50	44	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQHIGGLR*NQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTCTATTAGACAGGCCGATCCGCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	67	4.449728035279038E-4		53	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	3	9	10	24	35	50	44	60													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGTATGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPRYGTGELFF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	5	4	1	5	24	38	42	39	47						01,02							Vb 18	CASSPRYGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGATGGGGGGTACGAGCAGTACGTCGGGCCG	CASSDGGYEQYV	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	1	17	4	13	24	35	45	39	58													Vb 18	CASSDGGYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGAACACAGGGACTTTGGGGAGCTGTTTTTTGGAGAA	CASSPQEHRDFGELFF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	3	3	8	6	5	24	40	52	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQEHRDFGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGTCGAGGAACACTGAAGCTTTCTTTGGACAA	CASSLSRNTEAFF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	4	0	24	37	-1	41	44													Vb 18	CASSLSRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGACTCTGGAAACACCATATATTTTGGAGAG	CASSPPDSGNTIYF	In	VDJ	2	75	4.98103884546161E-4	5.805852299117511E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	1	8	0	0	0	24	-1	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATACCGGGACAGGGCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPIPGQGSGANVLTF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	0	3	4	6	4	24	38	53	44	57													Vb 18	CASSPIPGQGSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGACAGGGGTGGAGAAGAGACCCAGTACTTCGGGCCA	CASSPGDRGGEETQYF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	2	3	1	5	24	39	50	40	55													Vb 18	CASSPGDRGGEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTTGGACAGACCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLWTDLSYNEQFF	In	VDJ	2	87	5.778005060735467E-4	6.734788666976312E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	0	3	4	24	37	46	40	50													Vb 18	CASSLWTDLSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGGACTCGAGGGGCAGCCCCAGCATTTTGGTGAT	CASSPMGLEGQPQHF	In	VDJ	2	93	6.176488168372396E-4	7.199256850905712E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	0	10	7	2	7	24	39	47	41	54						01,02							Vb 18	CASSPMGLEGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGCCCAGCGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSPAQRGVNEQFF	In	VDJ	3	102	6.774212829827789E-4	7.895959126799814E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	1	6	5	1	24	38	52	43	53													Vb 18	CASSPAQRGVNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACCGGGCCGAACAATGAGCAGTTCTTCGGGCCA	CASSPTGPNNEQFF	In	VDJ	3	103	6.84062668110061E-4	7.973370490788048E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	8	0	5	4	3	24	38	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTGPNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGGGACAGGGTATCGAATGAGCAGTTCTTCGGGCCA	CASSPRDRVSNEQFF	In	VDJ	3	104	6.907040532373431E-4	8.050781854776281E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	2	5	24	38	49	40	54													Vb 18	CASSPRDRVSNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTATCCAGGTCCTACGAGCAGTACTTCGGGCCG	CASSPLSRSYEQYF	In	VDJ	3	104	6.907040532373431E-4	8.050781854776281E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	1	6	0	24	38	-1	44	48													Vb 18	CASSPLSRSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGATGGCGGGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSPDGGGGETQYF	In	VDJ	3	109	7.239109788737539E-4	8.437838674717449E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	4	5	1	24	38	52	43	53													Vb 18	CASSPDGGGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCCCGGGCGGAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASPRAESSGANVLTF	In	VDJ	3	114	7.571179045101647E-4	8.824895494658616E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	8	8	0	0	4	6	24	33	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASPRAESSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGAACAGGGGAGGACGAAAAACTGTTTTTTGGCAGT	CASSPRTGEDEKLFF	In	VDJ	3	121	8.036076004011396E-4	9.36677504257625E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	2	8	4	5	24	38	49	42	54													Vb 18	CASSPRTGEDEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAGGGAGGGGACAGATACGCAGTATTTTGGCCCA	CASSLREGTDTQYF	In	VDJ	4	160	0.0010626216203651433	0.0012385818238117355	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	3	3	1	24	37	47	40	48													Vb 18	CASSLREGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGATCAGAGCCGACAGCCCCAGCATTTTGGTGAT	CASSDQSRQPQHF	In	VDJ	4	170	0.0011290354716379648	0.001315993187799969	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	5	4	5	7	3	6	24	36	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSDQSRQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGGACGGGACGGGGAGCTGTTTTTTGGAGAA	CASSPPGRDGELFF	In	VDJ	7	270	0.0017931739843661794	0.0020901068276823038	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	3	7	4	0	24	41	-1	45	50													Vb 18	CASSPPGRDGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	150	5917	0.03929707579812846	0.04580430407183775	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	1	5	24	38	44	39	49													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAAGCCCTTTCAGATGTCCCTGTGTGCCACCAGCAGAGATCACAGCTATGGCTACACCTTCGGTTCG	CATSRDHSYGYTF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	39	TCRBVA	TCRBVA-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	16	3	5	4	16	0	22	25	-1	41	45														CATSRDHSYGYTF+TCRBVA-or09_02+TCRBJ01-02	TCRBVA-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCGGGACAGGGCATGAAAAACTGTTTTTTGGCAGT	CASRSGTGHEKLFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	6	4	1	26	37	50	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSGTGHEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGCAGGGGGGGAAATTGAGGGCACTGAAGCTTTCTTTGGACAA	CASSWAGGEIEGTEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV12						TCRBJ01	TCRBJ01-01	01	4	4	1	4	3	12	26	39	49	42	61		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWAGGEIEGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTTCGACAGGGGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFDRGGTGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	4	1	3	26	40	49	41	52	TCRBV02,TCRBV12													CASSFDRGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTGGGCTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGSSSYNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	0	0	5	36	-1	54	50	59	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLGSSSYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCAGGGTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	7.30552364001036E-5		38	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	0	9	1	0	2	26	-1	43	40	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACGGGGGCCTCAGACGGGTACTTCGGGCCA	CASSQTGASDGYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	2	6	0	13	2	9	26	41	49	43	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTGASDGYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTATGGACGGCCGTCTCTGGAAACACCATATATTTTGGAGAG	CASSLWTAVSGNTIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV03						TCRBJ01	TCRBJ01-03	01	6	1	7	0	5	6	26	37	46	42	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWTAVSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGCGGGGGGGCCCAGGATACGCAGTATTTTGGCCCA	CSGGGAQDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	7	0	6	2	5	26	31	42	33	47		TCRBV20-01,TCRBV20-or09_02												CSGGGAQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGCGGGGAGAGGCCATATATTTTGGAGAG	CSAPRGEAIYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	3	11	3	5	26	34	43	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPRGEAIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGTCCTTAGCGGGGTGGGCAGATACGCAGTATTTTGGCCCA	CSATSLAGWADTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	3	4	6	4	26	36	50	42	54		TCRBV20-01,TCRBV20-or09_02												CSATSLAGWADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCGGCAGGGAAAAGGGAAATGGCTACACCTTCGGTTCG	CSARDGGREKGNGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	6	6	9	26	40	51	46	60		TCRBV20-01,TCRBV20-or09_02												CSARDGGREKGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCAGGACTAGCGGGAAAAGAAACCCAGTACTTCGGGCCA	CSARDSGLAGKETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	1	3	8	4	6	26	40	56	44	62		TCRBV20-01,TCRBV20-or09_02												CSARDSGLAGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGAGACTAGCGGGGTAGAGACCCAGTACTTCGGGCCA	CSARGETSGVETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	2	3	4	4	1	26	39	54	43	55		TCRBV20-01,TCRBV20-or09_02												CSARGETSGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGCCGGGACAGGGGATGTGGATACGCAGTATTTTGGCCCA	CSARVAGTGDVDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	2	6	5	5	26	39	54	44	59		TCRBV20-01,TCRBV20-or09_02												CSARVAGTGDVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGAGCTCCCGATTCAAGAGACCCAGTACTTCGGGCCA	CSASGELPIQETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	3	2	0	11	26	-1	42	37	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGELPIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTGTCGGGAGACTATGGCTACACCTTCGGTTCG	CSARVSGDYGYTF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	2	3	5	0	26	37	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSARVSGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGGGGGGGCGCTTCCGAGACCCAGTACTTCGGGCCA	CSAPGGGASETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	1	9	26	35	44	36	53		TCRBV20-01,TCRBV20-or09_02												CSAPGGGASETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTGGCTGGGGGGTCGGAATCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGWGVGISYNEQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	0	7	7	26	35	48	42	55		TCRBV20-01,TCRBV20-or09_02												CSARGWGVGISYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCAATGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPMRDTGELFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	3	6	0	22	33	-1	39	44		TCRBV12-03,TCRBV12-04												CASSPMRDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGTGAAGCGCTTGCCGGTAATCAGCTCTAGCATTTTGGTGAT	CASSEALAGNQL*HF	Stop	VDJ	1	11	7.30552364001036E-5		45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	6	6	14	2	19	22	34	40	36	59	TCRBV03,TCRBV12					01,02								CASSEALAGNQL*HF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGATGGTCGCGGGGGGGCTGTAGATACGCAGTATTTTGGCCCA	CASSDGRGGAVDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	5	7	4	22	34	50	41	54		TCRBV12-03,TCRBV12-04												CASSDGRGGAVDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGGGGGGGAGATTCAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGRFSTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	0	0	6	22	-1	43	36	49		TCRBV12-03,TCRBV12-04												CASSLGGRFSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGTACAGACAGATACAATCAGCCCCAGCATTTTGGTGAT	CASTDRYNQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	2	5	3	4	3	22	30	39	34	42		TCRBV12-03,TCRBV12-04												CASTDRYNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGGGCCTCAGTGAAGCTTTCTTTGGACAA	CATSDPGLSEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	3	8	0	7	2	5	24	39	45	41	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDPGLSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTACAGGGGAAGCTTTCTTTGGACAA	CATSDSTGEAFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	8	2	0	24	40	-1	42	48		TCRBV24-01,TCRBV24-or09_02												CATSDSTGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCCGCGGGGTCAGCCCCAGCATTTTGGTGAT	CATSAPRGQPQHF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	3	6	4	0	24	37	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CATSAPRGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTCCGACCGGGACACTCGGGGAGACCCAGTACTTCGGGCCA	CATSAPTGTLGETQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	5	8	6	24	37	51	45	57		TCRBV24-01,TCRBV24-or09_02												CATSAPTGTLGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCACGACAGCCGAAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	7.30552364001036E-5		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	12	2	5	0	4	6	24	30	39	34	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCCGGGCCCCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	7.30552364001036E-5		50							TCRBJ01	TCRBJ01-05	01	0	8	0	0	3	4	18	35	42	38	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05			TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGCCGGCCATTGGGGCCCAGTACTTCGGGCCA	CASSLAGPAIGAQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	9	0	12	18	-1	40	35	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGPAIGAQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCCCGAGGTGGGCAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	7.30552364001036E-5		46	TCRBV05						TCRBJ01	TCRBJ01-01	01	3	8	0	1	9	1	19	32	45	41	46		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGACTCRGCCCTSTAYYTCTGTGCCAGCAGCTCCCTCGTAGGGGGACGTGAGCAGTTCTTCGGGCCA	CASSSLVGGREQFF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	1	9	7	3	19	32	45	39	48	TCRBV05,TCRBV13													CASSSLVGGREQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGACTAGCGGGGGACCCACCACAGATACGCAGTATTTTGGCCCA	CASSSTSGGPTTDTQYF	In	VDJ	1	11	7.30552364001036E-5	8.515250038705682E-5	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	2	1	6	19	32	45	33	51		TCRBV05-06,TCRBV05-07												CASSSTSGGPTTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCTKTGTATYTCTGTGCCAGCAGTCCGGTCCGGAGACACCATATATTTTGGAGAG		Out	VDJ	1	11	7.30552364001036E-5		37	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	10	2	8	8	0	22	33	-1	41	45	TCRBV07,TCRBV09													X+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTTCTGTGCCAGCAGTGCAATCAGTGTTTAGCGGGGGGCCCGGGGGTTTGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	7.30552364001036E-5		67	TCRBV21			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	1	13	12	4	15	38	28	50		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAGACCGCCAATGAAAAACTGTTTTTTGGCAGT	CASSQTANEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	6	2	7	5	3	4	26	37	43	40	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTANEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGGACAGAATCACAGATACGCAGTATTTTGGCCCA	CASSRDRITDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	2	2	3	26	37	46	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRDRITDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCTTACAGGGACTGAAGCTTTCTTTGGACAA	CASSLTGTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	4	0	26	37	-1	41	47	TCRBV12,TCRBV21													CASSLTGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGCGGGGGCTACAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGGGYSSGNTIYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	2	0	2	6	26	37	46	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGGGYSSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTCTGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSVALGGTDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	3	9	0	26	37	-1	46	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVALGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGGGACAGCCACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSGQPLAKNIQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	0	3	5	26	37	47	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSGQPLAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAAGTAGGAGGCGGCTACACCTTCGGTTCG	CASSEVGGGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	1	8	6	1	26	38	49	44	50	TCRBV09,TCRBV12													CASSEVGGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGAAGCCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSWEASSGANVLTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV12						TCRBJ02	TCRBJ02-06	01	4	0	8	0	0	6	26	-1	43	39	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWEASSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGCAAATCTCCTACGAGCAGTACTTCGGGCCG	CASSLGQISYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	9	0	0	0	4	26	-1	45	42	49		TCRBV12-03,TCRBV12-04												CASSLGQISYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTAGGAGTGAAAGAGACCCAGTACTTCGGGCCA	CASSLVGVKETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	10	2	3	2	3	26	42	48	44	51		TCRBV12-03,TCRBV12-04												CASSLVGVKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTYTCATCTTCGGGCCATCGGAAGAGACCCAGTACTTCGGGCCA	CASSXIFGPSEETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	8	0	3	7	6	26	40	51	47	57		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSXIFGPSEETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGTGAAAGGGCAGGGGAAGGCACTGAAGCTTTCTTTGGACAA	CASSERAGEGTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	4	4	24	39	49	43	53	TCRBV06,TCRBV22													CASSERAGEGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGTTCGAGCACTGAAGCTTTCTTTGGACAA	CASSQDRSSTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	2	4	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02												CASSQDRSSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTATGGACTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSQDLWTSGTDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	4	3	5	0	26	43	-1	48	59		TCRBV03-01,TCRBV03-02				01,02								CASSQDLWTSGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAATGGAGACTGTCGATACGCAGTATTTTGGCCCA	CASSLMETVDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	6	8	3	26	38	50	46	53		TCRBV03-01,TCRBV03-02				01,02								CASSLMETVDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTTAGTAGAATTGCGAAGGGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	7.969662152738576E-5		49	unresolved						TCRBJ01	TCRBJ01-02	01	5	0	7	4	16	0	26	38	-1	54	59	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
RGGGGACTYRGCYSTGTATCTCTGTGCCAGCAGCCTGCTGTGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLLWASTDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	0	9	1	22	32	45	41	46	TCRBV05,TCRBV07													CASSLLWASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGAGGACTCGGAAACATTCAGTACTTCGGCGCC	CSARGGLGNIQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	9	1	6	3	6	26	34	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSARGGLGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAGCGTTTTTGGGACAGGGAGGACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	12	7.969662152738576E-5		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	17	12	18	26	34	55	46	73		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGGACTTCGCACCAAGAGACCCAGTACTTCGGGCCA	CSATRTSHQETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	10	0	3	4	26	36	44	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSATRTSHQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCAAGGGGCGCAGTCCTATGGCTACACCTTCGGTTCG	CSARDQGAQSYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	4	3	7	26	40	48	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDQGAQSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGAGACCCAGTACTTCGGGCCA	CSARDGETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	0	10	4	1	0	26	40	-1	41	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGGGCTTCGGGAGGGGCTACACCTTCGGTTCG	CSARLGFGRGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	1	8	8	0	26	38	-1	46	53		TCRBV20-01,TCRBV20-or09_02												CSARLGFGRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAAACAGGGGGAAAGATGAAAAACTGTTTTTTGGCAGT	CSAINRGKDEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	1	6	3	4	26	36	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSAINRGKDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGGGACTAGCGGGGGCTCCACCGGGGAGCTGTTTTTTGGAGAA	CSALGTSGGSTGELFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	4	3	3	26	35	52	38	55		TCRBV20-01,TCRBV20-or09_02												CSALGTSGGSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGCCTAGGGAGGAGATACGGCTACACCTTCGGTTCG	CASSLGRRYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	8	4	6	22	33	43	37	49	TCRBV07,TCRBV12													CASSLGRRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAATCAGGGTATGGGAATTCACCCCTCCACTTTGGGAAC	CASSESGYGNSPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	7	4	6	22	34	43	38	49	TCRBV02,TCRBV12													CASSESGYGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGCGGAGGTGGGAGACCCAGTACTTCGGGCCA	CASSERRWETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	5	1	6	22	34	40	35	46	TCRBV02,TCRBV12					unresolved								CASSERRWETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCCCTAGCGGGGGGTAAATTAGATACGCAGTATTTTGGCCCA	CASSSLAGGKLDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	1	5	2	6	22	35	48	37	54		TCRBV12-03,TCRBV12-04												CASSSLAGGKLDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCCGGGACAGGTAATTACAATGAGCAGTTCTTCGGGCCA	CATSDSGTGNYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	4	4	4	24	38	50	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDSGTGNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAGGGGACAGGGGCGGGGAAGACCCAGTACTTCGGGCCA	CASKGTGAGKTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	0	2	6	5	6	24	31	46	36	52		TCRBV24-01,TCRBV24-or09_02												CASKGTGAGKTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCATGACAGGGCAAAATTCACCCCTCCATTTTGGGAAC	CASSPMTGQNSPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	22	5	18	24	36	48	41	66		TCRBV24-01,TCRBV24-or09_02												CASSPMTGQNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCATAAGGGTAGGGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	7.969662152738576E-5		49	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	0	10	0	15	0	24	31	-1	46	52		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTGGACAGTTCAGTGAAAAACTGTTTTTTGGCAGT	CASGQFSEKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	1	5	7	2	5	24	31	39	33	44		TCRBV24-01,TCRBV24-or09_02												CASGQFSEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACCCCCCGGCTATGGCTACACCTTCGGTTCG	CASSEPPGYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	39	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	8	5	4	5	0	23	38	-1	43	46		TCRBV06-01,TCRBV06-08				01,02								CASSEPPGYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCCTCAAGCGACAGGGACTATGGCTACACCTTCGGTTCG	CASSESSSDRDYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	3	9	0	23	38	-1	47	54		TCRBV06-01,TCRBV06-08												CASSESSSDRDYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGAACCCAGAATTCCGGGAATCCCCAAGAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	12	7.969662152738576E-5		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	8	3	7	12	11	18	26	43	38	54	TCRBV07,TCRBV11,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGTAATTTGGGTGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	7.969662152738576E-5		46	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	9	1	10	2	18	30	43	40	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGGCCGGGACTAGCATGAATACGCAGTATTTTGGCCCA	CASSQAGTSMNTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	7	6	4	18	30	45	36	49	TCRBV07,TCRBV11					01,02								CASSQAGTSMNTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGGACTGCCCGATACAATGAGCAGTTCTTCGGGCCA	CASSFGTARYNEQFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	4	1	6	18	32	39	33	45	TCRBV07,TCRBV11					01,02								CASSFGTARYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGTTCCACGGGGGGACGCACAGATACGCAGTATTTTGGCCCA	CASSSTGGRTDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	1	5	2	18	29	41	34	43	TCRBV05,TCRBV11													CASSSTGGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCATCAGGGCTGAGGGGGCGCAGGAAGGCTACACCTTCGGTTCG	CAIRAEGAQEGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	0	8	5	7	18	29	41	34	48	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CAIRAEGAQEGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCCAAATGGGGAATGGGACAGGGGGGACACTAAAGCTTTCTTTGGACAA		Out	VDJ	1	12	7.969662152738576E-5		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	1	9	9	7	20	35	55	44	62	TCRBV07,TCRBV23													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCTATGGAGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSYGGLQETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	1	1	4	3	20	31	40	35	43	TCRBV07,TCRBV23													CASSYGGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCRGCMMTGTATCKCTGYGCCACCAAGAAAGACAAAGGGGGGACAGGCCCAACGGGTGGCTACACCTTCGGTTCG	CATKKDKGGTGPTGGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	4	7	17	9	19	26	51	43	60	TCRBV07,TCRBV23													CATKKDKGGTGPTGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCRGCCMTGTATCKCTGTGCCAGCAGCAATTCGCCCGAGGATCAGCCCCAGCATTTTGGTGAT	CASSNSPEDQPQHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	1	5	9	0	19	31	-1	40	44	TCRBV05,TCRBV07													CASSNSPEDQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCAGCYWTGTATYKCTGTGCCAGCAGCCCCCAACCGTCAGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSPQPSGAQETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	2	1	10	1	19	31	47	41	48	TCRBV07,TCRBV09													CASSPQPSGAQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTGGGGGTCGGGCGATTGAACACTGAAGCTTTCTTTGGACAA	CASSLGVGRLNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	unresolved						TCRBJ01	TCRBJ01-01	01	3	6	1	0	0	9	19	-1	38	33	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGRLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTTCGTCAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFRQGNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	1	4	0	19	33	-1	37	42	TCRBV07,TCRBV11													CASSFRQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYRTGTATCTCTGTGCCAGTTACCTTGAGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASYLEGGNTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved						TCRBJ01	TCRBJ01-01	01	9	5	1	1	8	1	19	27	41	35	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYLEGGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAATCCCTCCGGGCTAGCGGGGGGGCGAGATACGCAGTATTTTGGCCCA	CASNPSGLAGGRDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	5	11	2	19	29	52	40	54	TCRBV05,TCRBV07													CASNPSGLAGGRDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCAATACCGGGACGGCAATGGCTACACCTTCGGTTCG	CASSQYRDGNGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	0	7	6	7	4	19	31	43	38	47	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQYRDGNGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCAGCAGGGACTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQQGLTNTGELFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	9	0	5	1	19	31	43	36	44	TCRBV05,TCRBV11					01,02								CASSQQGLTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCCCGGACAGCACCCATAATCTATGGCTACACCTTCGGTTCG	CASSPRTAPIIYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	4	4	10	19	31	41	35	51	TCRBV05,TCRBV11													CASSPRTAPIIYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCCCGGGGGGGGCGATTCACGGCTACACCTTCGGTTCG	CASSPGGAIHGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	8	1	9	19	31	40	32	49	TCRBV05,TCRBV23													CASSPGGAIHGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCGAGGGACAGAGGGATTCACCCCTCCACTTTGGGAAC	CASSEGQRDSPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	5	8	2	4	19	31	40	33	44	TCRBV05,TCRBV11													CASSEGQRDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGGACAACTAAACTATGGCTACACCTTCGGTTCG	CASSLGQLNYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	0	2	6	2	0	4	19	-1	39	35	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLGQLNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTTCAGGGGGCGTCCTACGAGCAGTACTTCGGGCCG	CASSFQGASYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	1	1	1	19	33	42	34	43	TCRBV05,TCRBV11													CASSFQGASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCGCCCACGGGGTGGGAACCGGGGAACTGTTTTTTGGAGAA	CASAHGVGTGELFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	3	14	5	14	19	28	38	33	52	TCRBV05,TCRBV07													CASAHGVGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCGGCTCGGGGACAGGGCCAGATACGCAGTATTTTGGCCCA	CASGSGTGPDTQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	4	2	1	19	32	43	34	44	TCRBV05,TCRBV11													CASGSGTGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCACCCCCGAGATCCGGGGAACTGAAGCTTTCTTTGGACAA	CASTPEIRGTEAFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	5	11	1	19	29	45	40	46	TCRBV05,TCRBV11													CASTPEIRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCSTGTATCTCYGTGCCAGCAGCCCAGGATCACTCGGCTCTGGAAACACCATATATTTTGGAGAG	XASSPGSLGSGNTIYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	4	0	1	9	19	31	36	32	45	TCRBV05,TCRBV07													XASSPGSLGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCACCCCGTTACCCGCGAGGGGAAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	12	7.969662152738576E-5		46	unresolved						TCRBJ01	TCRBJ01-04	01	7	5	2	8	14	2	22	32	51	46	53	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCACTACGCCGGGGGAGGAGTCACCCCTCCACTTTGGGAAC	CASSTTPGEESPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	8	2	10	7	5	22	34	47	41	52	TCRBV07,TCRBV11					01,02								CASSTTPGEESPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCTAGACGGTCTCCCTAACTATGGCTACACCTTCGGTTCG	CASSLDGLPNYGYTF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	8	0	0	9	22	-1	38	34	47	TCRBV07,TCRBV11					01,02								CASSLDGLPNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAACTCGGATTGAGTACGAAAGACCTATGGCTACACCTTCGGTTCG	CASNSD*VRKTYGYTF	Stop	VDJ	1	12	7.969662152738576E-5		48	unresolved						TCRBJ01	TCRBJ01-02	01	10	1	8	4	7	15	24	31	41	38	56	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNSD*VRKTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CWCMRGMSAMACAGCWYKGTAYTTCTGTGCCAGCAGTTCTGAGCGGGGGGTACCCTACGAGCAGTACTTCGGGCCG	CASSSERGVPYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	1	2	5	3	24	35	49	40	52	TCRBV21,TCRBV22													CASSSERGVPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTATCCTTCTTGGATTGGCCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSILLGLALSYEQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	unresolved						TCRBJ02	TCRBJ02-07	01	5	1	8	0	9	8	23	35	47	44	55	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSILLGLALSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCCTACAGGGGGTTAGGAGGTCTTCTCGGGAAAAACTGTTTTTTGGCAGT	CASLQGVRRSSREKLFF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	1	8	2	17	23	32	42	34	59	TCRBV02,TCRBV09													CASLQGVRRSSREKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCGTCTTGACTCCCGGAGAGACCCAGTACTTCGGGCCA	CAVLTPGETQYF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	2	10	4	5	5	23	29	38	34	43	TCRBV09,TCRBV21					01,02								CAVLTPGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGCCAGGACAGGGGGCTGGATTCACCCCTCCACTTTGGGAAC	CASSQDRGLDSPLHF	In	VDJ	1	12	7.969662152738576E-5	9.289363678588016E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	0	8	3	3	28	39	53	42	56	TCRBV06,TCRBV10													CASSQDRGLDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCTCGCGCGGGACTAGCGGGGGGCCCGAGCAGTTCTTCGGGCCA	CASSSRGTSGGPEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	10	7	3	26	37	59	44	62	TCRBV07,TCRBV12													CASSSRGTSGGPEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGTTCCGGACAGAGCAGTTCTTCGGGCCA	CASSLFRTEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	10	7	0	26	38	-1	45	50		TCRBV12-03,TCRBV12-04												CASSLFRTEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAGGGGATCAATACGCAGTATTTTGGCCCA	CASSEGINTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	TCRBV12						TCRBJ02	TCRBJ02-03	01	5	5	2	7	1	4	26	38	44	39	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGINTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCATCTGGCTACACCTTCGGTTCG	CASSLSSGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	33	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	6	7	1	2	26	41	44	42	46		TCRBV12-03,TCRBV12-04												CASSLSSGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGQGNTGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	3	1	1	0	26	40	-1	41	49		TCRBV12-03,TCRBV12-04												CASSFGQGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCAGGGCGGAAACACCATATATTTTGGAGAG	CASSQEQGGNTIYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	4	1	1	26	43	49	44	50		TCRBV03-01,TCRBV03-02												CASSQEQGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAAGTCCAGTTAGGAAAACTGTTTTTTGGCAGT	CASSQDQVQLGKLFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV03						TCRBJ01	TCRBJ01-04	01	0	4	5	10	7	5	26	43	53	50	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDQVQLGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGACAGGGGCCTAGGGGCTGAAGCTTTCTTTGGACAA	CASSPDRGLGAEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	6	2	8	26	39	49	41	57		TCRBV03-01,TCRBV03-02												CASSPDRGLGAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGACGCTTTGAGGTAACGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	8.633800665466789E-5		53	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	3	17	0	26	39	-1	56	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAAATCCGGGACAGGGGACATCTATGGCTACACCTTCGGTTCG	CSAKSGTGDIYGYTF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	4	7	4	26	34	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSAKSGTGDIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDPGTGSYNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	1	4	0	26	40	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CSARDPGTGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTTTGGGAAATCCGGGATCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSASFWEIRDLSNQPQHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	3	0	13	3	26	37	55	50	58		TCRBV20-01,TCRBV20-or09_02												CSASFWEIRDLSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACTGGGGCACTGAAGCTTTCTTTGGACAA	CSAYWGTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	6	2	4	4	0	26	35	-1	39	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYWGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGAGGGGGTTAAAGCTTTCTTTGGACAA	CASSQEGVKAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	3	5	1	9	2	3	23	37	45	39	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGVKAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTATCCTAGCGGTAGTTACAGATACGCAGTATTTTGGCCCA	CASSILAVVTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	5	3	3	5	22	34	44	37	49		TCRBV12-03,TCRBV12-04				01,02								CASSILAVVTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATCCACTGACACTGAAGCTTTCTTTGGACAA	CASSESTDTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	3	6	1	22	34	43	40	44		TCRBV12-03,TCRBV12-04				01,02								CASSESTDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGTGGAGACGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSVETGSYEQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	0	7	0	22	34	-1	41	45	TCRBV09,TCRBV12					01,02								CASSVETGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCATTGTAGCGCGGCTGGGGGCGGGAGATACGCAGTATTTTGGCCCA	CASIVARLGAGDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	5	6	3	22	39	51	45	54		TCRBV12-03,TCRBV12-04												CASIVARLGAGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCGGACAGGGGCCCTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	8.633800665466789E-5		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	2	0	2	5	24	38	49	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCCAAAAACATTCAGTACTTCGGCGCC		Out	VJ	1	13	8.633800665466789E-5		38	TCRBV24						TCRBJ02	TCRBJ02-04	01	1	0	0	1	0	0	24	-1	-1	-1	41		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGCAGGGAATGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	8.633800665466789E-5		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	10	3	5	24	42	50	45	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATTTTGAGGGGTCCTCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	13	8.633800665466789E-5		41	TCRBV24						TCRBJ02	TCRBJ02-02	01	11	5	2	7	9	4	24	31	45	40	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGCCAGGGGACTAGCGGGGGGACCTCTTCACAATGAGCAGTTCTTCGGGCCA	CASRARGLAGGPLHNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	57	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	0	1	5	6	8	24	35	56	41	64		TCRBV24-01,TCRBV24-or09_02												CASRARGLAGGPLHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGTCGGGGGGGATTAAACAACAGACCCAGTACTTCGGGCCA	CASSLRSGGIKQQTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	6	7	10	24	36	51	43	61		TCRBV24-01,TCRBV24-or09_02												CASSLRSGGIKQQTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCCCTCCCGGGACTAGCGGGGGGGCGAATCCAGATACGCAGTATTTTGGCCCA	CSAPPPGTSGGANPDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	0	4	10	6	24	32	58	42	64		TCRBV20-01,TCRBV20-or09_02												CSAPPPGTSGGANPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCACAGGTTTAGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	8.633800665466789E-5		37				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	7	0	6	22	-1	40	36	46	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCCCCAAACAGGGAACAGATACGCAGTATTTTGGCCCA	CASSPKQGTDTQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	3	5	1	19	31	42	36	43	TCRBV11,TCRBV23													CASSPKQGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAACTCCGACTACCTTGATGAGGAGACCCAGTACTTCGGGCCA	CASNSDYLDEETQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	9	5	5	10	19	29	39	34	49		TCRBV05-06,TCRBV05-07				01,02								CASNSDYLDEETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTCCTGACAGGGGGTCTGTACGAGCAGTACTTCGGGCCG	CASSLLTGGLYEQYF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	4	5	4	19	31	45	36	49		TCRBV05-06,TCRBV05-07												CASSLLTGGLYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCCCCTTGGGAGGGCCGGCGAACACTGAAGCTTTCTTTGGACAA	CASSSPLGGPANTEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	1	7	5	19	32	46	39	51		TCRBV05-06,TCRBV05-07												CASSSPLGGPANTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGATAGAGCGACTAGCGATCGGGGAGCTGTTTTTTGGAGAA	CASSSIERLAIGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	2	6	7	9	2	19	32	49	41	51		TCRBV05-06,TCRBV05-07				01,02								CASSSIERLAIGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTCCTTTCAGGGGGTTACTTGAAGCTTTCTTTGGACAA	CASSPFRGLLEAFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	7	6	5	19	30	43	36	48		TCRBV05-06,TCRBV05-07												CASSPFRGLLEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTCCGGGACAGGAGATGGGTTCAGAATGAGCAGTTCTTCGGGCCA	CASSFRDRRWVQNEQFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	7	3	12	22	35	46	38	58	TCRBV07,TCRBV23													CASSFRDRRWVQNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCCCGAAAGAGGGGGGGCGCGTGGGGAGCTGTTTTTTGGAGAA	CASSAPERGGARGELFF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	9	0	8	11	5	23	36	54	47	59	TCRBV09,TCRBV21													CASSAPERGGARGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGGAATACTGGGACGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGEYWDGSYNSPLHF	In	VDJ	1	13	8.633800665466789E-5	1.0063477318470352E-4	54	unresolved						TCRBJ01	TCRBJ01-06	01	5	0	7	0	11	2	23	34	50	45	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGEYWDGSYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACAGCGACTATGGACTGAAGCTTTCTTTGGACAA	CASRQRLWTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	9	5	5	3	26	37	47	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRQRLWTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACAGGGAATCCATGGCTACACCTTCGGTTCG	CASRQGIHGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	6	0	5	26	-1	43	37	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRQGIHGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGGACAGGGAATGTCAGATACGCAGTATTTTGGCCCA	CASSPGQGMSDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	4	4	5	26	37	49	41	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGQGMSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAAATAACAATGAGCAGTTCTTCGGGCCA	CASSVNNNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	9	5	2	4	26	37	41	39	45	TCRBV09,TCRBV12					01,02								CASSVNNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCGGGACAGGACCCCCAGCATTTTGGTGAT	CASRSGQDPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	10	3	2	26	37	48	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSGQDPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAGGGACAGGCGGCCTATGGCTACACCTTCGGTTCG	CASSQGQAAYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	4	2	4	26	38	48	40	52		TCRBV12-03,TCRBV12-04												CASSQGQAAYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGGGCCTTTGAGTATGGCTACACCTTCGGTTCG	CASSRAFEYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	5	8	0	5	1	7	26	38	43	39	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAFEYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCCTATGATGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSAYDGTGSYNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	1	9	0	26	38	-1	47	56		TCRBV12-03,TCRBV12-04												CASSAYDGTGSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCAGCCAGAACACTGAAGCTTTCTTTGGACAA	CASSLVSQNTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	4	5	1	1	3	26	42	46	43	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSQNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAGTCTAGTGGACCCCAATGAGCAGTTCTTCGGGCCA	CASSLSLVDPNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	1	7	6	9	2	26	40	53	49	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLVDPNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCGGGACAGGGGACCGGGGGCTACACCTTCGGTTCG	CASSPGQGTGGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	8	3	6	24	35	48	38	54	TCRBV06,TCRBV10													CASSPGQGTGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGAGGACAGGGTGCGGACATTCAGTACTTCGGCGCC	CASSQEGGQGADIQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	1	3	8	4	5	26	43	55	47	60		TCRBV03-01,TCRBV03-02												CASSQEGGQGADIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGAAAACTATGGCTACACCTTCGGTTCG	CASSQEENYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	1	8	2	0	1	26	-1	46	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEENYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTTTCAGCCCCAGCATTTTGGTGAT	CASSQGFQPQHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	36	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	0	10	6	0	2	26	-1	44	42	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGFQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCACAGGACAGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	9.297939178195004E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	2	2	0	26	40	-1	42	50	TCRBV03,TCRBV12													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAACCTTGGGACAGGGGGTGAAGCTTTCTTTGGACAA	CASSPNLGTGGEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	1	7	8	0	26	39	-1	47	58		TCRBV03-01,TCRBV03-02												CASSPNLGTGGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGCGGCTCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGSGNTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	1	3	6	26	39	46	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSLGGSGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGCGACGAAGAACGGGTGTACCAAGAGACCCAGTACTTCGGGCCA	CASSDEERVYQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	0	9	3	26	38	51	47	54	TCRBV03,TCRBV05					01,02								CASSDEERVYQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTKGRKGACTCWGCYRTGTAYTTCTGTGCCAGCAGCTTATCTCTGGAGACCCAGTACTTCGGGCCA	CASSLSLETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	10	5	4	3	26	38	44	42	47	TCRBV02,TCRBV03,TCRBV13					01,02								CASSLSLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGTTTCGTATGGGAACACTGAAGCTTTCTTTGGACAA	CSAPVSYGNTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	10	1	13	0	26	34	-1	47	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPVSYGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCATGACAGGGACGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	14	9.297939178195004E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	3	8	6	2	26	40	53	46	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTATTAGCGAGATCTTACAATGAGCAGTTCTTCGGGCCA	CSARVLARSYNEQFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	6	4	3	6	26	39	47	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLARSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCWSSSASWCAKCTGTGTACTTCTGTGCCAGCAGGGTGGCCTTAGGGAATGAAAAACTGTTTTTTGGCAGT	CASRVALGNEKLFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	6	5	3	5	9	0	22	33	-1	42	46	TCRBV06,TCRBV10,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVALGNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGGTCCGGGACAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASRSGTGGQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	1	4	0	22	33	-1	37	48	TCRBV12,TCRBV21													CASRSGTGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGTCCGGAGTGAAAAACTGTTTTTTGGCAGT	CASSEVRSEKLFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	2	7	7	0	22	34	-1	41	45	TCRBV09,TCRBV12													CASSEVRSEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTYGGSCSTRTATKTCTGTGCCAGCAGCTTCCGGGGGGGCCAGTATTCACCCCTCCACTTTGGGAAC	CASSFRGGQYSPLHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	8	0	8	1	5	22	36	45	37	50	TCRBV11,TCRBV12													CASSFRGGQYSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGCGGGGGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	9.297939178195004E-5		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	6	3	2	24	37	49	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGCAAGAGGGGAAGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	9.297939178195004E-5		43	TCRBV24						TCRBJ02	TCRBJ02-03	01	7	5	2	4	6	4	24	35	46	41	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTAACCCGGGCGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	9.297939178195004E-5		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	7	4	4	8	0	24	36	-1	44	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSSGGPQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	1	2	2	24	36	45	38	47		TCRBV24-01,TCRBV24-or09_02												CASSSGGPQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GARGACTCSGCCSTGTATCTCTGTGCCAGCAGCCCATCCTCCGGACAGGGCGGCAACTATGGCTACACCTTCGGTTCG	CASSPSSGQGGNYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	2	8	4	21	34	50	42	54	TCRBV04,TCRBV07													CASSPSSGQGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAAGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTGGCCTGGGACAGGGGGCCCGGTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	9.297939178195004E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	0	10	7	4	21	33	52	40	56	TCRBV04,TCRBV05,TCRBV11													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCGACACAGGGGGCGTACACTGAAGCTTTCTTTGGACAA	CASSPTQGAYTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	3	5	2	18	30	44	35	46	TCRBV07,TCRBV11													CASSPTQGAYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTGGGGCCTCAGGGCGCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	14	9.297939178195004E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	17	7	17	18	31	43	38	60	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGAGGGCAGCGGCTCTGGAAACACCATATATTTTGGAGAG	CASSQEEGSGSGNTIYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	6	5	0	7	0	18	35	-1	42	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQEEGSGSGNTIYF+X+TCRBJ01-03		TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGGGACAGAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	9.297939178195004E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	5	5	3	1	18	30	40	33	41	TCRBV07,TCRBV11													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCTGCGGGCGGGGGGGCCGCTCCAAGGATGGAGACCCAGTACTTCGGGCCA	CASSPAGGGAAPRMETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	0	5	7	14	18	30	46	37	60	TCRBV07,TCRBV11													CASSPAGGGAAPRMETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCTACCGGGACAGCCTGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	6	5	18	30	43	36	48	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGTGGGGGTCCAGAGCACAGATACGCAGTATTTTGGCCCA	CASSVGVQSTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	6	1	0	2	5	18	30	37	32	42	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGVQSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTAATAGGCCGGAGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	14	9.297939178195004E-5		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	10	2	3	8	0	18	31	-1	39	43	TCRBV07,TCRBV11													X+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCTGGACTAGGAACGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	9.297939178195004E-5		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	8	5	2	4	18	31	40	33	44	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTAGAGGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLEGSSTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	0	0	8	0	0	3	18	-1	39	35	42	TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGSSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCCCCGGGACAGGGGTACGAGCAGTACTTCGGGCCG	CASSLAPGQGYEQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	4	3	0	18	35	-1	38	48	TCRBV05,TCRBV07,TCRBV11													CASSLAPGQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAGGACCAGGGGTCCCCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	9.297939178195004E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	3	3	6	18	34	43	37	49	TCRBV05,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGAGTGCGGGGGGCTTACAAGAGACCCAGTACTTCGGGCCA	CASSLSAGGLQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	1	2	4	4	18	32	44	36	48	TCRBV07,TCRBV11													CASSLSAGGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCACCCCGGGGGGGGCCCGTGAAGCTTTCTTTGGACAA	CASTPGGAREAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	7	3	5	20	30	41	33	46	TCRBV07,TCRBV23													CASTPGGAREAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCTTGGCCAGCCCTCCGCCGATCGAGTGGCTACACCTTCGGTTCG	CASSPWPALRRSSGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	unresolved						TCRBJ01	TCRBJ01-02	01	6	4	5	7	8	16	20	31	42	39	58	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWPALRRSSGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCTCCCTCCGGGTAGCGGGGTTAGGAGATACGCAGTATTTTGGCCCA	CASSSLRVAGLGDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	5	11	5	20	31	50	42	55	TCRBV11,TCRBV23													CASSSLRVAGLGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCAGATTTGGGACAGGGGGCGACCACACAGATACGCAGTATTTTGGCCCA	CASSRFGTGGDHTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	0	2	6	5	19	31	49	37	54	TCRBV07,TCRBV23													CASSRFGTGGDHTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCCTATTGGGTGGAGGCACTGAAGCTTTCTTTGGACAA	CASSLLGGGTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	4	9	0	19	31	-1	40	45	TCRBV07,TCRBV23													CASSLLGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCGCTCCGGGACAACAGATATCTATGGCTACACCTTCGGTTCG	CASSRSGTTDIYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	4	6	8	19	31	43	37	51	TCRBV07,TCRBV11													CASSRSGTTDIYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCTCCCCCGGCAGTCCGGCTTTTTATGGCTACACCTTCGGTTCG	CASSSPGSPAFYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved						TCRBJ01	TCRBJ01-02	01	4	4	5	5	7	10	19	32	42	39	52	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGSPAFYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGGGACAGAGACTTCTGAAGCTTTCTTTGGACAA	CASSLGTETSEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	6	0	6	19	-1	41	35	47	TCRBV07,TCRBV11													CASSLGTETSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCCGACAGGGCTCGTTATGGCTACACCTTCGGTTCG	CASSSDRARYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	5	2	5	19	32	41	34	46	TCRBV05,TCRBV07													CASSSDRARYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGAGCGCGGGGGGGTAACCTACGAGCAGTACTTCGGGCCG	CASSLERGGVTYEQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	0	2	5	3	19	33	47	38	50	TCRBV05,TCRBV07													CASSLERGGVTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTCTCCCGGGACACTTAATCTTGTGGCGGGACCCAGTACTTCGGGCCA	CASSFSRDT*SCGGTQYF	Stop	VDJ	1	14	9.297939178195004E-5		54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	7	5	16	19	33	44	38	60	TCRBV05,TCRBV11													CASSFSRDT*SCGGTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGCCCCAGCGGATTCTCAAGAGACCCAGTACTTCGGGCCA	CASSLAPADSQETQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	6	5	2	4	5	19	35	44	39	49	TCRBV05,TCRBV11					01,02								CASSLAPADSQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTGTATCKCTGTGCCACTCAGGGAGGCAGCGACAATTCACCCCTCCACTTTGGGAAC	CATQGGSDNSPLHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	9	9	1	7	4	7	19	26	36	30	43	TCRBV05,TCRBV07													CATQGGSDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTGGCCCCTCTAGCGGGGGTAAATACGCAGTATTTTGGCCCA	CASSLAPLAGVNTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	7	5	3	19	35	50	40	53	TCRBV05,TCRBV07													CASSLAPLAGVNTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTTCTGGGAGGAGGCACTGAAGCTTTCTTTGGACAA	CASSFLGGGTEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	4	3	3	19	33	42	36	45	TCRBV05,TCRBV07													CASSFLGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGGGTCGGGGCCCAATTCACCCCTCCACTTTGGGAAC	CASSLGSGPNSPLHF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	1	7	0	7	4	2	22	38	47	42	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSGPNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGTCACGACAGTAACTATGGCTACACCTTCGGTTCG	CASSHDSNYGYTF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	1	4	0	22	33	-1	37	42	TCRBV07,TCRBV23													CASSHDSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCCCRAGGCCTTCACAGATACGCAGTATTTTGGCCCA	CASSPXAFTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	6	5	4	2	5	4	24	35	43	40	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSPXAFTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGGGCCTGGGACTTTACAGCACAGATACGCAGTATTTTGGCCCA	CASSEGLGLYSTDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	0	7	4	23	36	49	43	53	TCRBV09,TCRBV21					01,02								CASSEGLGLYSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTAGACGGACTAGCGGAAGCTTTCTTTGGACAA	CASSLDGLAEAFF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	1	6	8	2	0	23	39	-1	41	50	TCRBV09,TCRBV21					01,02								CASSLDGLAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCRGCYKTGTATKTCTGTGCCAGCAGTTTAGGAAGGGGCAGGGACGGATAGTTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	9.297939178195004E-5		58	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	0	14	8	23	34	53	48	61	TCRBV09,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTCAGTGACTCKGSCWTSTATCKCTGTGCCAGCAGCTCTCCGGGGGGGAGACCACGACCAGATACGCAGTATTTTGGCCCA	CASSSPGGRPRPDTQYF	In	VDJ	1	14	9.297939178195004E-5	1.0837590958352686E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	0	4	10	10	26	32	50	42	60	TCRBV07,TCRBV30													CASSSPGGRPRPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAAGGGAAAAACACTGAAGCTTTCTTTGGACAA	CASSEGKNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	0	8	2	3	2	26	38	45	41	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGKNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCAGGACGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRTGNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	4	1	7	1	3	3	26	39	46	42	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRTGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLWANTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	1	1	0	26	41	-1	42	46		TCRBV12-03,TCRBV12-04												CASSLWANTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTCGGACAGAAATGGCTACACCTTCGGTTCG	CASSLSDRNGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	6	3	2	26	40	49	43	51		TCRBV12-03,TCRBV12-04												CASSLSDRNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGGAGGGCAGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CATGGQGNTGELFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	10	0	2	2	6	24	31	39	33	45	TCRBV06,TCRBV10													CATGGQGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCCGGGACAGCCCACAGATACGCAGTATTTTGGCCCA	CASSPGQPTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	2	3	2	24	35	45	38	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPGQPTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGACAGGGCCGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	9.962077690923219E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	2	0	6	24	-1	44	37	50	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTTTGTTTGTGTTAGACGAGCAGTACTTCGGGCCG	CASSSLFVLDEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	13	0	26	38	-1	51	54		TCRBV03-01,TCRBV03-02				01,02								CASSSLFVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGTTAACTATGGCTACACCTTCGGTTCG	CASSQGGVNYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	9	1	1	0	1	26	-1	48	42	49		TCRBV03-01,TCRBV03-02												CASSQGGVNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLNSNQPQHF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	6	0	1	1	26	39	42	40	43		TCRBV03-01,TCRBV03-02												CASSLNSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCGAGGGAAGATGAAAAACTGTTTTTTGGCAGT	CASSREDEKLFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	11	0	6	2	3	26	35	42	37	45		TCRBV03-01,TCRBV03-02												CASSREDEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACAGGTACACAGATACGCAGTATTTTGGCCCA	CSARDRDRYTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	4	2	2	2	26	40	50	42	52		TCRBV20-01,TCRBV20-or09_02												CSARDRDRYTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGACATCGCGAACACTGAAGCTTTCTTTGGACAA	CSARDPDIANTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	1	3	4	26	40	48	43	52		TCRBV20-01,TCRBV20-or09_02												CSARDPDIANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGTCCGGGTTACTGAACACTGAAGCTTTCTTTGGACAA	CSARDGSGLLNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	0	6	4	26	40	50	46	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGSGLLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACTAGTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	9.962077690923219E-5		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	8	2	0	2	26	-1	46	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGCGAGAGGCTACACCTTCGGTTCG	CSARVARGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	9	0	8	1	4	26	39	43	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVARGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGCGGGGGGGGCCGCTCGGGCTACACCTTCGGTTCG	CSASRGGGRSGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	0	8	2	8	26	37	48	39	56		TCRBV20-01,TCRBV20-or09_02												CSASRGGGRSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCAGCCAGGAGTAAACTATGGCTACACCTTCGGTTCG	CSARQPGVNYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	4	4	2	5	4	26	37	46	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARQPGVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCATGGGCCAGATTATGGCTACACCTTCGGTTCG	CSARHGPDYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	5	4	5	26	37	45	41	50		TCRBV20-01,TCRBV20-or09_02												CSARHGPDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACGGGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSASTGGGYNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	3	5	0	26	37	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSASTGGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTCTCAGGGGTGGAGACCCAGTACTTCGGGCCA	CSASFSGVETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	5	2	26	37	48	42	50		TCRBV20-01,TCRBV20-or09_02												CSASFSGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGGGAGGGGGCACAGATACGCAGTATTTTGGCCCA	CSVGGGTDTQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	0	1	1	1	26	33	41	34	42		TCRBV20-01,TCRBV20-or09_02												CSVGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAAGACGGAGGCCCCCTACGAGCAGTACTTCGGGCCG	CASKTEAPYEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	10	1	2	4	3	22	32	41	36	44	TCRBV09,TCRBV12													CASKTEAPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCTCAAGCGACGTCGGCGATTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	9.962077690923219E-5		50	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	6	6	1	5	11	22	33	42	38	53		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTCCTCTCGGGCTTACTATGGCTACACCTTTGGTTCG	CASSSSRAYYGYTF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	8	0	20	8	19	22	33	45	41	64		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSRAYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACGCGGGGAACGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSDAGNGPYNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	2	3	7	22	34	43	37	50		TCRBV12-03,TCRBV12-04												CASSDAGNGPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCCGACTAGCGGGGGTGGATGCGAAGTTCTTCGGGCCA	CASSFRLAGVDAKFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	14	2	9	22	36	50	38	59		TCRBV12-03,TCRBV12-04												CASSFRLAGVDAKFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTTACCCAGTCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	15	9.962077690923219E-5		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	5	0	3	3	23	36	42	39	45	TCRBV27,TCRBV28													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGCCAAGGGGCTCTACAATGAGCAGTTCTTCGGGCCA	CATSDSAKGLYNEQFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	3	6	2	24	40	51	46	53		TCRBV24-01,TCRBV24-or09_02												CATSDSAKGLYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTCAGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLRGMNTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	2	0	3	2	24	35	44	38	46		TCRBV24-01,TCRBV24-or09_02												CASSLRGMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATTTTGGGGACAAACCAGAAGGAGACCCAGTACTTCGGGCCA	CASSILGTNQKETQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	5	6	9	24	36	48	42	57		TCRBV24-01,TCRBV24-or09_02												CASSILGTNQKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCAGTCCCTGACAACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	15	9.962077690923219E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	6	0	4	4	24	36	44	40	48	TCRBV06,TCRBV10,TCRBV24													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTGGGGAGACGGGCTAGCGGGGGTAAGTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	9.962077690923219E-5		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	9	12	6	24	36	58	48	64	TCRBV06,TCRBV24													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTCGGGAGCTTATCTGGGGAGCTGTTTTTTGGAGAA	CASSFGSLSGELFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	8	2	7	24	36	44	38	51	TCRBV06,TCRBV24													CASSFGSLSGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCMCAKACMTCTSWGTACYTSTGTGCCAGCAGTCAGGGAGCGCACGAGCAGTACTTCGGGCCG	CASSQGAHEQYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	5	4	3	5	0	5	23	-1	40	35	45	TCRBV06,TCRBV25			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGAHEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCAAACAGAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSQTEGSGNTIYF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	0	0	6	0	18	30	-1	36	41	TCRBV07,TCRBV11													CASSQTEGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCGGGCGGGGACAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASGRGQGSTEAFF	In	VDJ	1	15	9.962077690923219E-5	1.1611704598235021E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	2	4	5	2	19	28	43	33	45		TCRBV05-06,TCRBV05-07												CASGRGQGSTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCATGGGACAGGAACAATGAGCAGTTCTTCGGGCCA	CASSPWDRNNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	5	4	1	26	38	50	42	51		TCRBV12-03,TCRBV12-04												CASSPWDRNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCTGACACCGCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPDTAGNTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	1	9	0	26	38	-1	47	52	TCRBV12,TCRBV21					01,02								CASSPDTAGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGCAGGATCGTGGCTACACCTTCGGTTCG	CASSLGQDRGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	7	2	4	26	42	48	44	52		TCRBV12-03,TCRBV12-04												CASSLGQDRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGCAGGAGGCATAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAGGITNEKLFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	10	1	1	4	3	26	40	49	44	52		TCRBV12-03,TCRBV12-04												CASSLAGGITNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGTTGGGGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGWGAYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	2	2	6	0	26	40	-1	46	51		TCRBV12-03,TCRBV12-04												CASSFGWGAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTTCGCTTGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPLRLSSYEQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	2	0	10	0	26	39	-1	49	52		TCRBV03-01,TCRBV03-02												CASSPLRLSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGGACAGGGCACAATGAGCAGTTCTTCGGGCCA	CASSRGTGHNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	5	2	1	26	39	50	41	51		TCRBV03-01,TCRBV03-02												CASSRGTGHNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGGACAGGGTAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSGQGRVNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	6	0	6	26	-1	46	38	52	TCRBV03,TCRBV09													CASSGQGRVNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGACAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSGTVQETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	1	0	1	26	-1	45	38	46		TCRBV03-01,TCRBV03-02												CASSGTVQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCGACGGAGGGGCTCGACAATGAGCAGTTCTTCGGGCCA	CSATEGLDNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	10	0	5	6	5	26	31	43	37	48		TCRBV20-01,TCRBV20-or09_02												CSATEGLDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGACAGGGGCGTCAATCAGCCCCAGCATTTTGGTGAT	CSADRGVNQPQHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	2	3	1	3	26	34	43	35	46		TCRBV20-01,TCRBV20-or09_02												CSADRGVNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTAGCGGGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CSARDLSGGDSYEQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	0	0	3	1	26	40	54	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDLSGGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTACGTCAGGCTATGGCTACACCTTCGGTTCG	CSARDGTSGYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	4	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02												CSARDGTSGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGCGGGGGTGGGGATGAGCAGTTCTTCGGGCCA	CSASSGGGDEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	2	8	1	5	26	37	46	38	51		TCRBV20-01,TCRBV20-or09_02												CSASSGGGDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATTCCCTCCTAGCGGGGGGGAACACCTACGAGCAGTACTTCGGGCCG	CSADSLLAGGNTYEQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	2	9	4	26	35	56	44	60		TCRBV20-01,TCRBV20-or09_02												CSADSLLAGGNTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTCCTACCTGGGGAGGGGGGCACCAGCCCCAGCATTTTGGTGAT	CASSPTWGGGHQPQHF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	0	7	8	6	25	37	52	45	58	TCRBV24,TCRBV28													CASSPTWGGGHQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAGSSAMWCAGCTKTGTACTTCTGTGCCAGCAGAACTAGGGGAGGAGAGACCCAGTACTTCGGGCCA	CASRTRGGETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	1	4	6	0	22	33	-1	39	45	TCRBV12,TCRBV22													CASRTRGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGATACGGGACAGGGGAAACTGAAGCTTTCTTTGGACAA	CASRYGTGETEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	5	4	2	22	33	47	37	49		TCRBV12-03,TCRBV12-04												CASRYGTGETEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGCGTAGGGGGGTCGATGTTGTATGGCTACACCTTCGGTTCG	CASSVGGSMLYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	6	5	1	5	3	10	22	33	42	36	52	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGSMLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGGGGTGGGTCCTGGAAACACCATATATTTTGGAGAG	CASRGVGPGNTIYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	6	1	2	0	6	22	-1	38	33	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVGPGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGCTGGAAGATTGAACACTGAAGCTTTCTTTGGACAA	CASSEAGRLNTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	1	8	0	6	4	22	34	43	40	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAGRLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAGGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSEGSAKNIQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	11	0	0	0	3	22	-1	39	34	42		TCRBV12-03,TCRBV12-04												CASSEGSAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTCCCGGGCAGGACGAGCAGTACTTCGGGCCG	CATSGPGQDEQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	4	4	5	8	0	24	37	-1	45	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGPGQDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTATATTGGAGGTGGGGCACCATCAGTTCTTCGGGCCA	CASSILEVGHHQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	6	7	0	13	11	5	24	36	52	47	57	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSILEVGHHQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGAGGGCAGGGGGCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	1.0626216203651434E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	4	6	1	24	36	50	42	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTTCATCGGTGGGGCAGGGGAAACCTATGGCTACACCTTCGGTTCG	CASSEYFIGGAGETYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	57	TCRBV25			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	4	14	4	23	40	60	54	64		TCRBV25-01,TCRBV25-or09_02												CASSEYFIGGAGETYGYTF+TCRBV25-X+TCRBJ01-02	TCRBV25	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGGCAGACTCTACAATGAGCAGTTCTTCGGGCCA	CASSELGRLYNEQFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	10	3	7	0	23	38	-1	45	49		TCRBV06-01,TCRBV06-08				01,02								CASSELGRLYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCAAAGACACTTCTCAAGAGACCCAGTACTTCGGGCCA	CASSKDTSQETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	6	2	3	5	19	31	38	34	43	TCRBV07,TCRBV11													CASSKDTSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCTATCTTTACAGGAAACACCATATATTTTGGAGAG	CASSPIFTGNTIYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	4	3	6	4	9	0	19	31	-1	40	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPIFTGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCGCCTACAGGGTAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.0626216203651434E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	1	4	3	18	30	40	34	43	TCRBV05,TCRBV07													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGCGGCTTAGGAGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	2	12	0	18	30	-1	42	47	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAACCTCAGGGGGCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	17	4	14	18	33	45	37	59	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGAAGGGAGGAGGCGGGGGGTGGAAGCGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	1.0626216203651434E-4		55	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	1	17	12	19	18	32	52	44	71	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTKTATSTYTGYGCCAGCAGTCTCGACTGGATAATCACAGATACGCAGTATTTTGGCCCA	CASSLDWIITDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	10	2	4	7	18	29	37	33	44	TCRBV05,TCRBV11					01,02								CASSLDWIITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTCAGACAGCGGGGGGGACGGCAAAAACATTCAGTACTTCGGCGCC	CASSSDSGGDGKNIQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	6	0	3	7	4	20	31	48	38	52	TCRBV07,TCRBV23													CASSSDSGGDGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGTCGGGACTGGGGGGAAAAACTGTTTTTTGGCAGT	CASSRDWGEKLFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	0	10	8	0	5	20	-1	39	33	44	TCRBV07,TCRBV23					01,02								CASSRDWGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGCCAGGGGCCACTGGAAACACCATATATTTTGGAGAG	CASSLPGATGNTIYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	2	2	1	3	19	34	41	35	44		TCRBV05-06,TCRBV05-07												CASSLPGATGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGCGATTAACTCAAAGGGGGGAGACCCAGTACTTCGGGCCA	CASSLRLTQRGETQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	5	1	5	12	0	19	34	-1	46	52	TCRBV05,TCRBV11													CASSLRLTQRGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGTTGGGGGCAGGGGCTATGCTAACTATGGCTACACCTTCGGTTCG	CASSLVGGRGYANYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	0	7	5	19	35	48	42	53	TCRBV05,TCRBV11													CASSLVGGRGYANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGTCGCCGGACAGCACTAACTATGGCTACACCTTCGGTTCG	CASSLSPDSTNYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	0	5	2	19	34	45	39	47	TCRBV05,TCRBV11													CASSLSPDSTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCGCGGACATTGTGAACACTGAAGCTTTCTTTGGACAA	CASSADIVNTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	6	0	2	3	19	31	38	33	41	TCRBV05,TCRBV11													CASSADIVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYSTGTATCTCTGTGCCAGCAGCTCCTTAGCGGGGGGGCCGATTGGGACCCAGTACTTCGGGCCA	CASSSLAGGPIGTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	0	7	3	8	19	32	46	35	54	TCRBV05,TCRBV07													CASSSLAGGPIGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTAGTCGGCCTAAACACTGAAGCTTTCTTTGGACAA	CASSLVGLNTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	9	0	2	4	3	19	33	40	37	43	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTTTATCCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFYPGNTEAFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	4	1	5	0	19	33	-1	38	42	TCRBV05,TCRBV11					01,02								CASSFYPGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTATGGGACAGGGAGAGCTATGGCTACACCTTCGGTTCG	CASSLWDRESYGYTF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	4	1	4	22	37	47	38	51	TCRBV07,TCRBV11													CASSLWDRESYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTKGGKGACTYKGCTGTGTATYTCTGTGCCAGCAGCTTAGGCTGGACTCATCCTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	16	1.0626216203651434E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	10	1	6	7	22	35	46	41	53	TCRBV03,TCRBV07					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACGGGACTACCCACAGATACGCAGTATTTTGGCCCA	CASSTGLPTDTQYF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	2	1	2	24	37	45	38	47	TCRBV09,TCRBV21					01,02								CASSTGLPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTCCGTTGTTAATGAAAAACTGTTTTTTGGCAGT	CASSSVVNEKLFF	In	VDJ	1	16	1.0626216203651434E-4	1.2385818238117355E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	6	4	2	4	23	35	39	37	43	TCRBV02,TCRBV12					01,02								CASSSVVNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCACCCCGGACATAACAGATACGCAGTATTTTGGCCCA	CASSRTPDITDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	6	3	9	2	26	37	51	46	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTPDITDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCAGGGAGAGGAAACACCATATATTTTGGAGAG	CASSAGRGNTIYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	4	3	4	2	3	26	37	44	39	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGRGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGTCAGGTGGAAACACCATATATTTTGGAGAG	CASSGSGGNTIYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	4	4	3	5	0	26	37	-1	42	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSGGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGATAATTCACCCCTCCACTTTGGGAAC	CASSVDNSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	5	8	5	2	0	26	37	-1	39	42		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVDNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTCGCAACAGGGTAGAATCGGGAAACACCATATATTTTGGAGAG	CASSRNRVESGNTIYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	4	4	8	26	38	48	42	56	TCRBV03,TCRBV12													CASSRNRVESGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGGACTAGCGGGCCTCACAGATACGCAGTATTTTGGCCCA	CASSSGLAGLTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	4	2	2	3	26	39	52	41	55		TCRBV12-03,TCRBV12-04				01,02								CASSSGLAGLTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGATCTACTGGTATTCAGTACTTCGGCGCC	CASSSGSTGIQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	8	3	10	0	9	26	-1	44	39	53		TCRBV12-03,TCRBV12-04												CASSSGSTGIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCTGGACACACACTGAAGCTTTCTTTGGACAA	CASSQVWTHTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	3	3	1	26	42	50	45	51		TCRBV03-01,TCRBV03-02												CASSQVWTHTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCGCCCATTAGGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSHRPLGGTGELFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	1	5	9	1	26	40	55	49	56		TCRBV03-01,TCRBV03-02												CASSHRPLGGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAACCCAGAGAGACCTACGAGCAGTACGTCGGGCCG	CSAKPRETYEQYV	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	2	7	17	12	14	26	34	49	46	63		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKPRETYEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGAGGGTGGCGGACGCCTACAATGAGCAGTTCTTCGGGCCA	CSAKRVADAYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	0	2	1	9	26	36	42	37	51		TCRBV20-01,TCRBV20-or09_02												CSAKRVADAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGTCGTCGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDRRRGSYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	1	0	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02												CSARDRRRGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTAGCGGAGAAAGAGCAGTTCTTCGGGCCA	CSARLAEKEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	5	10	1	5	26	38	45	39	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLAEKEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACAGTTATAACTATGGCTACACCTTCGGTTCG	CSASDSYNYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	1	1	3	26	37	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSASDSYNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGACAGGGTCGGGCACTGAAGCTTTCTTTGGACAA	CSASETGSGTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	4	3	5	26	37	47	40	52		TCRBV20-01,TCRBV20-or09_02												CSASETGSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCACGGGGGGAGAGGGCTATGGCTACACCTTCGGTTCG	CSASSTGGEGYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	4	5	6	26	37	49	42	55		TCRBV20-01,TCRBV20-or09_02												CSASSTGGEGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCACAACTCCAATCTGCACCTTCGGTTCG	CSAPTTPICTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	3	6	13	3	11	26	35	41	38	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPTTPICTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAAGGGGGACAGGGGAGGGAAATATAATTCACCCCTCCACTTTGGGAAC	CSAPKGDRGGKYNSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	4	7	7	26	35	52	42	59		TCRBV20-01,TCRBV20-or09_02												CSAPKGDRGGKYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCTGGGTGGAGGGGGCGACGAGCAGTACTTCGGGCCG	CASSLGGGGDEQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	0	5	9	1	22	33	49	42	50		TCRBV12-03,TCRBV12-04												CASSLGGGGDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGTGGACTAGCGGGGGCCTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	1.1290354716379648E-4		50	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	5	5	4	22	34	52	39	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACCGGGACAGGGGTTCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	1.1290354716379648E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	2	0	2	5	24	34	46	36	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTCTCAAGGGCTACACCTTCGGTTCG	CATSDSLKGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	2	4	6	8	4	2	24	40	46	44	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSLKGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCACCCCTCGGGCAGGGAGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTPRAGRASYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	9	0	0	14	1	24	31	52	45	53	TCRBV24,TCRBV28													CASTPRAGRASYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCATAGGACGGATCAGCCCCAGCATTTTGGTGAT	CASSHRTDQPQHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	1	7	5	5	2	24	35	44	40	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRTDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTTTAGCGGGGGGACAGGGGAGACCCAGTACTTCGGGCCA	CASSSFSGGTGETQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	5	6	24	36	51	41	57		TCRBV24-01,TCRBV24-or09_02												CASSSFSGGTGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAGACAGACAGATACGCAGTATTTTGGCCCA	CASSSRQTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	3	4	0	24	36	-1	40	45		TCRBV24-01,TCRBV24-or09_02												CASSSRQTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGTATAGTCGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	1.1290354716379648E-4		41	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	0	9	3	1	8	24	36	40	37	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCCGGGACAGGGGGAGAGATGGCTACACCTTCGGTTCG	CAIRDRGRDGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	1	6	3	4	24	31	45	34	49		TCRBV24-01,TCRBV24-or09_02												CAIRDRGRDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCCTCAATGACGGGGTTGACTATGGCTACACCTTCGGTTCG	CALNDGVDYGYTF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	11	8	3	3	8	3	23	29	42	37	45	TCRBV06,TCRBV10													CALNDGVDYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAAGACTCGGCCSTGTATCTCTGTGCCAGCAGCCAAGGCTCGCGGTCCCGGCCCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGSRSRPRSYNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	0	8	11	18	30	42	38	53	TCRBV04,TCRBV11					01,02								CASSQGSRSRPRSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCAATAGCGGCGGGGTGAATGAGCAGTTCTTCGGGCCA	CASSSNSGGVNEQFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	5	7	4	7	18	31	41	35	48	TCRBV07,TCRBV11					01,02								CASSSNSGGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCTGGATCGGGACAGAGATACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.1290354716379648E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	0	5	0	12	4	22	25	44	37	48	TCRBV04,TCRBV17													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGATCGATTGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGSIGVNTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV05						TCRBJ01	TCRBJ01-01	01	0	6	2	0	8	0	19	35	-1	43	47		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSIGVNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTCGCGGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSRGTSGTDTQYF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	1	4	0	19	30	-1	34	44		TCRBV05-06,TCRBV05-07				01,02								CASSRGTSGTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTTTAAGACAGGGTTCGTGGGACACTGAAGCTTTCTTTGGACAA	CASSLRQGSWDTEAFF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	3	5	8	19	30	42	35	50		TCRBV05-06,TCRBV05-07												CASSLRQGSWDTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCTCCAGGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSLQGYNSPLHF	In	VDJ	1	17	1.1290354716379648E-4	1.315993187799969E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	2	4	4	0	24	35	-1	39	45	TCRBV09,TCRBV21													CASSLQGYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTAAGCCCGGGACGTGGAAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	1.1290354716379648E-4		44	unresolved						TCRBJ01	TCRBJ01-04	01	5	0	7	8	6	6	23	35	46	41	52	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGACAGGGGGGGCATCAGCCCCAGCATTTTGGTGAT	CASSGQGGHQPQHF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	1	5	1	3	26	37	48	38	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGQGGHQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGAAGAGGGGAACTATGGCTACACCTTCGGTTCG	CASSVEEGNYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	6	5	2	2	8	0	26	37	-1	45	50	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEEGNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGCTCGACAGGATCTGGAAACACCATATATTTTGGAGAG	CASSSTGSGNTIYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	1	3	1	26	37	46	40	47	TCRBV02,TCRBV12													CASSSTGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGACAGGACTAGGAAACACCATATATTTTGGAGAG	CASRPTGLGNTIYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	2	4	4	3	4	26	37	46	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPTGLGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTTGGGACGGAGACCCAGTACTTCGGGCCA	CASSFGTETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	36	unresolved						TCRBJ02	TCRBJ02-05	01	3	0	7	5	1	1	26	40	46	41	47	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGTETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGAAGACTCRGCYGYGTATSTCTGYGCCAGCAGCCCTACCGGGACAGGGGAGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.1954493229107863E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	5	5	4	23	36	51	41	55	TCRBV01,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGGACACGACCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSGDTTHTGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	3	0	6	24	-1	43	37	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSGDTTHTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACAGCCGGGTCCCTCTACAATGAGCAGTTCTTCGGGCCA	CASTAGSLYNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	4	3	4	5	26	36	44	40	49		TCRBV03-01,TCRBV03-02				01,02								CASTAGSLYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCKGCYRTGTATYKCTGTGCCAGCAGCAAACGGACTAGCGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSKRTSGGGTDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	1	4	0	26	38	-1	42	57	TCRBV03,TCRBV07													CASSKRTSGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCGAACACTGAAGCTTTCTTTGGACAA	CASSQDPNTEAFF	In	VJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	0	1	0	3	26	-1	43	-1	46		TCRBV03-01,TCRBV03-02												CASSQDPNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTGTCAGGGAGATTTGATACGCAGTATTTTGGCCCA	CASSQGVSGRFDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	4	3	6	6	6	26	42	53	48	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVSGRFDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCATGGACAGGGATACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSHGQGYSGANVLTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	0	1	3	26	40	49	41	52	TCRBV03,TCRBV12													CASSHGQGYSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGGACGGGGGCGGAGATACGCAGTATTTTGGCCCA	CASSPTDGGGDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	0	5	8	2	26	39	53	47	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDGGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGACGAGGATACGCAGTATTTTGGCCCA	CASSPDEDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	2	7	6	2	3	26	39	44	41	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDEDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGGACTAGTTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.1954493229107863E-4		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	8	5	2	3	26	39	48	41	51		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGTAGATGCGGGGGTATTTGATACGCAGTATTTTGGCCCA	CASSVDAGVFDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	6	6	5	26	38	51	44	56	TCRBV03,TCRBV09													CASSVDAGVFDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTTACTCGGCGTCGGCACAGATACGCAGTATTTTGGCCCA	CSLLGVGTDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	9	9	0	1	7	4	26	31	41	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSLLGVGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCTACCGCCGGAGACCCAGTACTTCGGGCCA	CSATLPPETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	9	5	4	6	26	34	41	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSATLPPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGTCTAGCGGGGGGCTGGGGGACCCAGTACTTCGGGCCA	CSAREGLAGGWGTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	7	4	6	26	40	55	44	61		TCRBV20-01,TCRBV20-or09_02												CSAREGLAGGWGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCAGGGAAAACGGCCGACACTGAAGCTTTCTTTGGACAA	CSARAPGKTADTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	3	3	10	26	39	47	42	57		TCRBV20-01,TCRBV20-or09_02												CSARAPGKTADTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACGACTACTCAAGAGACCCAGTACTTCGGGCCA	CSASTTTQETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	9	2	3	2	26	37	45	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASTTTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCACTCCAGCGGGGGGGCTAAGCGGGGAGCTGTTTTTTGGAGAA	CASSTPAGGLSGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	6	0	7	6	5	22	33	49	39	54		TCRBV12-03,TCRBV12-04												CASSTPAGGLSGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCAGGGACAATCTCTTTAGAAAAACTGTTTTTTGGCAGT	CASSPGTISLEKLFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	6	8	4	9	22	33	43	37	52		TCRBV12-03,TCRBV12-04												CASSPGTISLEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGTGGGGGGAGGAGGGTTCGAGACCCAGTACTTCGGGCCA	CASSVVGGGGFETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	9	1	5	6	10	22	33	45	39	55		TCRBV12-03,TCRBV12-04				01,02								CASSVVGGGGFETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGCGGGGGGCAGTGCAGATACGCAGTATTTTGGCCCA	CASRAGGSADTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	1	4	1	5	22	33	42	34	47		TCRBV12-03,TCRBV12-04												CASRAGGSADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATTAGCGGGGGTAGGAGAGACCCAGTACTTCGGGCCA	CASSELAGVGETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	2	4	4	4	22	34	47	38	51		TCRBV12-03,TCRBV12-04												CASSELAGVGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGCTAGACTAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.1954493229107863E-4		49	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	8	0	2	2	22	39	47	41	49		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTCCCCCGGGACAGGGGTTTACTGTCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.1954493229107863E-4		58				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	2	5	9	23	37	52	42	61	TCRBV09,TCRBV12	TCRBV09-01,TCRBV12-03,TCRBV12-04,TCRBV12-05												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACAGGGGGTTTAACAGATACGCAGTATTTTGGCCCA	CATTGGLTDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	1	3	0	4	24	-1	41	34	45		TCRBV24-01,TCRBV24-or09_02												CATTGGLTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCTTAGGCAGGGGAGGCTAAGGACCTTCGGTTCG		Out	VDJ	1	18	1.1954493229107863E-4		38	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	4	2	14	6	9	24	35	47	41	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGATGELFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	9	0	4	3	1	24	36	46	39	47		TCRBV24-01,TCRBV24-or09_02												CASSLGGATGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAAGGCAGGGTTGGGTGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRRQGWVSGANVLTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	3	1	4	7	23	34	43	38	50	TCRBV06,TCRBV10													CASRRQGWVSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACCCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSENPLNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	3	7	0	1	4	23	38	41	39	45		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENPLNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATATCAGTGCCCTCTGGAAACACCATATATTTTGGAGAG	CAISVPSGNTIYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	4	5	0	3	4	23	30	36	33	40	TCRBV06,TCRBV10													CAISVPSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCCGGGCCGGCGGGGGCCGGTAAATGAGCAGTTCTTCGGGCCA	CAISDPGRRGPVNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	2	7	11	6	23	35	53	46	59	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDPGRRGPVNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGTCGGGTTTCGCGACGCTGAAGCTTTCTTTGGACAA	CASSLVGFRDAEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	6	1	10	18	34	39	35	49	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02				01,02								CASSLVGFRDAEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGAAGCTTTTGGCCGGACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	1.1954493229107863E-4		43	unresolved						TCRBJ01	TCRBJ01-01	01	2	1	7	1	6	0	18	32	-1	38	42	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCCGGGGACAGGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSSRGQGSNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	6	4	2	18	31	45	35	47	TCRBV07,TCRBV11													CASSSRGQGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTCGCAGGGGGAAAGCACTGAAGCTTTCTTTGGACAA	CASSSQGESTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	4	2	4	18	31	40	33	44	TCRBV11,TCRBV12													CASSSQGESTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTGCTGGGCAGGGGCAGGGAGACCCAGTACTTCGGGCCA	CASSLLGRGRETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	6	4	18	32	44	38	48	TCRBV05,TCRBV11													CASSLLGRGRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTCCTTATAGCGGGGGGCGTCGATGAGCAGTTCTTCGGGCCA	CASSFLIAGGVDEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	8	8	5	20	31	49	39	54	TCRBV11,TCRBV23													CASSFLIAGGVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGGTGGCGGTTGCTCACAGATACGCAGTATTTTGGCCCA	CASSLGWRLLTDTQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	48	TCRBV05						TCRBJ02	TCRBJ02-03	01	2	5	3	2	0	11	19	-1	37	33	48		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWRLLTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMCTGTATCTCTGYGCCAGCAGCAGATCACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSRSQGNTEAFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	1	5	0	19	31	-1	36	42	TCRBV05,TCRBV23													CASSRSQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTTTGGAAGGGTTGGCTCTATGGCTACACCTTCGGTTCG	CASSFWKGWLYGYTF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	3	5	3	4	5	6	22	36	45	41	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFWKGWLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGCTTTTTTACATCCTATGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	1.1954493229107863E-4		46	unresolved						TCRBJ01	TCRBJ01-02	01	3	0	9	4	13	0	22	36	-1	49	52	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGGAGCGGGGGACAACAATGAGCAGTTCTTCGGGCCA	CASSLGAGDNNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	5	4	3	22	35	47	39	50	TCRBV07,TCRBV11													CASSLGAGDNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGTAGCGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSLVAGDQETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	5	2	0	3	0	22	35	-1	38	47	TCRBV07,TCRBV11													CASSLVAGDQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCCGGGGACCTCCAATGAGCAGTTCTTCGGGCCA	CASSPGTSNEQFF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	6	0	7	6	4	3	24	35	44	39	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTSNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAGCGCACGGGACAGGGGGCCACCAAGAGACCCAGTACTTCGGGCCA	CASSEAHGTGGHQETQYF	In	VDJ	1	18	1.1954493229107863E-4	1.3934045517882026E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	0	0	10	1	24	35	57	45	58	TCRBV02,TCRBV21													CASSEAHGTGGHQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCGGGACAGGGGGCCTTGTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.1954493229107863E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	0	2	2	6	23	33	47	35	53	TCRBV09,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCTCACAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPHRSYNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	1	5	0	26	37	-1	42	47	TCRBV09,TCRBV12													CASSPHRSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGGACAGGGCCAACTCGGGTATGGCTACACCTTCGGTTCG	CASRGQGQLGYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	5	0	10	26	-1	46	37	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGQGQLGYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCACAGGGTCGGGAAACACCATATATTTTGGAGAG	CASRSTGSGNTIYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	4	4	3	26	37	47	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSTGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGQMNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	0	0	1	26	-1	47	42	48	TCRBV12,TCRBV21													CASSLGQMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAGCGGGGGGCAGGGCACAGATACGCAGTATTTTGGCCCA	CASSFSGGQGTDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	1	0	4	26	-1	50	40	54		TCRBV12-03,TCRBV12-04												CASSFSGGQGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGGGTGAGGCTTTGGGGCTACACCTTCGGTTCG	CASSRVRLWGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	8	4	6	23	36	44	40	50	TCRBV01,TCRBV04													CASSRVRLWGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCAGTCAGGGAGTGGCCTCTAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	1.2618631741836078E-4		53							TCRBJ01	TCRBJ01-02	01	3	4	3	4	6	12	24	38	49	44	61	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02			TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCAGGCGGGGACAAGAGACCCAGTACTTCGGGCCA	CASTRRGQETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	7	3	2	4	1	26	36	46	40	47		TCRBV03-01,TCRBV03-02												CASTRRGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTGGGGTAGTGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPWGSGGATDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	0	2	11	1	26	39	57	50	58		TCRBV03-01,TCRBV03-02												CASSPWGSGGATDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGGACAACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARDNANTGELFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	0	2	3	26	34	42	36	45		TCRBV20-01,TCRBV20-or09_02												CSARDNANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTACCCCATGGGACGGTGGGCACTGAAGCTTTCTTTGGACAA	CSAVPHGTVGTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	7	4	10	6	26	34	49	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVPHGTVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACACGAGGAAGGGCAGAGACCCAGTACTTCGGGCCA	CSARTRGRAETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	5	3	4	9	1	26	38	51	47	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTRGRAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTAACCGGGACCTTCCGACCGGGGAGCTGTTTTTTGGAGAA	CSARPNRDLPTGELFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV20						TCRBJ02	TCRBJ02-02	01	2	0	7	5	7	6	26	38	50	45	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPNRDLPTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGGAGAGACCCAGTACTTCGGGCCA	CSAREGGETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	4	0	0	26	-1	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSAREGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTGGTGGGGGAGAGGGATCACCCCTCCACTTTGGGAAC	CSARDPGGGEGSPLHF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV20						TCRBJ01	TCRBJ01-06	01	0	6	1	10	7	7	26	40	52	47	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPGGGEGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTCGGTTCGCCGAGACCGGGGAGCTGTTTTTTGGAGAA	CSARDLRFAETGELFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	5	4	9	26	40	47	44	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLRFAETGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCGACTAAACGTGTTGGAGCAGTTCTTCGGGCCA	CSARARLNVLEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	9	10	3	9	26	39	47	42	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARARLNVLEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCGGGGGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASRRGSSYNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	0	3	2	26	37	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSASRRGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTACCGGGACAGGGGACAACTCCCTTGTCAGCTTTCTTTGGACAA	CSVPGQGTTPLSAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	2	10	4	14	26	33	47	37	61		TCRBV20-01,TCRBV20-or09_02												CSVPGQGTTPLSAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGATCGGGACAGCGTCTTTTCTGGAAACACCATATATTTTGGAGAG	CASSDRDSVFSGNTIYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	1	4	7	22	34	45	38	52		TCRBV12-03,TCRBV12-04												CASSDRDSVFSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCATCCTGTCTAGGACAGGGGGCGAGTAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	1.2618631741836078E-4		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	0	1	9	7	23	33	53	42	60	TCRBV24,TCRBV27													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCGGGAGGAGGGGCTTAAATAGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	1.2618631741836078E-4		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	8	1	8	4	15	24	31	42	35	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGGAYNEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	2	2	0	24	36	-1	38	46		TCRBV24-01,TCRBV24-or09_02												CASSPGGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACAGGGAGGGGCTACACCTTCGGTTCG	CASSSTGRGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	8	2	3	24	36	45	38	48		TCRBV24-01,TCRBV24-or09_02												CASSSTGRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGGACTAGCGGGGGTCGAGCAGTACTTCGGGCCG	CASSSGLAGVEQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	6	2	1	24	36	52	38	53		TCRBV24-01,TCRBV24-or09_02												CASSSGLAGVEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCAGTTTAAGGCCTGCCGCCAGCTACGAGCAGTACTTCGGGCCG	CASSLRPAASYEQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	6	4	5	3	14	0	24	36	-1	50	53	TCRBV24,TCRBV27,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPAASYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGACAGGGGAGGCTACACCTTCGGTTCG	CASSLSDRGGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	8	5	1	24	36	50	41	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSDRGGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGAAGTTCGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSEKFGGGTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	2	4	8	3	23	35	49	43	52	TCRBV06,TCRBV10					01,02								CASSEKFGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCWMCCAGACATCTRTGTACYTSTGTGCCAGCAGTTACTCGCAGGACACCATGAACACTGAAGCTTTCTTTGGACAA	CASSYSQDTMNTEAFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	0	3	3	23	40	48	43	51	TCRBV06,TCRBV28													CASSYSQDTMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGGGAGGTCCTTAGCTAATGAGCAGTTCTTCGGGCCA	CASSLGRSLANEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	10	1	7	0	9	18	-1	39	34	48	TCRBV05,TCRBV07													CASSLGRSLANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATCTCTGTACCTAGAACTAGATCTGGGGGCCAAGTCCGATGAAGGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	1.2618631741836078E-4		62				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	14	6	0	1	16	16	18	21	43	37	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCGCCTGCGGGGTGAAAAACTGTTTTTTGGCAGT	CASSPRLRGEKLFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	3	7	8	0	18	30	-1	38	44	TCRBV07,TCRBV11													CASSPRLRGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCTAAGGGACAGGGGGCAAATGAGCAGTTCTTCGGGCCA	CASSSKGQGANEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	7	4	1	18	31	47	35	48	TCRBV07,TCRBV11													CASSSKGQGANEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAAAACCTCTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASKTSSGQETQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	5	1	6	0	19	29	-1	35	42		TCRBV05-06,TCRBV05-07				01,02								CASKTSSGQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCAAGACTAGGCTTAGGTGAGCAGTTCTTCGGGCCA	CASSSRLGLGEQFF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	8	9	3	7	19	32	41	35	48		TCRBV05-06,TCRBV05-07				01,02								CASSSRLGLGEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTTACCGGGGAAGGGAACTATGGCTACACCTTCGGTTCG	CASSLVTGEGNYGYTF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	48	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	3	2	6	5	19	33	44	39	49		TCRBV05-06,TCRBV05-07												CASSLVTGEGNYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCCTTGGATGGCAGGGGGTTCGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGLGWQGVRGNQPQHF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	60	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	1	2	11	6	15	31	49	42	55		TCRBV12-03,TCRBV12-04												CASSLGLGWQGVRGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCATTCGGTGGGGGACAGATACGCAGTATTTTGGCCCA	CASIRWGTDTQYF	In	VDJ	1	19	1.2618631741836078E-4	1.4708159157764358E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	6	6	1	3	6	0	23	33	-1	39	44	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIRWGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGTCCTGGACAACCAAGAGACCCAGTACTTCGGGCCA	CASSVVLDNQETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	6	0	9	0	26	37	-1	46	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVVLDNQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACACAGGGCCCCGGGGTGGCTACACCTTCGGTTCG	CASSHTGPRGGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	7	3	8	26	38	47	41	55		TCRBV12-03,TCRBV12-04												CASSHTGPRGGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTGAGGGCGATGAACACTGAAGCTTTCTTTGGACAA	CASSLVRAMNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	0	0	1	3	26	42	48	43	51		TCRBV12-03,TCRBV12-04												CASSLVRAMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGCAGGCCCCTACGAGCAGTACGTCGGGCCG	CASSQGAGPYEQYV	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	17	3	17	26	42	49	45	66		TCRBV03-01,TCRBV03-02												CASSQGAGPYEQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAAGCAGGGAGACGCTGGAAACACCATATATTTTGGAGAG	CASSLKQGDAGNTIYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	4	3	2	5	5	26	39	49	44	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKQGDAGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACCGACTTCATACCCTATATGGCTACACCTTCGGTTCG	CSANRLHTLYGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	5	5	10	26	34	43	39	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSANRLHTLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGTCTAGCGGGGGTCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	1.328277025456429E-4		46	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	2	5	2	26	34	49	39	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSARVGENTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	6	1	1	1	1	26	39	45	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGGGGGGGTTCACAGATACGCAGTATTTTGGCCCA	CSARLGGFTDTQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	2	2	2	26	38	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSARLGGFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGACGGAGGGGGAAGTCAGCCCCAGCATTTTGGTGAT	CSASRDGGGSQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	5	1	6	9	3	26	37	52	46	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRDGGGSQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGGACTAGCGGGGGGGTGACGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.328277025456429E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	0	3	3	5	26	37	55	40	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCGGGCCTAGGTTACAATGAGCAGTTCTTCGGGCCA	CSAPPGLGYNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	8	0	4	5	6	26	35	44	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPPGLGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTCTAGCGGGGGGTACCGGGGAGCTGTTTTTTGGAGAA	CSAGLAGGTGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	5	3	1	26	35	49	38	50		TCRBV20-01,TCRBV20-or09_02												CSAGLAGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGAGCCACCCGGGGGTTGGCTACACCTTCGGTTCG	CASSQESHPGVGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	2	7	8	1	23	40	54	48	55	TCRBV01,TCRBV04													CASSQESHPGVGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCACCGTCTGCACAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	1.328277025456429E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	6	3	10	1	22	35	48	45	49		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGTCTTTCGCCGGGACAGGGGGCTTCGGGCGGGGAGCTGTTTTTTGGAGAA	CASLSPGQGASGGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	0	0	7	9	6	23	31	52	40	58	TCRBV24,TCRBV27													CASLSPGQGASGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACATGGGCTATGGCTACACCTTCGGTTCG	CATSDMGYGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	9	4	3	0	24	38	-1	41	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDMGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGTATCCTCCGGCGGTGGCTACACCTTCGGTTCG	CATSDVSSGGGYTF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	7	10	0	24	39	-1	49	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDVSSGGGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTGGGGACAGGGGGCGCCGGAATCAGCCCCAGCATTTTGGTGAT	CATSGGDRGRRNQPQHF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	0	4	3	5	24	37	52	40	57		TCRBV24-01,TCRBV24-or09_02												CATSGGDRGRRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACCCCCCGGCCCAATGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.328277025456429E-4		44	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	9	0	7	9	7	24	36	48	45	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGCCGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGSTGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	4	5	0	24	36	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CASSLAGSTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTACAACGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSTTTGGNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	1	5	0	23	35	-1	40	49	TCRBV06,TCRBV10													CASSTTTGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCWSCCARACAKCTKTGTACTTSTGTGCCAGCAGTGAGCCGAGGACAGGGTAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	1.328277025456429E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	2	7	2	23	35	50	42	52	TCRBV06,TCRBV22													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGTAGGGACCGTCTACCGACCAAGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	1.328277025456429E-4		59							TCRBJ01	TCRBJ01-05	01	0	0	7	7	6	16	18	35	46	41	62	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05			TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAATAGCAAAATTCTACAATGAGCAGTTCTTCGGGCCA	CASSPIAKFYNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	3	4	6	18	30	38	34	44	TCRBV07,TCRBV11					01,02								CASSPIAKFYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTACGGGCTTATGGACACTGAAGCTTTCTTTGGACAA	CASSLAYGLMDTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48							TCRBJ01	TCRBJ01-01	01	0	8	0	3	4	6	18	35	43	39	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAYGLMDTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTGGGGGGGCAGGGCAGCGAGACCCAGTACTTCGGGCCA	CASSLGGQGSETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	3	9	0	5	0	9	18	-1	39	32	48	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLGGQGSETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGTAAAGTCCAAGCGGGGGGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.328277025456429E-4		52	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	1	3	9	2	19	35	53	44	55	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGSYNSPLHF	In	VJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	1	0	0	0	0	1	19	-1	35	-1	36	TCRBV07,TCRBV11													CASSLGSYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTCGTTTACACCAGGAACACTGAAGCCTTCTTTGGACAA	CASSLVYTRNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	14	11	12	19	31	46	42	58		TCRBV05-06,TCRBV05-07												CASSLVYTRNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGTCCCGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLVPGNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	2	5	0	19	33	-1	38	43	TCRBV05,TCRBV11													CASSLVPGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCCTCTTGGGCGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSPPLGRWNTEAFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	5	8	0	1	9	4	24	36	49	45	53	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPLGRWNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCTTACTATTGGGAGCTACGGAGAGACCCAGTACTTCGGGCCA	CASSLTIGSYGETQYF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	2	4	10	6	23	34	49	44	55	TCRBV02,TCRBV12													CASSLTIGSYGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGGAGAAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGESTGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	11	2	4	0	4	23	-1	39	36	43	TCRBV02,TCRBV12													CASSGESTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTACCAGCAGCGCCACTGACTCGTACACCGGGGAGCTGTTTTTTGGAGAA	CTSSATDSYTGELFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	2	10	3	5	3	23	36	45	41	48	TCRBV09,TCRBV21					01,02								CTSSATDSYTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCWMYCAGACMTCTSTGTACTTCTGTGCCAGCAGTTGGGGAAGGGGGAACCCCTACAATGAGCAGTTCTTCGGGCCA	CASSWGRGNPYNEQFF	In	VDJ	1	20	1.328277025456429E-4	1.5482272797646694E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	2	6	4	28	40	52	46	56	TCRBV06,TCRBV27													CASSWGRGNPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACGATTAGGGGGCCTCACAGATACGCAGTATTTTGGCCCA	CASRRLGGLTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	2	6	2	26	37	50	43	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRLGGLTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGTGGACTGCCTCCACAGATACGCAATATTTTGGCCCA	CASSSWTASTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	10	15	5	18	26	37	47	42	65		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSSWTASTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGCTACAGGGAGCACTGAAGCTTTCTTTGGACAA	CASRATGSTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	4	4	2	26	37	47	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRATGSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGACAGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPTGFTGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	4	2	2	26	38	47	40	49		TCRBV12-03,TCRBV12-04												CASSPTGFTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACGCACGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSLTHGLNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	8	0	0	6	0	26	41	-1	47	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTHGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACGCCCCCCTGACAGGGGGAATGAAGCTTTCTTTGGACAA	CASRRPPDRGNEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	7	10	2	24	35	54	45	56	TCRBV06,TCRBV10													CASRRPPDRGNEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGACCTAGCGGATCACAGATACGCAGTATTTTGGCCCA	CASRT*RITDTQYF	Stop	VDJ	1	21	1.3946908767292507E-4		42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	5	2	3	2	24	35	45	38	47	TCRBV06,TCRBV10					01,02								CASRT*RITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCATCCCGGGACAGGGGGGCTATGGCTACACCTTCGGTTCG	CASIPGQGGYGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	4	4	1	24	34	49	38	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASIPGQGGYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGAGCGGCTACACCTTCGGTTCG	CASSQTGSGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	8	0	3	26	-1	47	41	50		TCRBV03-01,TCRBV03-02												CASSQTGSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCTCGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSQASGAGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	2	6	5	0	26	40	-1	45	51		TCRBV03-01,TCRBV03-02												CASSQASGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGTTTGACAGCTGAAGGCACTGAAGCTTTCTTTGGACAA	CASSPRLTAEGTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	4	7	7	26	39	51	46	58		TCRBV03-01,TCRBV03-02												CASSPRLTAEGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCAACCTCCCTAGGCGTTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	1.3946908767292507E-4		55	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	4	8	0	10	6	26	39	53	49	59		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGACAGCCAGAGGGGCTACACCTTCGGTTCG	CASSLDSQRGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	8	1	7	26	39	46	40	53		TCRBV03-01,TCRBV03-02												CASSLDSQRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCGGGCGGGGGGGCCCCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSPGRGGPLYNEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	3	6	6	26	37	52	43	58		TCRBV03-01,TCRBV03-02												CASSPGRGGPLYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCACAGGGCTACGGGCTTGAAGCTTTCTTTGGACAA	CSAPQGYGLEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	7	3	9	26	34	43	37	52		TCRBV20-01,TCRBV20-or09_02												CSAPQGYGLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGACTAGCGGGGGAACTCAATGAGCAGTTCTTCGGGCCA	CSARLAGELNEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	6	0	4	26	-1	48	38	52		TCRBV20-01,TCRBV20-or09_02												CSARLAGELNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGAGGATTGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CSARERIGSYNSPLHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	11	1	0	0	5	26	-1	44	40	49		TCRBV20-01,TCRBV20-or09_02												CSARERIGSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCCGGGCCTTCTACGGCAGCCCCAGCATTTTGGTGAT	CSARGPGLLRQPQHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	8	0	7	4	9	26	39	47	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGPGLLRQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTCAGAGGTCCTGAGATGGCTACACCTTCGGTTCG	CSARSQRS*DGYTF	Stop	VDJ	1	21	1.3946908767292507E-4		42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	1	6	5	7	26	38	47	43	54		TCRBV20-01,TCRBV20-or09_02												CSARSQRS*DGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCACCCTATGACACTAAGGGGCTATGGCTACACCTTCGGTTCG	CSASHPMTLRGYGYTF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	2	4	16	0	26	37	-1	53	58		TCRBV20-01,TCRBV20-or09_02												CSASHPMTLRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGACAGGAGCGGGTGAAGCTTTCTTTGGACAA	CSAPRTGAGEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	7	4	6	26	35	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSAPRTGAGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAGGACAGGGACGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGRYTGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	3	2	5	23	36	46	38	51	TCRBV01,TCRBV04													CASSPGQGRYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGTTGGGACTTAGCAGCACAGATACGCAGTATTTTGGCCCA	CASRLGLSSTDTQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	3	4	22	33	42	36	46		TCRBV12-03,TCRBV12-04				01,02								CASRLGLSSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTCTCGGGGGCCAGCGGGAGACCCAGTACTTCGGGCCA	CASSFLGGQRETQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	6	0	5	4	6	22	36	46	40	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGGQRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCATCCTAGTTTGGACAGGGGGTAATGAAGCTTTCTTTGGACAA	CAILVWTGGNEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	1	7	9	3	22	29	48	38	51	TCRBV09,TCRBV12													CAILVWTGGNEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGAGGGGGGACAGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	1.3946908767292507E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	5	0	5	0	24	35	-1	40	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTACGGTACGGGCCCGGGGAGCTGTTTTTTGGAGAA	CATSDLRYGPGELFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	TCRBV24						TCRBJ02	TCRBJ02-02	01	1	8	0	6	7	0	24	41	-1	48	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLRYGPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATACAGCCAGACGGTGCAGTACTTCGGGCCG	CASSEYSQTVQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	9	1	9	23	38	43	39	52		TCRBV06-01,TCRBV06-08												CASSEYSQTVQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCTGGTGGGAGCTTCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	1.3946908767292507E-4		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	2	10	8	3	23	35	48	43	51	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCATCCCTCTTGAGGGGGGCCAGTAGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	1.3946908767292507E-4		50	unresolved						TCRBJ02	TCRBJ02-03	01	7	5	1	4	9	8	23	33	48	42	56	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACCGGGGCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAISEPGPSSYNEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48							TCRBJ02	TCRBJ02-01	01	2	7	0	0	2	4	23	38	45	40	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEPGPSSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCAGCAGTTACTACCGCGTGGCAGGCCAAGAGACCCAGTACTTCGGGCCA	CASSYYRVAGQETQYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	1	4	4	1	9	0	26	42	-1	51	55	TCRBV06,TCRBV24			TCRBD01,TCRBD02										CASSYYRVAGQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTGGAAACAGGGAGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	21	1.3946908767292507E-4		41				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	8	4	3	18	31	41	35	44	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGATTAGGGGCAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRLGAGSSYNEQFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	48							TCRBJ02	TCRBJ02-01	01	1	4	3	0	3	2	18	34	42	37	44	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGAGSSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCCGGACAGGGGGGATCACCATATATTTTGGAGAG	CASSPRTGGITIYF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	1	9	4	3	19	31	45	35	48		TCRBV05-06,TCRBV05-07												CASSPRTGGITIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GARGACTCGGCCCTKTATCTYTGCGCCAGCAGCCCCTACAGAGCAATGAACACTGAAGCTTTCTTTGGACAA	CASSPYRAMNTEAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	0	4	5	19	31	39	35	44	TCRBV04,TCRBV05													CASSPYRAMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCACACCGGGCGCGTTCACCCCTCCACTTTGGGAAC	CASSEAHRARSPLHF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	0	8	0	9	5	3	23	40	49	45	52	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAHRARSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGACAGTATTGAACACTAAAGCTTTCTTTGGACAA	CASSETVLNTKAFF	In	VDJ	1	21	1.3946908767292507E-4	1.625638643752903E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	9	1	12	23	36	42	37	54	TCRBV09,TCRBV21													CASSETVLNTKAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGTACCCTCTSASWCRKCYGTGTAYKTCTGTGCCAGCAGTGAAAGACGTTAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSERR*NTGELFF	Stop	VDJ	1	21	1.3946908767292507E-4		45	unresolved						TCRBJ02	TCRBJ02-02	01	3	2	7	1	2	4	28	42	47	44	51	TCRBV06,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERR*NTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGYWCCCTCYCAGACATCTGTRTACTTCTGTGCCATCAGTGAGTCCGACTAGCGGGGGATCGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	1.3946908767292507E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	9	4	4	28	42	58	46	62	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCCCCCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSFPPAGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	6	6	6	0	26	40	-1	46	48		TCRBV12-03,TCRBV12-04				01,02								CASSFPPAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTTGGGAAGGAGGGACACCTGTCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSWEGGTPVLAKNIQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	57	unresolved						TCRBJ02	TCRBJ02-04	01	13	0	6	0	18	8	24	27	51	45	59	TCRBV22,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWEGGTPVLAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTACCGGACAGGCGGGTGGCTACACCTTCGGTTCG	CASSTGQAGGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	7	3	4	24	36	46	39	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSTGQAGGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTCCCCAGGGAGGTAATGAAAAACTGTTTTTTGGCAGT	CASSPQGGNEKLFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	1	4	5	0	24	36	-1	41	47	TCRBV06,TCRBV10													CASSPQGGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTTGGACAGGGTGGGACAGCCCCAGCATTTTGGTGAT	CASSLDRVGQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	7	1	5	24	37	46	38	51		TCRBV06-05,TCRBV06-06												CASSLDRVGQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGCTCGCGGAGGTCACAGATACGCAGTATTTTGGCCCA	CAIRLAEVTDTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	1	2	6	1	24	35	46	41	47	TCRBV06,TCRBV10													CAIRLAEVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATAAGTGAGGAACACTGAAGCTTTCTTTGGACAA	CASSQE*VRNTEAFF	Stop	VDJ	1	22	1.461104728002072E-4		45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	2	1	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02												CASSQE*VRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGGGGTGGAAACACTGAAGCTTTCTTTGGACAA	CASSQEGGGNTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	1	2	0	4	26	-1	49	43	53		TCRBV03-01,TCRBV03-02												CASSQEGGGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAACCGGGGGCTCTACACCTTCGGTTCG	CASSQDNRGLYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	6	0	10	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRGLYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSHGDTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	3	3	0	0	26	-1	-1	40	45		TCRBV03-01,TCRBV03-02												CASSHGDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGACAGCCGACCTACGAGCAGTACTTCGGGCCG	CASSRGQPTYEQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	2	1	4	26	39	47	40	51		TCRBV03-01,TCRBV03-02												CASSRGQPTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGGGGGCAAAGGACTATGGCTACACCTTCGGTTCG	CASSPGAKDYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	6	6	0	3	3	5	26	37	46	40	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAKDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATGGGGGACAGGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.461104728002072E-4		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	6	3	0	26	36	-1	39	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCCACCCAGGGGGGAAAAATACGCAGTATTTTGGCCCA	CASSHPGGKNTQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	7	4	5	20	32	43	36	48	TCRBV07,TCRBV11													CASSHPGGKNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCGAGCGAAGGGGATGAGCAGTTCTTCGGGCCA	CSAPSEGDEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	8	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAPSEGDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCCGGGAGAAATGGAGAGAACACTGAAGCTTTCTTTGGACAA	CSASGRNGENTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	2	1	3	9	26	34	43	37	52		TCRBV20-01,TCRBV20-or09_02												CSASGRNGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGACACTGAAGCTTTCTTTGGACAA	CSAREDTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	10	3	0	0	26	-1	-1	40	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTTGCCGGTCAGCCCCAGCATTTTGGTGAT	CSAREVAGQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	6	6	0	26	40	-1	46	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREVAGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCCGGGGGGAGATACTGAAGCTTTCTTTGGACAA	CSARGPGGDTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	5	3	4	26	39	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSARGPGGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGTTAGCGGGGGGTTCTTCGGGCCA	CSARGVSGGFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	15	4	0	26	39	-1	43	52		TCRBV20-01,TCRBV20-or09_02												CSARGVSGGFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTAGTGGGGGACACACCTACAATGAGCAGTTCTTCGGGCCA	CSARGSGGHTYNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	6	2	7	2	26	39	52	46	54		TCRBV20-01,TCRBV20-or09_02												CSARGSGGHTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCWSCCAGACMTMTSTGTACYWSTGTGCCAGCAGTTTAGACAGGGCGGGCGGAAACACCATATATTTTGGAGAG	CASSLDRAGGNTIYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	4	5	5	22	32	44	37	49	TCRBV06,TCRBV08													CASSLDRAGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCACCCGTATCCTGGGGGGAGAGACCCAGTACTTCGGGCCA	CATRILGGETQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	9	1	4	10	0	22	29	-1	39	45		TCRBV12-03,TCRBV12-04												CATRILGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATCCCCCAACACCCAGAAGATATGGCTACACCTTCGGTTCG	CATNPPTPRRYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	6	5	8	9	24	34	45	42	54		TCRBV24-01,TCRBV24-or09_02												CATNPPTPRRYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAAGGGAGGAACTGAAGCTTTCTTTGGACAA	CATSDKGGTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	1	5	3	1	24	38	47	41	48		TCRBV24-01,TCRBV24-or09_02												CATSDKGGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCAGGACTGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDPGLDSNQPQHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	1	10	0	3	3	24	39	47	42	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPGLDSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLWGSSYNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	6	1	0	4	2	24	36	45	40	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCACTACAAGAGGCCACTAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	22	1.461104728002072E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	7	3	9	4	2	12	23	33	39	35	51	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACGGGCTGGGAGGACACTGAAGCTTTCTTTGGACAA	CASSETGWEDTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	3	7	0	23	38	-1	45	51		TCRBV06-01,TCRBV06-08												CASSETGWEDTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAATCGCCTCCTATCAGGATGGCTACACCTTCGGTTCG	CASSEIASYQDGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	6	12	0	23	38	-1	50	54		TCRBV06-01,TCRBV06-08												CASSEIASYQDGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCGTCTAGCGAGGGCGATACCTATGGTCGTAAAGAGCAGTACTTCGGGCCG	CSAKPSSEGDTYGRKEQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	57	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	6	7	6	23	24	34	46	40	69		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKPSSEGDTYGRKEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGGTCAGGGCGGAAGGGAGACCCAGTACTTCGGGCCA	CASSGQGGRETQYF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	5	3	7	19	31	39	34	46	TCRBV07,TCRBV11													CASSGQGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTACCGGGACAGTAACACTGAAGCTTTCTTTGGACAA	CASSYRDSNTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	2	3	1	19	32	42	35	43	TCRBV07,TCRBV11													CASSYRDSNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGGTAACAGCAATTCACCCCTCCACTTTGGGAAC	CASSQEGNSNSPLHF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	5	7	5	1	18	35	44	40	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGNSNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGATGGGACAGGGGGTAAATGAGCAGTTCTTCGGGCCA	CASSLMGQGVNEQFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	7	3	2	18	32	46	35	48	TCRBV05,TCRBV11													CASSLMGQGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTGTGGGGGGAATCAACTGAAGCTTTCTTTGGACAA	CASSLWGESTEAFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	5	2	5	19	33	41	35	46	TCRBV07,TCRBV11													CASSLWGESTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGCTACAGGGCATTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRYRALNTGELFF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	1	4	4	19	31	41	35	45		TCRBV05-06,TCRBV05-07												CASSRYRALNTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCCAAGAGGGCAGGGAGAGCTATGGCTACACCTTCGGTTCG	CASSQEGRESYGYTF	In	VDJ	1	22	1.461104728002072E-4	1.7030500077411365E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	4	3	4	8	4	22	34	47	42	51	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGRESYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCGGCCCGGTCTAACTATGGCTACACCTTCGGTTCG	CASSAARSNYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	5	0	1	6	26	37	42	38	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSAARSNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGTCGTCCCGGACCCAAACTACGAGCAGTACTTCGGGCCG	CASSLGVVPDPNYEQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	51	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	6	1	3	0	16	26	-1	45	40	61		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVVPDPNYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGGTCAAGCGGGGGCGGGACAGATACGCAGTATTTTGGCCCA	CARSSGGGTDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	6	2	3	7	4	26	31	46	38	50	TCRBV12,TCRBV21													CARSSGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTCGGGACTTTCAAGGAGACCCAGTACTTCGGGCCA	CASSQDFGTFKETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	5	4	6	26	43	53	47	59		TCRBV03-01,TCRBV03-02				01,02								CASSQDFGTFKETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAGGGACAGGAGCTTCACCCCTCCACTTTGGGAAC	CSAQGTGASPLHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	4	9	4	3	26	34	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSAQGTGASPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGTCGGGACAGGGTTACAATGAGCAGTTCTTCGGGCCA	CSAPSGQGYNEQFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	4	6	1	26	34	49	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPSGQGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTATAGCGGGGGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CSAPIAGGLQETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	1	5	3	26	34	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSAPIAGGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGGAGAACTATGGCTACACCTTCGGTTCG	CSARTGENYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	2	0	2	26	-1	45	37	47		TCRBV20-01,TCRBV20-or09_02												CSARTGENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGCGGGGCTCGGGGAGAGACCCAGTACTTCGGGCCA	CSASSGARGETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	3	4	0	7	26	-1	45	37	52		TCRBV20-01,TCRBV20-or09_02												CSASSGARGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGGGGCCTAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	1.5275185792748935E-4		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	3	1	4	26	37	45	38	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTCCGGGACAGGGGGCATTGAACACTGAAGCTTTCTTTGGACAA	CSASGPGQGALNTEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	0	6	2	26	37	55	43	57		TCRBV20-01,TCRBV20-or09_02												CSASGPGQGALNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATACAGGGGAAACTGAAGCTTTCTTTGGACAA	CSAHTGETEAFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	5	3	2	26	35	45	38	47		TCRBV20-01,TCRBV20-or09_02												CSAHTGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTATTACCTGGGGGCTTGGATCAGCCCCAGCATTTTGGTGAT	CSVLPGGLDQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	6	0	5	8	4	26	33	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSVLPGGLDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTCTTTCTCACACCGGGACACCTGAGCCCCAGCATTTTGGTGAT	CASSLSHTGTPEPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	6	8	12	4	25	37	55	49	59	TCRBV27,TCRBV28													CASSLSHTGTPEPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCACTGGACAACTCAAGGGGATGAGCAGTTCTTCGGGCCA	CASSHWTTQGDEQFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	8	4	10	22	34	43	38	53		TCRBV12-03,TCRBV12-04												CASSHWTTQGDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCAGCCCTAACTATGGCTACACCTTCGGTTCG	CASSSSPNYGYTF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	4	4	5	0	1	2	23	36	40	37	42	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSPNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGTGGACAAACAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	1.5275185792748935E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	5	3	4	24	39	47	42	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGAAACGGGACTAGGTGGGTATGAGCAGTTCTTCGGGCCA	CATETGLGGYEQFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	8	8	5	6	24	33	46	38	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATETGLGGYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCCTGCGGGATCGGCTAAACTGTTTTTTGGCAGT		Out	VDJ	1	23	1.5275185792748935E-4		37	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	7	3	11	4	6	24	33	43	37	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAATAACCGGGGGAGGTCAGCCCCAGCATTTTGGTGAT	CASRITGGGQPQHF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	2	6	6	3	24	35	47	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASRITGGGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCTAGCGGGGCCACAAGAGACCCAGTACTTCGGGCCA	CASSLALAGPQETQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	2	1	3	18	35	45	36	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALAGPQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGCCCAGGTTAGAACTCACAGATACGCAGTATTTTGGCCCA	CASSLPRLELTDTQYF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	4	2	3	8	18	32	39	35	47	TCRBV07,TCRBV11													CASSLPRLELTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTATCCGGACAGGGCAAATAGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	23	1.5275185792748935E-4		61				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	3	0	3	10	19	34	45	37	55	TCRBV07,TCRBV11	TCRBV07-09,TCRBV11-01												X+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCAGCTGTGTATTTTTGTGCCAGCAGATATTTTAGGAAATATGCGGGACTAGCAAATGACGGGGAGCTGTTTTTTGGAGAA	CASRYFRKYAGLANDGELFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	60	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	7	7	18	6	15	26	53	44	59		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRYFRKYAGLANDGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGGGGACTCRGCYKTGTATYTCTGTGCCAGCAGCGTCGGGGAAGGAACTGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	1.5275185792748935E-4		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	5	0	12	23	-1	42	37	54	TCRBV09,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCATGGGCAGCGAAAGACTTCGGTTTTTTGGCAGT	CASMGSERLRFF	In	VDJ	1	23	1.5275185792748935E-4	1.78046137172937E-4	36	unresolved						TCRBJ01	TCRBJ01-04	01	6	8	0	16	1	14	23	33	38	34	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMGSERLRFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAAACAAAATGAAAAACTGTTTTTTGGCAGT	CASRKQNEKLFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	6	5	3	1	26	37	43	40	44		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRKQNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGCGGGTGGCTCGGGCGAGCAGTACGTCGGGCCG	CASSPAGGSGEQYV	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	17	4	20	26	37	46	41	66		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPAGGSGEQYV+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGGACTCGACAGGAGCAATTCACCCCTCCACTTTGGGAAC	CASSVGLDRSNSPLHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	4	7	10	3	26	37	53	47	56	TCRBV12,TCRBV21													CASSVGLDRSNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCCCAAGCGGGGGTTGGGGAGACCCAGTACTTCGGGCCA	CASSPPQAGVGETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	2	5	8	5	26	38	54	46	59		TCRBV12-03,TCRBV12-04												CASSPPQAGVGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGAACAGGGGTTGGAGAGACCCAGTACTTCGGGCCA	CASSPGTGVGETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	4	6	4	26	38	51	44	55		TCRBV12-03,TCRBV12-04												CASSPGTGVGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCTCGGGGTCCGCACAGATACGCAGTATTTTGGCCCA	CASSLALGVRTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	1	3	3	26	43	51	46	54		TCRBV12-03,TCRBV12-04												CASSLALGVRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGATCGGGGGGGGCCGTGATGAGCAGTTCTTCGGGCCA	CASSQEIGGGRDEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	8	3	6	26	43	54	46	60		TCRBV03-01,TCRBV03-02												CASSQEIGGGRDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCGGCGGGTTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	1.593932430547715E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	4	0	4	3	26	42	51	46	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTACGGCAAGCTATGGCTACACCTTCGGTTCG	CASSQVTASYGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	9	0	4	4	3	26	42	49	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVTASYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGAAGGGACTGAAGCTTTCTTTGGACAA	CASSQVEGTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	5	3	5	4	0	26	42	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVEGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGACTTCAAGAGACCCAGTACTTCGGGCCA	CASSLGLQETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	2	1	1	26	39	46	40	47		TCRBV03-01,TCRBV03-02				01,02								CASSLGLQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGACAGGGCACACAGATACGCAGTATTTTGGCCCA	CSAKTGHTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	3	2	26	34	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSAKTGHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDRGNTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	1	2	0	26	34	-1	36	46		TCRBV20-01,TCRBV20-or09_02												CSARDRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGACAGGGGAATCCTACGAGCAGTACTTCGGGCCG	CSARDPTGESYEQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	1	3	2	26	40	51	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDPTGESYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCTTAGGGAAGCCCTCCAAGAGACCCAGTACTTCGGGCCA	CSARGLREALQETQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	0	8	1	6	6	26	39	49	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGLREALQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTGGCCCTCGGGAGCTATGGCTACACCTTCGGTTCG	CSASLALGSYGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	2	4	9	0	26	37	-1	46	52		TCRBV20-01,TCRBV20-or09_02												CSASLALGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAAGGGGCGCGGGGACTGAAGCTTTCTTTGGACAA	CSARTRGAGTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	5	10	0	26	37	-1	47	53		TCRBV20-01,TCRBV20-or09_02												CSARTRGAGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCAGGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	1.593932430547715E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	0	3	2	26	35	42	38	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGGACAGGGTATGGCTACACCTTCGGTTCG	CSAPGTGYGYTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	5	3	0	26	35	-1	38	47		TCRBV20-01,TCRBV20-or09_02												CSAPGTGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGCGGGGGCCTCTACGAGCAGTACTTCGGGCCG	CSAPSGGLYEQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	2	3	3	3	26	35	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPSGGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGGGGGGGATCAGCCCCAGCATTTTGGTGAT	CSAEGGDQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	5	3	0	26	35	-1	38	45		TCRBV20-01,TCRBV20-or09_02												CSAEGGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGACGGGGATCAGCCCCAGCATTTTGGTGAT	CSAVDGDQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	5	5	0	26	35	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSAVDGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCTCGAGTGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLSSAGTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	1	8	0	23	36	-1	44	48	TCRBV01,TCRBV04					01,02								CASSLSSAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTGGGTCGATTCGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSWVDSGSTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	8	3	0	9	0	22	35	-1	44	49		TCRBV12-03,TCRBV12-04												CASSWVDSGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCAGGCTTACAGGGGTATACAGGGCGGATGAAAAACTGTTTTTTGGCAGT	CASSRLTGVYRADEKLFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	6	7	12	23	34	48	41	60	TCRBV24,TCRBV27													CASSRLTGVYRADEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCACAGGGACATCGCAGATACGCAGTATTTTGGCCCA	CATSHRDIADTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	4	4	3	24	36	46	40	49		TCRBV24-01,TCRBV24-or09_02												CATSHRDIADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGGCTCGGAGGAATTGGGTTACAATGAGCAGTTCTTCGGGCCA	CATSDFGSEELGYNEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	10	1	4	6	8	24	41	52	47	60		TCRBV24-01,TCRBV24-or09_02												CATSDFGSEELGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGGGGGCCATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	1.593932430547715E-4		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	0	6	3	1	24	36	46	39	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGACGGTGGAACACTGAAGCTTTCTTTGGACAA	CASGRWNTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	1	7	1	2	4	24	31	37	33	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRWNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCTAGCAGGAGTGGCAACCTATCCTACGAGCAGTACGTCGGGCCG	CASRSGNLSYEQYV	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	13	4	4	17	3	28	24	29	36	32	64	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSGNLSYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACTGCTGGAGGTTCCAATGAGCAGTTCTTCGGGCCA	CATAGGSNEQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	10	1	6	5	3	23	30	40	35	43	TCRBV06,TCRBV10													CATAGGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAAGAGGGACAAACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASKEGQTSNQPQHF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	6	0	4	3	23	33	43	37	46	TCRBV06,TCRBV10													CASKEGQTSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCGTTAACAGGGAAAAGCAGTTCTTCGGGCCA	CASSVNREKQFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	11	5	3	23	34	45	39	48	TCRBV06,TCRBV10													CASSVNREKQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGCCTGGGACAGGGGACGAGCAGTACGTCGGGCCG	CASRPGTGDEQYV	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	17	4	12	23	34	48	38	60	TCRBV06,TCRBV10													CASRPGTGDEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCGGGGGACAGGGGGACACTGAAGCTTTCTTTGGACAA	CAISGGQGDTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	3	3	0	23	34	-1	37	48	TCRBV06,TCRBV10													CAISGGQGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTCCACCTGGGGCGATTGGGAAAGCTTTCTTTGGACAA	CASSPPGAIGKAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	9	6	8	26	38	49	44	57	TCRBV06,TCRBV10													CASSPPGAIGKAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTCACAGGGGAGGCGGGAAACACCATATATTTTGGAGAG	CASSFTGEAGNTIYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	2	4	1	5	18	32	40	33	45	TCRBV05,TCRBV07													CASSFTGEAGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGTACGGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVRGSGANVLTF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	3	1	3	1	18	30	38	33	39	TCRBV07,TCRBV11													CASSVRGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGAAGGACAGGGCAGTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	1.593932430547715E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	3	1	6	18	35	44	36	50	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGAGGGGACAGGGTTTGAAGCTTTCTTTGGACAA	CASSLEGTGFEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	7	7	2	20	31	47	38	49	TCRBV07,TCRBV11,TCRBV23													CASSLEGTGFEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCCCTGACGGCAGGGAATGGACTGAAGCTTTCTTTGGACAA	CASSPDGREWTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	5	8	5	19	31	44	39	49	TCRBV05,TCRBV23													CASSPDGREWTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAACTGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSLTGQNTEAFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	1	4	1	19	33	41	37	42	TCRBV05,TCRBV11													CASSLTGQNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGGGTTAGGGGACACAGATACGCAGTATTTTGGCCCA	CASSLGLGDTDTQYF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	2	6	1	19	33	44	39	45	TCRBV05,TCRBV11	TCRBV05-05,TCRBV11-01,TCRBV11-03												CASSLGLGDTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGGGATCCGGGACAGGGCATCTAATGAAAAACTGTTTTTTGGCAGT	CASSGIRDRASNEKLFF	In	VDJ	1	24	1.593932430547715E-4	1.8578727357176033E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	3	6	3	23	36	51	42	54	TCRBV09,TCRBV12													CASSGIRDRASNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAGGGACAGAACGTAATCTATGGCTACACCTTCGGTTCG	CASSEGQNVIYGYTF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	4	3	8	26	37	47	40	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSEGQNVIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGATAAAAAGGTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	1.6603462818205365E-4		41	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	5	4	6	8	1	26	41	52	49	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGAGACAGGACAAAACACTGAAGCTTTCTTTGGACAA	CASSLAETGQNTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	4	2	3	4	26	43	52	46	56		TCRBV12-03,TCRBV12-04												CASSLAETGQNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGCAGACCCATGAAAAACTGTTTTTTGGCAGT	CASSQTGQTHEKLFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	3	6	0	7	26	-1	47	41	54		TCRBV03-01,TCRBV03-02												CASSQTGQTHEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATGGGGGATACGCAGTATTTTGGCCCA	CASSQEMGDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	6	2	6	3	0	26	43	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEMGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCTAGCGGGACTGGGGAGACCCAGTACTTCGGGCCA	CASSQASGTGETQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	3	5	2	5	26	40	51	42	56		TCRBV03-01,TCRBV03-02												CASSQASGTGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTGCCGGACAGGCTTTTGGGAAATCTGTTTTTTGGCAGT	CASSLPDRLLGNLFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	4	14	3	12	20	34	44	37	56	TCRBV07,TCRBV11													CASSLPDRLLGNLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCGGGGGCGAAAACTGAAGCTTTCTTTGGACAA	CSANPGAKTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	6	0	5	4	4	26	36	46	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPGAKTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGAGGATCACAATGAGCAGTTCTTCGGGCCA	CSANEDHNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	1	5	2	3	26	36	42	38	45		TCRBV20-01,TCRBV20-or09_02												CSANEDHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGTGAGGAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.6603462818205365E-4		35	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	6	5	0	26	38	-1	43	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDMGQGNTEAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	1	3	0	26	40	-1	43	52		TCRBV20-01,TCRBV20-or09_02												CSARDMGQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGTGGTCCAGATACGCAGTATTTTGGCCCA	CSARVGGPDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	0	10	4	2	5	26	39	43	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATATGGGGCGCTCACCGGGGAGCTGTTTTTTGGAGAA	CSARYGALTGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	7	0	4	3	3	26	38	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARYGALTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCCGAGAGGCCAGCGGGGAAGAGACCCAGTACTTCGGGCCA	CSAGREASGEETQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	3	3	12	0	26	35	-1	47	54		TCRBV20-01,TCRBV20-or09_02												CSAGREASGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATATCCTAGCGGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDILAGVNTGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	1	4	1	23	40	54	44	55	TCRBV01,TCRBV04													CASSQDILAGVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGTAGTGAGGCCTCAGCAGCCCCAGCATTTTGGTGAT	CASSQVVRPQQPQHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	1	7	4	6	23	39	47	43	53	TCRBV04,TCRBV23													CASSQVVRPQQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCACGTTTGGTGGTCAGGAGCACAGCACGGTATTTCTGTGCCAGCAGCGCCTCCGGGACAGACTACAATGAGCAGTTCTTCGGGCCA	CASSASGTDYNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	3	6	1	36	48	61	54	62		TCRBV21-or09_02,TCRBV21-01												CASSASGTDYNEQFF+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGGACAGGATGGGGGAGCTTTCTTTGGACAA	CATSDSGQDGGAFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	4	10	1	7	24	40	49	41	56		TCRBV24-01,TCRBV24-or09_02												CATSDSGQDGGAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGTGGCCCATGGAATGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	25	1.6603462818205365E-4		44	TCRBV24						TCRBJ02	TCRBJ02-07	01	2	1	8	17	9	14	24	40	52	49	66		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGACAGATTTCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	1.6603462818205365E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	5	0	0	6	24	-1	38	33	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGGGAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLYGEGGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	0	7	7	0	24	36	-1	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLYGEGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCCCTAAGCGGCAGGGCGATTCACCCCTCCACTTTGGGAAC	CASPKRQGDSPLHF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	11	4	3	8	11	2	24	31	47	42	49	TCRBV08,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASPKRQGDSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	33	48	60	54	79		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCATGGACAGACCCCTCTAGAAACACCATATATTTTGGAGAG	CASSPWTDPSRNTIYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	5	4	9	18	30	40	34	49	TCRBV07,TCRBV11													CASSPWTDPSRNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCAAGGAGGGCCGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSKEGRASYNEQFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	51	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	0	4	6	19	32	42	36	48		TCRBV05-06,TCRBV05-07												CASSSKEGRASYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAAGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSLEGSTDTQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	42	TCRBV05						TCRBJ02	TCRBJ02-03	01	2	1	8	0	4	0	19	33	-1	37	40		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGACCGACTAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSGPTSGGQETQYF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	1	5	0	24	36	-1	41	53	TCRBV09,TCRBV21													CASSGPTSGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACACGGCGGGGGGCCTACGAGCAGTACGTCGGGCCG	CASTRRGAYEQYV	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	1	17	4	15	23	33	45	37	60	TCRBV02,TCRBV09													CASTRRGAYEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCCGGGACTCTCAGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSAGTLSAGELFF	In	VDJ	1	25	1.6603462818205365E-4	1.9352840997058368E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	6	4	7	23	34	44	38	51	TCRBV02,TCRBV09					01,02								CASSAGTLSAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTCGTACACGGCGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSSYTAPNEKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	6	3	6	3	5	6	26	37	45	42	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYTAPNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGACTAGCGGGGAAGAGCAGTTCTTCGGGCCA	CASSWTSGEEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	10	0	2	26	-1	51	39	53		TCRBV12-03,TCRBV12-04												CASSWTSGEEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGATAACGTGGGAGGTTGATCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	1.7267601330933578E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	1	7	9	5	23	37	52	46	57	TCRBV01,TCRBV04													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGCCCCAGGGAGCAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSQPQGAANEKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	3	4	3	3	4	5	23	37	46	41	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPQGAANEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDNTGANVLTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	5	9	2	0	3	26	-1	45	43	48		TCRBV03-01,TCRBV03-02				01,02								CASSQDNTGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGCAGGGGGCAATGAAAAACTGTTTTTTGGCAGT	CASSQDAGGNEKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	0	5	2	0	26	43	-1	45	53		TCRBV03-01,TCRBV03-02												CASSQDAGGNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGACATTATAATTCACCCCTCCACTTTGGGAAC	CASSQD*HYNSPLHF	Stop	VDJ	1	26	1.7267601330933578E-4		45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	6	4	2	1	26	43	49	45	50		TCRBV03-01,TCRBV03-02												CASSQD*HYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTTAGGGGGACCAATGGCTACACCTTCGGTTCG	CASSQDFRGTNGYTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	6	4	4	26	43	53	47	57		TCRBV03-01,TCRBV03-02												CASSQDFRGTNGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTTATAGGGCTGGGAAACACCATATATTTTGGAGAG	CASSPLIGLGNTIYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	5	3	4	7	3	26	39	50	46	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLIGLGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCTGACAGGGAGGTCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	1.7267601330933578E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	2	3	6	3	6	26	30	40	33	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGACCTGAGGGACAATGAGCAGTTCTTCGGGCCA	CSAKDLRDNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	5	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAKDLRDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGCAAGAAGCCTATGGCTACACCTTCGGTTCG	CSAGQEAYGYTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	7	0	4	0	7	26	-1	39	34	46		TCRBV20-01,TCRBV20-or09_02												CSAGQEAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGACAGATTTAACTCTGGAAACACCATATATTTTGGAGAG	CSARPDRFNSGNTIYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	5	0	3	6	26	38	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSARPDRFNSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCTGACAAATGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	1.7267601330933578E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	6	1	6	4	26	40	50	46	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTGGGGAGGGCCCAGATACGCAGTATTTTGGCCCA	CSARDLGEGPDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	4	5	2	26	40	52	45	54		TCRBV20-01,TCRBV20-or09_02												CSARDLGEGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCAAGCGGCTTAACCGGGGAGCTGTTTTTTGGAGAA	CSARDASGLTGELFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	5	5	4	4	26	40	49	44	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDASGLTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACTAGAAGCACAGATACGCAGTATTTTGGCCCA	CSARDGTRSTDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	8	0	1	1	26	40	49	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGTRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGGAAATGAGCAGTTCTTCGGGCCA	CSARGGNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	1	7	0	1	26	-1	43	39	44		TCRBV20-01,TCRBV20-or09_02												CSARGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGGGGTCTATGGCTACACCTTCGGTTCG	CSARVGVYGYTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	2	4	1	1	26	39	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSARVGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCTCACTGCAGGGGGACATCAAGGAGACCCAGTACTTCGGGCCA	CSVSLQGDIKETQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	1	5	8	8	26	33	48	41	56		TCRBV20-01,TCRBV20-or09_02												CSVSLQGDIKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CYMCCWMYCAGACWTCTRTKTACYTCTGTGCCAGCAGCCCATCGGAGGCCCCGCGAGGCGCTGAAGCTTTCTTTGGACAA	CASSPSEAPRGAEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	6	6	12	25	36	47	42	59	TCRBV06,TCRBV28													CASSPSEAPRGAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCTAGCGGGACAACTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	26	1.7267601330933578E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	5	3	3	0	3	23	-1	44	36	47	TCRBV01,TCRBV04													X+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGGTACAGGGCCGATGAACACTGAAGCTTTCTTTGGACAA	CASSEGTGPMNTEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	0	6	4	22	34	46	40	50		TCRBV12-03,TCRBV12-04												CASSEGTGPMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTATAACAGGGAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSYNRETYNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	2	3	3	22	35	44	38	47		TCRBV12-03,TCRBV12-04												CASSYNRETYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCAGGGGTCAAACTATGGCTACACCTTCGGTTCG	CATSEQGSNYGYTF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	2	1	3	24	38	45	39	48		TCRBV24-01,TCRBV24-or09_02												CATSEQGSNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAACCGACAGGGGGTCTTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	1.7267601330933578E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	1	7	4	3	24	35	48	39	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGACTACCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLWDYPYNEQFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	4	4	4	24	36	47	40	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLWDYPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCAGGGGTGGGACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	26	1.7267601330933578E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	17	3	20	24	36	45	39	65		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGGACACTTAGCACAGATACGCAGTATTTTGGCCCA	CASSRTLSTDTQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	6	0	1	3	23	35	41	36	44	TCRBV06,TCRBV10													CASSRTLSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTGGACTAGCGGGGGGCCCCGAGCAGTACGTCGGGCCG	CASGLAGGPEQYV	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	1	1	17	1	14	23	31	46	32	60	TCRBV06,TCRBV10													CASGLAGGPEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCATTCAGGGATACTACGAGCAGTACGTCGGGCCG	CASSSIQGYYEQYV	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	17	5	17	19	32	42	37	59	TCRBV07,TCRBV11													CASSSIQGYYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGAGCAGGCCTCCTACGAGCAGTACGTCGGGCCG	CASSLEQASYEQYV	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	0	4	4	17	2	18	18	34	40	36	58	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLEQASYEQYV+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGGGGGGAGTACTGAAGCTTTCTTTGGACAA	CASSLGGSTEAFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	5	1	5	3	4	20	31	40	34	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGGGAGGACCATAGGCGGGAAAAACTGTTTTTTGGCAGT	CASREDHRREKLFF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	7	5	8	8	0	23	38	-1	46	50	TCRBV06,TCRBV10					unresolved								CASREDHRREKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCGGAGGGGGGAAGCCAAAAACATTCAGTACTTCGGCGCC	CASRRGEAKNIQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	42	unresolved						TCRBJ02	TCRBJ02-04	01	8	5	1	0	3	2	23	32	41	35	43	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGEAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGAGGGACGGGGATATAATTCACCCCTCCACTTTGGGAAC	CASSEEGRGYNSPLHF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	48	unresolved						TCRBJ01	TCRBJ01-06	01	5	0	7	4	6	5	23	34	45	40	50	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEGRGYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGTAATCCCGGGACTAGCAGTAGAGACCCAGTACTTCGGGCCA	CASVIPGLAVETQYF	In	VDJ	1	26	1.7267601330933578E-4	2.0126954636940703E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	7	4	8	3	23	32	49	40	52	TCRBV02,TCRBV09					01,02								CASVIPGLAVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAGACAGGGTTGGCGAGTAATGAGCAGTTCTTCGGGCCA	CASSETGLASNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	7	3	9	26	37	47	40	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSETGLASNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGACCAGGGCAGGGAGACCCAGTACTTCGGGCCA	CASSDQGRETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	5	3	4	26	38	46	41	50		TCRBV12-03,TCRBV12-04												CASSDQGRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTAAGGCGATCAACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	27	1.7931739843661795E-4		40	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	9	17	10	11	26	39	53	49	64		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGCCTGGGTACCGGGACAGTCAAGAGACCCAGTACTTCGGGCCA	CASSPPGYRDSQETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	2	14	1	26	37	58	51	59		TCRBV03-01,TCRBV03-02												CASSPPGYRDSQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTCAATCCTTGTAGTCTATGGCTACACCTTCGGTTCG	CASSSILVVYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	5	8	4	11	1	26	37	51	48	52		TCRBV03-01,TCRBV03-02				01,02								CASSSILVVYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACCCCAGACTAGCGGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CSANPRLAGGYNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	1	4	8	1	26	34	55	42	56		TCRBV20-01,TCRBV20-or09_02												CSANPRLAGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTATAGGCGGGGGAATGAGCAGTTCTTCGGGCCA	CSAYRRGNEQFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	2	7	6	0	26	34	-1	40	47		TCRBV20-01,TCRBV20-or09_02												CSAYRRGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGAAGACAGGGAGTTATGGCTACACCTTCGGTTCG	CSASKTGSYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	5	6	3	26	34	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSASKTGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGGGATTCGATCAGCCCCAGCATTTTGGTGAT	CSARDGGFDQPQHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	2	5	0	5	26	-1	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSARDGGFDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGCAGTATCGAGAGACCCAGTACTTCGGGCCA	CSARDRQYRETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	4	5	4	4	5	26	40	47	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRQYRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGCGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CSARDQAGAGELFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	6	2	6	3	0	26	40	-1	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDQAGAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCCGACAGGGGAGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	27	1.7931739843661795E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	2	8	6	2	26	37	51	43	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCAAGAGATCCAGTACTTCGGGCCA	CSASRQEIQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	5	4	10	1	8	26	37	41	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRQEIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGAGTTCAAGAGACCCAGTACTTCGGGCCA	CSAGGVQETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	6	1	2	0	4	26	-1	40	35	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGAAGAGACAGGGGGAAACACCATATATTTTGGAGAG	CASSEEETGGNTIYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	4	8	0	22	34	-1	42	49		TCRBV12-03,TCRBV12-04												CASSEEETGGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGAATCAGCGGGCAGGTCTGGAAACACCATATATTTTGGAGAG	CASSEESAGRSGNTIYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	6	4	1	8	4	22	34	48	42	52		TCRBV12-03,TCRBV12-04				01,02								CASSEESAGRSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCGACAGGGTGGCGAGACCCAGTACTTCGGGCCA	CATSDFRQGGETQYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	3	5	2	4	24	41	50	43	54		TCRBV24-01,TCRBV24-or09_02												CATSDFRQGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGATCCTTGAACACTGAAGCTTTCTTTGGACAA	CATSGSLNTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	2	8	0	0	4	24	-1	39	37	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGSLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCACCAGTGACTCGACAGGGTTTACCTATGGCTACACCTTCGGTTCG	CVTSDSTGFTYGYTF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	3	5	24	38	48	41	53		TCRBV24-01,TCRBV24-or09_02												CVTSDSTGFTYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGAACCCGCTGATACGAGTTCACCCCTCCACTTTGGGAAC	CASSLEPADTSSPLHF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	2	11	2	9	15	0	19	33	-1	48	51	TCRBV05,TCRBV07													CASSLEPADTSSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGTAACTGGTGGAAACACCATATATTTTGGAGAG	CASSLVTGGNTIYF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	3	10	3	4	2	19	33	40	37	42	TCRBV05,TCRBV11					01,02								CASSLVTGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCGGCCGTGTATSTCTGTGCCAGCAGCCAAAAAATCCCCGGGACAGGGGAAAAGAGACTAATGAACACTGAAGCTTTCTTTGGACAA	CASSQKIPGTGEKRLMNTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	66				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	0	9	12	15	30	49	39	61	TCRBV04,TCRBV07,TCRBV11	TCRBV04-02,TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSQKIPGTGEKRLMNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGGGGCAGGGTTTATTGACACTGAAGCTTTCTTTGGACAA	CASSEGAGFIDTEAFF	In	VDJ	1	27	1.7931739843661795E-4	2.090106827682304E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	3	3	7	23	39	47	42	54	TCRBV02,TCRBV12													CASSEGAGFIDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLAVNTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	0	0	10	0	0	0	26	-1	-1	43	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGTTGGGGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSFVGGPNYGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	6	0	0	5	0	26	40	-1	45	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFVGGPNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGTCTGACTAGCGGGGGGCCTACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	1.8595878356390008E-4		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	0	2	4	24	36	51	38	55	TCRBV06,TCRBV10,TCRBV22													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCTCGACAGTCCGTGGGGGCTTTCTTTGGACAA	CASSQDPRQSVGAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	11	5	9	26	43	53	48	62		TCRBV03-01,TCRBV03-02												CASSQDPRQSVGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGACACGGGAGCTCTGAAGCTTTCTTTGGACAA	CASSRGHGSSEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	0	6	6	1	8	26	39	46	40	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGHGSSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGGACTCSGCCSTGTATCTCTGTGCCAGCAGCAGCGACGGTGGTCAGCCCCAGCATTTTGGTGAT	CASSSDGGQPQHF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	6	6	6	0	7	20	-1	36	32	43	TCRBV05,TCRBV07					01,02								CASSSDGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTCCCGGACAGCAACTCCTACGAGCAGTACTTCGGGCCG	CSAVPDSNSYEQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	0	6	3	26	34	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSAVPDSNSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCCCCACTCAATGAGCAGTTCTTCGGGCCA	CSAAPLNEQFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	9	0	6	0	6	26	-1	37	34	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAPLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGCAGGTCCTACGGCTACACCTTCGGTTCG	CSARAGRSYGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	4	4	8	4	6	26	39	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAGRSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTTGATAGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CSAVDRGTNEKLFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	2	6	0	26	35	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAVDRGTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATAAAAACCGGACGAGGCCCGAACGAGTAGTACGTCGGGCCG		Out	VDJ	1	28	1.8595878356390008E-4		49	unresolved						TCRBJ02	TCRBJ02-07	01	3	1	7	17	8	21	23	37	49	45	70	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCCAGGTGGCCCGAGCGGTTATGAGGTTGGAGACCCAGTACTTCGGGCCA	CASQVARAVMRLETQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	6	5	5	11	11	22	31	47	42	58		TCRBV12-03,TCRBV12-04				01,02								CASQVARAVMRLETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGGACAGGGGTCACACTACGAGCAGTACGTCGGGCCG	CATSDRGQGSHYEQYV	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	17	3	19	24	38	51	41	70		TCRBV24-01,TCRBV24-or09_02												CATSDRGQGSHYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTCATGGGGAAGCCAATGAGCAGTTCTTCGGGCCA	CATSDFHGEANEQFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	1	0	8	6	5	3	24	41	50	46	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFHGEANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGAGGGGGGCGCGGATGGCTACACCTTCGGTTCG	CATEGGADGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	10	5	1	6	2	6	24	32	40	34	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATEGGADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAAATGACACGTTACACTGAAGCTTTCTTTGGACAA	CASKMTRYTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	6	3	7	4	24	31	42	38	46		TCRBV24-01,TCRBV24-or09_02												CASKMTRYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACCCGGACAGGGGTGGGTAATTCACCCCTCCACTTTGGGAAC	CASTRTGVGNSPLHF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	1	2	6	6	4	24	31	46	37	50	TCRBV24,TCRBV27													CASTRTGVGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLKGNTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	5	3	1	4	0	24	36	-1	40	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAAGGTAGGGCAGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSFKVGQTVNTEAFF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	0	14	0	24	36	-1	50	55		TCRBV24-01,TCRBV24-or09_02												CASSFKVGQTVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGGAGTAACCGGGACAGGGGAAAACTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	28	1.8595878356390008E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	7	4	7	23	35	49	39	56	TCRBV06,TCRBV10													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCATGTATCKCTGTGCCAGAAGCTCTCAAGGGGCCCTTGGGATCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.8595878356390008E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	4	4	10	19	32	41	36	51	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGCGAGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLARGQETQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	0	5	2	2	1	1	19	36	42	37	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLARGQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCRGCYSTSTATYTYTGTGCCAACGCCCCCTTGGTCTCTGGAAACACCATATATTTTGGAGAG	CANAPLVSGNTIYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	9	0	10	0	10	1	19	26	38	36	39	TCRBV05,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANAPLVSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAAGGGACAGCGTCTATGGCTAYACCTTCGGTTCG	CASSLRDSVYGYTF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	14	2	13	19	33	42	35	55	TCRBV05,TCRBV11													CASSLRDSVYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGTTCCCCGGGGGCGCAAGAGACCCAGTACTTCGGGCCA	CASSSPGAQETQYF	In	VDJ	1	28	1.8595878356390008E-4	2.1675181916705371E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	6	0	2	6	1	19	30	42	36	43	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGAQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCACCCGGCGACAGGGGATTCGGGGAGCTGTTTTTTGGAGAA	CASSPPGDRGFGELFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	7	9	3	26	38	55	47	58	TCRBV12,TCRBV21													CASSPPGDRGFGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACCACAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSLTTGPTDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	2	4	2	26	40	50	44	52		TCRBV12-03,TCRBV12-04												CASSLTTGPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGATAGGGGAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	1.9260016869118224E-4		44				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	0	2	5	1	24	35	47	40	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ01-05		TCRBD02-01*02	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATCTGCCGGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	1.9260016869118224E-4		47	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	8	3	8	0	26	43	-1	51	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGTCTAGCGGGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSQDLSSGGVTDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	2	5	1	26	43	60	48	61		TCRBV03-01,TCRBV03-02												CASSQDLSSGGVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGGAGGCTGGTGGCTACACCTTCGGTTCG	CSAPGEAGGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	7	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPGEAGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAAGGACTAGCGGGGGAAACAATGAGCAGTTCTTCGGGCCA	CSATRTSGGNNEQFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	5	3	2	26	36	52	39	54		TCRBV20-01,TCRBV20-or09_02												CSATRTSGGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGGAACGACCCAAGAGACCCAGTACTTCGGGCCA	CSATGTTQETQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	1	8	1	2	5	26	36	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATGTTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTCGGACTACGAGCAGTACTTCGGGCCG	CSARASDYEQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	1	8	3	4	0	26	39	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARASDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGAGAGGGGTTCACCCCTCCACTTTGGGAAC	CSASRERGSPLHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	4	3	9	0	7	26	-1	42	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRERGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGATCCGGGACAGTAACTATGGCTACACCTTCGGTTCG	CSAREIRDSNYGYTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	1	8	0	26	37	-1	45	52		TCRBV20-01,TCRBV20-or09_02												CSAREIRDSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGACAGTCCTTACGAGCAGTACTTCGGGCCG	CSASWDSPYEQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	4	2	4	26	37	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSASWDSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAGCGGGTCCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	29	1.9260016869118224E-4		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	4	17	0	19	26	-1	42	35	61		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGTGAGGGGGATAAGTCAGCCCCAGCATTTTGGTGAT	CASSVRGISQPQHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	6	3	5	22	34	43	37	48	TCRBV09,TCRBV12													CASSVRGISQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAAATGACCCAAGGCAGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	1.9260016869118224E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	4	7	15	0	24	38	-1	53	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CATSDTSGANVLTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	TCRBV24						TCRBJ02	TCRBJ02-06	01	3	3	7	4	0	4	24	-1	41	39	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCTGGACAGAAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSDTWTEDSGANVLTF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	5	0	4	4	24	39	49	43	53		TCRBV24-01,TCRBV24-or09_02												CATSDTWTEDSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAAAGGACAGGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASRKDRGGNQPQHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	2	3	2	23	34	46	37	48	TCRBV06,TCRBV10													CASRKDRGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGAATTCGGAGGGATACGCAGTATTTTGGCCCA	CASSEQGIRRDTQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	TCRBV06						TCRBJ02	TCRBJ02-03	01	2	4	3	6	0	10	23	-1	43	38	53		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEQGIRRDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCTCCGGCCACTGAACACTGAAGCTTTCTTTGGACAA	CASLRPLNTEAFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	8	9	0	0	4	3	23	32	39	36	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLRPLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAATCCCGGACAGGGGCTATTGGCGACAATGAGCAGTTCTTCGGGCCA	CAISESRTGAIGDNEQFF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	5	4	9	23	38	51	42	60	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISESRTGAIGDNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATCCCGCCCCAGGGGGATCGGGAAACACCATATATTTTGGAGAG	CAISDPAPGGSGNTIYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	1	4	10	4	23	35	52	45	56	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDPAPGGSGNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATCCAGCGGGGGGTCTAGAGACCCAGTACTTCGGGCCA	XASSQDPAGGLETQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	1	4	3	3	22	39	51	42	54	TCRBV01,TCRBV04													XASSQDPAGGLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCACCGAGGGGGTGAATAATTCACCCCTCCACTTTGGGAAC	CASSTEGVNNSPLHF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	5	1	5	4	3	22	34	44	38	47	TCRBV07,TCRBV12													CASSTEGVNNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGATGCGGGGGGCGACGAGCAGTACTTCGGGCCG	CASSVDAGGDEQYF	In	VDJ	1	29	1.9260016869118224E-4	2.2449295556587707E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	1	5	2	2	23	39	49	41	51	TCRBV09,TCRBV21													CASSVDAGGDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCTCGGTGGGCGTCACAGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	1.9924155381846438E-4		53	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	2	15	0	26	39	-1	54	59		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGTTGGGGAATGAGCAGTTCTTCGGGCCA	CASSLGLGNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	6	2	7	0	6	26	-1	44	40	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCCATGACCCGGGACGTATGAACACTGAAGCTTTCTTTGGACAA	CASHDPGRMNTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	10	0	7	0	10	3	24	31	46	41	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHDPGRMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCCCCAGAGAACACTGAAGCTTTCTTTGGACAA	CASSQPPENTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	1	4	1	26	41	48	45	49		TCRBV03-01,TCRBV03-02												CASSQPPENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGCCAATTCACCCCTCCACTTTGGGAAC	CASSHANSPLHF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	36	TCRBV03						TCRBJ01	TCRBJ01-06	01	3	10	0	7	1	1	26	40	43	41	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHANSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAAGGGGCTTTCGCGGCATGTCAATGAGCAGTTCTTCGGGCCA	CASSPKGLSRHVNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	6	3	14	26	39	47	42	61		TCRBV03-01,TCRBV03-02												CASSPKGLSRHVNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAGGAGGGGGGAAAACTATGGCTACACCTTCGGTTCG	CASSPRRGENYGYTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	5	1	2	5	3	26	39	50	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRRGENYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTCACCAGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	1.9924155381846438E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	4	2	7	2	26	39	50	46	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAGACCCGGCTAGGAACAGATACGCAGTATTTTGGCCCA	CSAQTRLGTDTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	3	10	2	26	34	48	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQTRLGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTGGGGCGGGACTCCTCGAGAGACCCAGTACTTCGGGCCA	CSARDWGGTPRETQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	4	7	5	26	40	53	47	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDWGGTPRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCGGACCTCTTATGAGCAGTACTTCGGGCCG	CSARDSRTSYEQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	1	7	7	5	7	26	40	49	45	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSRTSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAGCGGGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	1.9924155381846438E-4		40	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	6	3	2	2	0	26	39	-1	41	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGATGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	1.9924155381846438E-4		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	3	0	1	4	26	37	43	38	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGCAGGGGGTCTTTGAACACTGAAGCTTTCTTTGGACAA	CSASGRGSLNTEAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	0	3	4	26	37	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSASGRGSLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGACCGAACCCAACAGGGCCTGCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	30	1.9924155381846438E-4		50	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	7	12	5	22	33	51	45	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTCTGTAGCGGGGGCCTTATACAATGAGCAGTTCTTCGGGCCA	CASSSVAGALYNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	4	3	5	23	36	48	39	53	TCRBV06,TCRBV27													CASSSVAGALYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTCTCGACGGACGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSLSTDAGANVLTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV24						TCRBJ02	TCRBJ02-06	01	7	1	7	2	9	1	24	35	48	44	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLSTDAGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGACTACCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDRDYLSYNEQFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	0	2	3	24	38	47	40	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDRDYLSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCACAGGGGGCGGAAGAGACCCAGTACTTCGGGCCA	CATSDAQGAEETQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	0	3	2	2	24	39	50	41	52		TCRBV24-01,TCRBV24-or09_02												CATSDAQGAEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTTCCCCCGCCAGGGTAATGAGGGCTACACCTTCGGTTCG		Out	VDJ	1	30	1.9924155381846438E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	8	8	7	24	36	49	44	56	TCRBV22,TCRBV24													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGATTCTTCCGGGACATAGGACGGACCCAGTACTTCGGGCCA	CASRFFRDIGRTQYF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	7	8	7	23	34	48	42	55	TCRBV06,TCRBV10													CASRFFRDIGRTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGCGGCAGGTGACTAGCTTTAGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	30	1.9924155381846438E-4		52	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	7	5	9	6	19	31	47	40	53		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGAAAGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGKLSGANVLTF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	10	7	5	0	0	6	24	-1	35	31	41	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASGKLSGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGAAGGGACAGGGGCTAAAGCTTTCTTTGGACAA	CASSEGTGAKAFF	In	VDJ	1	30	1.9924155381846438E-4	2.3223409196470042E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	9	2	3	23	36	48	38	51	TCRBV02,TCRBV09													CASSEGTGAKAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGATCCCGTTGAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLDPVEGNQPQHF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	48	TCRBV12						TCRBJ01	TCRBJ01-05	01	1	5	2	4	9	0	26	42	-1	51	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPVEGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGTCAGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSLVRETGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	5	3	2	26	40	48	43	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLVRETGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGGCCTTGGCACAGATACGCAGTATTTTGGCCCA	CASSDGLGTDTQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42							TCRBJ02	TCRBJ02-03	01	3	9	0	1	1	4	24	38	42	39	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGLGTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCACATTTCCCATTTCTTTCTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	2.0588293894574652E-4		50	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	3	6	5	3	17	26	38	44	41	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGCCCGCGAACCCTCCGAACACCGGGGAGCTATTTTTTGGAGAA	CSAKPANPPNTGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	3	17	24	5	26	34	63	58	68		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKPANPPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCCTGGGACAGAAAAACACTGAAGCTTTCTTTGGACAA	CSARSLGQKNTEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	2	5	3	26	38	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARSLGQKNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGACTAGCCGGCGGGGAGCTGTTTTTTGGAGAA	CSARRGLAGGELFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	7	7	2	3	26	38	49	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRGLAGGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGTACTAGCGTCAATTGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	2.0588293894574652E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	8	4	9	26	39	50	43	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGCACCAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	2.0588293894574652E-4		37	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	9	0	3	2	5	26	37	42	39	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAACCGACCGGACACAAGAGACCCAGTACTTCGGGCCA	CSASTDRTQETQYF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	6	2	10	0	26	35	-1	45	50		TCRBV20-01,TCRBV20-or09_02												CSASTDRTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGGGAAGCGGGGGACGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGEAGDVSYNEQFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	0	5	4	22	34	47	39	51		TCRBV12-03,TCRBV12-04												CASSGEAGDVSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGACAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATSDQTGAYNEQFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	2	3	0	24	38	-1	41	49		TCRBV24-01,TCRBV24-or09_02												CATSDQTGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCGGTCGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSSVGPYNEQFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	7	9	0	2	7	1	24	35	45	42	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSVGPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGGATGGCGGGTGATAATTCACCCCTCCACTTTGGGAAC	CASRMAGDNSPLHF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	11	7	4	5	8	2	24	31	44	39	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASRMAGDNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCACCGGACAGGACTATGGCTACACCTTCGGTTCG	CASTGQDYGYTF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	4	3	2	0	23	33	-1	35	42	TCRBV09,TCRBV12													CASTGQDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCAGGGGGAGGGAAAGAAGAAAAACTGTTTTTTGGCAGT	CASSPGGGKEEKLFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	4	4	1	8	1	10	23	35	43	36	53	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGGKEEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCAACGCGGTGACAGGCCATGAAGCTTTCTTTGGACAA	CASSANAVTGHEAFF	In	VDJ	1	31	2.0588293894574652E-4	2.3997522836352378E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	7	10	3	23	36	52	46	55	TCRBV09,TCRBV21													CASSANAVTGHEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGCGGACAGGAGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	2.1252432407302868E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	4	0	4	2	26	37	48	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGACCGAAGGTGAAGCTTTCTTTGGACAA	CASSGTEGEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	7	7	1	6	26	37	43	38	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTEGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAATGGCCCTCCTCCGTAGAGATACGCAGTATTTTGGCCCA	XASSQMALLRRDTQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	2	9	0	5	2	12	23	38	43	40	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQMALLRRDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGCCGGGACGGTGAACACTGAAGCTTTCTTTGGACAA	CASSQEAGTVNTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	7	0	4	2	26	43	52	47	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEAGTVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATATGGCGGACAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSPYGGQGYTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	3	8	1	26	39	56	47	57		TCRBV03-01,TCRBV03-02												CASSPYGGQGYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACCAACAGGGGACCACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	2.1252432407302868E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	2	2	6	4	26	34	47	40	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACTTGACAGGGGTCTATGGCTACACCTTCGGTTCG	CSADLTGVYGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	4	6	1	26	34	48	40	49		TCRBV20-01,TCRBV20-or09_02												CSADLTGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGTGGGGGCGTACTATGGCTACACCTTCGGTTCG	CSAKVGAYYGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	3	4	2	26	36	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAKVGAYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGCCCGGAGGAAAAACTGTTTTTTGGCAGT	CSARPGPEEKLFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	2	8	0	8	2	6	26	38	44	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPGPEEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGACAGGGTGATCAGCCCCAGCATTTTGGTGAT	CSARDRQGDQPQHF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	3	5	2	2	26	40	49	42	51		TCRBV20-01,TCRBV20-or09_02												CSARDRQGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTACCCTAGCAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARDLYPSRNTGELFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	7	1	8	2	26	40	53	48	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLYPSRNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGAGTCCATGGCTACACCTTCGGTTCG	CSARAGVHGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	7	2	6	1	3	26	37	45	38	48		TCRBV20-01,TCRBV20-or09_02												CSARAGVHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCAAAGCAGATACGCAGTATTTTGGCCCA	CSASKADTQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	4	6	4	2	3	26	35	39	37	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASKADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTGGCCCTCCTGCGGGCACTGAAGCTTTCTTTGGACAA	CSAFGPPAGTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	4	12	0	26	35	-1	47	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAFGPPAGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCAGGGGTCGGAGTGACTGAAACTTTCTTTGGACAA	CASSQAGVGVTETFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	2	12	0	15	23	-1	45	39	60	TCRBV01,TCRBV04													CASSQAGVGVTETFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CATSAGTAYGYTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	2	1	24	37	46	39	47		TCRBV24-01,TCRBV24-or09_02												CATSAGTAYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAATTGGGTTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLIGFGTDTQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	2	0	9	1	3	4	18	33	39	36	43	TCRBV03,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGFGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCTCGGGACAGGGCCAAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSASGQGQTGANVLTF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	3	2	5	5	24	36	50	41	55	TCRBV09,TCRBV21													CASSASGQGQTGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGAGCGGGGGCCCGTCTTATTTACTGGAGACCCAGTACTTCGGGCCA	CASSQDRSGGPSYLLETQYF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	60	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	2	5	4	16	15	32	44	36	60		TCRBV03-01,TCRBV03-02												CASSQDRSGGPSYLLETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGCGGGACAGGCCTACACTGAAGCTTTCTTTGGACAA	CASSAGQAYTEAFF	In	VDJ	1	32	2.1252432407302868E-4	2.477163647623471E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	3	3	3	23	34	45	37	48	TCRBV09,TCRBV12													CASSAGQAYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAACAGGGAACCGGAAACACCATATATTTTGGAGAG	CASSEQGTGNTIYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	4	2	4	26	38	46	40	50		TCRBV12-03,TCRBV12-04												CASSEQGTGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAAGCTAGCGGGCTATACAGATACGCAGTATTTTGGCCCA	CASSQDKLAGYTDTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	4	3	4	4	26	43	55	47	59		TCRBV03-01,TCRBV03-02				01,02								CASSQDKLAGYTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTAAACAGTAACGAGCAGTACGTCGGGCCG	CASSQDLNSNEQYV	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	5	17	5	14	26	43	52	48	66		TCRBV03-01,TCRBV03-02												CASSQDLNSNEQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCAGGGTGGGCACTGAAGCTTTCTTTGGACAA	CASSQGRVGTEAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	4	1	4	26	42	48	43	52		TCRBV03-01,TCRBV03-02												CASSQGRVGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGAGTGTATACGAGCAGTACTTCGGGCCG	CASSLSVYEQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	2	4	1	4	26	39	43	40	47		TCRBV03-01,TCRBV03-02												CASSLSVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGACAGGACAGGGGTGTCTACACCTTCGGTTCG	CSARQDRGVYTF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	2	10	2	3	26	38	49	40	52		TCRBV20-01,TCRBV20-or09_02												CSARQDRGVYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACCGGGAAACACCATATATTTTGGAGAG	CSAREPGNTIYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	36	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	3	7	4	0	2	26	-1	42	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREPGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCACCCTCTCGACAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	2.1916570920031082E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	1	11	1	26	39	55	50	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCCCCGGGACAGGGACAGATACGCAGTATTTTGGCCCA	CSAGPGTGTDTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	3	6	0	26	35	-1	41	50		TCRBV20-01,TCRBV20-or09_02												CSAGPGTGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGGTATCGTGGGACAGGCCCTAACAGATACGCAGTATTTTGGCCCA	CASSEGIVGQALTDTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	3	11	5	22	34	53	45	58		TCRBV12-03,TCRBV12-04												CASSEGIVGQALTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAGGCTCGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	2.1916570920031082E-4		46	TCRBV24						TCRBJ01	TCRBJ01-01	01	0	5	4	0	0	5	24	-1	45	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCATCCAGTGGGAGAAAAAGTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	33	2.1916570920031082E-4		50	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	2	4	9	8	24	36	50	45	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACTCGACAGGGGATGGAAAAACTGTTTTTTGGCAGT	CASSTRQGMEKLFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	2	8	4	3	24	36	48	40	51		TCRBV24-01,TCRBV24-or09_02												CASSTRQGMEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGGAAGAGCGGGATTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CSARDPGRAGLAGADTQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	4	17	0	24	38	-1	55	64		TCRBV20-01,TCRBV20-or09_02												CSARDPGRAGLAGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCATAAGGGGGAACTAGCGGGCGGGTGCTCATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	2.1916570920031082E-4		61				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	4	3	10	11	18	30	49	40	60	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGAGCCTAGCGGGGAAGAGACCCAGTACTTCGGGCCA	XASSQEPSGEETQYF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	3	2	0	22	39	-1	41	50	TCRBV01,TCRBV04													XASSQEPSGEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCAGGCGCCGGGACAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSRRRDSGTGELFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	4	7	3	19	31	45	38	48		TCRBV05-06,TCRBV05-07												CASSRRRDSGTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGAGTACTTTCCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	2.1916570920031082E-4		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	4	3	1	12	0	24	31	-1	43	52	TCRBV09,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCCCAGCTTGGGGGAGAGGAGCTTTCTTTGGACAA	CASTPAWGRGAFF	In	VDJ	1	33	2.1916570920031082E-4	2.5545750116117046E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	6	1	10	9	5	23	33	47	42	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPAWGRGAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCRGCYRTGTATYTYTGTGCCAGCAGCTTAACGGGCGGGGGGTGGACAGATACGCAGTATTTTGGCCCA	CASSLTGGGWTDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	1	3	4	3	26	41	53	45	56	TCRBV11,TCRBV12													CASSLTGGGWTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGACAGGGGCCTATGGCTACACCTTCGGTTCG	CASSQRTGAYGYTF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	2	4	1	1	26	41	51	42	52		TCRBV03-01,TCRBV03-02												CASSQRTGAYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGCTAGAGACTATGGCTACACCTTCGGTTCG	CASSQEARDYGYTF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	8	3	2	2	26	43	49	45	51		TCRBV03-01,TCRBV03-02				01,02								CASSQEARDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSGTDTQYF	In	VJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	0	0	1	0	1	26	-1	38	-1	39		TCRBV03-01,TCRBV03-02												CASSGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGGCATTGACGGCCTCTGGAGCTATGGCTACACCTTCGGTTCG	CASSGIDGLWSYGYTF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	4	17	0	26	37	-1	54	58		TCRBV03-01,TCRBV03-02												CASSGIDGLWSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTAGTTGGGGCACTAAACACCGGGGAGCTGTTTTTTGGAGAA	CSAVVGALNTGELFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	7	0	2	7	4	26	34	46	41	50		TCRBV20-01,TCRBV20-or09_02												CSAVVGALNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCATTCCAGGGTCGGAGGCACCCCTCCACTTTGGGAAC	CSARDPIPGSEAPLHF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	48	TCRBV20						TCRBJ01	TCRBJ01-06	01	0	4	3	11	8	7	26	40	53	48	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPIPGSEAPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGTCCTAGCGGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	34	2.2580709432759295E-4		44	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	4	7	6	0	26	40	-1	46	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCGGGACAGGGCAACCTACGAGCAGTACTTCGGGCCG	CSASPRDRATYEQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	5	3	26	37	51	42	54		TCRBV20-01,TCRBV20-or09_02												CSASPRDRATYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGCAGGGGGGGCACTGAAGCTTTCTTTGGACAA	CSARTGRGGTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	4	1	4	6	2	26	37	50	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTGRGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGGACCGCTACAGATACGCAGTATTTTGGCCCA	CSARAGTATDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	3	1	6	26	37	44	38	50		TCRBV20-01,TCRBV20-or09_02												CSARAGTATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTGAGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	34	2.2580709432759295E-4		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	11	2	0	3	0	26	37	-1	40	43		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCCGAGGTGCGGCAGGGAAGGGCACTGAAGCTTTCTTTGGACAA	CSGRGAAGKGTEAFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	4	12	5	26	33	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSGRGAAGKGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTATATAGCGGGGCAGAGACCCAGTACTTCGGGCCA	CASSVYSGAETQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	3	4	5	1	22	34	47	39	48		TCRBV12-03,TCRBV12-04												CASSVYSGAETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGGGACAGGGATCCCCGGGGAGCTGTTTTTTGGAGAA	CASSGTGIPGELFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	6	1	4	24	35	45	36	49		TCRBV24-01,TCRBV24-or09_02												CASSGTGIPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGGCCACCCCGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGATPTGELFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	5	2	8	24	36	43	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLGATPTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCATCTCTAGGACTAGCGGGGCAATCACAGATACGCAGTATTTTGGCCCA	CASISRTSGAITDTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	1	3	2	9	4	24	31	52	40	56	TCRBV06,TCRBV24													CASISRTSGAITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCTCACAGTCCGGGGCTCTAGAGAAGGGGCAGTACGTCGGGCCG		Out	VDJ	1	34	2.2580709432759295E-4		41	unresolved						TCRBJ02	TCRBJ02-07	01	12	5	2	17	22	7	23	28	55	50	62	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGACAACAGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	2.2580709432759295E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	1	3	1	18	29	39	32	40	TCRBV11,TCRBV12													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAGAGGGTGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEGVSYNEQFF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	2	11	0	0	1	3	19	33	39	34	42	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLEGVSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCCAACGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSPNGGADTQYF	In	VDJ	1	34	2.2580709432759295E-4	2.631986375599938E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	4	6	0	4	6	1	23	35	47	41	48	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNGGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTATAGGCACTGAAGCTTTCTTTGGACAA	CASSVAIGTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	7	4	2	6	26	37	43	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVAIGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGTAGGCTTTTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	2.3244847945487512E-4		43							TCRBJ02	TCRBJ02-01	01	4	5	4	2	1	6	24	37	41	38	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01			TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGCCAGGGCCGAGGCTACACCTTCGGTTCG	CASSPGQGRGYTF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	8	5	4	26	39	49	44	53		TCRBV03-01,TCRBV03-02												CASSPGQGRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACTAGCGGGGGCCCGTGGTGAGCAGTACTTCGGGCCG	CSARLAGARGEQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	7	0	8	26	-1	48	38	56		TCRBV20-01,TCRBV20-or09_02												CSARLAGARGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTACTAGCGGGGGGGCTCAGTTCTTCGGGCCA	CSATTSGGAQFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	13	2	2	26	36	51	38	53		TCRBV20-01,TCRBV20-or09_02												CSATTSGGAQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGACAGGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDMDRGGNTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	1	1	3	2	26	40	53	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDMDRGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCAGGTGGACACTGAAGCTTTCTTTGGACAA	CSARGQVDTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	3	2	3	26	39	45	41	48		TCRBV20-01,TCRBV20-or09_02												CSARGQVDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCGCCCTAGCACAGATACGCAGTATTTTGGCCCA	CSARGRPSTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	10	0	0	3	3	26	39	44	42	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGRPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACCTGGGCAGCGGGTGGGGAGTTTTTTGGCAGT	CSARTWAAGGEFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	6	4	16	9	6	26	37	52	46	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTWAAGGEFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACAGGGGTCTGGCTAATGAAAAACTGTTTTTTGGCAGT	CSASDRGLANEKLFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	2	3	1	5	26	37	46	38	51		TCRBV20-01,TCRBV20-or09_02												CSASDRGLANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACTTAACACTGAAGCTTTCTTTGGACAA	CSAPLNTEAFF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	2	2	1	26	35	40	37	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCTAATCAGGGGGCCTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	2.3244847945487512E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	0	7	2	26	35	50	42	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAAAAGAGCATAATCAGCCCCAGCATTTTGGTGAT	CSVKEHNQPQHF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	6	7	4	6	2	26	33	42	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSVKEHNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGACTAGCGGACAAGAGACCCAGTACTTCGGGCCA	CATGTSGQETQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	0	5	2	0	1	24	-1	44	33	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATGTSGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACGCGGGGGGACGGCACAGATACGCAGTATTTTGGCCCA	CASSETRGDGTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	1	1	2	3	23	38	48	40	51		TCRBV06-01,TCRBV06-08												CASSETRGDGTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGTAGCGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSESSGGGTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	0	1	2	0	23	38	-1	40	51		TCRBV06-01,TCRBV06-08												CASSESSGGGTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCYGTGTATCTCTGTGCCAGCAGCCAAGATCCCTCACTAGCGGGGGGGCTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDPSLAGGLSSTDTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	63	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	0	0	6	6	18	35	54	41	60	TCRBV03,TCRBV04													CASSQDPSLAGGLSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCACCGGACAGGGGCAAGTAGCAGATACGCAGTATTTTGGCCCA	CASTGQGQVADTQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	2	4	2	7	18	28	39	30	46	TCRBV07,TCRBV11													CASTGQGQVADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGATTAGCGGTTCTCAAGAGACCCAGTACTTCGGGCCA	CASSLISGSQETQYF	In	VDJ	1	35	2.3244847945487512E-4	2.7093977395881716E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	5	5	2	3	4	18	32	41	35	45	TCRBV07,TCRBV11					01,02								CASSLISGSQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCCCGTTCAACTGAAGCTTTCTTTGGACAA	CASRPRSTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	3	7	5	0	8	26	-1	39	37	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGTTACGGCAGCCCGCCCAATGGTGGGAAC		Out	VDJ	1	36	2.3908986458215725E-4		38	unresolved						TCRBJ01	TCRBJ01-06	01	1	4	5	24	6	12	26	42	51	48	63	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATGGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSQEMGQQETQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	5	2	3	0	26	43	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQEMGQQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTCAAAGCACTGAAGCTTTCTTTGGACAA	CASSQGTQSTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	4	0	5	26	-1	47	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGTQSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAACAGGCCCGATACGCAGTATTTTGGCCCA	CASSQNRPDTQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	4	6	2	3	26	40	47	42	50		TCRBV03-01,TCRBV03-02												CASSQNRPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCGGACAGGGTGATGATGAGCAGTTCTTCGGGCCA	CASSPPGQGDDEQFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	8	5	5	26	39	52	44	57		TCRBV03-01,TCRBV03-02												CASSPPGQGDDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCGGACGGATAAGAATTCACCCCTCCACTTTGGGAAC	CASSPRTDKNSPLHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV03						TCRBJ01	TCRBJ01-06	01	4	1	7	7	3	7	26	39	46	42	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTDKNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLSTDTQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	9	0	0	0	26	-1	-1	39	41		TCRBV03-01,TCRBV03-02				01,02								CASSLSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCCCACCGGGGGGGGAAGAGACCCAGTACTTCGGGCCA	CSAPPGGEETQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	8	0	3	8	1	26	31	47	39	48		TCRBV20-01,TCRBV20-or09_02												CSAPPGGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGAACAACTAATGAAAAACTGTTTTTTGGCAGT	CSAKGTTNEKLFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	0	8	0	3	1	26	34	41	37	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGTTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGACCCAGGGATGAACTATGGCTACACCTTCGGTTCG	CSARDPGMNYGYTF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	2	8	3	26	34	47	42	50		TCRBV20-01,TCRBV20-or09_02												CSARDPGMNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCCCCCCGGGGGGAAAGGGCAATCAGCCCCAGCATTTTGGTGAT	CSAAPPGGKGNQPQHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	1	2	8	5	26	34	49	42	54		TCRBV20-01,TCRBV20-or09_02												CSAAPPGGKGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGATTACAGGGGAATTAGGGGAGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	36	2.3908986458215725E-4		47	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	3	2	17	5	25	26	34	46	39	71		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGATCCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CSARKIPGTGELFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	4	7	0	26	38	-1	45	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARKIPGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTGTGGGGGCCTATGAAGCTTTCTTTGGACAA	CSARPVGAYEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	6	0	7	5	3	26	38	49	43	52		TCRBV20-01,TCRBV20-or09_02												CSARPVGAYEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCTACAGCTCACTGGAAACACCATATATTTTGGAGAG	CSARGLQLTGNTIYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	5	2	4	4	26	39	47	43	51		TCRBV20-01,TCRBV20-or09_02												CSARGLQLTGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAACGAACCTAATGAAAAACTGTTTTTTGGCAGT	CSASNEPNEKLFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	2	8	3	4	2	26	37	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASNEPNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAAAAGGGGCACTATGGCTACACCTTCGGTTCG	CSASEKGHYGYTF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	2	3	5	1	26	37	47	42	48		TCRBV20-01,TCRBV20-or09_02												CSASEKGHYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGAAGAGGGAGGCTATGGCTACACCTTCGGTTCG	CSAREEGGYGYTF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	1	4	8	0	26	35	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAREEGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAGGCACAATAGCGAAGGGCTGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVGTIAKGWNTGELFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	5	6	1	9	8	26	33	47	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSVGTIAKGWNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGAATCGGGACAGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSRIGTGGADTQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	1	4	6	2	24	36	53	42	55		TCRBV24-01,TCRBV24-or09_02												CASSRIGTGGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTCCAGACAGGTATCTCACCCCTCCACTTTGGGAAC	CASSLQTGISPLHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	4	10	5	4	24	36	47	41	51	TCRBV24,TCRBV27													CASSLQTGISPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTCGACAGGGCCGTACGAGCAGTACTTCGGGCCG	CASSSSTGPYEQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	4	5	3	24	36	48	41	51		TCRBV24-01,TCRBV24-or09_02												CASSSSTGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCTGGACAGCCCAAAGAGCACTGAAGCTTTCTTTGGACAA	CASSFLDSPKSTEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	4	5	9	24	36	47	41	56		TCRBV24-01,TCRBV24-or09_02												CASSFLDSPKSTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGTATGGGGCCCTACGAGCAGTACGTCGGGCCG	CASSLGMGPYEQYV	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	17	4	15	19	35	44	39	59		TCRBV05-06,TCRBV05-07												CASSLGMGPYEQYV+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGAAGCTGCGAAGGGCGCCGGGAAGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	36	2.3908986458215725E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	0	11	4	22	35	51	46	55	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTAGGGGTAGGTCAGCCCCAGCATTTTGGTGAT	CASSLGVGQPQHF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	5	5	2	6	2	4	24	36	43	38	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSLGVGQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGACGGGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSDGTGPYEQYF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	2	1	23	36	47	38	48	TCRBV09,TCRBV12													CASSDGTGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCCGGGGCTACTGAAGCTTTCTTTGGACAA	CASSAGATEAFF	In	VDJ	1	36	2.3908986458215725E-4	2.786809103576405E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	3	7	0	5	2	1	23	36	43	38	44	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGATEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTCCCAGGGGGCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSQGAATNEKLFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	0	2	2	26	39	49	41	51		TCRBV12-03,TCRBV12-04												CASSSQGAATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCTCCCTCGGACAAGGAGAGACCCAGTACTTYGGGCCA	CASSLGQGETQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	unresolved		12	1	6	22	10	19	26	31	46	41	65	TCRBV09,TCRBV12							TCRBJ02-01,TCRBJ02-05						CASSLGQGETQYF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	unresolved	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTCAACAGGCTAACTATGGCTACACCTTCGGTTCG	CASSQVQQANYGYTF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	4	0	4	0	26	42	-1	46	51		TCRBV03-01,TCRBV03-02												CASSQVQQANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCTAAGCCTCGGAAGTGAGCAGTTCTTCGGGCCA	CASSRLSLGSEQFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	1	8	9	11	2	26	39	53	50	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLSLGSEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSRGSDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	1	4	0	1	26	-1	44	39	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTCGGGACACCAGGACTGAAGCTTTCTTTGGACAA	CASSRRDTRTEAFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	5	3	5	26	39	48	42	53		TCRBV03-01,TCRBV03-02												CASSRRDTRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCGGGCGAGAGGCTACACCTTCGGTTCG	CSAARARGYTF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	8	0	8	4	4	26	35	43	39	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAARARGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGTCATGGGGGGATTCGGATACGCAGTATTTTGGCCCA	CSAGSWGDSDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	1	6	7	5	26	35	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSAGSWGDSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CYMCCWMYCAGACWTCTRTKTACYTCTGTGCCAGCAGGCATGCGCCTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRHAPSGSSYNEQFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	0	8	0	25	36	-1	44	54	TCRBV06,TCRBV28													CASRHAPSGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGACAACAGGGGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASRQQGAYNSPLHF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	2	3	0	22	33	-1	36	44		TCRBV12-03,TCRBV12-04												CASRQQGAYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTAGCGGGGTTGGAGATACGCAGTATTTTGGCCCA	CATSDPSGVGDTQYF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	5	1	4	24	39	49	40	53		TCRBV24-01,TCRBV24-or09_02												CATSDPSGVGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTATACGGGCCCCCTGGCTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLYGPPGFTGELFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	51	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	8	0	4	6	10	24	36	46	42	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYGPPGFTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGGGGACGGAAATACCGGGGAGCTGTTTTTTGGAGAA	CASRGDGNTGELFF	In	VDJ	1	37	2.457312497094394E-4	2.8642204675646387E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	6	0	7	5	2	6	23	34	41	36	47	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGDGNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQEGSNQPQHF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	0	8	1	0	0	26	-1	-1	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGGGTCCGATTGAGCAGTTCTTCGGGCCA	CSASGPIEQFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	9	2	6	26	34	40	36	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGPIEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAGATTAGGAAATTCCTACACTGAAGCTTTCTTTGGACAA	CSATRLGNSYTEAFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	4	8	3	0	14	26	-1	40	36	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSATRLGNSYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGACAGGGGGCGATGAAAAACTGTTTTTTGGCAGT	CSARDRTGGDEKLFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	0	6	2	1	26	40	53	42	54		TCRBV20-01,TCRBV20-or09_02												CSARDRTGGDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTAGCGGGGGGACACGGGAGTTCTTCGGGCCA	CSARDFSGGTREFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	14	3	7	26	40	53	43	60		TCRBV20-01,TCRBV20-or09_02												CSARDFSGGTREFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSARAGGYNEQFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	3	2	0	26	37	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSARAGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCAGGGAGGTCCGGAGAAAGATACGCAGTATTTTGGCCCA	CSARQGGPEKDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	1	5	5	9	26	35	46	40	55		TCRBV20-01,TCRBV20-or09_02												CSARQGGPEKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCCGATGTCGCATCTTCTATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	38	2.5237263483672155E-4		35	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	11	4	9	10	14	0	26	29	-1	43	46		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGTAGGGGGCCGGTGGCAGTACGTCGGGCCG	CATRVGGRWQYV	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	0	17	3	13	24	35	45	38	58		TCRBV24-01,TCRBV24-or09_02												CATRVGGRWQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGACACAGGGGATGAGCAGTTCTTCGGGCCA	CATSEDTGDEQFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	8	4	0	24	38	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSEDTGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCGGGATACCAAGATACGCAGTATTTTGGCCCA	CASSLAGYQDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42							TCRBJ02	TCRBJ02-03	01	0	0	8	5	0	5	18	-1	39	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGYQDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCGGGACAGGACACAGATACGCAGTATTTTGGCCCA	CASSPGQDTDTQYF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	2	2	1	22	34	44	36	45	TCRBV07,TCRBV11													CASSPGQDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTTTCGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSVSPYNEQFF	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	5	10	0	2	5	0	24	36	-1	41	43	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSPYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGATGTACCTAGCGGGGGCCTGGGTAGGTACGTCGGGCCG	CASSDVPSGGLGRYV	In	VDJ	1	38	2.5237263483672155E-4	2.9416318315528717E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	17	5	14	23	37	52	42	66	TCRBV02,TCRBV12													CASSDVPSGGLGRYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAATCTTTCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	2.590140199640037E-4		50	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	4	6	4	10	10	26	38	50	48	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATATACGAGCGATAGGCAGGGCCTCTGGTAGGCTACACCTTCGGTTCG		Out	VDJ	1	39	2.590140199640037E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	3	8	16	9	26	30	51	46	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGACGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CSADGLAGYNEQFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	4	3	4	0	26	34	-1	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSADGLAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSARDTGANTEAFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	6	0	1	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACCACCCGGGTTCCATAATTCACCCCTCCACTTTGGGAAC	CSARGPPGFHNSPLHF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	8	4	5	7	4	26	39	50	46	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGPPGFHNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSEDSSYNEQFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	0	0	0	24	-1	-1	38	44		TCRBV24-01,TCRBV24-or09_02												CATSEDSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGAGAGGTCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSVRGPGANVLTF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	1	2	3	2	24	37	44	40	46		TCRBV24-01,TCRBV24-or09_02												CATSVRGPGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01*02	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGGTCGCCCCATGACAGGGGTCAAATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVVAP*QGSNYSNQPQHF	Stop	VDJ	1	39	2.590140199640037E-4		66				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	0	14	8	15	29	51	43	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSLVVAP*QGSNYSNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAACTAGTTTTAATCCGTCTTGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQTSFNPSWTNTGELFF	In	VDJ	1	39	2.590140199640037E-4	3.019043195541105E-4	60	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	8	0	0	17	15	-1	35	30	52		TCRBV03-01,TCRBV03-02				01,02								CASSQTSFNPSWTNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAAAGGAAGAGACACCATATATTTTGGAGAG	CASSQEKGRDTIYF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	1	8	8	4	4	26	43	50	47	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEKGRDTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCCTCCCTGGGGCTACACCTTCGGTTCG	CASSQGPPWGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	9	0	8	0	8	26	-1	45	42	53		TCRBV03-01,TCRBV03-02												CASSQGPPWGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAACGGGGGCTACACCTTCGGTTCG	CASSQGNGGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	8	4	0	26	42	-1	46	50		TCRBV03-01,TCRBV03-02				01,02								CASSQGNGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTCAGGGGGGGCCCACCACTGAAGCTTTCTTTGGACAA	CASSQVQGGPTTEAFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	4	1	4	2	7	26	42	51	44	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVQGGPTTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCGCAAGATACTCTCAGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	40	2.656554050912858E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	4	4	15	0	26	32	-1	47	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCCCTCCGGGGGATACATACTATGGCTACACCTTCGGTTCG	CSASPPGDTYYGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	2	3	8	6	26	34	48	42	54		TCRBV20-01,TCRBV20-or09_02												CSASPPGDTYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACACAGGCTCTGGAAACACCATATATTTTGGAGAG	CSANTGSGNTIYF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	4	0	2	0	26	36	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSANTGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTTGGCGGGGGATAGTGAGGGCTTTCTTTGGACAA	CSATWRGIVRAFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	2	11	4	9	26	36	47	40	56		TCRBV20-01,TCRBV20-or09_02												CSATWRGIVRAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAAGCGACAGGGGGCTTTGTGGGTTCACCCCTCCACTTTGGGAAC	CSARQATGGFVGSPLHF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	2	0	9	5	8	26	38	53	43	61		TCRBV20-01,TCRBV20-or09_02												CSARQATGGFVGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCCCGCGGGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CSARPPAGGAGELFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	0	6	6	1	26	38	53	44	54		TCRBV20-01,TCRBV20-or09_02												CSARPPAGGAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCGGGGAGGGTGGAACATTCAGTACTTCGGCGCC	CSARDSRGGWNIQYF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	9	0	7	6	3	26	40	53	46	56		TCRBV20-01,TCRBV20-or09_02												CSARDSRGGWNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGCCCGACGGCCTTCCACAGATACGCAGTATTTTGGCCCA	CSARGARRPSTDTQYF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	2	7	2	6	7	26	39	48	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGARRPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCCTCGGGGGGAAAAACTGTTTTTTGGCAGT	CSARGPRGEKLFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	2	8	5	0	26	39	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSARGPRGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACAGGGCTCAATCAGCCCCAGCATTTTGGTGAT	CSAGTGLNQPQHF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	3	0	2	26	-1	44	35	46		TCRBV20-01,TCRBV20-or09_02												CSAGTGLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCACAGGGGATGAGCTATGGCTACACCTTCGGTTCG	CSASQGMSYGYTF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	2	5	26	35	44	37	49		TCRBV20-01,TCRBV20-or09_02												CSASQGMSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGYACCCCCTAAGGGTATCAGAGCTATGGCTACACCTTCGGTTCG	CASTP*GYQSYGYTF	Stop	VDJ	1	40	2.656554050912858E-4		45	TCRBV24						TCRBJ01	TCRBJ01-02	01	11	5	3	4	10	8	24	31	45	41	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTP*GYQSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTACAGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQGSSYNEQFF	In	VDJ	1	40	2.656554050912858E-4	3.096454559529339E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	0	2	2	18	30	39	32	41	TCRBV05,TCRBV11													CASSLQGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGAAGCAACTATGGCTACACCTTCGGTTCG	CASSQEGSNYGYTF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	1	8	2	1	3	26	43	47	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGSNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTCTCAGGGGGGTATGGCTACACCTTCGGTTCG	CASSQDLSGGYGYTF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	5	5	1	26	43	55	48	56		TCRBV03-01,TCRBV03-02												CASSQDLSGGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGGTACAGGGGGCCAGTTTGGCTACACCTTCGGTTCG	CASSQVGTGGQFGYTF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	0	7	5	5	26	42	56	47	61		TCRBV03-01,TCRBV03-02												CASSQVGTGGQFGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCCCCCGGGACCCCGCAGATGGCTACACCTTCGGTTCG	CASSQFPRDPADGYTF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	2	0	7	6	7	7	26	41	53	48	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFPRDPADGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGAGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	2.72296790218568E-4		43	TCRBV03						TCRBJ01	TCRBJ01-05	01	6	5	2	0	3	2	26	37	45	40	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCGGACAGGGAAGACTATGGCTACACCTTCGGTTCG	CSAPDREDYGYTF	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	3	3	3	26	34	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPDREDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGAGGAAACAAGAGATCGGGCCA	CASSLSRRKQEI	In	VDJ	1	41	2.72296790218568E-4	3.1738659235175723E-4	36				TCRBD02	TCRBD02-01	02	TCRBJ02			6	10	1	20	7	10	24	36	48	43	58	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01						TCRBJ02-01,TCRBJ02-05						CASSLSRRKQEI+X+TCRBJ02-X		TCRBD02-01*02	TCRBJ02	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGTGAACACTGAAGCTTTCTTTGGACAA	CASSQDVNTEAFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	6	0	0	0	26	-1	-1	43	45		TCRBV03-01,TCRBV03-02				01,02								CASSQDVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGTGACAGGATCGGGGGAGCTGTTTTTTGGAGAA	CASSQEVTGSGELFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	4	8	3	4	26	43	52	46	56		TCRBV03-01,TCRBV03-02												CASSQEVTGSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGCAGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSQGAGNNSPLHF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	5	3	1	26	42	50	45	51		TCRBV03-01,TCRBV03-02												CASSQGAGNNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAAACGACAACAATGAGCAGTTCTTCGGGCCA	CASSLNDNNEQFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	5	6	0	26	38	-1	44	48		TCRBV03-01,TCRBV03-02												CASSLNDNNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTAAAGACAGTCACCATGAACACTGAAGCTTTCTTTGGACAA	CSALKTVTMNTEAFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	0	6	6	26	34	45	40	51		TCRBV20-01,TCRBV20-or09_02												CSALKTVTMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGTACAGATACGCAGTATTTTGGCCCA	CSARDQGTDTQYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	5	4	3	3	1	26	40	46	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAATGGGGTCCGGGGGAGTTCTTCGGGCCA	CATSEWGPGEFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	14	8	0	24	38	-1	46	52		TCRBV24-01,TCRBV24-or09_02												CATSEWGPGEFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGGTAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDSGRSYNEQFF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	4	1	0	4	24	-1	44	40	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSGRSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATCCAGCGGGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	2.7893817534585015E-4		40	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	11	6	1	3	7	0	24	31	-1	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGAAACGACAGGTGCTGGAAACACCATATATTTTGGAGAG	CASSETTGAGNTIYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	4	2	5	2	18	30	41	35	43	TCRBV07,TCRBV11													CASSETTGAGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSASSTDTQYF	In	VDJ	1	42	2.7893817534585015E-4	3.251277287505806E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	0	2	0	18	35	-1	37	39	TCRBV07,TCRBV11					01,02								CASSSASSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTTAGGGGCTAGCGCCAGCAATGAGCAGTTCTTCGGGCCA	CASSLGASASNEQFF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	6	6	3	4	26	42	51	45	55	TCRBV02,TCRBV12					01,02								CASSLGASASNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCGCGTCTTACCTGATGACCAAAAACATTCAGTACTTCGGCGCC	CASASYLMTKNIQYF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	12	6	6	2	1	15	26	31	36	32	51	TCRBV12,TCRBV21					01,02								CASASYLMTKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGACGGTTCGGACACAGATACGCAGTATTTTGGCCCA	XASSQDGSDTDTQYF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	0	1	8	2	6	0	23	40	-1	46	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQDGSDTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGAGACAAGGACCTACACAGATACGCAGTATTTTGGCCCA	CASETRTYTDTQYF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	10	1	7	2	9	3	24	31	44	40	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASETRTYTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGGGGACTTTTTCCTATCAGCCCCAGCATTTTGGTGAT	CSASKGTFSYQPQHF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	0	10	5	4	7	26	37	47	41	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASKGTFSYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTAAGGGAGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	43	2.8557956047313226E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	9	1	6	2	0	24	40	-1	42	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATSTCTGTGCCAGCATACTGTATATCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG	CASILYISRKTYGYTF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	48	unresolved						TCRBJ01	TCRBJ01-02	01	7	2	7	4	19	0	18	28	-1	47	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASILYISRKTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCCAGACCCAGGGAGTTCGGGGCTACACCTTCGGTTCG	CASSQTQGVRGYTF	In	VDJ	1	43	2.8557956047313226E-4	3.3286886514940394E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	4	3	8	6	7	19	31	42	37	49	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTQGVRGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCCGGACAGATTACAATGAGCAGTTCTTCGGGCCA	CSASRTDYNEQFF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	5	4	5	2	26	34	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSASRTDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTCCCGTTTCGGGGAGATGGAAACACCATATATTTTGGAGAG	CSAFPFRGDGNTIYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	8	3	3	10	3	26	34	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAFPFRGDGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGACAGAGGGCACAGATACGCAGTATTTTGGCCCA	CSARDPTEGTDTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	5	1	3	3	26	40	48	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDPTEGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGGACTGGCGGTCGACCCAGTACTTCGGGCCA	CSAADWRSTQYF	In	VDJ	1	44	2.922209456004144E-4	3.406100015482273E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	10	7	2	7	26	35	42	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAADWRSTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGCTAAGACCCAACCCGGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	2.922209456004144E-4		53	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	2	6	15	0	24	40	-1	55	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGTAAAGGAAAGATAAGGACGACGGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	2.922209456004144E-4		61	unresolved						TCRBJ02	TCRBJ02-06	01	1	1	7	2	14	5	19	34	52	48	57	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAATGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	2.988623307276966E-4		34	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	10	6	5	0	26	40	-1	45	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGATAATGAAAAACTGTTTTTTGGCAGT	CASSQGDNEKLFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	39	TCRBV03						TCRBJ01	TCRBJ01-04	01	3	6	1	4	0	1	26	-1	45	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCATACGGACAGGGTCAGAGACCCAGTACTTCGGGCCA	CAIRTGSETQYF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	1	3	4	3	2	26	33	44	36	46		TCRBV03-01,TCRBV03-02												CAIRTGSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCACGGGACTTTGGTGAAAAACTGTTTTTTGGCAGT	CSARARDFGEKLFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	0	10	7	3	4	26	39	48	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARARDFGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGATCACTAGCGGGGAGACAGATACGCAGTATTTTGGCCCA	CSARGITSGETDTQYF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	3	3	3	5	2	26	39	54	44	56		TCRBV20-01,TCRBV20-or09_02												CSARGITSGETDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAACTAGCGGGGGGGCTTGGTGAGCAGTTCTTCGGGCCA	CSARELAGGLGEQFF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	3	0	9	3	5	26	37	53	40	58		TCRBV20-01,TCRBV20-or09_02												CSARELAGGLGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCACCCAGTCAATTACAGGGTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	45	2.988623307276966E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	0	13	2	24	35	54	48	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTACGAGGGTCAGGCACAGATACGCAGTATTTTGGCCCA	CASSLRGSGTDTQYF	In	VDJ	1	45	2.988623307276966E-4	3.4835113794705065E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	11	0	1	1	4	18	33	39	34	43	TCRBV07,TCRBV11													CASSLRGSGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGGGCGTGAAAAACTGTTTTTTGGCAGT	CASSQDPGREKLFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	0	7	0	7	3	1	26	43	51	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPGREKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCAGTGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSQGSGMNTEAFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	8	0	5	0	26	42	-1	47	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSGMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGCCGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGAGGANVLTF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	6	0	3	0	3	26	-1	46	40	49		TCRBV03-01,TCRBV03-02												CASSQGAGGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAGGACTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	3.055037158549787E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	1	10	4	3	13	26	39	47	42	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGGGGGGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSSGGAGEKLFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	0	7	2	4	26	38	48	40	52		TCRBV03-01,TCRBV03-02												CASSSGGAGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAAGGATGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	3.055037158549787E-4		44	TCRBV24						TCRBJ01	TCRBJ01-05	01	3	1	8	2	3	3	24	39	45	42	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTCGGACAGGGAAGACCTTCGCTGGAAGCAGTACGTCGGGCCG	CASSFSDREDLRWKQYV	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	17	5	24	24	36	49	41	73		TCRBV24-01,TCRBV24-or09_02												CASSFSDREDLRWKQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGGGAGGGGTGTTTTTGGTGAAAAACTGTTTTTTGGCAGT	CASGRGVFGEKLFF	In	VDJ	1	46	3.055037158549787E-4	3.56092274345874E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	0	7	0	10	23	-1	39	32	49	TCRBV09,TCRBV12													CASGRGVFGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSQGQGDTEAFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	3	2	0	26	42	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQGQGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCAGACAGGATTGAGGGAGACCCAGTACTTCGGGCCA	CSQTGLRETQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	2	4	5	3	7	26	31	40	34	47		TCRBV20-01,TCRBV20-or09_02												CSQTGLRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAGCCTGTGGAGGCAGGTCGCGGAACTGAAGCTTTCTTTGGACAA	CSAQPVEAGRGTEAFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	5	9	11	26	34	48	43	59		TCRBV20-01,TCRBV20-or09_02												CSAQPVEAGRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGCGGGGGGCGGGCCCCGCAGTTCTTCGGGCCA	CSATSGGRAPQFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	1	12	2	8	26	36	47	38	55		TCRBV20-01,TCRBV20-or09_02												CSATSGGRAPQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGAGACAGGGTTGAAACAGCCCCAGCATTTTGGTGAT	CSARDETGLKQPQHF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	3	7	3	6	26	40	50	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDETGLKQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CSARGQLNTEAFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	0	0	1	26	-1	44	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCGAGGGGATTACTATCTGCGGGGGCCAACGTCCTGACTTTCGGGGCC	CSASARGLLSAGANVLTF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	54	TCRBV20						TCRBJ02	TCRBJ02-06	01	3	5	2	4	4	13	26	37	46	41	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASARGLLSAGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAAGCGGACAATGAGCAGTTCTTCGGGCCA	CSASQADNEQFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	5	3	0	26	37	-1	40	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSASQADNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGGGGCCTCTCTGGAGACCCAGTACTTCGGGCCA	CSASGGASLETQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	5	1	8	26	37	45	38	53		TCRBV20-01,TCRBV20-or09_02												CSASGGASLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACAGGGGAACGAGCAGTACGTCGGGCCG	CSALQGNEQYV	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	17	2	13	26	35	44	37	57		TCRBV20-01,TCRBV20-or09_02												CSALQGNEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCCGGGACTAGCGGGGGCCGGGTGAACAATGAGCAGTTCTTCGGGCCA	CATSDSGTSGGRVNNEQFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	57	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	5	4	8	24	38	56	42	64		TCRBV24-01,TCRBV24-or09_02												CATSDSGTSGGRVNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGGGACAGGGATGAAGCTTTCTTTGGACAA	CATSDRDRDEAFF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	7	1	1	24	39	49	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDRDRDEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCACTGCAATCAGAGACAACTACGAGCAGTACTTCGGGCCG	CASTAIRDNYEQYF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	6	3	11	1	18	28	43	39	44	TCRBV07,TCRBV11													CASTAIRDNYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCCGGGCGGCGGGATCAGCCCCAGCATTTTGGTGAT	CASSPGRRDQPQHF	In	VDJ	1	47	3.1214510098226086E-4	3.638334107446973E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	7	4	5	9	0	20	31	-1	40	45	TCRBV07,TCRBV23					01,02								CASSPGRRDQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGCTAGCGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQDASGGQETQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	2	2	0	26	43	-1	45	56		TCRBV03-01,TCRBV03-02												CASSQDASGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGCGGGACTAGCGGAGGTCACAGATACGCAGTATTTTGGCCCA	CSATAGLAEVTDTQYF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	5	2	4	4	26	36	51	40	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSATAGLAEVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCTGGACCCAAACACTGAAGCTTTCTTTGGACAA	CSASLDPNTEAFF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	1	7	2	5	3	26	35	44	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLDPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCCCGTATCGGGCAGGGGAATGATGGCTACACCTTCGGTTCG	CASSEARIGQGNDGYTF	In	VDJ	1	48	3.18786486109543E-4	3.7157454714352065E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	6	15	4	22	34	55	49	59	TCRBV02,TCRBV12													CASSEARIGQGNDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCTTGCGGGACAGGTAAGAAGAGACCCAGTACTTCGGGCCA	CASSLLRDR*EETQYF	Stop	VDJ	1	49	3.2542787123682513E-4		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	3	6	4	23	36	50	42	54	TCRBV01,TCRBV04													CASSLLRDR*EETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGTTTGCTCCCATCCATTCCGACAATGAGCAGTTCTTCGGGCCA	CASSGFAPIHSDNEQFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	51	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	0	9	5	0	19	26	-1	41	38	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGFAPIHSDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCGAGATTAAATACTACAGGGGGCGCCGGGGCAGCCCCAGCATTTTGGTGAT	CSRD*ILQGAPGQPQHF	Stop	VDJ	1	49	3.2542787123682513E-4		51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	0	7	14	7	26	32	55	46	62		TCRBV20-01,TCRBV20-or09_02												CSRD*ILQGAPGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGTTCTGTCGGAAATCAGCCCCAGCATTTTGGTGAT	CSARDGGSVGNQPQHF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	6	1	4	1	10	26	40	46	41	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGGSVGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCTCCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	49	3.2542787123682513E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	8	0	7	0	3	26	-1	43	39	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGAAACTATGGCTACACCTTCGGTTCG	CSASGGNYGYTF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	2	2	0	1	26	-1	43	37	44		TCRBV20-01,TCRBV20-or09_02												CSASGGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGACAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSDRDRDTGELFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	3	1	0	24	39	-1	40	49		TCRBV24-01,TCRBV24-or09_02												CATSDRDRDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCCATTCACCTCGGGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	49	3.2542787123682513E-4		44				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	8	3	4	9	0	18	30	-1	39	44	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-03		TCRBD02-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCCATCAGGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSSHQGLNTEAFF	In	VDJ	1	49	3.2542787123682513E-4	3.79315683542344E-4	45	TCRBV05						TCRBJ01	TCRBJ01-01	01	3	0	7	0	7	0	19	32	-1	39	44		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSHQGLNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCTAGCGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSASGGQETQYF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	2	2	1	26	37	49	39	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSASGGQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTCGGACCGAGATACGCAGTATTTTGGCCCA	CASSLSDRDTQYF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	1	7	5	3	2	26	40	47	43	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSDRDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGTGGGGCAGATACGCAGTATTTTGGCCCA	CASSQDSGADTQYF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	6	2	4	4	0	26	43	-1	47	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATCCACAGATACGCAGTATTTTGGCCCA	CASSPSTDTQYF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	6	2	0	2	26	-1	41	39	43		TCRBV03-01,TCRBV03-02												CASSPSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATTAGCGGGGGGCGACCTCAATGAGCAGTTCTTCGGGCCA	CASSSLAGGDLNEQFF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	6	4	6	26	38	52	42	58		TCRBV03-01,TCRBV03-02												CASSSLAGGDLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGTGAGACCCAGTACTTCGGGCCA	CSARDSETQYF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	5	5	0	1	26	-1	43	40	44		TCRBV20-01,TCRBV20-or09_02												CSARDSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGTCGGAGAATATAGCTACACCTTCGGTTCG	CSARVVGEYSYTF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	9	5	6	26	39	48	44	54		TCRBV20-01,TCRBV20-or09_02												CSARVVGEYSYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGACAGGGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASRTGYSGANVLTF	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	0	2	2	26	37	47	39	49		TCRBV20-01,TCRBV20-or09_02												CSASRTGYSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	1	50	3.320692563641073E-4	3.8705681994116736E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	33	48	60	54	79		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGAGACTAGCGCCCACAGATACGCAGTATTTTGGCCCA	CASSRRLAPTDTQYF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	6	2	3	2	26	39	50	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSRRLAPTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACGGGGGAAGGGGTGAAAAACTGTTTTTTGGCAGT	CSARDYGGRGEKLFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	2	7	3	6	26	40	49	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDYGGRGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGCAGGGAGAAGGCACCGGGGAGCTGTTTTTTGGAGAA	CSASGQGEGTGELFF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	4	3	4	4	6	26	37	46	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGQGEGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCCGACGGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSDGDSGANVLTF	In	VDJ	1	51	3.3871064149138946E-4	3.947979563399907E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	2	0	6	1	24	36	46	42	47	TCRBV09,TCRBV21													CASSSDGDSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGTCTCAGGGAGGTCACCCCTCCACTTTGGGAAC	CASSQVVSGRSPLHF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	9	1	10	8	0	26	42	-1	50	56		TCRBV03-01,TCRBV03-02												CASSQVVSGRSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGAACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASSLEQGDTEAFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	3	0	2	26	-1	49	43	51		TCRBV03-01,TCRBV03-02												CASSLEQGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTAGAGATGACTGGATCAATGAGCAGTTCTTCGGGCCA	CNARDDWINEQFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	10	6	1	4	26	40	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CNARDDWINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGTCGGGGGGCCACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	52	3.4535202661867156E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	8	4	26	35	50	43	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCACGGGCGGACTCTATGGCTACACCTTCGGTTCG	CATSDTTGGLYGYTF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	1	10	4	9	0	24	39	-1	48	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDTTGGLYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGGGCCTGGGGCGTACACCGGGGAGCTGTTTTTTGGAGAA	CATSDFGPGAYTGELFF	In	VDJ	1	52	3.4535202661867156E-4	4.0253909273881407E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	3	7	2	24	41	53	48	55		TCRBV24-01,TCRBV24-or09_02												CATSDFGPGAYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCAACAAAGGGGATACGAGCAGTACGTCGGGCCG		Out	VDJ	1	53	3.5199341174595373E-4		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	17	5	14	23	35	45	40	59	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCCTGAGGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	53	3.5199341174595373E-4		35	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	11	1	8	5	1	26	36	45	41	46		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAACGCCAGGGTAGCTGGAGAGACCCAGTACTTCGGGCCA	CASSRNARVAGETQYF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	4	7	7	26	39	51	46	58		TCRBV03-01,TCRBV03-02												CASSRNARVAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCCGAACACTGAAGCTTTCTTTGGACAA	CAISDPNTEAFF	In	VDJ	1	53	3.5199341174595373E-4	4.102802291376374E-4	36							TCRBJ01	TCRBJ01-01	01	5	2	7	1	0	2	23	-1	38	35	40	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDPNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTCCGACCTCGGGACAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSSDLGTGGEKLFF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	0	8	8	0	24	37	-1	45	57		TCRBV06-05,TCRBV06-06												CASSSDLGTGGEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACGACAGCTCGGTACGCAGTATTTTGGCCCA	CASSLRQLGTQYF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	8	3	5	26	39	47	42	52		TCRBV03-01,TCRBV03-02												CASSLRQLGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGATGATGCTCCTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	55	3.6527618200051805E-4		46	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	2	8	5	0	16	26	-1	40	38	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCTCAGGGGTGCTAATGAAAAACTGTTTTTTGGCAGT	CSAPLRGANEKLFF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	3	5	2	26	35	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAPLRGANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTTCTGTGCCAGCAGCGTAGCTACGGGGGGACAGGGGGCCATAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVATGGQGAISSGANVLTF	In	VDJ	1	55	3.6527618200051805E-4	4.257625019352841E-4	66	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	0	0	11	6	4	16	39	27	45		TCRBV21-or09_02,TCRBV21-01												CASSVATGGQGAISSGANVLTF+TCRBV21-X+TCRBJ02-06	TCRBV21	TCRBD01-01*01	TCRBJ02-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGACCGAGGGAAACACCATATATTTTGGAGAG	CASSQDRTEGNTIYF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	0	1	7	4	2	4	23	40	46	42	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRTEGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGACTACCGCGGGAGCCGCGAAGAGGAGACCCAGTACTTCGGGCCA	CSAPDYRGSREEETQYF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	2	5	11	10	26	34	52	45	62		TCRBV20-01,TCRBV20-or09_02												CSAPDYRGSREEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGCTCGTCTTAACAATGAGCAGTTCTTCGGGCCA	CSAREARLNNEQFF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	7	5	0	8	26	-1	43	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREARLNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGACAGTCTATGGCTACACCTTCGGTTCG	CSARDPTVYGYTF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	4	3	1	26	40	48	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDPTVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGACAGGGTCTGGACACCATATATTTTGGAGAG	CSAPRQGLDTIYF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	8	4	5	26	35	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSAPRQGLDTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCGAGTGGAAACACCATATATTTTGGAGAG	CSAPSSGNTIYF	In	VDJ	1	56	3.7191756712780016E-4	4.3350363833410743E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	2	3	5	0	26	35	-1	40	43		TCRBV20-01,TCRBV20-or09_02												CSAPSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTTTCCGGGGCGGCTGAAGCTTTCTTTGGACAA	CASSQDLSGAAEAFF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	7	0	6	7	2	26	43	55	50	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLSGAAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGCCGGGACTAGCCATTGCTAGCACAGATACGCAGTATTTTGGCCCA	CSAEPGLAIASTDTQYF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	0	5	7	26	35	49	40	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEPGLAIASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCCCGGGACAGGACTATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	57	3.785589522550823E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	1	5	5	26	35	48	40	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAACTCCTGGCTCAGGGGAGCAGTATTTTGGCCCA	CASSLTPGSGEQYF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	11	11	1	19	33	50	44	51	TCRBV05,TCRBV11													CASSLTPGSGEQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGTGGACTAGCGGGGTTCGACGAGCAGTACTTCGGGCCG	CASSGGLAGFDEQYF	In	VDJ	1	57	3.785589522550823E-4	4.412447747329308E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	5	2	4	23	36	50	38	54	TCRBV09,TCRBV21													CASSGGLAGFDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCAGGTCGACCAGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	58	3.852003373823645E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	2	2	10	23	40	46	42	56	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCCCGCTGGGGAGGATAGTACGCAAATACAATGAGCAGTTCTTCGGGCCA	CSASPLGRIVRKYNEQFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	4	10	12	26	34	50	44	62		TCRBV20-01,TCRBV20-or09_02												CSASPLGRIVRKYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGACAGGAGATTAATGAGCAGTTCTTCGGGCCA	CSARDLGQEINEQFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	7	4	5	26	40	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDLGQEINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAGCGAAATGAGCAGTTCTTCGGGCCA	CATSDLQRNEQFF	In	VDJ	1	58	3.852003373823645E-4	4.4898591113175414E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	7	1	1	24	42	47	43	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLQRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TTCTACATCTGCAGTGCTAGATTGATTGTATGTTGAGACAGGGGCAGTTGGGGCACCTACGAGCAGTACGTCGGGCCG	CSARLIVC*DRGSWGTYEQYV	Stop	VDJ	1	58	3.852003373823645E-4		63	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	17	15	26	9	21	44	36	70		TCRBV20-01,TCRBV20-or09_02												CSARLIVC*DRGSWGTYEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGATCCCCAATCAGCCCCAGCATTTTGGTGAT	CASSQIPNQPQHF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	3	2	8	3	0	4	26	-1	42	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQIPNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAGGGACAGCCTCTGGAAACACCATATATTTTGGAGAG	CSARPGTASGNTIYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	5	0	3	1	26	38	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARPGTASGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGCTGAACACTGAAGCTTTCTTTGGACAA	CSARDWLNTEAFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	0	2	0	26	40	-1	42	45		TCRBV20-01,TCRBV20-or09_02												CSARDWLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCAGAGGGGGGAGGGAAGACTACGAGCAGTACTTCGGGCCG	CSVRGGREDYEQYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	9	0	3	8	4	26	33	48	41	52		TCRBV20-01,TCRBV20-or09_02												CSVRGGREDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGGGTCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	59	3.918417225096466E-4		41	TCRBV24						TCRBJ01	TCRBJ01-03	01	4	6	1	2	0	2	24	-1	43	38	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAAGGACAGGGGTCTTCTCTGGAAACACCATATATTTTGGAGAG	CATSGRTGVFSGNTIYF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	2	0	3	4	24	37	49	40	53		TCRBV24-01,TCRBV24-or09_02												CATSGRTGVFSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCGGACGGGGACCGATCAGCAAATAAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	59	3.918417225096466E-4		56	unresolved						TCRBJ01	TCRBJ01-06	01	6	0	7	5	6	14	23	34	45	40	59	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGGACTGACCGACTTGTACTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEGLTDLYSTNEKLFF	In	VDJ	1	59	3.918417225096466E-4	4.567270475305775E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	0	4	14	23	34	43	38	57	TCRBV09,TCRBV12					01,02								CASSEGLTDLYSTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTAGCGGGGATACAAGAGACCCAGTACTTCGGGCCA	CASSLLAGIQETQYF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	2	0	3	26	-1	50	41	53		TCRBV12-03,TCRBV12-04												CASSLLAGIQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAGGACAGGGGGTGATTCCCTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSEKDRG*FPPYNEQFF	Stop	VDJ	2	60	3.9848310763692876E-4		57	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	1	2	2	10	23	38	50	40	60		TCRBV06-01,TCRBV06-08												CASSEKDRG*FPPYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCGGCCTCCGGGGACAGGGAACTTGAACACTGAAGCTTTCTTTGGACAA	CASSQRPPGTGNLNTEAFF	In	VDJ	2	60	3.9848310763692876E-4	4.6446818392940084E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	0	10	4	24	38	57	48	61		TCRBV03-01,TCRBV03-02												CASSQRPPGTGNLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTAGGACTAGTGACTGAAGCTTTCTTTGGACAA	CASSLGLVTEAFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	8	5	4	2	26	37	48	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLGLVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGCCGAGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	61	4.051244927642109E-4		47	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	5	2	1	7	0	26	41	-1	48	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGACAGATGAAAAACTGTTTTTTGGCAGT	CSARTDEKLFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	6	2	0	26	34	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CSARTDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTACAGGGGCTTGGGAGCAGTTCTTCGGGCCA	CSARPTGAWEQFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	2	10	3	5	26	38	48	41	53		TCRBV20-01,TCRBV20-or09_02												CSARPTGAWEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	2	61	4.051244927642109E-4	4.722093203282242E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	3	3	26	37	49	40	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCACCGGGACGGATAATGAAAAACTGTTTTTTGGCAGT	CASSSTGTDNEKLFF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	4	0	7	4	5	3	26	39	49	44	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGTDNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGCAGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSLRQGNEKLFF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	5	3	0	26	41	-1	44	50		TCRBV12-03,TCRBV12-04												CASSLRQGNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAAGTACTAGCGGGGGGACCCTGAGCACAGATACGCAGTATTTTGGCCCA	CSAKSTSGGTLSTDTQYF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	0	7	6	26	34	53	41	59		TCRBV20-01,TCRBV20-or09_02												CSAKSTSGGTLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGACAGCTATACAATGAGCAGTTCTTCGGGCCA	CSARVGQLYNEQFF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	5	4	1	3	26	39	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSARVGQLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACAGGGGCCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDRGRNTGELFF	In	VDJ	2	62	4.1176587789149303E-4	4.7995045672704755E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	1	1	3	23	34	43	35	46	TCRBV02,TCRBV09													CASSDRGRNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCGGCGCGCAGGCTCTGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	63	4.184072630187752E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	4	8	10	6	26	40	54	50	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAGAACGGAGCGGGGGCTGGACTACAATGAGCAGTTCTTCGGGCCA	CSATRTERGLDYNEQFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	3	9	5	26	36	53	45	58		TCRBV20-01,TCRBV20-or09_02												CSATRTERGLDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCAGGGGGCAAGGCCGGGGAGCTGTTTTTTGGAGAA	CSARAGGKAGELFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	6	2	4	26	37	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSARAGGKAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAGACCAGGAGGATAACACTGAAGCTTTCTTTGGACAA	CATRDQEDNTEAFF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	1	2	6	2	24	35	46	41	48		TCRBV24-01,TCRBV24-or09_02												CATRDQEDNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGTCTGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSVWDSSYEQYF	In	VDJ	2	63	4.184072630187752E-4	4.876915931258709E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	0	4	0	18	30	-1	34	41	TCRBV07,TCRBV11													CASSVWDSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	64	4.2504864814605736E-4		37	TCRBV24						TCRBJ01	TCRBJ01-01	01	3	5	5	1	1	0	24	39	-1	40	42		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCCTCGACGGGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPRRGSSYNSPLHF	In	VDJ	2	64	4.2504864814605736E-4	4.954327295246942E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	7	8	3	0	7	3	24	35	47	42	50	TCRBV24,TCRBV27													CASSPRRGSSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRMNTGELFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	2	8	1	0	1	26	-1	39	37	40		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATAGTGAAGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDIVKGTNEKLFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	51	TCRBV03						TCRBJ01	TCRBJ01-04	01	0	5	3	1	8	0	26	43	-1	51	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDIVKGTNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAAGTACAGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CSARDLSTGGMNTEAFF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	1	0	7	2	26	40	55	47	57		TCRBV20-01,TCRBV20-or09_02												CSARDLSTGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAAGACCGATATCCAATCAGCCCCAGCATTTTGGTGAT	CAISERPISNQPQHF	In	VDJ	2	65	4.3169003327333947E-4	5.031738659235176E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	2	2	7	3	1	7	23	38	42	39	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISERPISNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGGACGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDVSSYNEQFF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	1	7	0	3	5	26	34	41	37	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEDVSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGAGGGAGATGGAAGCTTTCTTTGGACAA	CSARDRREMEAFF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	8	2	5	26	40	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDRREMEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTCGGACAGGTACGCGAGCAGTACTTCGGGCCG	CASSVGQVREQYF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	6	3	4	22	34	44	37	48	TCRBV02,TCRBV12													CASSVGQVREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAGGAGGGGGTTTCTATGGCTACACCTTCGGTTCG	CASSLGGGFYGYTF	In	VDJ	2	66	4.3833141840062163E-4	5.109150023223409E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	2	5	1	4	3	3	19	33	42	36	45	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLGGGFYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCCGGGCCTAGCCCCAGATACGCAGTATTTTGGCCCA	CASSPPGLAPDTQYF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	7	4	10	2	26	37	52	47	54	TCRBV09,TCRBV12					01,02								CASSPPGLAPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGCCACACAGATACGCAGTATTTTGGCCCA	CSASGGHTDTQYF	In	VDJ	2	67	4.449728035279038E-4	5.186561387211643E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	6	0	2	1	2	26	37	44	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCTCGGGTGGGGGGGAGAATGAGCAGTTCTTCGGGCCA	CSARDPSGGGENEQFF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	7	10	2	26	40	57	50	59		TCRBV20-01,TCRBV20-or09_02												CSARDPSGGGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTCGTGGACTGCCTCCACAGATACGCAGTATTTTGGCCCA	CASSSWTASTDTQYF	In	VDJ	2	68	4.516141886551859E-4	5.263972751199876E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	10	2	4	5	23	35	44	39	49	TCRBV09,TCRBV12					01,02								CASSSWTASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTCGAAGGGACAGGGACCCAATGAGCAGTTCTTCGGGCCA	CASSSKGQGPNEQFF	In	VDJ	2	70	4.6489695890975023E-4	5.418795479176343E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	6	3	18	29	44	35	47	TCRBV07,TCRBV11													CASSSKGQGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTAGAGGGACGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDFRGTVNTGELFF	In	VDJ	2	72	4.781797291643145E-4	5.57361820715281E-4	51	TCRBV24						TCRBJ02	TCRBJ02-02	01	1	0	7	1	4	3	24	41	50	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFRGTVNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGACTAGGACAGTATGGCGGGGAGCTGTTTTTTGGAGAA	CASRLGQYGGELFF	In	VDJ	2	72	4.781797291643145E-4	5.57361820715281E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	7	4	5	19	30	40	34	45		TCRBV05-06,TCRBV05-07												CASRLGQYGGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGACCCCTCGAGCTACACCTTCGGTTCG	CASSQGDPSSYTF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	0	7	9	0	7	26	-1	47	42	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDPSSYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGGCGAAAGCGGGGGCTATGAAGGGGATGAGCAGTTCTTCGGGCCA	CASSVGESGGYEGDEQFF	In	VDJ	2	73	4.8482111429159667E-4	5.651029571141044E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	8	5	11	23	39	52	44	63	TCRBV09,TCRBV12													CASSVGESGGYEGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACAGGGGGTGAACATTCAGTACTTCGGCGCC	CSARPGQGVNIQYF	In	VDJ	2	74	4.914624994188788E-4	5.728440935129277E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	1	7	3	2	26	37	51	40	53		TCRBV20-01,TCRBV20-or09_02												CSARPGQGVNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGCTTTCAGGTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGFQVANTGELFF	In	VDJ	2	75	4.98103884546161E-4	5.805852299117511E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	4	0	8	3	26	39	51	47	54		TCRBV03-01,TCRBV03-02												CASSPGFQVANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACCGGGACTACTAAATCAGCCCCAGCATTTTGGTGAT	CSARGPGLLNQPQHF	In	VDJ	2	75	4.98103884546161E-4	5.805852299117511E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	9	4	4	3	26	39	50	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGPGLLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCCGGGACTAGCGGAATATACAATGAGCAGTTCTTCGGGCCA	CASGTSGIYNEQFF	In	VDJ	2	76	5.047452696734431E-4	5.883263663105743E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	0	5	4	3	4	24	30	44	33	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASGTSGIYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCACAGGGTCACCTCTGGAAACACCATATATTTTGGAGAG	CASSQGHRVTSGNTIYF	In	VDJ	2	77	5.113866548007252E-4	5.960675027093977E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	3	0	3	4	26	42	51	45	55		TCRBV03-01,TCRBV03-02												CASSQGHRVTSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCAGCTTCTACATCTGCAGTGCTAGATCAGATACTAGCGGGGGGAAGGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARSDTSGGKAGSYNEQFF	In	VDJ	2	78	5.180280399280074E-4	6.03808639108221E-4	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	1	6	9	15	27	45	33	54		TCRBV20-01,TCRBV20-or09_02												CSARSDTSGGKAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGGGACAGCATGAAAAACTGTTTTTTGGCAGT	CASSPGQHEKLFF	In	VDJ	2	78	5.180280399280074E-4	6.03808639108221E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	3	1	26	37	47	40	48		TCRBV03-01,TCRBV03-02												CASSPGQHEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGATTACTCTGGAAACACCATATATTTTGGAGAG	CASSPDYSGNTIYF	In	VDJ	2	79	5.246694250552895E-4	6.115497755070444E-4	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	1	8	0	1	3	26	39	43	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDYSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAACTAGCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAELASSYNEQFF	In	VDJ	2	79	5.246694250552895E-4	6.115497755070444E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	7	0	3	3	26	34	43	37	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAELASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGATGCGAGACTAGCGGGGGGCGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDARLAGGGDSYNEQFF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	0	5	6	15	29	47	34	53		TCRBV20-01,TCRBV20-or09_02												CSARDARLAGGGDSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGTGGGACAGAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGWDRSSGNTIYF	In	VDJ	2	80	5.313108101825716E-4	6.192909119058678E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	3	3	23	36	46	39	49	TCRBV09,TCRBV21													CASSGWDRSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACTAGCGGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGGYTGELFF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	0	3	0	1	26	-1	56	42	57		TCRBV12-03,TCRBV12-04												CASSLGLAGGYTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTAGGGAGACTTTACAATGAGCAGTTCTTCGGGCCA	CASSELGRLYNEQFF	In	VDJ	2	81	5.379521953098539E-4	6.270320483046911E-4	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	2	4	3	4	23	38	46	41	50		TCRBV06-01,TCRBV06-08												CASSELGRLYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAAGGGGGCTATGGCTACACCTTCGGTTCG	CSAREEGGYGYTF	In	VDJ	2	82	5.44593580437136E-4	6.347731847035145E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	4	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAREEGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCAGGGACGGGTGGCTACACCTTCGGTTCG	CASSESGTGGYTF	In	VDJ	2	83	5.512349655644181E-4	6.425143211023378E-4	39	TCRBV06						TCRBJ01	TCRBJ01-02	01	2	0	7	7	3	3	23	38	46	41	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESGTGGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCGGGCGGGGGGACCTTACAATGAGCAGTTCTTCGGGCCA	CASRAGGPYNEQFF	In	VDJ	2	84	5.578763506917003E-4	6.502554575011612E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	1	4	3	4	22	31	42	34	46	TCRBV02,TCRBV12													CASRAGGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCCTTTGGGGGGGCCGAGGCAGCCCCAGCATTTTGGTGAT	XASSPLGGPRQPQHF	In	VDJ	2	84	5.578763506917003E-4	6.502554575011612E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	7	5	6	22	34	46	39	52	TCRBV01,TCRBV07,TCRBV17													XASSPLGGPRQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATGGGGATATAATTCACCCCTCCACTTTGGGAAC	CASSLWGYNSPLHF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	6	0	8	4	5	0	24	36	-1	41	45	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGGGGCGGGGGGAACCCAAGAGACCCAGTACTTCGGGCCA	CASSEGAGGTQETQYF	In	VDJ	2	85	5.645177358189824E-4	6.579965938999845E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	1	1	2	3	23	39	49	41	52	TCRBV02,TCRBV12													CASSEGAGGTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGAGCATAACGACGGCGAAAAACTGTTTTTTGGCAGT	CASSQGEHNDGEKLFF	In	VDJ	2	86	5.711591209462645E-4	6.657377302988079E-4	48	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	2	7	8	11	3	26	42	56	53	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGEHNDGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAAATTTAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEKFNSYNEQFF	In	VDJ	2	88	5.844418912008288E-4	6.812200030964546E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	9	0	6	1	26	43	51	49	52		TCRBV03-01,TCRBV03-02				01,02								CASSQEKFNSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCATCGATTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	88	5.844418912008288E-4		52	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	2	8	5	5	16	26	38	45	43	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCGGGACTAGAATCCGGGGAGCTGTTTTTTGGAGAA	CSAKPGLESGELFF	In	VDJ	2	88	5.844418912008288E-4	6.812200030964546E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	8	6	4	3	26	36	48	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKPGLESGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGACTAGCGGGGGACGGGACCCAGTACTTCGGGCCA		Out	VDJ	2	88	5.844418912008288E-4		43	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	2	2	7	2	4	26	38	52	40	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTGGGGGATCCCAAAGAGACCCAGTACTTCGGGCCA	CATSDLGDPKETQYF	In	VDJ	2	88	5.844418912008288E-4	6.812200030964546E-4	45	TCRBV24						TCRBJ02	TCRBJ02-05	01	4	6	1	3	3	6	24	38	46	41	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLGDPKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCAAGGGAGGGAGGCCGAAGGTTATAGGGGGCAGAAACACCATATATTTTGGAGAG		Out	VDJ	2	88	5.844418912008288E-4		56	TCRBV24						TCRBJ01	TCRBJ01-03	01	12	5	0	5	25	1	24	30	62	55	63		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	89	5.91083276328111E-4		35	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	2	8	4	2	2	26	39	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGDTGELFF	In	VDJ	2	90	5.977246614553932E-4	6.967022758941013E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	3	3	4	0	26	39	-1	43	48		TCRBV03-01,TCRBV03-02												CASSPPGDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGAACGTGGGCACTGAAGCTTTCTTTGGACAA	CSAREGNVGTEAFF	In	VDJ	2	90	5.977246614553932E-4	6.967022758941013E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	8	4	1	7	26	40	45	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGNVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAAACAGGGCTCGCCATGGGTACGCAGTATTTTGGCCCA	CSARETGLAMGTQYF	In	VDJ	2	90	5.977246614553932E-4	6.967022758941013E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	8	4	11	26	37	47	41	58		TCRBV20-01,TCRBV20-or09_02												CSARETGLAMGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCTAGTAGCCGCGGGGGCAGATACGCAGTATTTTGGCCCA	CSARLVAAGADTQYF	In	VDJ	2	92	6.110074317099574E-4	7.12184548691748E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	4	12	0	26	35	-1	47	54		TCRBV20-01,TCRBV20-or09_02												CSARLVAAGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGGATGACAGGGGAGGTGTTTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	94	6.242902019645217E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	9	7	6	26	39	54	46	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGGTATTGCGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	97	6.442143573463681E-4		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	5	2	7	0	24	37	-1	44	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCCCGTTCGCGGGGCTGAAGACCCAGTACTTCGGGCCA	CASSPFAGLKTQYF	In	VDJ	2	98	6.508557424736503E-4	7.58631367084688E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	6	7	4	26	37	50	44	54	TCRBV07,TCRBV12													CASSPFAGLKTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCGGAGGGGGACACCAAAAATGATAATTCACCCCTCCACTTTGGGAAC	CASSEAEGDTKNDNSPLHF	In	VDJ	3	99	6.574971276009325E-4	7.663725034835114E-4	57	unresolved						TCRBJ01	TCRBJ01-06	01	0	0	6	5	5	9	23	40	51	45	60	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAEGDTKNDNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGACAGGGGGACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDGQGDYSNQPQHF	In	VDJ	3	103	6.84062668110061E-4	7.973370490788048E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	1	0	1	4	24	38	49	39	53		TCRBV24-01,TCRBV24-or09_02												CATSDGQGDYSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGAAGGGGACAGGAGTCAGGAATGAGCAGTTCTTCGGGCCA	CASSEKGTGVRNEQFF	In	VDJ	3	103	6.84062668110061E-4	7.973370490788048E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	7	4	7	23	37	49	41	56	TCRBV02,TCRBV12													CASSEKGTGVRNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTTGGGACCTGTGGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	105	6.973454383646253E-4		40	unresolved						TCRBJ02	TCRBJ02-01	01	7	0	7	8	3	8	23	33	41	36	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTCCCAGAGGGGCACAGATACGCAGTATTTTGGCCCA	CSARASQRGTDTQYF	In	VDJ	3	106	7.039868234919075E-4	8.205604582752748E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	1	7	0	26	39	-1	46	51		TCRBV20-01,TCRBV20-or09_02												CSARASQRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGGACTAGCGGGGGGTAGAGGGATACGCAGTATTTTGGCCCA	CATSDGTSGG*RDTQYF	Stop	VDJ	3	106	7.039868234919075E-4		51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	6	1	6	24	38	54	39	60		TCRBV24-01,TCRBV24-or09_02												CATSDGTSGG*RDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCACAGGGGTCCTCTATGACTAATCAGCCCCAGCATTTTGGTGAT	CASSSQGSSMTNQPQHF	In	VDJ	3	107	7.106282086191896E-4	8.283015946740982E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	4	2	12	26	38	47	40	59		TCRBV03-01,TCRBV03-02												CASSSQGSSMTNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTAATGGGAAGCGAGCAGTACGTCGGGCCG		Out	VDJ	3	107	7.106282086191896E-4		37	unresolved						TCRBJ02	TCRBJ02-07	01	6	0	8	17	6	13	24	36	46	42	59	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCTTGGACGGGGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	114	7.571179045101647E-4		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	1	3	7	0	26	42	-1	49	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACAGAGGGGGTTGACTACACCTTCGGTTCG		Out	VDJ	3	114	7.571179045101647E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	1	10	6	4	26	34	46	40	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTGTGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPVTGGTGELFF	In	VDJ	3	114	7.571179045101647E-4	8.824895494658616E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	1	4	5	0	24	36	-1	41	50		TCRBV24-01,TCRBV24-or09_02												CASSPVTGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAACATTGGGATCACTGAAGCTTTCTTTGGACAA	CASRNIGITEAFF	In	VDJ	3	117	7.770420598920111E-4	9.057129586623316E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	0	8	4	7	1	24	35	46	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNIGITEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACGATTGGGGTAAGGAGTGAAGCTTTCTTTGGACAA	CSTIGVRSEAFF	In	VDJ	3	118	7.836834450192932E-4	9.13454095061155E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	8	6	2	7	6	7	26	32	42	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTIGVRSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGCCGCAGCGGGGGCTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAAAGATNTGELFF	In	VDJ	3	119	7.903248301465754E-4	9.211952314599783E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	6	2	0	4	3	19	35	47	39	50	TCRBV05,TCRBV11													CASSLAAAGATNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCTGCATACTATGGCTACACCTTCGGTTCG	CASSSAYYGYTF	In	VDJ	3	122	8.102489855284218E-4	9.444186406564484E-4	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	4	6	3	5	1	26	37	44	42	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCAGGCACAGGGTGGGGAAAAACTGTTTTTTGGCAGT	CASSQQAQGGEKLFF	In	VDJ	3	125	8.301731409102683E-4	9.676420498529185E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	8	6	4	26	40	52	46	56		TCRBV03-01,TCRBV03-02												CASSQQAQGGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCACTCCCAGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSDHSQGTYNEQFF	In	VDJ	3	125	8.301731409102683E-4	9.676420498529185E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	2	9	1	23	35	50	44	51	TCRBV06,TCRBV10													CASSDHSQGTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGCAGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQAGGSYNEQFF	In	VDJ	3	134	8.899456070558076E-4	0.0010373122774423285	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	1	2	1	23	37	46	39	47	TCRBV01,TCRBV04													CASSQAGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTACAAAAGTTTACGTGTCGATACGCAGTATTTTGGCCCA	CASSYKSLRVDTQYF	In	VDJ	3	136	9.032283773103718E-4	0.0010527945502399752	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	7	3	6	6	2	14	24	35	40	37	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYKSLRVDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCAGGGAGGCACCACTGAAGCTTTCTTTGGACAA	CSALQGGTTEAFF	In	VDJ	4	143	9.497180732013469E-4	0.0011069825050317387	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	4	5	3	26	35	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSALQGGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACCCATGGCAGGGACGGCTATGGCTACACCTTCGGTTCG	CATSDTHGRDGYGYTF	In	VDJ	4	143	9.497180732013469E-4	0.0011069825050317387	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	7	4	11	2	24	38	54	49	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTHGRDGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGTTGTTTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	4	145	9.630008434559111E-4		52	TCRBV03						TCRBJ02	TCRBJ02-04	01	5	0	9	4	0	19	26	-1	41	38	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGAGAGCGGGGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASRESGGAYNEQFF	In	VDJ	4	160	0.0010626216203651433	0.0012385818238117355	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	4	4	2	23	34	48	38	50	TCRBV02,TCRBV09													CASRESGGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTGGYNEQFF	In	VDJ	4	164	0.001089187160874272	0.001269546369407029	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	1	3	0	0	19	-1	-1	35	45	TCRBV07,TCRBV11													CASSLGTGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTTGGGTGGTCTTACACTGAAGCTTTCTTTGGACAA	CASSFGWSYTEAFF	In	VDJ	4	167	0.0011091113162561184	0.001292769778603499	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	9	3	1	7	19	33	37	34	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGWSYTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCCTCCGGGACGGAAGAGACCCAGTACTTCGGGCCA	CASSLSSGTEETQYF	In	VDJ	5	180	0.0011954493229107863	0.0013934045517882026	45	unresolved						TCRBJ02	TCRBJ02-05	01	2	0	7	3	6	2	18	33	44	39	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSGTEETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCACTCCCCGGGGGCGTCACAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	183	0.0012153734782926328		49	unresolved						TCRBJ01	TCRBJ01-01	01	7	6	0	0	6	7	18	28	40	34	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSARPGGGQETQYF	In	VDJ	5	193	0.001281787329565454	0.001494039324972906	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	2	1	4	0	26	38	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARPGGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCAGGGTGACTGAAGCTTTCTTTGGACAA	CASSQARVTEAFF	In	VDJ	5	200	0.0013282770254564292	0.0015482272797646694	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	5	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02												CASSQARVTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAGGGTGACTATGGCTACACCTTCGGTTCG	CATSDEGDYGYTF	In	VDJ	5	202	0.0013415597957109934	0.0015637095525623161	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	0	3	0	2	24	-1	44	39	46		TCRBV24-01,TCRBV24-or09_02												CATSDEGDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGCTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGSSSYNEQFF	In	VDJ	5	205	0.0013614839510928398	0.0015869329617587862	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	0	2	5	24	36	42	38	47		TCRBV24-01,TCRBV24-or09_02												CASSLGSSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTGGGGACAGGGTGGGTAATGAGCAGTTCTTCGGGCCA	CASSFGDRVGNEQFF	In	VDJ	6	219	0.00145446334287479	0.001695308871342313	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	2	5	18	32	43	34	48	TCRBV07,TCRBV11													CASSFGDRVGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGTCACCTCCTACGAGCAGTACTTCGGGCCG	CASSQGVTSYEQYF	In	VDJ	6	221	0.0014677461131293542	0.0017107911441399597	42	unresolved						TCRBJ02	TCRBJ02-07	01	1	0	9	0	0	4	23	-1	42	39	46	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVTSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGATTTGCCAGGCCGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	6	241	0.0016005738156749973		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	4	5	1	3	24	42	47	43	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCAGTTCCCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQDPVPSNEKLFF	In	VDJ	6	242	0.0016072152008022793	0.00187335500851525	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	5	3	2	6	23	40	45	42	51	TCRBV01,TCRBV04													CASSQDPVPSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCGATGGCTCGGGAAAACTGTTTTTTGGCAGT	CASSPDGSGKLFF	In	VDJ	7	261	0.00173340151822064	0.002020436600092894	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	10	10	0	23	35	-1	45	49	TCRBV09,TCRBV21					01,02								CASSPDGSGKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGAGGGCGGAGGTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSEEGGGSSGNTIYF	In	VDJ	7	282	0.0018728706058935651	0.002183000464468184	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	1	0	10	3	23	34	49	44	52	TCRBV02,TCRBV09													CASSEEGGGSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGCCCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASRARGSTDTQYF	In	VDJ	7	291	0.0019326430720391044	0.002252670692057594	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	2	0	4	0	26	37	-1	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRARGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTGGAAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDSGRSYNEQFF	In	VDJ	8	301	0.001999056923311926	0.0023300820560458275	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	2	1	8	1	2	3	24	40	45	42	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSGRSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGCGGACGGCGGGGGCAAGGGCTACACCTTCGGTTCG	CSATADGGGKGYTF	In	VDJ	8	323	0.002145167396112133	0.0025003870568199413	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	2	8	9	4	26	36	52	45	56		TCRBV20-01,TCRBV20-or09_02												CSATADGGGKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGTCTGAGTCCGATCCCTGAAGCTTTCTTTGGACAA	CASSSLSPIPEAFF	In	VDJ	9	366	0.0024307469565852655	0.0028332559219693453	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	2	6	5	8	26	38	46	43	54		TCRBV12-03,TCRBV12-04												CASSSLSPIPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGAGTGCGGGTTATGGCTACACCTTCGGTTCG	CATSDQSAGYGYTF	In	VDJ	11	415	0.0027561748278220905	0.003212571605511689	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	7	4	5	7	1	24	38	50	45	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDQSAGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTCTAGCGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGLAGANTGELFF	In	VDJ	12	482	0.0032011476313499945	0.0037312277442328535	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	0	2	0	23	39	-1	41	51	TCRBV01,TCRBV04													CASSQGLAGANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGTCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CSAPGREYNEQFF	In	VDJ	14	544	0.0036129135092414872	0.004211178200959901	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	4	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAPGREYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTTTTTCACACCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPLFHTSNTGELFF	In	VDJ	14	549	0.003646120434877898	0.0042498838829540175	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	0	10	3	26	35	48	45	51		TCRBV20-01,TCRBV20-or09_02												CSAPLFHTSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGGGCGTGACGAACACTGAAGCTTTCTTTGGACAA	CASSLEGVTNTEAFF	In	VDJ	68	2670	0.01773249828984333	0.020668834184858337	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	5	3	1	0	6	26	-1	46	42	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGVTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	86	3372	0.022394750649195397	0.026103111936832325	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	24	39	51	45	70		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B2	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4731	4058	635	36	0	2980	2529	419	32	0	150571	129180	20223	1168	0	0.149925247	9.6095438	0.140051991	9.9247427				49578	0.0765384734	0.0600402541	0.0515105836	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:38	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8577467532008963	MSKCC- Snyder- P01-02		3795.0	
